Sentence,class,file
PRS Global Open • 2016 4PRSGlobalOpen.com or available at http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/0b/c6/gox-4-e1066.PMC5055029.pdf
this video is available in the r elated Videos section of the Full text  article on PrSglobalOpen.com or available at http://links.lww.com/PRSGO/A268.,Non-OADS,/arxiv_data1/oa_pdf/0b/c6/gox-4-e1066.PMC5055029.pdf
This video is available in the Related Videos section of the Full Text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A268.).,Non-OADS,/arxiv_data1/oa_pdf/0b/c6/gox-4-e1066.PMC5055029.pdf
This video is available in the “related  videos” section of the full-text article on PRSGlobalO-pen.com or available at http://links.lww.com/PRSGO/ A272.),Non-OADS,/arxiv_data1/oa_pdf/ea/d0/gox-4-e1067.PMC5055030.pdf
this video is available in the “related vid- eos” section of the full-text article on prSGlobalOpen.com or avail-able at http://links.lww.com/PRSGO/A272.,Non-OADS,/arxiv_data1/oa_pdf/ea/d0/gox-4-e1067.PMC5055030.pdf
this video is available in the “related videos” section of the  full-text article on prSGlobalOpen.com or available at http://links.lww.com/PRSGO/A273.,Non-OADS,/arxiv_data1/oa_pdf/ea/d0/gox-4-e1067.PMC5055030.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4a/14/prbm-9-277.PMC5055039.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4a/14/prbm-9-277.PMC5055039.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2016:9 277–284Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 277 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S115657 Reliability and validity of the Italian version of the  14-item Resilience Scale Camilla Callegari1 Lorenza Bertù2 Melissa Lucano1 Marta Ielmini1 Elena Braggio1 Simone Vender1 1Department of Clinical and  Experimental Medicine – Psychiatric  Division, 2Department of Clinical and  Experimental Medicine, Centre for Research EPIMED – Epidemiology and Preventive Medicine, University of Insubria, Varese, ItalyBackground: In recent years resilience has gained clinical relevance in sociological, psychologi - cal, and medical disciplines, and a lot of scales measuring resilience have been developed and  have been utilized in the western countries.",Non-OADS,/arxiv_data1/oa_pdf/4a/14/prbm-9-277.PMC5055039.pdf
"Keywords: resilience, measuring scales,  psychometrics, factor analysis, adolescence, adulthood Introduction Resilience is the process of a capacity for or an outcome of successful adaptation  despite challenging or threatening circumstances.1 Resilient people are characterized  by interior strength, competence, optimism, flexibility, and coping ability in the face Correspondence: Camilla Callegari Department of Clinical and Experimental Medicine – Psychiatric Division, University of Insubria, Via O. Rossi 9, 21100 Varese, ItalyTel +39 332 270 655Fax +39 332 270 667Email camilla.callegari@uninsubria.itJournal name: Psychology Research and Behavior Management Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Callegari et alRunning head recto: Reliability and validity of the Italian version of the RS-14DOI: http://dx.doi.org/10.2147/PRBM.S115657",Non-OADS,/arxiv_data1/oa_pdf/4a/14/prbm-9-277.PMC5055039.pdf
"Psychology Research and Behavior Management 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/4a/14/prbm-9-277.PMC5055039.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e5/4c/tcrm-12-1497.PMC5055040.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1497–1506Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1497Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S9406 2 New developments in acne treatment: role of  combination adapalene–benzoylperoxide Su Y oun Kim Falk R Ochsendorf Clinic for Dermatology, venereology,   and Allergology, University Hospital,   Frankfurt/M, GermanyAbstract:  The fixed-dose combination adapalene 0.1%/benzoylperoxide 2.5% (A/BPO) was  introduced as an acne vulgaris therapeutic in 2007.",Non-OADS,/arxiv_data1/oa_pdf/e5/4c/tcrm-12-1497.PMC5055040.pdf
"Poor adherence was  evident in 40%–50% of treated acne patients.11 Therefore, therapies and methods that  improve adherence should be preferred.Correspondence: Falk R Ochsendorf Clinic for Dermatology, venereology,  and Allergology, University Hospital,  Theodor-Stern-Kai 7, Frankfurt/M 60590,  Germany Tel +49 69 6301 6661 Fax +49 69 6301 5117 email ochsendorf@em.uni-frankfurt.d eJournal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Kim and Ochsendorf Running head recto: Adapalene–BPO acne treatment DOI: http://dx.doi.org/10.2147/TCRM.S94062",Non-OADS,/arxiv_data1/oa_pdf/e5/4c/tcrm-12-1497.PMC5055040.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e5/4c/tcrm-12-1497.PMC5055040.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/4c/tcrm-12-1497.PMC5055040.pdf
"Different from TNFR2, which correspondence: Xiaoyan Wang Department of Gastroenterology,  The Third Xiangya Hospital of Central  south University, changsha 410000,  Hunan, People’s Republic of China Tel +86 731 8863 8888 email xiaoyw06@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: Infliximab enhances the therapeutic effects of 5-fluorouracil DOI: http://dx.doi.org/10.2147/OTT.S109342",Non-OADS,/arxiv_data1/oa_pdf/2b/2e/ott-9-5999.PMC5055041.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets­and­therapy­journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2b/2e/ott-9-5999.PMC5055041.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/2e/ott-9-5999.PMC5055041.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f8/f0/opth-10-1905.PMC5055042.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1905–1912Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1905Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8041 2 Refractive lenticule extraction (ReLex) through  a small incision (SMiLe) for correction of myopia  and myopic astigmatism: current perspectives Alper Ag ˘ca1 Ahmet Demirok2 Yusuf Yıldırım1 Ali Demircan1 Dilek Yaşa1 Ceren Yeşilkaya1 l·rfan Perente1 Muhittin Taşkapılı1 1Beyog ˘lu Eye Research and  Training Hospital, 2Department of  Ophthalmology, istanbul Medeniyet  University, istanbul, T urkeyAbstract:  Small-incision lenticule extraction (SMILE) is an alternative to laser-assisted in situ  keratomileusis (LASIK) and photorefractive keratectomy (PRK) for the correction of myopia  and myopic astigmatism.",Non-OADS,/arxiv_data1/oa_pdf/f8/f0/opth-10-1905.PMC5055042.pdf
"However, as it is now possible to generate an intrastromal incision via femtosecond Correspondence: Alper Ag ˘ca Beyog ˘lu Eye Research and Training  Hospital, Galata, Beyog ˘lu, Istanbul  34349, Turkey email agcaalper@yahoo.co mJournal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: A ğca et al Running head recto: SMILE procedure for myopia  DOI: http://dx.doi.org/10.2147/OPTH.S80412",Non-OADS,/arxiv_data1/oa_pdf/f8/f0/opth-10-1905.PMC5055042.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f8/f0/opth-10-1905.PMC5055042.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/f0/opth-10-1905.PMC5055042.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1967–1977Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1967OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10562 4 scale up use of family planning services to prevent  maternal transmission of hiV among discordant  couples: a cross-sectional study within a  resource-limited setting Martin Kuete1,2 hongFang Yuan1 Aude laure Tchoua  Kemayou2 emmanuel Ancel songo2 Fan Yang1 Xiulan Ma1 cheng liang Xiong1 huiPing Zhang1 1Obstetrics and gynecology,   reproductive center, Family Planning  and research institute, Tongji Medical  college, huazhong University of  science and T echnology, Wuhan,   hubei, People’s republic of china;   2Main Maternity of Obstetrics and  gynecology, Yaounde central hospital,   Faculty of Medicine and Biomedical  sciences, Yaounde, cameroonBackground:  Integration of family planning services (FPS) into human immunodeficiency  virus (HIV) care for HIV -infected women is an important aspect of the global prevention of  mother-to-child transmission (PMTCT) strategy.",Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
"Keywords:  contraception, HIV infected women, transmission, interventions, education Introduction In the year 2000, the world leaders pledged to reduce child mortality by three fourths,  improve maternal health, and combat human immunodeficiency virus/acquired immu - nodeficiency syndrome (HIV/AIDS) by 2015, as outlined in the Millennium Devel - opment Goals 4, 5, and 6.1 Therefore, 2015 was expected to be the turning point for correspondence: huiPing Zhang Family Planning and research institute,  Tongji Medical college, huazhong  University of science and Technology,  13 hangkong road, Wuhan 430030,  hubei, People’s republic of china Tel +86 130 3513 3247 Fax +86 27 8369 2651 email familyplanning2013@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kuete et al Running head recto: FP for prevention of maternal transmission of HIV DOI: http://dx.doi.org/10.2147/PPA.S105624",Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
2000; Available  from: http://www.un.org/en/events/pastevents/millennium_summit.,Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
Available from: http://www.unfpa.,Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
"Available from: http://www.unaids.org/ sites/default/files/media_asset/JC2702_GARPR2015guidelines_en.pd f.  Accessed June 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
"Available  from: http://www.unaids.org/en/media/unaids/contentassets/documents/ epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pd f.  Accessed July 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
"Available from: http://www.unaids.org/ sites/default/files/sub_landing/files/JC2034_UNAIDS_Strategy_en.pd f.  Accessed June 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
"Available from: http://www.unaids.org/sites/default/files/ media_asset/GARPR_2014_guidelines_en_0.pd f. Accessed June 10,  2015.",Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
"2014;  Available from: http://www.unaids.org/sites/default/files/country/docu - ments/CMR_narrative_report_2014.pd f. Accessed August 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
"Available from: http://www.cdc.gov/reproductivehealth/ UnintendedPregnancy/PDF/Contraceptive_methods_508.pd f. Accessed  March 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e7/82/ppa-10-1967.PMC5055043.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6d/e2/pgpm-9-097.PMC5055044.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6d/e2/pgpm-9-097.PMC5055044.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pharmacogenomics and Personalized Medicine 2016:9 97–106Pharmacogenomics and Personalized Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  97 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S86013Pharmacogenomics of statins: understanding  susceptibility to adverse effects Joseph P Kitzmiller1 eduard B Mikulik1 Anees M Dauki2 Chandrama Murkherjee1 Jasmine A Luzum3 1Department of Biological Chemistry  and Pharmacology, College of  Medicine, 2College of Pharmacy, The  Ohio State University, Columbus, OH,   3Department of Clinical Pharmacy,   University of Michigan College of Pharmacy, Ann Arbor, M i, USAAbstract:  Statins are a cornerstone of the pharmacologic treatment and prevention of athero- sclerotic cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/6d/e2/pgpm-9-097.PMC5055044.pdf
"3–5Correspondence: Joseph Kitzmiller Biological Chemistry and Pharmacology, College of Medicine, The Ohio State University Medical Center, 5086 Graves Hall, 333 west 10th Avenue, Columbus, OH 43210, USATel +1 614 292 8438email joseph.kitzmiller@osumc.eduJournal name: Pharmacogenomics and Personalized Medicine Article Designation: REviEwY ear: 2016volume: 9 Running head verso: Kitzmiller et alRunning head recto: Pharmacogenomics of statin toxicityDOi: http://dx.doi.org/10.2147/PGPM.S86013",Non-OADS,/arxiv_data1/oa_pdf/6d/e2/pgpm-9-097.PMC5055044.pdf
"©PharmGKB.37 (Reproduced with permission  from the Pharmacogenomics Knowledge Base [PharmGKB] and Stanford University, https://www.pharmgkb.org/pathway/PA145011108 )71, whirl-Carrillo M, McDonagh eM,  Hebert JM, et al.",Non-OADS,/arxiv_data1/oa_pdf/6d/e2/pgpm-9-097.PMC5055044.pdf
"Pharmacogenomics and Personalized Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journalPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/6d/e2/pgpm-9-097.PMC5055044.pdf
visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6d/e2/pgpm-9-097.PMC5055044.pdf
Available from: https://www.pharmgkb.org/pathway/ PA145011108.,Non-OADS,/arxiv_data1/oa_pdf/6d/e2/pgpm-9-097.PMC5055044.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/45/ppa-10-2021.PMC5055045.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2021–2029Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2021OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11066 7 Individual difficulties and resources – a qualitative  analysis in patients with advanced lung cancer and  their relatives Anika sparla1 sebastian Flach-Vorgang1 Matthias Villalobos2 Katja Krug1 Martina Kamradt1 Kadiatou coulibaly1 Joachim szecsenyi1 Michael Thomas2 sinikka gusset-Bährer2 Dominik Ose1,3 1Department of general Practice and  health services research, heidelberg  University hospital, 2internistische  Onkologie der Thoraxtumoren,   Thoraxklinik im Universitätsklinikum  heidelberg, Translational lung  research center heidelberg  (Tlrc-h), Member of the german  center for lung research, heidelberg,   germany; 3University of Utah,   Department of Population health  sciences, health system innovation  and research, salt lake city, UT, UsAPurpose:  Lung cancer is a disease with a high percentage of patients diagnosed in an advanced  stage.",Non-OADS,/arxiv_data1/oa_pdf/95/45/ppa-10-2021.PMC5055045.pdf
"Keywords:  inoperable lung cancer, palliative care, difficulties, resources, health services  research, qualitative research Introduction Lung cancer is one of the most common types of cancers in both males and females  worldwide and at the same time the most common cause of cancer death.1,2 It has the  poorest 5-year survival rate of ~15% in the US and Europe.3,4 Within the particular context of advanced lung cancer, it is important to include  both patients and their family caregivers into the palliative care plan.5–7 Particular  context means among others a very poor prognosis of approximately ,1 year, which  leads to existential burden and psychological distress.8–12 A majority of research uses correspondence: Anika sparla Department of general Practice and  health services research, University  hospital heidelberg, im neuenheimer  Feld 130, 69120 heidelberg, germany Tel +49 6221 56 6263 Fax +49 6221 56 1972 email sparla@stud.uni-heidelberg.d e Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Sparla et al Running head recto: Advanced lung cancer patients and relatives: difficulties and resources DOI: http://dx.doi.org/10.2147/PPA.S110667",Non-OADS,/arxiv_data1/oa_pdf/95/45/ppa-10-2021.PMC5055045.pdf
Available from: http://www.who.int/cancer/palliative/definition/en/.,Non-OADS,/arxiv_data1/oa_pdf/95/45/ppa-10-2021.PMC5055045.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/95/45/ppa-10-2021.PMC5055045.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0c/d2/ppa-10-2039.PMC5055046.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2039–2049Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2039OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11460 2 Type 2 diabetes: cost-effectiveness of medication  adherence and lifestyle interventions T omaž Nerat igor locatelli Mitja Kos Faculty of Pharmacy, University of  ljubljana, ljubljana, sloveniaIntroduction:  Type 2 diabetes is a major burden for the payer, however, with proper medication  adherence, diet and exercise regime, complication occurrence rates, and consequently costs  can be altered.",Non-OADS,/arxiv_data1/oa_pdf/0c/d2/ppa-10-2039.PMC5055046.pdf
"In the scope of global  estimates, the prevalence will rise and consequently the costs.1,2 The disease inci - dence, prevalence, progression, and complication occurrence are dependent on a  number of factors: weight, fat distribution, fasting glucose, glycated hemoglobin  (HbA1c), blood lipids, blood pressure, physical inactivity, family history, race, and  age.3 Therefore, accurate drug regime adherence and improved lifestyle regarding  diet and exercise are the key to decelerate the disease progression and the incidence Correspondence: Tomaž Nerat University of ljubljana, Faculty  of Pharmacy, Aškerčeva cesta 7,  si-1000 ljubljana, slovenia Tel +386 31 868 627 email tomaz.nerat@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Nerat et al Running head recto: Type 2 diabetes: medication adherence and lifestyle interventions DOI: http://dx.doi.org/10.2147/PPA.S114602",Non-OADS,/arxiv_data1/oa_pdf/0c/d2/ppa-10-2039.PMC5055046.pdf
Available from: http://www.mz.gov.si/ en/media_room/news/article/670/6912/f6d5fe577cd4459d97c19d207 - b2a6b0d /.,Non-OADS,/arxiv_data1/oa_pdf/0c/d2/ppa-10-2039.PMC5055046.pdf
Available from: https://partner.zzzs.si/ wps/wcm/connect/94bb0e3f-3d23-4156-926f-47732415acd8/ Zdravila +OZZ +2001_2014_i.xlsx?MOD =AJPERES&ContentCache =  NONE.,OADS,/arxiv_data1/oa_pdf/0c/d2/ppa-10-2039.PMC5055046.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/0c/d2/ppa-10-2039.PMC5055046.pdf
"Available from: https://partner.zzzs.si/wps/wcm/   connect/94bb0e3f-3d23-4156-926f-47732415acd8/Zdravila+OZZ +  2001_2014_i.xlsx?MOD =AJPERES&ContentCache =NON E. Accessed  December 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0c/d2/ppa-10-2039.PMC5055046.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/aa/ce/ppa-10-2031.PMC5055047.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2031–2037Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2031OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11682 3 is it appropriate regarding patient preference  to take Myrtol standardized enteric-coated soft  capsules after a meal rather than at fasted state?",Non-OADS,/arxiv_data1/oa_pdf/aa/ce/ppa-10-2031.PMC5055047.pdf
"Keywords:  dosing method, eucalyptol, food-drug interaction, gas chromatography mass spec - trometry, GC-MS, patient preference, bioequivalence, herbcorrespondence: ling-ling Zhu ViP care Ward, Division of nursing,  The Second Affiliated Hospital, School  of Medicine, Zhejiang University, Jiefang  road no 88, shangcheng District,  hangzhou 310009, Zhejiang Province,  People’s republic of china Tel +86 571 8778 3690 email zhouquan142602@aliyun.co m Quan Zhou Department of Pharmacy, The second  Affiliated Hospital, School of Medicine,  Zhejiang University, Jiefang road no 88,  shangcheng District, hangzhou 310009,  Zhejiang Province, People’s republic  of china Tel +86 571 8778 4615 Fax +86 571 8702 2776 email zhouquan142602@zju.edu.c nJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zhao et al Running head recto: Myrtol standardized capsules and dosing method DOI: http://dx.doi.org/10.2147/PPA.S116823",Non-OADS,/arxiv_data1/oa_pdf/aa/ce/ppa-10-2031.PMC5055047.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/aa/ce/ppa-10-2031.PMC5055047.pdf
"Available from: http://www.gelomyrtol.ca/pdf/ gelomyrtol_patient_information.pd f. Accessed June 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/aa/ce/ppa-10-2031.PMC5055047.pdf
"Available from: http://www.fda.gov/downloads/ RegulatoryInformation / Guidances/UCM126833.pd f. Accessed June 12, 2016.",OADS,/arxiv_data1/oa_pdf/aa/ce/ppa-10-2031.PMC5055047.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/58/c8/ppa-10-1853.PMC5055048.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1853–1854Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1853Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/PPA.S11846 9 Depression and anxiety in age-related macular  degeneration eung Suk Kim1 Y onguk Kim1 Seung-Y oung Yu1 Moosang Kim2 1Department of Ophthalmology,   Kyung Hee University Hospital, Kyung  Hee University, Seoul, 2Department of  Ophthalmology, School of Medicine,   Kangwon National University,   Chuncheon, KoreaDear editor We read with great interest the article titled “Treatment satisfaction of patients  undergoing ranibizumab therapy for neovascular age-related macular degeneration  in a real-life setting” by Gohil et al.1 We are in agreement with their findings.",Non-OADS,/arxiv_data1/oa_pdf/58/c8/ppa-10-1853.PMC5055048.pdf
"2011;31(4):   375–380.Correspondence: Moosang Kim Department of Ophthalmology,  School of Medicine, Kangwon National  University, Baengnyeong-ro 156,  Chuncheon, Kangwon, 200-722, Korea tel +82 33 258 2014 Fax +82 33 258 2000 email kimmoo-79@hanmail.ne t Journal name: Patient Preference and Adherence Article Designation: Letter Y ear: 2016 Volume: 10 Running head verso: Kim et al Running head recto: Depression and anxiety in AMD DOI: http://dx.doi.org/10.2147/PPA.S118469",Non-OADS,/arxiv_data1/oa_pdf/58/c8/ppa-10-1853.PMC5055048.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/58/c8/ppa-10-1853.PMC5055048.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/99/3f/nss-8-297.PMC5055050.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/99/3f/nss-8-297.PMC5055050.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2016:8 297–304Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  297 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S113709Epiglottis cross-sectional area and oropharyngeal  airway length in male and female obstructive sleep  apnea patients Melinda A Ma1 Rajesh Kumar2–4 Paul M Macey4,5 Frisca L Yan-Go6 Ronald M Harper1,4 1Department of Neurobiology,   2Department of Anesthesiology,   3Department of Radiological Sciences,   David Geffen School of Medicine,   4Brain Research Institute, 5UCLA  School of Nursing, 6Department of  Neurology, David Geffen School of  Medicine, University of California at Los Angeles, Los Angeles, CA, USAIntroduction: Obstructive sleep apnea (OSA) is a male-predominant condition, characterized  by repeated upper-airway collapse with continued diaphragmatic efforts during sleep, and is  accompanied by severe physiological consequences.",Non-OADS,/arxiv_data1/oa_pdf/99/3f/nss-8-297.PMC5055050.pdf
"Although reduced contraction forces of upper-airway dilators restrict airway dimensions, Correspondence: Ronald M Harper Department of Neurobiology, David Geffen School of Medicine at UCLA, University of California, 10833 Le Conte Avenue, Los Angeles, CA 90095-1763, USATel +1 310 825 5303Fax +1 310 825 2224Email rharper@ucla.eduJournal name: Nature and Science of Sleep Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Ma et alRunning head recto: Diminished airway dimensions in OSADOI: http://dx.doi.org/10.2147/NSS.S113709",Non-OADS,/arxiv_data1/oa_pdf/99/3f/nss-8-297.PMC5055050.pdf
"Data processing and analysis We used the statistical parametric mapping package SPM8, (http://www.fil.ion.ucl.ac.uk/spm), MRIcroN (http://people.",OADS,/arxiv_data1/oa_pdf/99/3f/nss-8-297.PMC5055050.pdf
"cas.sc.edu/rorden/mricron/index.html), and MatLab-based (http://www.mathworks.com) custom-written software  for data processing and analyses.",Non-OADS,/arxiv_data1/oa_pdf/99/3f/nss-8-297.PMC5055050.pdf
"Nature and Science of Sleep 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/99/3f/nss-8-297.PMC5055050.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cc/72/ott-9-6009.PMC5055051.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6009–6019OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6009Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11092 3 mir-590-5p regulates gastric cancer cell growth  and chemosensitivity through recK and the  aKT/erK pathway Bo shen* shaorong Yu* Yan Zhang Yuan Yuan Xiaoyou li Jian Zhong Jifeng Feng Department of Oncology, Jiangsu  cancer hospital affiliated to nanjing  Medical University, nanjing, Jiangsu,   People’s republic of china *These authors contributed equally  to this workBackground:  The aim of this study was to determine the role of miRNA-590-5p in gastric  cancer (GC) progression.",Non-OADS,/arxiv_data1/oa_pdf/cc/72/ott-9-6009.PMC5055051.pdf
"miRNAs exert their  oncogenic or tumor-suppressive effects through base-pairing with the 3 ′ untranslated  region (3′-UTR) of target mRNAs4 and have been widely demonstrated to be critical correspondence: Jifeng Feng Department of Oncology, Jiangsu cancer  Hospital Affiliated to Nanjing Medical  University, 42 Baiziting, nanjing, Jiangsu  210009, People’s republic of china Tel +86 25 8328 3554 email fengjf0518@126.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Shen et al Running head recto: miR-590 regulates cell growth and chemosensitivity in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S110923",Non-OADS,/arxiv_data1/oa_pdf/cc/72/ott-9-6009.PMC5055051.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cc/72/ott-9-6009.PMC5055051.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/72/ott-9-6009.PMC5055051.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/42/main.PMC5055063.pdf
Immunochemical assays revealed that ameloblastin co-localized with amelogenin during the early stages of tooth development [15].Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2016.05.007 2405-5808/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/42/main.PMC5055063.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: Amel, Amelogenin; Ambn, Ameloblastin; TRAP, Tyrosine Rich Amelogenin Polypeptide; CD, Circular Dichroism; HPLC, High Performance LiquidChromatography nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/5d/42/main.PMC5055063.pdf
Appendix A. Transperancy document Transperancy document associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.,Non-OADS,/arxiv_data1/oa_pdf/5d/42/main.PMC5055063.pdf
"Res., 2016,http://dx.doi.org/10.1177/0022034516645389 (In press).",Non-OADS,/arxiv_data1/oa_pdf/5d/42/main.PMC5055063.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f7/89/ahmt-7-109.PMC5055103.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f7/89/ahmt-7-109.PMC5055103.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Adolescent Health, Medicine and Therapeutics 2016:7 109–115Adolescent Health, Medicine and Therapeutics Dovepress submit your manuscript | www.dovepress.com Dovepress  109 OriginAl reseArcH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S108531contraceptive knowledge, sexual behavior, and  factors associated with contraceptive use among  female undergraduate university students in  Kilimanjaro region in Tanzania Mussa n sweya1 sia e Msuya2,3 Michael J Mahande2 rachel Manongi1,3 1community Health Department,   Kilimanjaro christian Medical  University college, 2Department  of epidemiology and Biostatistics,   institute of Public Health, Kilimanjaro  christian Medical University,   3community Health Department,   Kilimanjaro christian Medical  centre,  Moshi, TanzaniaBackground: Previous studies have shown that knowledge of contraceptives, especially among  the youth in universities, remains limited, and the rate of premarital sexual activity, unwanted  pregnancies, and illegal abortions remains higher among university students.",Non-OADS,/arxiv_data1/oa_pdf/f7/89/ahmt-7-109.PMC5055103.pdf
"2 Family planning helps couples to correspondence: Michael J Mahande Department of epidemiology and Biostatistics, institute of Public Health, Kilimanjaro christian Medical University, PO Box 2240, Moshi, Kilimanjaro, Tanzaniaemail jmmahande@gmail.comJournal name: Adolescent Health, Medicine and Therapeutics Article Designation: Original ResearchY ear: 2016V olume: 7Running head verso: Sweya et alRunning head recto: Contraceptive knowledge, sexual behavior, and contraceptive useDOI: http://dx.doi.org/10.2147/AHMT.S108531",Non-OADS,/arxiv_data1/oa_pdf/f7/89/ahmt-7-109.PMC5055103.pdf
Available from: https://core.ac.uk/download/pdf/11958426.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/89/ahmt-7-109.PMC5055103.pdf
Available from: http://www.who.int/whosis/whostat/EN_WHS08_TOCintro.pdf.,OADS,/arxiv_data1/oa_pdf/f7/89/ahmt-7-109.PMC5055103.pdf
Available from: http://www.nbs.go.tz/nbs/takwimu/census2012/Pop_dist_by_enu_me_area_as_per_2002_pop_and_housing_census.pdf.,OADS,/arxiv_data1/oa_pdf/f7/89/ahmt-7-109.PMC5055103.pdf
Available from: http://www.nbs.go.tz/nbs/takwimu/references/2010TDHS.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/89/ahmt-7-109.PMC5055103.pdf
"Adolescent Health, Medicine and Therapeutics 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journalAdolescent Health, Medicine and Therapeutics is an international,   peer-reviewed, open access journal focusing on health, pathology, and  treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/f7/89/ahmt-7-109.PMC5055103.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/89/ahmt-7-109.PMC5055103.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/45/17/copd-11-2467.PMC5055104.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2467–2473International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2467OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11607 2 Comparison of the clinical characteristics and  treatment outcomes of patients requiring hospital  admission to treat eosinophilic and neutrophilic  exacerbations of COPD hye seon Kang Chin Kook rhee sung Kyoung Kim Jin Woo Kim sang haak lee hyung Kyu Y oon Joong hyun ahn Y ong hyun Kim Division of Pulmonary, allergy and  Critical Care Medicine, Department  of Internal Medicine, Bucheon  st Mary’s hospital, College of  Medicine, The Catholic University  of Korea, seoul, republic of KoreaPurpose:  We compared the clinical characteristics and treatment outcomes of patients with  eosinophilic and neutrophilic COPD exacerbations requiring hospital admission.",Non-OADS,/arxiv_data1/oa_pdf/45/17/copd-11-2467.PMC5055104.pdf
"As expected, the bacterial cluster was the largest, but the eosinophilia- predominant cluster constituted 28% of all exacerbations.3Correspondence: Yong hyun Kim Division of Pulmonary, allergy and Critical  Care Medicine, Department of Internal  Medicine, Bucheon st Mary’s hospital,  College of Medicine, The Catholic  University of Korea, 327 sosa-ro,  Wonmi-gu, Bucheon-si, gyeonggi-do,  14647, seoul, republic of Korea Tel +82 32 340 7039 Fax +82 32 340 2669 email kyh30med@catholic.ac.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kang et al Running head recto: Neutrophilic and eosinophilic AECOPD DOI: http://dx.doi.org/10.2147/COPD.S116072",Non-OADS,/arxiv_data1/oa_pdf/45/17/copd-11-2467.PMC5055104.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/45/17/copd-11-2467.PMC5055104.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/17/copd-11-2467.PMC5055104.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/54/08/jpr-9-757.PMC5055105.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/54/08/jpr-9-757.PMC5055105.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 757–762Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  757 PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S115407New topical treatment of vulvodynia based on  the pathogenetic role of cross talk between  nociceptors, immunocompetent cells, and  epithelial cells J M Keppel Hesselink1 D J Kopsky2 N Sajben3 1Institute for Neuropathic Pain, Bosch  en Duin, 2Institute for Neuropathic  Pain, Amsterdam, The Netherlands;   3Scripps Memorial Hospital La Jolla,   La Jolla, CA, USAAbstract : Topical treatments of localized neuropathic pain syndromes in general are mostly  neglected, mainly due to the fact that most pain physicians expect that a topical formulation needs  to result in a transdermal delivery of the active compounds.",Non-OADS,/arxiv_data1/oa_pdf/54/08/jpr-9-757.PMC5055105.pdf
"Most LPV cases can be regarded as a manifestation of a (localized) neuropathic pain  disorder because vulvodynia is described by patients as burning, stinging, irritation, Correspondence: J M Keppel Hesselink Institute for Neuropathic Pain, Spoorlaan 37a, 3735 MV, Bosch en Duin,   The NetherlandsTel +31 6 5170 0527Email jan@neuropathie.nuJournal name: Journal of Pain Research  Article Designation: PERSPECTIVESY ear: 2016V olume: 9Running head verso: Keppel Hesselink et alRunning head recto: New topical treatment of vulvodyniaDOI: http://dx.doi.org/10.2147/JPR.S115407 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/54/08/jpr-9-757.PMC5055105.pdf
Or use: http://youtu.be/R4pJICQIeA4,Non-OADS,/arxiv_data1/oa_pdf/54/08/jpr-9-757.PMC5055105.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/54/08/jpr-9-757.PMC5055105.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 762 Keppel Hesselink et al  40.,Non-OADS,/arxiv_data1/oa_pdf/54/08/jpr-9-757.PMC5055105.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8b/0c/jep-8-021.PMC5055106.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8b/0c/jep-8-021.PMC5055106.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2016:8 21–33Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  21 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S106084Characteristics of intracellular Ca2+ signals  consisting of two successive peaks in hepatocytes  during liver regeneration after 70% partial  hepatectomy in rats Zenei Taira Yukari Ueda Hiroshi Monmasu Daisuke YamaseSayaka MiyakeMaya Shiraishi Faculty of Pharmaceutical Sciences,   T okushima Bunri University,  T okushima, JapanAbstract:  Two specific signals for regulating liver regeneration were found after 70% partial  hepatectomy (PH) in rats.",Non-OADS,/arxiv_data1/oa_pdf/8b/0c/jep-8-021.PMC5055106.pdf
"6 This loss of function causes liver failure and requires liver  regeneration to restore the functions.7 The remnant liver lobes compensate for the liver Correspondence: Zenei Taira Institute for Foods & Kampo Medicines, 1443 Kamihachimancho, Tokushima 770-8041, JapanTel +81 90 1173 3682Fax +81 88 602 8468Email tairaz118@orange.plala.or.jpJournal name: Journal of Experimental Pharmacology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Taira et alRunning head recto: Intracellular Ca 2+ signals in hepatectomy DOI: http://dx.doi.org/10.2147/JEP .S106084",Non-OADS,/arxiv_data1/oa_pdf/8b/0c/jep-8-021.PMC5055106.pdf
"Journal of Experimental Pharmacology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/8b/0c/jep-8-021.PMC5055106.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/0c/jep-8-021.PMC5055106.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/ad/ndt-12-2509.PMC5055107.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2509–2520Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2509Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11484 6 Role of berberine in Alzheimer’s disease Zhiyou Cai1,* Chuanling wang1,* wenming Yang2 1Department of Neurology, Renmin  Hospital, Hubei University of  Medicine, Shiyan Renmin Hospital,   Shiyan, Hubei Province, 2Department  of Neurology, The First Affiliated  Hospital of Anhui University of  Chinese Medicine, Hefei, Anhui  Province, People’s Republic of China *These authors contributed equally  to this workAbstract:  Berberine, an important protoberberine isoquinoline alkaloid, has several  pharmacological activities, including antimicrobial, glucose- and cholesterol-lowering,  antitumoral, and immunomodulatory properties.",Non-OADS,/arxiv_data1/oa_pdf/cb/ad/ndt-12-2509.PMC5055107.pdf
"It is unlikely that none of the drugs can be successful  for the cure of AD.14Correspondence: Zhiyou Cai Department of Neurology, Renmin  Hospital, Hubei University of Medicine,  Shiyan Renmin Hospital, No 39 Chaoyang  Middle Road, Shiyan 442000, Hubei  Province, People’s Republic of China   Tel/fax +86 719 863 7909 email caizy@hbmu.edu.c n  wenming Yang Department of Neurology, The First  Affliated Hospital of Anhui University  of Chinese Medicine, 117, Meishan Road,  Hefei, Anhui 230031, People’s Republic  of China Tel +86 551 6283 8707   Fax +86 551 6282 1605   email yangwm8810@126.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Cai et al Running head recto: Berberine in Alzheimer’s disease DOI: http://dx.doi.org/10.2147/NDT.S114846",Non-OADS,/arxiv_data1/oa_pdf/cb/ad/ndt-12-2509.PMC5055107.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/cb/ad/ndt-12-2509.PMC5055107.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/ad/ndt-12-2509.PMC5055107.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/35/3f/ijn-11-4991.PMC5055108.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4991–5002International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4991OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11430 2 Pluronic-based micelle encapsulation potentiates  myricetin-induced cytotoxicity in human  glioblastoma cells Xiang-Jun Tang1,* Kuan-Ming huang1,* hui gui1,* Jun-Jie Wang2 Jun-Ti lu1 long-Jun Dai1,3 li Zhang1 gang Wang2 1Department of Neurosurgery,   Taihe hospital, hubei University  of Medicine, shiyan, 2Department  of Pharmaceutics, shanghai eighth  People’s hospital, Jiangsu University,   shanghai, People’s republic of china;   3Department of surgery, University  of British columbia, Vancouver,   Bc, canada *These authors contributed equally  to this workAbstract:  As one of the natural herbal flavonoids, myricetin has attracted much research interest,  mainly owing to its remarkable anticancer properties and negligible side effects.",Non-OADS,/arxiv_data1/oa_pdf/35/3f/ijn-11-4991.PMC5055108.pdf
"In addition, the existence of the blood–brain barrier and  local hypoxia microenvironment make tumor cells resistant to standard radiation and  chemotherapy.5 In order to explore truly effective therapy for this most devastating  and difficult-to-treat cancer, it is essential to search for an agent which specifically correspondence: gang Wang  Department of Pharmaceutics, shanghai  eighth People’s hospital, 8 caobao road,  shanghai 200235, People’s republic of  china email wanggan139@163.co m  long-Jun Dai Department of surgery, University of  British columbia, 400-828 West 10th  avenue, Vancouver, Bc V5Z 1l8 canada email ljdai@mail.ubc.c a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Tang et al Running head recto: Pluronic-based micelle encapsulation of myricetin DOI: http://dx.doi.org/10.2147/IJN.S114302",Non-OADS,/arxiv_data1/oa_pdf/35/3f/ijn-11-4991.PMC5055108.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/35/3f/ijn-11-4991.PMC5055108.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/3f/ijn-11-4991.PMC5055108.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/b2/dddt-10-3253.PMC5055109.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3253–3265Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3253Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11684 8 stability of apomorphine in solutions containing  selected antioxidant agents Zen Yang ang Michael Boddy Yandi liu Bruce sunderland school of Pharmacy, Faculty of health  sciences, curtin University, Bentley,   Wa, australiaAbstract:  Apomorphine in solution undergoes rapid autoxidation, producing greenish colored  solutions, making it difficult to formulate as a stable pharmaceutical solution.",Non-OADS,/arxiv_data1/oa_pdf/ce/b2/dddt-10-3253.PMC5055109.pdf
"An earlier study of the kinetics of this  reaction showed a marked increase in the rate of oxidation in solution from pH 5.2 to  6.8.6 Oxidative instability has become a barrier to the formulation of apomorphine,  particularly in aqueous solution.1correspondence: Zen Yang ang Pharmacy Department, Oncology  and radiotherapy institution,  general hospital of Kuala  lumpur, Kuala lumpur, Malaysia Tel +60 13 488 9045 email angzenyang@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ang et al Running head recto: Stability of apomorphine in solutions containing selected antioxidant agents DOI: http://dx.doi.org/10.2147/DDDT.S116848 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/ce/b2/dddt-10-3253.PMC5055109.pdf
Or use: http://youtu.be/JQ2niZTUxP YVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/ce/b2/dddt-10-3253.PMC5055109.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ce/b2/dddt-10-3253.PMC5055109.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/b2/dddt-10-3253.PMC5055109.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/77/33/dddt-10-3237.PMC5055111.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3237–3252Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3237Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11355 6 homology modeling, molecular dynamics, and  virtual screening of NorA efflux pump inhibitors  of Staphylococcus aureus Baki Vijaya Bhaskar1 Tirumalasetty Muni  Chandra Babu1 netala Vasudeva reddy2 Wudayagiri rajendra1 1Division of Molecular Biology,   Department of Zoology,   2Department of Biotechnology, sri  Venkateswara University, Tirupati,   andhra Pradesh, indiaAbstract:  Emerging drug resistance in clinical isolates of Staphylococcus aureus  might be  implicated to the overexpression of NorA efflux pump which is capable of extruding numerous  structurally diverse compounds.",Non-OADS,/arxiv_data1/oa_pdf/77/33/dddt-10-3237.PMC5055111.pdf
"In recent times, the complete  genome sequence of S. aureus  explored 30 efflux pump genes which belong to the major  facilitator super family (MFS).2 MFS transporters reveal that all MFS proteins possess a  uniform topology of 12 transmembrane (TM) α-helices which are connected by hydro - philic loops at amino (N) and carboxyl (C) termini in the cytoplasm.3 MFS proteins are correspondence: Wudayagiri rajendra Division of Molecular Biology,  Department of Zoology, sri  Venkateswara University, Tirupati 517  502, andhra Pradesh, india Tel +91 9849667236 email rajendraw2k@yahoo.co.i n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Bhaskar et al Running head recto: NorA efflux pump inhibitors of S. aureus DOI: http://dx.doi.org/10.2147/DDDT.S113556",Non-OADS,/arxiv_data1/oa_pdf/77/33/dddt-10-3237.PMC5055111.pdf
"Covalent interactions between  hydrogen and heavy atoms were constrained using SHAKE/ RATTLE algorithm.44 Model assessment The quality of the model was assessed by calculating the  stereochemical properties, compatibility of the atomic model  (3D) with its own amino acid residues (1D), bond lengths,  bond angles, and side-chain planarity using SAVES server  (http://nihserver.mbi.ucla.edu/SAVES /).",OADS,/arxiv_data1/oa_pdf/77/33/dddt-10-3237.PMC5055111.pdf
"The best docked ligand confor - mations were saved, and the bond angles, bond lengths,  and hydrogen bonding interactions were analyzed using  PyMOL.52T oxicity risk assessment and lipinski  rule of five Lipinski rule of five, that is, molecular weight ( ,500 Da),  H-bond acceptor ( ,10), H-bond donor ( ,5), and cLogP ( ,5)  values; toxicity properties such as mutagenic, tumorogenic,  irritant, and reproductive effects; and absorption, distribution,  metabolize, excretion, and transport properties were assessed  using OSIRIS server ( http://www.organic-chemistry.org/ prog/pe o) and Molinspiration ( http://www.molinspiration.",OADS,/arxiv_data1/oa_pdf/77/33/dddt-10-3237.PMC5055111.pdf
"Variations in secondary structural elements such as  irregular helices, sheets, and loops were identified by super - imposing with template, and a small loop, observed between  Ala20 and Val22 of Helix-I, was renovated using MOD loop  server ( https://modbase.compbio.ucsf.edu/modloo p).",OADS,/arxiv_data1/oa_pdf/77/33/dddt-10-3237.PMC5055111.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/77/33/dddt-10-3237.PMC5055111.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/33/dddt-10-3237.PMC5055111.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3267–3279Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3267Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8646 3 A fixed-dose combination of memantine  extended-release and donepezil in the treatment  of moderate-to-severe Alzheimer’s disease William James Deardorff George T Grossberg Department of Psychiatry, St Louis  University School of Medicine,   St Louis, MO, USAAbstract:  Currently available therapies for the treatment of Alzheimer’s disease (AD) consist  of cholinesterase inhibitors (ChEIs), such as donepezil, and the N-methyl- d-aspartate receptor  antagonist memantine.",Non-OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
"Memantine, an N-methyl- d-aspartate Correspondence: George T Grossberg Department of Psychiatry, St Louis  University School of Medicine,  1438 South Grand St Louis,  MO 63104, USA Tel +1 314 977 4829 Fax +1 314 977 4878 email grossbgt@slu.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Deardorff and Grossberg Running head recto: A fixed-dose combination of memantine and donepezil DOI: http://dx.doi.org/10.2147/DDDT.S86463",Non-OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
"Available from: https://www.alz.co.uk/ research/WorldAlzheimerReport2015.pd f. Accessed Aug 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
"Available from: https://www.accessdata.fda.gov/drugsatfda_docs/ nda/2014/206439Orig1s000TOC.cf m. Accessed May 17, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
"Available from: https://www.accessdata.fda.gov/ drugsatfda_docs/nda/2010/022525Orig1s000MedR.pd f. Accessed   Aug 13, 2016.24.",Non-OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
Available from: https://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
"Available from: https://www.access - data.fda.gov/drugsatfda_docs/nda/2010/022525Orig1s000SumR.pd f.  Accessed Aug 13, 2016.",OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
"Available from: http://journals.lww.com/ neurotodayonline/Fulltext/2012/04190/Two_Drugs_Are_Not_Bet - ter_Than_One_for_Treating.10.asp x. Accessed May 17, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
"Avail - able from: http://caselaw.findlaw.com/us-2nd-circuit/1702157.htm l.  Accessed May 17, 2016.81.",Non-OADS,/arxiv_data1/oa_pdf/c7/b5/dddt-10-3267.PMC5055113.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/99/9d/jmdh-9-493.PMC5055114.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/99/9d/jmdh-9-493.PMC5055114.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 493–497Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 493 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S113045Same-day physical therapy consults in an  outpatient neuromuscular disease physician clinic Evan M Pucillo1 Nancy Christensen-Mayer2 Shelly D Poole2 Denise M Whitten2 Danielle Freeman3 Blake R Bohe4 Brandon R Swensen3 A Gordon Smith1 Nicholas E Johnson1 1Department of Neurology, School  of Medicine, 2Department of  Physical Medicine & Rehabilitation,   3Outpatient Neurology, University  of Utah Hospitals and Clinics,   4Business Support, University of Utah  Information T echnology, Salt Lake City,   UT, USABackground: Team-based care has been shown to offer more comprehensive benefits to  patients when compared to standard physician-based care alone in clinics for chronic conditions.",Non-OADS,/arxiv_data1/oa_pdf/99/9d/jmdh-9-493.PMC5055114.pdf
"13Correspondence: Evan M Pucillo Department of Neurology, Eccles Institute of Human Genetics, University of Utah, 15N 2030E, Room #2270A, Salt Lake City, UT 84112, USATel +1 801 585 1499Email epucillo@genetics.utah.eduJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Pucillo et alRunning head recto: Same-day PT consults in an outpatient NMD clinicDOI: http://dx.doi.org/10.2147/JMDH.S113045",Non-OADS,/arxiv_data1/oa_pdf/99/9d/jmdh-9-493.PMC5055114.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/99/9d/jmdh-9-493.PMC5055114.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 497 Same-day PT consults in an outpatient NMD clinic Intermountain West Region and may not be applicable to  other regions across the US.16 One study demonstrated an  analysis of travel times and distances to health care in which the Intermountain West Region holds a larger portion of highly rural areas when compared to other regions of the US.,Non-OADS,/arxiv_data1/oa_pdf/99/9d/jmdh-9-493.PMC5055114.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/80/a7/ijn-11-5003.PMC5055115.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5003–5014International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5003OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11547 3 silver nanoparticles outperform gold nanoparticles  in radiosensitizing U251 cells in vitro and in an  intracranial mouse model of glioma Peidang liu1,2 haizhen Jin1 Zhirui guo3 Jun Ma4 Jing Zhao1 Dongdong li1 hao Wu2 Ning gu2 1school of Medicine, 2state Key  laboratory of Bioelectronics, Jiangsu  Key laboratory for Biomaterials and  Devices, southeast University, 3The  second affiliated hospital of Nanjing  Medical University, 4Traditional  chinese Medicine hospital of  Jiangsu Province, Nanjing, People’s  republic of chinaAbstract:  Radiotherapy performs an important function in the treatment of cancer, but resistance  of tumor cells to radiation still remains a serious concern.",Non-OADS,/arxiv_data1/oa_pdf/80/a7/ijn-11-5003.PMC5055115.pdf
"Recently,  the addition of metal-based nanoparticles has been proposed as a novel strategy to  improve the therapeutic index of radiation therapy.4 Among these nanomaterials,  gold nanoparticles (AuNPs) received a great deal of attention owing to their attrac - tive properties, such as good biocompatibility, chemical stability, ease of surface  modification, and high X-ray absorption coefficients.5 Studies have implicated that  the biological mechanisms of AuNPs radiosensitization may be involved in cell cycle correspondence: Peidang liu school of Medicine, southeast University,  87 Dingjiaqiao road, Nanjing 210009,  Jiangsu, People’s republic of china Tel/fax +86 25 8327 2554 email seulpd@163.co m  Ning gu state Key laboratory of Bioelectronics,  Jiangsu Key laboratory for Biomaterials  and Devices, southeast University,  4 sipailou, Nanjing 210096, Jiangsu,  People’s republic of china email guning@seu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: Radiosensitizing effects of AuNPs and AgNPs on glioma DOI: http://dx.doi.org/10.2147/IJN.S115473",Non-OADS,/arxiv_data1/oa_pdf/80/a7/ijn-11-5003.PMC5055115.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/80/a7/ijn-11-5003.PMC5055115.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/a7/ijn-11-5003.PMC5055115.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/24/dddt-10-3211.PMC5055116.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3211–3223Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3211Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11472 4 rapid disintegrating tablets of simvastatin  dispersions in polyoxyethylene–polypropylene  block copolymer for maximized disintegration  and dissolution gehan F Balata1,2 ahmad s Zidan2 Mohamad as abourehab1,3 ebtessam a essa4 1Department of Pharmaceutics,   Faculty of Pharmacy, Umm al-Qura  University, Makkah, saudi arabia;   2Department of Pharmaceutics,   Faculty of Pharmacy, Zagazig  University, Zagazig, 3Department of  Pharmaceutics, Faculty of Pharmacy,   el-Minia University, el-Minia,   4Department of Pharmaceutics,   Faculty of Pharmacy, Tanta University,   Tanta, egyptAbstract:  The objective of this research was to improve the dissolution of simvastatin and  to incorporate it in rapid disintegrating tablets (RDTs) with an optimized disintegration and  dissolution characteristics.",Non-OADS,/arxiv_data1/oa_pdf/4c/24/dddt-10-3211.PMC5055116.pdf
"Generally, the process selected to manufacture RDTs could significantly alter the correspondence: gehan F Balata Faculty of Pharmacy, Umm al-Qura  University, PO Box 715, Makkah 21421,  saudi arabia Tel +966 5 4184 1800 Fax +966 2 550 7042 4225 email jfsyed@uqu.edu.s a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Balata et al Running head recto: Rapid disintegrating tablets of simvastatin DOI: http://dx.doi.org/10.2147/DDDT.S114724",Non-OADS,/arxiv_data1/oa_pdf/4c/24/dddt-10-3211.PMC5055116.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4c/24/dddt-10-3211.PMC5055116.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/24/dddt-10-3211.PMC5055116.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1b/e8/dddt-10-3225.PMC5055118.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3225–3236Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3225Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S10593 2 Spotlight on frovatriptan: a review of its efficacy  in the treatment of migraine Gianni Allais Chiara Benedetto Department of Surgical Sciences,   women’s Headache Center, University  of T urin, T urin, italyAbstract:  Migraine is a common neurovascular disorder, affecting millions of people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/1b/e8/dddt-10-3225.PMC5055118.pdf
"A treatment algorithm for migraine has  recently been created8 (Figure 1).Correspondence: Gianni Allais Department of Surgical Sciences,  women’s Headache Center,  University of Turin, via ventimiglia 3,  10126 Turin, italy Tel +39 11 355 023 Fax +39 11 355 320 email gb.allais@tiscali.i t Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Allais and Benedetto Running head recto: Review of frovatriptan in migraine DOI: http://dx.doi.org/10.2147/DDDT.S105932 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/1b/e8/dddt-10-3225.PMC5055118.pdf
Or use: http://youtu.be/f7DnflfD5f svideo abstract,Non-OADS,/arxiv_data1/oa_pdf/1b/e8/dddt-10-3225.PMC5055118.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1b/e8/dddt-10-3225.PMC5055118.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/e8/dddt-10-3225.PMC5055118.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/67/ff/ceor-8-551.PMC5055119.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/67/ff/ceor-8-551.PMC5055119.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 551–558ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  551 REviEw open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S115103Health and economic benefits of physical activity  for patients with spinal cord injury Larry E Miller1  william G Herbert1,2 1Miller Scientific Consulting, Inc.,   Asheville, NC, 2Department of Human  Nutrition, Foods & Exercise, Virginia  T ech, Blacksburg, VA, USAAbstract: Spinal cord injury (SCI) is a traumatic, life-disrupting event with an annual incidence  of 17,000 cases in the US.",Non-OADS,/arxiv_data1/oa_pdf/67/ff/ceor-8-551.PMC5055119.pdf
"3,4 Further, these patients will endure  severe long-term medical, functional, and psychological complications following the injury, thus increasing their risk for loss of employment or employability, decreasing Correspondence: Larry E Miller Miller Scientific Consulting, Inc., 1854 Hendersonville Road, #231, Asheville, NC 28803, USATel +1 828 450 1895 Email larry@millerscientific.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ReviewY ear: 2016V olume: 8Running head verso: Miller and HerbertRunning head recto: Benefits of physical activity for patients with SCIDOI: http://dx.doi.org/10.2147/CEOR.S115103",Non-OADS,/arxiv_data1/oa_pdf/67/ff/ceor-8-551.PMC5055119.pdf
Available from: https://www.nscisc.uab.edu/reports.aspx.,Non-OADS,/arxiv_data1/oa_pdf/67/ff/ceor-8-551.PMC5055119.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/67/ff/ceor-8-551.PMC5055119.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 558 Miller and Herbert 36.,Non-OADS,/arxiv_data1/oa_pdf/67/ff/ceor-8-551.PMC5055119.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/36/dddt-10-3281.PMC5055120.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3281–3290Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3281Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11319 5 intracerebroventricular urocortin 3 counteracts  central acyl ghrelin-induced hyperphagic and  gastroprokinetic effects via crF receptor 2 in rats chun Yeh1 ching-heng Ting2 Ming-luen Doong3 chin-Wen chi4,5 shou-Dong lee1 chih-Yen chen6–8 1Division of gastroenterology,   Department of internal Medicine,   cheng-hsin general hospital,   2Department of Pathology, Mackay  Memorial hospital, 3institute of  Physiology, 4institute of Pharmacology,   national Yang-Ming University  school of Medicine, 5Department  of Medical research, Taipei Veterans  general hospital, 6Division of  gastroenterology and hepatology,   Department of Medicine, Taipei  Veterans general hospital, 7Faculty  of Medicine, national Yang-Ming  University school of Medicine,   Taipei, 8Taiwan association for the  study of small intestinal Diseases,   guishan, TaiwanPurpose:  Urocortin 3 is a key neuromodulator in the regulation of stress, anxiety, food intake,  gut motility, and energy homeostasis, while ghrelin elicits feeding behavior and enhances gastric  emptying, adiposity, and positive energy balance.",Non-OADS,/arxiv_data1/oa_pdf/9f/36/dddt-10-3281.PMC5055120.pdf
"Central  urocortin 3 has also been demonstrated to be responsible for anxiety-like behaviors and  metabolic functions.8 Taken together, urocortin 3 appears to be a key neuromodulator correspondence: shou-Dong lee;  chih-Yen chen Division of gastroenterology and  hepatology, Department of Medicine,  Taipei Veterans general hospital, 201,  sec 2, shih-Pai road, Taipei 112, Taiwan Tel +886 2 2871 2121 ext 3763 Fax +886 2 2871 1058 email chency@vghtpe.gov.t w Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Y eh et al Running head recto: ICV Ucn3 vs ghrelin on FI & GE DOI: http://dx.doi.org/10.2147/DDDT.S113195",Non-OADS,/arxiv_data1/oa_pdf/9f/36/dddt-10-3281.PMC5055120.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9f/36/dddt-10-3281.PMC5055120.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/36/dddt-10-3281.PMC5055120.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/41/cia-11-1379.PMC5055121.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1379–1385Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1379OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11451 5 Vitamin e administration may decrease  the incidence of pneumonia in elderly males harri hemilä Department of Public health,   University of helsinki,   helsinki, FinlandBackground:  Vitamin E has influenced the immune system in laboratory studies.",Non-OADS,/arxiv_data1/oa_pdf/74/41/cia-11-1379.PMC5055121.pdf
"Vitamin E both  increased and decreased common cold incidence in the subgroups of participants who  were aged .65 years,8,9 and extended the life span over the whole ATBC cohort.10,11Correspondence: harri hemilä Department of Public health, University  of helsinki, POB 20, helsinki,  FIn-00014, Finland Tel +358 41 532 9987 email harri.hemila@helsinki.fi  Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hemilä Running head recto: Vitamin E and the risk of pneumonia in males DOI: http://dx.doi.org/10.2147/CIA.S114515",Non-OADS,/arxiv_data1/oa_pdf/74/41/cia-11-1379.PMC5055121.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/74/41/cia-11-1379.PMC5055121.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/74/41/cia-11-1379.PMC5055121.pdf
Available  from: https://www.r-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/74/41/cia-11-1379.PMC5055121.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/9b/ijn-11-4975.PMC5055126.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4975–4990International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4975OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10908 8 antidepressant effects of curcumin and hU-211  coencapsulated solid lipid nanoparticles against  corticosterone-induced cellular and animal  models of major depression Xiaolie he* Yanjing Zhu* Mei Wang guoxin Jing rongrong Zhu shilong Wang research center for Translational  Medicine at east hospital, school  of life science and T echnology,   T ongji University, shanghai,   People’s  republic of china *These authors contributed equally  to this workAbstract:  Major depression is a complex neuropsychiatric disorder with few treatment  approaches.",Non-OADS,/arxiv_data1/oa_pdf/b1/9b/ijn-11-4975.PMC5055126.pdf
"It has been reported that CORT can induce correspondence: shilong Wang;   rongrong Zhu research center for Translational  Medicine at east hospital, school of  life science and Technology, Tongji  University, 1239 siping road, shanghai  200092, People’s republic of china Tel +86 21 6598 2595 Fax +86 21 6598 2286 email wsl@tongji.edu.c n;   rrzhu@tongji.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: He et al Running head recto: Antidepressant effects of curcumin and HU-211 coencapsulated SLNs DOI: http://dx.doi.org/10.2147/IJN.S109088",Non-OADS,/arxiv_data1/oa_pdf/b1/9b/ijn-11-4975.PMC5055126.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b1/9b/ijn-11-4975.PMC5055126.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/ijn-11-4975.PMC5055126.pdf
"Once isolated, cells were plated (4.8 × 10 4cm/C02) onto lethally irradiated 3T3-J2 cells (2.4 × 104cm/C02) and cultured in 5% CO 2, using a mixture of DMEM (Life Technologies, Italy) and Ham ’s F12 (Life Technologies, Italy) media (2:1) contain- ing FCS (10%; Life Technologies, Italy), penicillin-Tables of Links TARGETS Other protein targetsaOther ion channelsb TNF- α Cx43 (connexin 43)LIGANDS IL-1β TGFβ1 Il-6 VEGFA These Tables list key protein targets and ligands in this article which are hyperlinked to corresponding entries in http://www.guidetopharmacolog y.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 (a,bAlexander et al., 2015a,b).Connexin 43 mimetic peptide Gap27 for corneal wound healing BJP British Journal of Pharmacology (2016) 173 2880 –2893 2881",Non-OADS,/arxiv_data1/oa_pdf/8f/ec/BPH-173-2880.PMC5055138.pdf
"Curr Opin Ophthalmol 12: 237 –241.Supporting Information Additional Supporting Information may be found in the on- line version of this article at the publisher ’s web-site: http://dx.doi.org/10.1111/bph.13568Figure S1 Gap27 did not affect the expression pattern of Cx43, ZO-1, K12 or p63.",Non-OADS,/arxiv_data1/oa_pdf/8f/ec/BPH-173-2880.PMC5055138.pdf
"The RPE65  (Gene ID: 6121; OMIM: 180069 ) gene  encodes the RPE-specific protein 65 kDa (RPE65), which is  an essential visual cycle enzyme required for the conversion Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > Received 16 June 2016 | Accepted 6 October 2016 | Published 8 October 2016© 2016 Molecular Vision 1156Proinflammatory cytokines decrease the expression of genes  critical for RPE function R. Krishnan Kutty,1 William Samuel,1 Kaifa Boyce,1 Aswini Cherukuri,1 Todd Duncan,1 Cynthia Jaworski,1  Chandrasekharam N. Nagineni,2 T. Michael Redmond1 1Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, MD;  2Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD Purpose:  Proinflammatory cytokines interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), and interleukin-1  beta (IL-1β) secreted by infiltrating lymphocytes or macrophages may play a role in triggering RPE dysfunction as - sociated with age-related macular degeneration (AMD).",Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
"Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  1157of all- trans -retinol to 11- cis-retinol [ 22,23].",Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
"Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  1158168461 ), CDH2  (Gene ID: 1000; OMIM: 114020 ), ZEB1  (Gene  ID: 6935; OMIM: 189909 ), SNAI1  (Gene ID: 6615; OMIM:  604238 ), MITF , TRPM1 , and TRPM3 .",Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  1159 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
"Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  1160mixture of IFN-γ, TNF-α, and IL-1β for 20 h under serum- free conditions, as described for the gene expression studies,  were initially employed for the western blot analysis of the  CDH1 and RLBP1 proteins.",Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  1161 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
"Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  1162a mixture of IFN-γ (10 u/ml), TNF-α (1 ng/ml), and IL-1β (1  ng/ml) either for 20 h under serum-free conditions or for 4  days in the presence of 1% serum, and the gene expression  was analyzed with real-time PCR (Figure 5).",Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  1163Nagineni et al.,Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  1164of their encoded proteins.,Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  1165that was associated with the decreased expression of the  RPE characteristic genes RLBP1  and RPE65  [30].,Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  11667.,Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  116731.,Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
"Molecular Vision  2016; 22:1156-1168 <http://www.molvis.org/molvis/v 22/1156 > © 2016 Molecular Vision  1168Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/57/ed/mv-v22-1156.PMC5055142.pdf
"Using miRanda (http://www.microrna.org), Notch1 was predicted to be a target of miR-101.",OADS,/arxiv_data1/oa_pdf/43/9a/or-36-05-2511.PMC5055196.pdf
"The study was approved by the regional Ethics  Committee (Regional komité for medisinsk forskningsetikk  Sør‑Øst, Norge; http://helseforskning.etikkom.no), and written informed consent was obtained from the patient to publication of the case details.",Non-OADS,/arxiv_data1/oa_pdf/49/32/or-36-05-2455.PMC5055197.pdf
"Total RNA (3  µg) was sent for high‑throughput  paired‑end RNA‑sequencing at the Norwegian Sequencing  Centre, ullevål Hospital (http://www.sequencing.uio.no/).",OADS,/arxiv_data1/oa_pdf/49/32/or-36-05-2455.PMC5055197.pdf
The software  FusionCatcher  (10) (https://github.com/ndaniel/fusioncatcher)  was used for the discovery of fusion transcripts.,OADS,/arxiv_data1/oa_pdf/49/32/or-36-05-2455.PMC5055197.pdf
The B lAST software (http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/49/32/or-36-05-2455.PMC5055197.pdf
"PANA gOPO ulOS et al :  gENE F uSIONS IN SOFT TISS uE AN gIOFIBROMA 2458 from the Norwegian Sequencing Centre, ullevål Hospital  (http://www.sequencing.uio.no/), 39 potential fusions were  found: 28 fusions were described as readthrough short‑distance  fusions and 5 as pse udogenes (Table Ⅲ).",OADS,/arxiv_data1/oa_pdf/49/32/or-36-05-2455.PMC5055197.pdf
"The three genes AHRR , NCOA2 , and ETV4  map to chromo - some subbands 5p15.33, 8q13.3, and 17q21.31, respectively (https://genome.ucsc.edu/).",Non-OADS,/arxiv_data1/oa_pdf/49/32/or-36-05-2455.PMC5055197.pdf
This protein may also be involved in the transcriptional regulation of the components of the mTOR complex (http://www.ncbi.nlm.nih.gov/gene/93627).,Non-OADS,/arxiv_data1/oa_pdf/49/32/or-36-05-2455.PMC5055197.pdf
The protein encoded by the P4HA2  gene is one of several  different types of  α subunit of the prolyl 4‑hydroxylase and  provides the major part of the catalytic site of the active enzyme (http://www.ncbi.nlm.nih.gov/gene/8974).,Non-OADS,/arxiv_data1/oa_pdf/49/32/or-36-05-2455.PMC5055197.pdf
bioRxiv 011650; doi: http://dx.doi.org/10.1101/011650.,OADS,/arxiv_data1/oa_pdf/49/32/or-36-05-2455.PMC5055197.pdf
"The study was approved by the regional ethics  committee (Regional komité for medisinsk forskningsetikk Sør-Øst, Norge, http://helseforskning.etikkom.no), and written informed consent was obtained from the patient's parents to publication of the case details.",Non-OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
"As part of our stan - dard cytogenetic diagnosis, initial interphase FISH analyses  of bone marrow cells were performed with the Cytocell multiprobe ALL panel (Cytocell, http://www.cytocell.co.uk/) looking for MYC  rearrangements, CDKN2A  (P16) deletion,  TCF3 (E2A)  rearrangements, ETV6-RUNX1  fusion, hyper - diploidy, MLL  rearrangements, BCR-ABL1  fusion, and IGH  rearrangements.",Non-OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
"On the basis of findings made using the above panel, further FISH was performed on metaphase spreads and interphase nuclei using the v ysis LSI TEL/AML1 ES Dual  Color Translocation Probe (Abbott Molecular, http://www.abbottmolecular.com) .",OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
The FASTQC software was used for quality control of the raw sequence data (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
The software deFuse was used for the discovery of fusion transcripts (38) (http://compbio.bccrc.ca/software/defuse/).,OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
"In addition, the ‘grep’ command (http://en.wikipedia.org/ wiki/Grep) was used to search the fastq files of the sequence  Figure 1.",OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
"The  results were obtained with the Cytocell multiprobe ALL panel (Cytocell, http://www.cytocell.co.uk/).",OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
PANAGOPOULOS  et al :  RUNX1  TRUNCATION IN ACUTE MYELOID LEU kEMIA 2484 data (http://en.wikipedia.org/wiki/FASTQ_format) for RUNX1   fusion sequences (NM_001754 version 4).,OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
The sequences obtained by ‘grep’ were blasted against the human genomic plus transcript database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) as well as the reference sequences NM_001754 version 4 (RUNX1)  and NC_000006.12 (chromosome 6).,OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
"The remaining PCR products were purified using the GeneJET PCR Purification kit (Thermo Fisher Scientific, Oslo, Norway) and sequenced at GATC Biotech (Germany, http://www.gatc-biotech.com/en/home.html).",Non-OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
The BLAST software (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used for computer analysis of sequence data.,OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
"Wiley-Blackwell, 2015. http://dx.doi.org/10.1002/9781118795569.",Non-OADS,/arxiv_data1/oa_pdf/a2/98/or-36-05-2481.PMC5055202.pdf
"1, e959874 (9 pages)http://dx.doi.org/10.4161/21592527.2014.959874",Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Heart 2001; 86:563-9; PMID:11602554;http://dx.doi.org/10.1136/heart.86.5.563 2.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
J Biomed Mater Res 2001; 58:69-74; PMID:11153000; http://dx.doi.org/10.1002/1097-4636(2001)58:1 <69::AID-JBM100 >3.0.CO;2-9 5.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Acta Mater 2013; 61:782-817; http://dx.doi.org/10.1016/j.actamat.2012.10.038 6.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Acta Metall Mater 1995; 43:3971-81; http://dx.doi.org/10.1016/0956-7151(95)00110-H 7.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Mater Sci Eng: A 2006; 441:1-7; http://dx.doi.org/10.1016/j.msea.2006.08.095 8.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
J Am College of Cardiol 2003; 41:1283-8; PMID:12706922; http://dx.doi.org/ 10.1016/S0735-1097(03)00119-0 10.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Acta Biomater 2009; 5:945-58; http://dx.doi.org/10.1016/j.actbio.2008.11.012 11.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Mater Sci Eng: A 2006; 417:40- 8; http://dx.doi.org/10.1016/j.msea.2005.11.007 12.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Am J Cardiol 2004; 93:477-80; PMID:14969629;http://dx.doi.org/10.1016/j.amjcard.2003.10.049 13.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Am Heart J 2012; 163:608-16;PMID:22520527; http://dx.doi.org/10.1016/j.ahj.2012.01.007 14.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
J Biomed Mater Res Part B: Appl Biomater 2014; http://dx.doi.org/10.1002/jbm.b.33242 15.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Acta Biomater2013; 9(4):6245-58; http://dx.doi.org/10.1016/j.actbio.2012.12.003 16.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
ScriptaMater 2010; 63:1201-4; http://dx.doi.org/10.1016/j.scriptamat.2010.08.035 17.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Corrosion 2010; 66:075005-13; http://dx.doi.org/ 10.5006/1.3462912 19.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Mater Sci Eng: B2011; 176:1812-22; http://dx.doi.org/10.1016/j.mseb.2011.02.031 20.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Biomed Mater 2010; 5:065015; PMID:21079282;http://dx.doi.org/10.1088/1748-6041/5/6/065015 21.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Scripta Mater 2004; 51:801-6; http://dx.doi.org/10.1016/j.scriptamat.2004.06.002 22.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Mater SciEng: A 2008; 485:200-9; http://dx.doi.org/10.1016/j.msea.2007.07.077 23.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Corros Sci2009; 51:1844-9; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
J Phys Chem B 2006;110:377-82; PMID:16471545; http://dx.doi.org/10.1021/jp0538971 25.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
J Appl Electrochem 2010; 40:1949-56; http://dx.doi.org/10.1007/s10800-010-0171-1 27.,Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Corros Sci 1968; 8:573-82;http://dx.doi.org/10.1016/S0010-938X(68)80093-9 29.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
JMater sci 1983; 18:2732-42; http://dx.doi.org/10.1007/BF0054759030.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
"West Conshohocken, PA: ASTM;2013; http://dx.doi.org/10.1520/E0008_E0008M 31.",Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
Acta Bio-mater 2008; 4:284-95; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
"West Conshohocken, PA: ASTM;2012; http://dx.doi.org/10.1520/G0031-12A 33.",Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
"West Con-shohocken, PA: ASTM; 2009; http://dx.doi.org/10.1520/G0059-97R09BIOMATTER e959874-9",Non-OADS,/arxiv_data1/oa_pdf/c3/8b/kbim-06-01-959874.PMC5055204.pdf
"1, e1123842 (13 pages)http://dx.doi.org/10.1080/21592535.2015.1123842",Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Biomaterials 1998; 19:467-78; PMID:9645552;http://dx.doi.org/10.1016/S0142-9612(97)00126-9 3.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
J Materials Chem 2011; 21:1319;http://dx.doi.org/10.1039/C0JM02309D 5.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
J Materials Chem 2012; 22:2824; http://dx.doi.org/10.1039/c2jm14880c 6.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Acta Biomaterialia 2009;5:498-507; PMID:18640084; http://dx.doi.org/10.1016/j.actbio.2008.06.011 7.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Biomaterials 2001;22:3191-6; PMID:11603591; http://dx.doi.org/10.1016/S0142-9612(01)00071-0 8.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
J Dental Res 2000; 79:709-14; PMID:10728971;http://dx.doi.org/10.1177/00220345000790020301 9.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Biomaterials 1990; 12:155-63; http://dx.doi.org/10.1016/0142-9612(91)90194-F 1 0 .,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Dent Mater 2008; 24:653-9; PMID:17727942; http://dx.doi.org/10.1016/j.dental.2007.06.028 11.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
J Materials Sci Materials Med 2006; 17:967-78; PMID:17122907; http://dx.doi.org/10.1007/s10856-006-0432-z 12.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
AcCCC ta Biomaterialia 2013; 9:4457-86; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Biomate-rials 2005; 26:5934-41; PMID:15958240; http://dx.doi.org/10.1016/j.biomaterials.2005.03.008 14.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
J Biomater App 2004; 19:5-20; PMID:15245640; http://dx.doi.org/10.1177/0085328204044538 15.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Dent Mater 2005; 21:201-9; PMID:15705426; http://dx.doi.org/10.1016/j.dental.2004.03.006 16.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Biomed Materials 2013; 8:032001; PMID:23567351; http://dx.doi.org/10.1088/1748-6041/8/3/032001 17.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Scripta Metallurgica EtMaterialia 1994; 31:1001-5; http://dx.doi.org/10.1016/0956-716X(94)90517-7 18.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Materials Sci Engineering: C 2005; 25:455-61; http://dx.doi.org/10.1016/j.msec.2004.12.003 19.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Dent Mater2011; 27:407-22; PMID:21353694; http://dx.doi.org/10.1016/j.dental.2011.02.001 20.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Ceramics 2011; 01:49-52; http://dx.doi.org/10.4236/ njgc.2011.12008 21.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
J Sol-Gel Sci Tech 2010; 58:33-41; http://dx.doi.org/10.1007/s10971-010-2351-1 22.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Dent Mater 2006;22:647-52; PMID:16226806; http://dx.doi.org/ 10.1016/j.dental.2005.08.003 24.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Dent Mater 2008; 24:341-50; PMID:17659330; http://dx.doi.org/10.1016/j.dental.2007.06.004 28.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Biomaterials 2009; 30:2175-9; PMID:19176246;http://dx.doi.org/10.1016/j.biomaterials.2009.01.008 29.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Biomaterials 2006;27:2907-15; PMID:16448693; http://dx.doi.org/10.1016/ j.biomaterials.2006.01.017 30.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Dent Mater 2011; 27:e134-57; PMID:21529922; http://dx.doi.org/10.1016/j.dental.2011.03.011 31.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Dent Mater 2011; 27:e134-57; PMID:21529922; http://dx.doi.org/10.1016/j.dental.2011.03.011 33.,Non-OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Biomaterials 2005; 26:4366-73; PMID:15701365; http://dx.doi.org/10.1016/j.biomaterials.2004.11.022 34.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Biomaterials 2001;22:2007-12; PMID:11426878; http://dx.doi.org/10.1016/S0142-9612(00)00386-0 36.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
Bioma- terials 2004; 25:1755-61; PMID:14738838; http://dx.doi.org/10.1016/j.biomaterials.2003.08.024 37.,OADS,/arxiv_data1/oa_pdf/00/d8/kbim-06-01-1123842.PMC5055208.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/80/rjw167.PMC5055282.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/a4/rjw165.PMC5055286.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/24/rjw169.PMC5055301.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Trends in Hearing 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/85/80/10.1177_2331216516662003.PMC5055367.pdf
"For the sake of reprodu-cibility and accessibility, we incorporated the model baumgartner 2016 as well as the modeled experiments exp_baumgartner2016 in the Auditory ModelingToolbox (http://www.amtoolbox.sf.net; Søndergaard &Majdak, 2013).",OADS,/arxiv_data1/oa_pdf/85/80/10.1177_2331216516662003.PMC5055367.pdf
[cited 2006]; Available from: URL:  http://www.idf.org/webdata/docs/MetS_def_update  2006.pdf  5.,Non-OADS,/arxiv_data1/oa_pdf/1b/f2/ARYA-12-146.PMC5055373.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1600972/DC1Supplementary Materials and Methods fig.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/1600972.PMC5055382.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1601737/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/18/3b/1601737.PMC5055383.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1601006/DC1Description of modeling and calculations for IR vibrational nano-crystallographyDescription of nonresonant signal and signal penetration depthfig.,Non-OADS,/arxiv_data1/oa_pdf/69/0b/1601006.PMC5055384.pdf
"Motifs that existed in SDIfamily proteins were predicted by InterProScan (www.ebi.ac.uk/interpro/ search/sequence-search) ( 38), Motif Scan (http://myhits.isb-sib.ch/cgi- bin/motif_scan) ( 63), and PROSITE (http://pr osite.expasy.org/) ( 64).",OADS,/arxiv_data1/oa_pdf/3e/99/1601087.PMC5055385.pdf
Phylogenetic relationship of SDI family of nine different species was analyzed using the protein sequences of SDI family homologs ob- tained from the PLAZA website (http://bioinformatics.psb.ugent.be/plaza/versions/plaza_v2_5/) ( 41).,OADS,/arxiv_data1/oa_pdf/3e/99/1601087.PMC5055385.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1601087/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/3e/99/1601087.PMC5055385.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1601026/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/cf/76/1601026.PMC5055386.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1600993/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/19/6c/1600993.PMC5055388.pdf
"In mammals, six GATA family members (GATA1-6) control cellular differentiation and  organogenesis during development and in adults ( Chlon and Crispino, 2012 ; Duncan, 2005 ),  including hematopoiesis ( Rodrigues et al., 2005 ; Weiss and Orkin, 1995 ), cardiac  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0d/dc/nihms820016.PMC5055475.pdf
"Treatment decisions are based on in-ofﬁce measurements of IOP to assess diurnal variation and to deﬁne successful management of disease; however, theseEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/23E4 F06031FE36D5 .",Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Adv Ther (2016) 33:1679–1690 1687",Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
11. http://www.reichert.com/eye_care.cfm .,Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
21. http://icare-usa.com .,Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
38. http://www.ziemergroup.com/products/pascal/dct- lens.html .,Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
40. http://www.fda.gov/News Events/Newsroom/Press Announcements/ucm489308.htm .,Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
41. http://www.sensimed.ch/en/sensimed-triggerﬁsh/ sensimed-triggerﬁsh.html .,Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
54. http://implandata.com/en/ .,Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
58. https://clinicaltrials.gov/ct2/show/NCT02434692 .,Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
59. http://www.aao.org/interview/technology-advances- in-iop-monitoring .,Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
60. http://www.launchpnt.com/portfolio/biomedical/ .,Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
62. http://eyetubeod.com/series/Glaucoma-Today- Journal-Club/ebesi/ .,Non-OADS,/arxiv_data1/oa_pdf/cc/01/12325_2016_Article_388.PMC5055550.pdf
UponEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/3295 F0604A1B548E .,Non-OADS,/arxiv_data1/oa_pdf/48/44/12325_2016_Article_402.PMC5055551.pdf
In 95.2% of patients a goodEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ D3E4F06050C2BEC3 .,Non-OADS,/arxiv_data1/oa_pdf/95/b0/12325_2016_Article_391.PMC5055552.pdf
Funding: Pﬁzer Inc.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 9AE4F06044A0FCF4 .,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
http://www.selfcareforum.org/about-us/ what-do-we-mean-by-self-care-and-why-is-good-for- people/ .,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
http://www.nmafaculty.org/about-nma .,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
World Self-Medication Industry; 2014. http://www.wsmi.,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
World Health Organization; 1998.http://apps.who.int/medicinedocs/pdf/whozip32e/ whozip32e.pdf .,OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
Report from the Global Respiratory Infection Partnership; 2015. http://www.grip-initiative.org/media/114428/recstr-grip-cta-meeting-report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
PGEU; 2015. http://www.pgeu.eu/ en/component/content/art icle/34-homepage-topics/ 16-pgeu-annual-report.html .,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
Nielsen Company; 2009. http://www.selfcareforum.org/wp-content/ uploads/2011/07/AESGPResearchJun09.pdf .,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
World Self-Medication Industry; 2009.http://www.wsmi.org/wp-content/data/pdf/wsmi_ switchbrochure.pdf .,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
European Commission; 2013. http://ec.europa.eu/ DocsRoom/documents/7623?locale=en .,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
"McKinsey Global Institute; 2012.http://www.mckinsey.com/insights/employment_and_growth/the_world_at_work .A c c e s s e dJ u n e1 6 , 2016.",Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
Health Affairs; 2013. http://www.healthaffairs.org/ healthpolicybriefs/brief.php?brief_id=86 .,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
World Gastroenterology Organisation;2013. http://www.worldgastroenterology.org/ assets/export/userﬁles/2013_FINAL_Common%20GI%20Symptoms%20_long.pdf .,Non-OADS,/arxiv_data1/oa_pdf/70/e8/12325_2016_Article_395.PMC5055554.pdf
"The Neuropathy Disability Score (NDS) was used to quantify DPN and abnormal ratio of the longest electrocardiographic RR interval between the 28th and 32nd beats, after standing to the shortest interval between the 13th and 17thEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 3885F060449C321B .",Non-OADS,/arxiv_data1/oa_pdf/77/22/12325_2016_Article_399.PMC5055555.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/77/22/12325_2016_Article_399.PMC5055555.pdf
They also wanted individualized healthcare that took their preferences and personal and emotional issues into account.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 0AE4F06044A472AD .,Non-OADS,/arxiv_data1/oa_pdf/ad/e7/12325_2016_Article_394.PMC5055556.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ad/e7/12325_2016_Article_394.PMC5055556.pdf
Geneva: World HealthOrganization; 2003. http://www.who.int/chp/ knowledge/publications/adherence_introduction.,Non-OADS,/arxiv_data1/oa_pdf/ad/e7/12325_2016_Article_394.PMC5055556.pdf
http://salutweb.gencat.cat/ web/.content/home/el_departament/estadistiques_ sanitaries/enquestes/onada09/esca2014_resultats.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ad/e7/12325_2016_Article_394.PMC5055556.pdf
"Results : The use of MVI in most scenarios was related to a reduced con sumption of hospital staff time and reduced length of patients’ stay in hospital wards, leading to lower total costs with MVI when compared to local comparators.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ ABE4F06039CDBBF9 .",Non-OADS,/arxiv_data1/oa_pdf/5e/09/12325_2016_Article_397.PMC5055557.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5e/09/12325_2016_Article_397.PMC5055557.pdf
Clinical Guideline July 2008. https://www.nice.org.uk/Guidance/cg70 .,Non-OADS,/arxiv_data1/oa_pdf/5e/09/12325_2016_Article_397.PMC5055557.pdf
http://www.medicine.ox.a c.uk/bandolier/painres/ download/whatis/What_is_ind_comp.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5e/09/12325_2016_Article_397.PMC5055557.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c8/e4/12325_2016_Article_410.PMC5055559.pdf
Available at: http://www.omicsonline.,Non-OADS,/arxiv_data1/oa_pdf/c8/e4/12325_2016_Article_410.PMC5055559.pdf
Available at: http://www.cu.edu.eg/data_journals/6/articles/1316/submission/copyedit/1316-2555-1-CE.pdf .L a s t accessed: 11 Aug 2016.,Non-OADS,/arxiv_data1/oa_pdf/c8/e4/12325_2016_Article_410.PMC5055559.pdf
"Results : In unﬁt patients, the main NMA (ﬁve studies for PFS and four for OS) demonstrated clear preference in terms of PFS for obinutuzumab ?chlorambucil (G-Clb) versus rituximab ?chlorambucil (R-Clb), ofatumumab ?chlorambucil (O-Clb), ﬂudarabine and chlorambucil (median hazard ratios [HRs] 0.43, 0.33, 0.20, and 0.19,Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ CCE4F0607458A32A .",Non-OADS,/arxiv_data1/oa_pdf/8a/6b/12325_2016_Article_398.PMC5055565.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8a/6b/12325_2016_Article_398.PMC5055565.pdf
Version 1.2016. http://www.nccn.org/ professionals/physician_gls/f_guidelines.asp#site .,Non-OADS,/arxiv_data1/oa_pdf/8a/6b/12325_2016_Article_398.PMC5055565.pdf
2014. http://www.nicedsu.org.uk/evidence- synthesis-tsd-series(2391675).htm .,Non-OADS,/arxiv_data1/oa_pdf/8a/6b/12325_2016_Article_398.PMC5055565.pdf
2003.https://www.r-project.org/conferences/DSC-2003/Drafts/Plummer.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8a/6b/12325_2016_Article_398.PMC5055565.pdf
"However, the most common drivers for the initiation of biologic therapy were the development of steroid refractoriness (66.8%) and steroid dependencyEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ E9E4F0602AD975D5 .",Non-OADS,/arxiv_data1/oa_pdf/83/db/12325_2016_Article_393.PMC5055568.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercialuse, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/83/db/12325_2016_Article_393.PMC5055568.pdf
https://www.ecco-ibd.eu/index.php/ publications/congress-abst ract-s/abstracts-2015/item/ p403-colectomy-is-not-a-cure-for-ulcerative-colitis-a- systematic-review.html .,Non-OADS,/arxiv_data1/oa_pdf/83/db/12325_2016_Article_393.PMC5055568.pdf
https://www.ecco-ibd.eu/ index.php/publications/congress-abstract-s/abstracts-2015/item/p690-current-views-and-concerns-of- european-uc-patients-based-on-an-online-survey.,Non-OADS,/arxiv_data1/oa_pdf/83/db/12325_2016_Article_393.PMC5055568.pdf
https://www.ecco- ibd.eu/index.php/publications/congress-abstract-s/ abstracts-2015/item/p645-perception-of-social-and- emotional-impact-of-ulcerative-colitis-by-spanish-patients-uc-life-survey.html .,Non-OADS,/arxiv_data1/oa_pdf/83/db/12325_2016_Article_393.PMC5055568.pdf
"Lo ´pez-Sanroma ´n A, Carpio D, Calvet X, Cea-Calvo L, Romero C, Argu ¨elles F. Perception about disease activity and treatment attributes in patients withulcerative colitis from Spain—UC-life survey (P670).https://www.ecco-ibd.eu/index.php/publications/ congress-abstract-s/abstracts-2015/item/p670-perce ption-about-disease-acti vity-and-treatment-attri butes-in-patients-with-ulcerative-colitis-from-spain-uc-life-survey.html .",Non-OADS,/arxiv_data1/oa_pdf/83/db/12325_2016_Article_393.PMC5055568.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Rodrigo Liberal,  Institute of Liver  Studies, King’s College London School of Medicine at King’s College  Hospital, Denmark Hill, London SE5 9RS,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/19/8d/WJH-8-1157.PMC5055585.pdf
Cirrhosis and autoimmune liver disease: Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i28.1157World J Hepatol   2016  October 8; 8(28): 1157-1168 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/19/8d/WJH-8-1157.PMC5055585.pdf
World J Hepatol  2016; 8(28): 1157 ­1168   Available from: URL:  http://www.wjgnet.co m/1948 ­5182 /full/ v8/i28/1157.,Non-OADS,/arxiv_data1/oa_pdf/19/8d/WJH-8-1157.PMC5055585.pdf
"htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i28.1157 INTRODUCTION Liver disorders with probable autoimmune aetiology include  autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC)  and primary sclerosing cholangitis (PSC).",Non-OADS,/arxiv_data1/oa_pdf/19/8d/WJH-8-1157.PMC5055585.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/19/8d/WJH-8-1157.PMC5055585.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Memmet Mihmanli, MD, Professor,   Department of General Surgery, Sisli Hamidiye Etfal Training  and Research Hospital, Halaskargazi Caddesi, 34371 Istanbul,  Turkey.",Non-OADS,/arxiv_data1/oa_pdf/90/ee/WJH-8-1169.PMC5055586.pdf
"Mihmanli M, Idiz UO, Kaya C, Demir U, Bostanci O, Omeroglu  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i28.1169World J Hepatol   2016  October 8; 8(28): 1169-1181 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/90/ee/WJH-8-1169.PMC5055586.pdf
World J Hepatol  2016; 8(28): 1169 ­1181   Available from: URL:  http://www.wjgnet.co m/1948 ­5182 /full/ v8/i28/1169.,Non-OADS,/arxiv_data1/oa_pdf/90/ee/WJH-8-1169.PMC5055586.pdf
"htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i28.1169 INTRODUCTION Cystic echinococcus  (CE) is a parasitic illness, caused by  infection with Echinococcus granulosus  (E. granulosus ) in  its larval stage[1].",Non-OADS,/arxiv_data1/oa_pdf/90/ee/WJH-8-1169.PMC5055586.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/90/ee/WJH-8-1169.PMC5055586.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Alagappan Annamalai,  Com - prehensive Transplant Center, Cedars Sinai Medical Center, 8900  Beverly Blvd, 2nd fl.",Non-OADS,/arxiv_data1/oa_pdf/02/f7/WJH-8-1182.PMC5055587.pdf
World J Hepatol  2016;  8(28): 1182-1193  Available from: URL:  http://www.wjgnet .Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i28.1182World J Hepatol   2016  October 8; 8(28): 1182-1193 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/02/f7/WJH-8-1182.PMC5055587.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/f7/WJH-8-1182.PMC5055587.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/02/f7/WJH-8-1182.PMC5055587.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to:  Kiyoshi Asada, MD, PhD, Research  Scientist,  Third Department of Internal Medicine, Nara Medical  University, 840 Shijocho, Kashihara, Nara 634-8521,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/a9/58/WJH-8-1194.PMC5055588.pdf
Agtr1a  methylation and its  gene expression were also analyzed during the activation  of HSCs.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i28.1194World J Hepatol   2016  October 8; 8(28): 1194-1199 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/a9/58/WJH-8-1194.PMC5055588.pdf
World J Hepatol  2016; 8(28): 1194-1199  Available  from: URL:  http://www.wjgnet.com/ 1948-5182 /full/v8/i28/1194.,Non-OADS,/arxiv_data1/oa_pdf/a9/58/WJH-8-1194.PMC5055588.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i28.1194 INTRODUCTION Liver fibrosis is a characteristic feature of chronic liver  disease regardless of the etiology.,Non-OADS,/arxiv_data1/oa_pdf/a9/58/WJH-8-1194.PMC5055588.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/a9/58/WJH-8-1194.PMC5055588.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Takashi Kokudo, MD,  Division of Gastro - enterological Surgery, Saitama Cancer Center, 780 Komuro, Ina,  Kita-adachi gun, Saitama Prefecture 362-0806,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/a9/c2/WJH-8-1200.PMC5055589.pdf
"In addition, the  hypertrophic rate after PVE was significantly lower in Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i28.1200World J Hepatol   2016  October 8; 8(28): 1200-1204 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/a9/c2/WJH-8-1200.PMC5055589.pdf
wjgnet.com/ 1948-5182 /full/v8/i28/1200.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/c2/WJH-8-1200.PMC5055589.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/a9/c2/WJH-8-1200.PMC5055589.pdf
"11, 1388–1394 doi:10.1093/gerona/glw112 Advance Access publication August 16, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/ licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/a3/glw112.PMC5055650.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/ licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or  transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/27/glw126.PMC5055651.pdf
https://www.nia.nih.gov/ research/dgcg/clinical-research-study-investigators-toolbox .,Non-OADS,/arxiv_data1/oa_pdf/b0/27/glw126.PMC5055651.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/79/aapm-06-03-33724.PMC5055710.pdf
Available from: http://www.wfsahq.org/documents/306%20Anaesthesia% 20for%20Electro-convulsive%20Therapy%20ECT.pdf .,Non-OADS,/arxiv_data1/oa_pdf/36/79/aapm-06-03-33724.PMC5055710.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/ licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or  transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/bb/ntw141.PMC5055742.pdf
2015.  http://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesin - gredients/ucm397725.htm .,Non-OADS,/arxiv_data1/oa_pdf/8b/bb/ntw141.PMC5055742.pdf
2015. http://www.femaflavor.org/safety-assessment-and- regulatory-authority-use-flavors-focus-e-cigarettes .,Non-OADS,/arxiv_data1/oa_pdf/8b/bb/ntw141.PMC5055742.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/b6/ijem-14-02-37018.PMC5055747.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/cb/ijem-14-02-33273.PMC5055748.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/11/aapm-06-03-28768.PMC5055753.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/d0/ijcp-09-04-4144.PMC5055754.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/e7/ijcp-09-04-4277.PMC5055759.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/37/ijcp-09-04-3836.PMC5055760.pdf
Available from: https://www.researchgate.net/publication/268743704_Anti- proliferative_effect_of_sulfated_carrageenan_extracted_from_ Laurencia_papillosa_on_T98G_glioblastoma_cancer_cells .,OADS,/arxiv_data1/oa_pdf/e7/37/ijcp-09-04-3836.PMC5055760.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/a6/ijcp-09-04-4080.PMC5055761.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/tobaccocontrol-2015-052805).,Non-OADS,/arxiv_data1/oa_pdf/50/b4/tobaccocontrol-2015-052805.PMC5055844.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Managing the challenges in Western Europe.,Non-OADS,/arxiv_data1/oa_pdf/50/b4/tobaccocontrol-2015-052805.PMC5055844.pdf
Secondary Capsule rollout 2011. http://www.bat.com/ group/sites/UK__9ZTFCM.nsf/vwPagesWebLive/DO8GLLKH/$FILE/14_Mark Cobben —Capsule Rollout.pdf?openelement 3 Gilmore AB.,Non-OADS,/arxiv_data1/oa_pdf/50/b4/tobaccocontrol-2015-052805.PMC5055844.pdf
"Secondary Tobacco Surveillance System TPackSS 2013. http://globaltobaccocontrol.org/tpackss/countries/mexico/ 20 Sáenz de Miera Juárez B, Thrasher JF, Reynales Shigematsu LM, et al.",OADS,/arxiv_data1/oa_pdf/50/b4/tobaccocontrol-2015-052805.PMC5055844.pdf
Secondary Good performance in a challenging environment 2014. http://www.bat.com/group/sites/ UK__9D9KCY.nsf/vwPagesWebLive/DO9Q4LNB?opendocument 40 C. L. Flavor capsule ﬁlter: Concept-product test: RJ Reynolds.,Non-OADS,/arxiv_data1/oa_pdf/50/b4/tobaccocontrol-2015-052805.PMC5055844.pdf
2014. http://ec.europa.eu/health/tobacco/docs/dir_ 201440_en.pdf 43 FDA issues orders that will stop further U.S. sale and distribution of four R.J. Reynolds Tobacco Company cigarette products.,Non-OADS,/arxiv_data1/oa_pdf/50/b4/tobaccocontrol-2015-052805.PMC5055844.pdf
"U.S.Food and Drug Administration, 2015. http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm462407.htm 44 Canadian provinces ﬁ rsts in world to ban menthol ﬂavour.",Non-OADS,/arxiv_data1/oa_pdf/50/b4/tobaccocontrol-2015-052805.PMC5055844.pdf
"http://www.fctc.org/fca-news/opinion-pieces/1328-canadian-provinces- ﬁrst-to-ban-menthol- ﬂavouring 45 Elkin L, Thomson G, Wilson N. Connecting world youth with tobacco brands: YouTube and the internet policy vacuum on Web 2.0.",Non-OADS,/arxiv_data1/oa_pdf/50/b4/tobaccocontrol-2015-052805.PMC5055844.pdf
http://fs.planeacion.,Non-OADS,/arxiv_data1/oa_pdf/50/b4/tobaccocontrol-2015-052805.PMC5055844.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Hoon Jai Chun, MD, PhD, AGAF,  Division of Gastroenterology and Hepatology, Department of  Internal Medicine, Institute of Digestive Disease and Nutrition,  Korea University College of Medicine, 126-1, Anam-dong 5 ga,  Seongbuk-gu, Seoul 02841, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/8d/2a/WJG-22-8247.PMC5055856.pdf
"Here,  we review the major research data concerning the  deregulation of homeobox genes in GI cancers and  their underlying mechanisms.EDITORIALSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8247 8247 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8247-8256  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/8d/2a/WJG-22-8247.PMC5055856.pdf
World J Gastroenterol  2016; 22(37):  8247-8256  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/8d/2a/WJG-22-8247.PMC5055856.pdf
com/1007-9327/full/v22/i37/8247.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/2a/WJG-22-8247.PMC5055856.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/8d/2a/WJG-22-8247.PMC5055856.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: María-Victoria Alvarez-Sánchez,  MD, Department of Gastroenterology, Complejo Hospitalario  Universitario de Pontevedra, Instituto de Investigación Sanitaria  Galicia Sur, Av.",Non-OADS,/arxiv_data1/oa_pdf/a4/af/WJG-22-8257.PMC5055857.pdf
"Anecdotal reports REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8257 8257 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8257-8270  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/a4/af/WJG-22-8257.PMC5055857.pdf
wjgnet.com/1007-9327/full/v22/i37/8257.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/af/WJG-22-8257.PMC5055857.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/a4/af/WJG-22-8257.PMC5055857.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Thomas Vanwolleghem, MD, PhD,  Department of Gastroenterology and Hepatology, Antwerp  University Hospital, Wilrijkstraat 10, 2650 Edegem,  Belgium.",Non-OADS,/arxiv_data1/oa_pdf/9e/50/WJG-22-8271.PMC5055858.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8271 8271 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8271-8282  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/9e/50/WJG-22-8271.PMC5055858.pdf
World J Gastroenterol  2016;  22(37): 8271-8282  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/9e/50/WJG-22-8271.PMC5055858.pdf
com/1007-9327/full/v22/i37/8271.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/50/WJG-22-8271.PMC5055858.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/9e/50/WJG-22-8271.PMC5055858.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: J Eugene Lee, PhD,  Center for Bioanalysis,  Korea Research Institute of Standards and Science, Daejeon 34113,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/94/38/WJG-22-8283.PMC5055859.pdf
"World J Gastroenterol  2016;  22(37): 8283-8293  Av ailable from: URL: http://www.wjgnet.REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8283 8283 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8283-8293  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/94/38/WJG-22-8283.PMC5055859.pdf
com/1007-9327/full/v22/i37/8283.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/38/WJG-22-8283.PMC5055859.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/94/38/WJG-22-8283.PMC5055859.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Joseph K Lim, MD, Associate Professor,  Yale Liver Center, Section of Digestive Diseases, Yale University  School of Medicine, 333 Cedar Street, LMP 1080, New Haven,  CT 06520, United States.",Non-OADS,/arxiv_data1/oa_pdf/cf/50/WJG-22-8294.PMC5055860.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8294 8294 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8294-8303  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/cf/50/WJG-22-8294.PMC5055860.pdf
World J  Gastroenterol  2016; 22(37): 8294-8303  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i37/8294.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i37.8294 INTRODUCTION Hepatocellular carcinoma (HCC) is the fifth most  prevalent cancer and third most common cause of  cancer-related mortality worldwide[1-3].,Non-OADS,/arxiv_data1/oa_pdf/cf/50/WJG-22-8294.PMC5055860.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/cf/50/WJG-22-8294.PMC5055860.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Mario Morino, MD, Professor, Department  of Surgical Sciences,  University of Torino, Corso A. M. Dogliotti,  14, 10126 Torino, Italy.",Non-OADS,/arxiv_data1/oa_pdf/31/1a/WJG-22-8304.PMC5055861.pdf
"Key words:  Conversion; Laparoscopy; Open surgery; MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8304 8304 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8304-8313  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/31/1a/WJG-22-8304.PMC5055861.pdf
"World J  Gastroenterol  2016; 22(37): 8304-8313  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i37/8304.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i37.8304 INTRODUCTION Since its introduction in the early nineties[1], laparo­ scopic resection for colorectal cancer has increasingly  gained popularity[2].",Non-OADS,/arxiv_data1/oa_pdf/31/1a/WJG-22-8304.PMC5055861.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/31/1a/WJG-22-8304.PMC5055861.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Sang Hoon Ahn, MD, PhD,  Department  of Internal Medicine, Yonsei University College of Medicine , 50  Yonsei-ro, Seodaemun-gu, Seoul 03722,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/6b/ad/WJG-22-8314.PMC5055862.pdf
"Key words:  Chronic hepatitis B; Hepatocellular carcinoma;  Development; Prediction modelsMINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8314 8314 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8314-8321  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/6b/ad/WJG-22-8314.PMC5055862.pdf
"World J  Gastroenterol  2016; 22(37): 8314-8321  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i37/8314.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i37.8314 INTRODUCTION Chronic hepatitis B virus (HBV) infection is the main  cause of cirrhosis, hepatic failure, and hepatocellular  carcinoma (HCC) globally[1].",Non-OADS,/arxiv_data1/oa_pdf/6b/ad/WJG-22-8314.PMC5055862.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/6b/ad/WJG-22-8314.PMC5055862.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Juliana E Bajic, BHSc (Hons),  Discipline  of Physiology, Faculty of Health Sciences, School of Medicine,  The University of Adelaide, Frome Road, Adelaide 5005,  Australia.",Non-OADS,/arxiv_data1/oa_pdf/0b/f0/WJG-22-8322.PMC5055863.pdf
"juliana.bajic@adelaide.edu.a u Telephone:  +61-8- 83137591 Fax:  +61-8-83133788 Received:  April 11, 2016 Peer-review started:  April 13, 2016 First decision:  June 20, 2016 Revised:  July 7, 2016 Accepted:  August 8, 2016 Article in press:  August 8, 2016 Published online: October 7, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8322 8322 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8322-8333  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/0b/f0/WJG-22-8322.PMC5055863.pdf
World J Gastroenterol  2016; 22(37): 8322-8333  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i37/8322.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i37.8322 INTRODUCTION Traditional herbal medicines have been used for  centuries in the maintenance and improvement of  health or the treatment of illnesses.,Non-OADS,/arxiv_data1/oa_pdf/0b/f0/WJG-22-8322.PMC5055863.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/0b/f0/WJG-22-8322.PMC5055863.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Rajaraman Eri, DVM, PhD,  School of  Health Sciences, University of Tasmania, Launceston, Churchill  Avenue, Launceston TAS 7250, Australia.",Non-OADS,/arxiv_data1/oa_pdf/c4/2b/WJG-22-8334.PMC5055864.pdf
"rderi@utas.edu.au Telephone:  +61-3-62262999  Received:  June 27, 2016 Peer-review started:  June 28, 2016 First decision:  July 29, 2016 Revised:  August 15, 2016 Accepted:  September 6, 2016   Article in press:  September 6, 2016 Published online: October 7, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8334 8334 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8334-8348  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c4/2b/WJG-22-8334.PMC5055864.pdf
"World J  Gastroenterol  2016; 22(37): 8334-8348  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i37/8334.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i37.8334 INTRODUCTION Ulcerative colitis (UC) is a life-long immune disorder  that presents as a chronic remitting and relapsing  inflammation of the colon, which is also associated with  an increased risk of colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/c4/2b/WJG-22-8334.PMC5055864.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/c4/2b/WJG-22-8334.PMC5055864.pdf
"The  changes were more prominent at sites where gastritis  was severe, but significant ch anges were also observed Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8349 8349 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8349-8360  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/81/ea/WJG-22-8349.PMC5055865.pdf
World J  Gastroenterol  2016; 22(37): 8349­8360  Available from: URL:  http://www.wjgnet.com/1007 ­9327/full/v22/i37/8349.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i37.8349 INTRODUCTION Inflammation of the gastric mucosa is an important  cause of chronic abdominal pain in children.,Non-OADS,/arxiv_data1/oa_pdf/81/ea/WJG-22-8349.PMC5055865.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/81/ea/WJG-22-8349.PMC5055865.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Ingorn Kimkong, Assistant Professor,  Department of Microbiology, Faculty of Science, Kasetsart  University, Bangkok 10900, Thailand.",Non-OADS,/arxiv_data1/oa_pdf/81/cf/WJG-22-8361.PMC5055866.pdf
"fsciiok@ku.ac.th Telephone:  +66-25625555 Fax:  +66-25792081 Received:  May 21, 2016   Peer-review started:  May 23, 2016 First decision:  June 20, 2016 Revised:  July 4, 2016   Accepted:  August 1, 2016   Article in press:  August 1, 2016 Published online: October 7, 2016 Abstract AIM To investigate autophagy-related genes, particularly  ATG12, in apoptosis and cell cycle in hepatitis B virus  (HBV)-associated hepatocellular carcinoma (HCC) and  non-HBV-HCC cell lines.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8361 8361 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8361-8374  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/81/cf/WJG-22-8361.PMC5055866.pdf
World J Gastroenterol  2016; 22(37): 8361-8374  Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i37/8361.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/81/cf/WJG-22-8361.PMC5055866.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/81/cf/WJG-22-8361.PMC5055866.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Hong Shi, MD,  Department of Gastro­ intestinal Endoscopy, Fujian Provincial Cancer Hospital,  Affiliated Cancer Hospital of Fujian Medical University, Fuzhou  350014, Fujian Province, China.",Non-OADS,/arxiv_data1/oa_pdf/75/9a/WJG-22-8375.PMC5055867.pdf
"A gastrostomy was made using a 2-cm Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8375 8375 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8375-8381  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/75/9a/WJG-22-8375.PMC5055867.pdf
World J Gastroenterol  2016;  22(37): 8375 ­8381  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/75/9a/WJG-22-8375.PMC5055867.pdf
com/1007 ­9327/full/v22/i37/8375.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/9a/WJG-22-8375.PMC5055867.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/75/9a/WJG-22-8375.PMC5055867.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Gen Tohda, MD, PhD,  Department of  Gastroenterology, Fukui Kosei Hospital, Shimo-rokujyo 201,  Fukui, Fukui 918-8537, Japan.",Non-OADS,/arxiv_data1/oa_pdf/4c/12/WJG-22-8382.PMC5055868.pdf
"Between the groups,  there was no significant difference in the technical  success rates (95.1% vs 95.2%) or endoscopic Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8382 8382 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8382-8388  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/4c/12/WJG-22-8382.PMC5055868.pdf
World J Gastroenterol  2016;  22(37): 8382-8388  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/4c/12/WJG-22-8382.PMC5055868.pdf
com/1007-9327/full/v22/i37/8382.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/12/WJG-22-8382.PMC5055868.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/4c/12/WJG-22-8382.PMC5055868.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Bhumsuk Keam, MD, PhD, Clinical  Associate Professor,  Department of Internal Medicine, Seoul  National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul  03080, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/34/2c/WJG-22-8389.PMC5055869.pdf
"bhumsuk@snu.ac.kr Telephone:  +82-2-20727215   Fax:  +82-2-7642199 Received:  June 1, 2016 Peer-review started:  June 2, 2016 First decision:  July 12, 2016 Revised:  July 27, 2016 Accepted:  August 23, 2016   Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8389 8389 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8389-8397  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/34/2c/WJG-22-8389.PMC5055869.pdf
wjgnet.com/1007-9327/full/v22/i37/8389.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/2c/WJG-22-8389.PMC5055869.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/34/2c/WJG-22-8389.PMC5055869.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Ri-Xing Bai, MD, PhD,  Department of  General Surgery, Beijing Tian Tan Hospital, Capital Medical  University, 6 Tiantan Xili, Dongcheng District, Beijing 100050,  China.",Non-OADS,/arxiv_data1/oa_pdf/3a/1b/WJG-22-8398.PMC5055870.pdf
"The outcome  parameters of concomitant diseases were significantly  improved too.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8398 8398 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8398-8405  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/3a/1b/WJG-22-8398.PMC5055870.pdf
World J Gastroenterol  2016;  22(37): 8398-8405  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/3a/1b/WJG-22-8398.PMC5055870.pdf
com/1007-9327/full/v22/i37/8398.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/1b/WJG-22-8398.PMC5055870.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/3a/1b/WJG-22-8398.PMC5055870.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Simona Ruta, MD, PhD,  Professor,  Chair of Virology, Emergent Diseases Department, Stefan S.  Nicolau Institute of Virology, 285 Mihai Bravu Bvd, 030304  Bucharest, Romania.",Non-OADS,/arxiv_data1/oa_pdf/21/0a/WJG-22-8406.PMC5055871.pdf
"simona@simonaruta.r o  Telephone:  +40-213242590  Fax:  +40-213242590  Received:  June 24, 2016 Peer-review started:  June 28, 2016 First decision:  July 29, 2016 Revised:  August 9, 2016 Accepted:  August 23, 2016   Article in press:  August 23, 2016 Published online: October 7, 2016 Abstract   AIM To determine whether hepatitis C virus (HCV) core  substitutions play a role in the response to interferon-Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8406 8406 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8406-8413  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/21/0a/WJG-22-8406.PMC5055871.pdf
"Sultana C, Oprişan G, Teleman MD, Dinu S; HepGen 88/2012  Project Team; Oprea C, V oiculescu M, Ruta S. Impact of hepatitis  C virus core mutations on the response to interferon-based  treatment in chronic hepatitis C. World J Gastroenterol  2016;  22(37): 8406-8413  Available from: URL: http://www.wjgnet.",Non-OADS,/arxiv_data1/oa_pdf/21/0a/WJG-22-8406.PMC5055871.pdf
com/1007-9327/full/v22/i37/8406.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/0a/WJG-22-8406.PMC5055871.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/21/0a/WJG-22-8406.PMC5055871.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Gina Brown, Consultant Radiologist,  Professor,  Department of Radiology, Royal Marsden Hospital, Downs Rd, Sutton SM2 5PT,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/3a/96/WJG-22-8414.PMC5055872.pdf
"Data were extracted by two authors  working independently and using pre-defined outcome  measures.SYSTEMATIC REVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8414 8414 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8414-8434  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/3a/96/WJG-22-8414.PMC5055872.pdf
World J Gastroenterol  2016;  22(37): 8414-8434  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/3a/96/WJG-22-8414.PMC5055872.pdf
com/1007-9327/full/v22/i37/8414.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/96/WJG-22-8414.PMC5055872.pdf
Available from: URL: http://www.crd.york.,Non-OADS,/arxiv_data1/oa_pdf/3a/96/WJG-22-8414.PMC5055872.pdf
"Available from: URL:  http://www.doc88.com/p-030414137867.html 11 Deeks JJ , Altman DG, Bradburn MJ.",Non-OADS,/arxiv_data1/oa_pdf/3a/96/WJG-22-8414.PMC5055872.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/3a/96/WJG-22-8414.PMC5055872.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Gyu Yeol Kim, MD, PhD,  Department of  Surgery, Ulsan University Hospital, University of Ulsan College  of Medicine, 877 Bangeojinsunhwando-ro, Dong-gu, Ulsan  44033, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/b1/d5/WJG-22-8435.PMC5055873.pdf
"ataxic gait following total CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8435 8435 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8435-8438  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b1/d5/WJG-22-8435.PMC5055873.pdf
World J Gastroenterol  2016;  22(37): 8435-8438  available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/b1/d5/WJG-22-8435.PMC5055873.pdf
com/1007-9327/full/v22/i37/8435.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/d5/WJG-22-8435.PMC5055873.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/b1/d5/WJG-22-8435.PMC5055873.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Wei-Lin Wang, PhD, MD,  Division  of Hepatobiliary and Pancreatic Surgery, Department of  Surgery, First Affiliated Hospital, School of Medicine, Zhejiang  University, No.",Non-OADS,/arxiv_data1/oa_pdf/e1/cb/WJG-22-8439.PMC5055874.pdf
"Pancreatic CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i37.8439 8439 October 7, 2016 |Volume 22 |Issue 37 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 7; 22(37): 8439-8446  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/e1/cb/WJG-22-8439.PMC5055874.pdf
World J Gastroenterol  2016;  22(37): 8439-8446  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/e1/cb/WJG-22-8439.PMC5055874.pdf
com/1007-9327/full/v22/i37/8439.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/cb/WJG-22-8439.PMC5055874.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   7",Non-OADS,/arxiv_data1/oa_pdf/e1/cb/WJG-22-8439.PMC5055874.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/df/ijcp-09-04-5045.PMC5056011.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/ff/ijcp-09-04-8098.PMC5056015.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/89/ijcp-09-04-5461.PMC5056016.pdf
Available from: http://www.who.int/cancer/detection/ breastcancer/en/index1.html .,Non-OADS,/arxiv_data1/oa_pdf/b9/89/ijcp-09-04-5461.PMC5056016.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/f6/ijcp-09-04-4190.PMC5056017.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/6f/ijcp-09-04-6565.PMC5056018.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/83/ijcp-09-04-4467.PMC5056019.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/24/ijcp-09-04-4404.PMC5056020.pdf
"Any of these states may be the native state – that is, the state relevant to a protein’s biological function (http://www.disprot.org )[2,18] .",Non-OADS,/arxiv_data1/oa_pdf/c7/33/main.PMC5056116.pdf
http://dx.doi.org/10.1016/j.gpb.2012.01.002⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/c7/33/main.PMC5056116.pdf
"Based on the published experimental data on protein disordered regions in their native state, DisProt database (http://www.disprot.org )[22]currently (February, 2011) contains 643 deposited proteins, originating from variousprokaryotic, eukaryotic organisms and their viruses.",OADS,/arxiv_data1/oa_pdf/c7/33/main.PMC5056116.pdf
"They used dataset, consisting of 197 proteins from Protein Data Bank (PDB) ( http://www.pdb.org ), as training data to construct secondary structure predictor.",OADS,/arxiv_data1/oa_pdf/c7/33/main.PMC5056116.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/ j.gpb.2012.01.002 .",OADS,/arxiv_data1/oa_pdf/c7/33/main.PMC5056116.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357We Should Not Forget Lessons Learned from the Woo Suk  Hwang’s Case of Research Misconduct and Bioethics Law  Violation Sung-Tae Hong Editor-in-Chief, Journal of Korean Medical Science  http://dx.doi.org/10.3346/jkms.2016.31.11.1671  • J Korean Med Sci 2016; 31: 1671-1672 On September 28, 2016, the National Academy of Medicine of  Korea (NAMOK, President Namsik Chung) hosted the 7th NA­ MOK Academic Forum at Yonsei University, Seoul.",Non-OADS,/arxiv_data1/oa_pdf/4c/54/jkms-31-1671.PMC5056195.pdf
Hong S-T • Lessons from Woo Suk Hwang’s Case 1672  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1671sis placed on the diversification of financial flows and support  of large bottom­up research groups.,Non-OADS,/arxiv_data1/oa_pdf/4c/54/jkms-31-1671.PMC5056195.pdf
"ORCID  Sung­ Tae Hong http://orcid.org/0000­0002­0300­1944Address for Correspondence: Sung-Tae Hong, MD Editor-in-Chief Journal of Korean Medical Science Department of Parasitology and Tropical Medicine, Seoul National University College of  Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: hst@snu.ac.kr Speakers and participants of the 7th NAMOK Academic Forum, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4c/54/jkms-31-1671.PMC5056195.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Molecular Strain Typing of Mycobacterium tuberculosis : A Review  of Frequently Used Methods Tuberculosis, caused by the bacterium Mycobacterium tuberculosis , remains one of the  most serious global health problems.",Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
"Keywords:  Tuberculosis, Mycobacterium tuberculosis , Molecular Strain Typing Phyu Win Ei,1 Wah Wah Aung,1   Jong Seok Lee,2 Go-Eun Choi,3   and Chulhun L. Chang4 1Advanced Molecular Research Centre, Department  of Medical Research, Yangon, Myanmar;  2International Tuberculosis Research Center,  Changwon, Korea; 3Institute of Convergence   Bio-Health, Dong-A University, Busan, Korea;   4Department of Laboratory Medicine, Pusan  National University Yangsan Hospital, Yangsan,  Korea Received: 15 February 2016 Accepted: 6 August 2016 Address for Correspondence: Chulhun L. Chang, MD Department of Laboratory Medicine, Pusan National University  Yangsan Hospital, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612,  Korea E-mail: cchl@pusan.ac.kr Funding:  This study was supported financially by the Korea  International Co-operation Agency (KOICA) (2015 APP Track  1-1).http://dx.doi.org/10.3346/jkms.2016.31.11.1673  • J Korean Med Sci 2016; 31: 1673-1683 INTRODUCTION Tuberculosis (TB) is one of the most common global health  problems and also one of the world’s deadliest communicable  diseases.",Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
• Methods for Molecular Strain Typing of M. tuberculosis 1674  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1673standard is insertion sequence IS 6110 -based restriction frag - ment length polymorphism (RFLP) analysis (8-10).,Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
"• Methods for Molecular Strain Typing of M. tuberculosis http://jkms.org   1675 http://dx.doi.org/10.3346/jkms.2016.31.11.1673 The IS 6110 -RFLP method is highly discriminatory and repro - ducible, and its profiles are stable over time.",Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
• Methods for Molecular Strain Typing of M. tuberculosis 1676  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1673Each of the spacers produces either a dark band (indicating the  presence of the spacer) or no band (indicating the spacer’s ab - sence).,Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
"An international spoligotyping database, which  can be accessed online (http://www.pasteur-guadeloupe.fr.8081),  describes 1,939 shared types (STs; i.e., spoligotype patterns shared  by two or more isolates) and 3,370 orphan types (i.e., spoligo - type patterns reported for only singleisolates) from a total of  39,295 M. tuberculosis  complex isolates from 122 countries, clas - sified temporarily into 62 clades/lineages.",OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
• Methods for Molecular Strain Typing of M. tuberculosis http://jkms.org   1677 http://dx.doi.org/10.3346/jkms.2016.31.11.1673with specific primers complementary to the flanking regions  followed by gel electrophoresis.,Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
• Methods for Molecular Strain Typing of M. tuberculosis 1678  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1673that also work on non-tuberculous mycobacteria (NTM).,Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
"Bio-informative programs such as CLC Genomics Work - bench (www.clcbio.com/products/clc-main-workbench/), and  UniproUGENE (http://ugene.unipro.ru/) can be used for WGS  data analysis (75).",OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
"• Methods for Molecular Strain Typing of M. tuberculosis http://jkms.org   1679 http://dx.doi.org/10.3346/jkms.2016.31.11.1673culture within one day, and they are expressed in digital format.",Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
"• Methods for Molecular Strain Typing of M. tuberculosis 1680  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1673the spatial distribution of the cases, contact tracing data, and  involvement of multiple source cases (15,75).",Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
ORCID Phyu Win Ei http://orcid.org/0000-0002-2486-3260 Wah Wah Aung http://orcid.org/0000-0002-5780-4961 Jong Seok Lee http://orcid.org/0000-0002-4340-9856 Go-Eun Choi http://orcid.org/0000-0002-6852-907X Chulhun L. Chang http://orcid.org/0000-0001-9117-4919REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
Available at http://www.who.int/tb/publications/global_report/en/ [ac - cessed on 9 September 2016].,Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
• Methods for Molecular Strain Typing of M. tuberculosis http://jkms.org   1681 http://dx.doi.org/10.3346/jkms.2016.31.11.1673sis and Mycobacterium avium complex strains.,Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
• Methods for Molecular Strain Typing of M. tuberculosis 1682  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1673(VNTR) markers for human gene mapping.,Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
• Methods for Molecular Strain Typing of M. tuberculosis http://jkms.org   1683 http://dx.doi.org/10.3346/jkms.2016.31.11.1673culosis  with identical DNA fingerprints.,Non-OADS,/arxiv_data1/oa_pdf/2b/24/jkms-31-1673.PMC5056196.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Ecology of Medical Care in Korea This study aimed to describe the ecology of medical care in Korea.",Non-OADS,/arxiv_data1/oa_pdf/dc/b8/jkms-31-1684.PMC5056197.pdf
"Keywords:  Delivery of Health Care; Primary Health Care; Health Services Research;  Republic of KoreaYong-Soo Kim1 and Yong-jun Choi2,3 1Public Health Policy Institute, Seoul Metropolitan  Government, Seoul, Korea; 2Department of Social  and Preventive Medicine, College of Medicine,  Hallym University, Chuncheon, Korea; 3Health  Services Research Center, Hallym University,  Chuncheon, Korea Received: 12 April 2016 Accepted: 6 August 2016 Address for Correspondence: Yong-jun Choi, MD Department of Social and Preventive Medicine, College of  Medicine and Health Services Research Center, Hallym  University, 1 Hallymdaehak-gil, Chuncheon 24252, Korea E-mail: ychoi@hallym.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.11.1684  • J Korean Med Sci 2016; 31: 1684-1688 INTRODUCTION Reform of the care delivery system is a significant component  of the health policy agenda.",Non-OADS,/arxiv_data1/oa_pdf/dc/b8/jkms-31-1684.PMC5056197.pdf
• Ecology of Medical Care in Korea http://jkms.org   1685 http://dx.doi.org/10.3346/jkms.2016.31.11.1684medical utilization and expenditure during the same year.,Non-OADS,/arxiv_data1/oa_pdf/dc/b8/jkms-31-1684.PMC5056197.pdf
"• Ecology of Medical Care in Korea 1686  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1684lation in 2012), and then multiplied by 1,000 to finally get the  number of those who used each kind of medical care per 1,000  people in an average month (8).",OADS,/arxiv_data1/oa_pdf/dc/b8/jkms-31-1684.PMC5056197.pdf
• Ecology of Medical Care in Korea http://jkms.org   1687 http://dx.doi.org/10.3346/jkms.2016.31.11.1684in primary care with the exception that the Health Insurance  Review and Assessment Service periodically evaluates the qual - ity of hypertension and diabetes treatment.,Non-OADS,/arxiv_data1/oa_pdf/dc/b8/jkms-31-1684.PMC5056197.pdf
• Ecology of Medical Care in Korea 1688  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1684YJ.,Non-OADS,/arxiv_data1/oa_pdf/dc/b8/jkms-31-1684.PMC5056197.pdf
ORCID Yong-Soo Kim http://orcid.org/0000-0002-7486-9089 Yong-jun Choi http://orcid.org/0000-0002-1622-3175 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/b8/jkms-31-1684.PMC5056197.pdf
Avail - able at http://kosis.kr [accessed on 18 March 2016].,Non-OADS,/arxiv_data1/oa_pdf/dc/b8/jkms-31-1684.PMC5056197.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Gender Differences in Sleep Disturbance among Elderly  Koreans: Hallym Aging Study Sleep is an important component in our lives as it is necessary throughout one’s entire life  span.",Non-OADS,/arxiv_data1/oa_pdf/9e/b3/jkms-31-1689.PMC5056198.pdf
"Received: 23 February 2016 Accepted: 23 July 2016 Address for Correspondence: Dong-Hyun Kim, MD Department of Social and Preventive Medicine, Hallym  University College of Medicine, 39 Hallymdaehak-gil,  Chuncheon 24252, Korea E-mail: dhkims@hallym.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.11.1689  • J Korean Med Sci 2016; 31: 1689-1695 INTRODUCTION Sleep is a complex amalgam of physiologic and behavioral pro - cesses.",Non-OADS,/arxiv_data1/oa_pdf/9e/b3/jkms-31-1689.PMC5056198.pdf
"• Gender Differences in Sleep Disturbance among Elderly Koreans 1690  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1689which is a population-based prospective cohort study among  45 years and older in Chuncheon, a small city of Korea.",Non-OADS,/arxiv_data1/oa_pdf/9e/b3/jkms-31-1689.PMC5056198.pdf
"• Gender Differences in Sleep Disturbance among Elderly Koreans http://jkms.org   1691 http://dx.doi.org/10.3346/jkms.2016.31.11.1689tract (LUT) symptoms (incomplete emptying, frequency, inter - mittency, urgency, weak stream, straining and nocturia) and  one question for quality of life (QoL).",Non-OADS,/arxiv_data1/oa_pdf/9e/b3/jkms-31-1689.PMC5056198.pdf
• Gender Differences in Sleep Disturbance among Elderly Koreans 1692  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1689Table 2.,Non-OADS,/arxiv_data1/oa_pdf/9e/b3/jkms-31-1689.PMC5056198.pdf
• Gender Differences in Sleep Disturbance among Elderly Koreans http://jkms.org   1693 http://dx.doi.org/10.3346/jkms.2016.31.11.1689the contribution of each single variable after age adjustment for  sleep disturbance.,OADS,/arxiv_data1/oa_pdf/9e/b3/jkms-31-1689.PMC5056198.pdf
• Gender Differences in Sleep Disturbance among Elderly Koreans 1694  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1689to exercise than men.,Non-OADS,/arxiv_data1/oa_pdf/9e/b3/jkms-31-1689.PMC5056198.pdf
Final approval: all authors.ORCID Shan-Ai Quan http://orcid.org/0000-0002-1073-1697 Yong-Chun Li http://orcid.org/0000-0001-6626-7582 Wen-Jie Li http://orcid.org/0000-0002-8927-6518 Yan Li http://orcid.org/0000-0002-9335-1322 Jin-Young Jeong http://orcid.org/0000-0002-2381-1135 Dong-Hyun Kim http://orcid.org/0000-0003-3352-5375 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/b3/jkms-31-1689.PMC5056198.pdf
• Gender Differences in Sleep Disturbance among Elderly Koreans http://jkms.org   1695 http://dx.doi.org/10.3346/jkms.2016.31.11.168916.,Non-OADS,/arxiv_data1/oa_pdf/9e/b3/jkms-31-1689.PMC5056198.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Facing Complaining Customer and Suppressed Emotion at  Worksite Related to Sleep Disturbance in Korea This study aimed to investigate the effect of facing complaining customer and suppressed  emotion at worksite on sleep disturbance among working population.",Non-OADS,/arxiv_data1/oa_pdf/b4/59/jkms-31-1696.PMC5056199.pdf
"Keywords:  Stress; Workplace; Emotions; Sleep Disorder; Dyssomnias; Occupational  Exposure; KoreaSung-Shil Lim,1 Wanhyung Lee,2,3,4  Kwanyoung Hong,5 Dayee Jeung,6,7   Sei-Jin Chang,6,7 and Jin-Ha Yoon2,3,8 1Severance Hospital, Yonsei University Health  System, Seoul, Korea; 2The Institute for Occupational  Health, Yonsei University College of Medicine, Seoul,  Korea; 3Graduate School of Public Health, Yonsei  University College of Medicine, Seoul, Korea; 4Incheon Worker’s Health Center, Incheon, Korea; 5Department of Anesthesiology and Pain Medicine,  Samsung Medical Center, Seoul, Korea; 6Institute Occupational and Environmental  Medicine, Yonsei University Wonju College of  Medicine, Wonju, Korea; 7Department of Preventive  Medicine, Yonsei University Wonju College of  Medicine, Wonju, Korea; 8Department of Preventive  Medicine, Yonsei University College of Medicine,  Seoul, Korea Received: 15 March 2016 Accepted: 12 August 2016 Address for Correspondence: Jin-Ha Yoon, MD The Institute for Occupational Health, Yonsei University College  of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea E-mail: flyinyou@gmail.comhttp://dx.doi.org/10.3346/jkms.2016.31.11.1696  • J Korean Med Sci 2016; 31: 1696-1702 INTRODUCTION In recent years, there has been increasing interest in emotional  labour because of the shift of the economy from the manufac - turing to the service sector.",Non-OADS,/arxiv_data1/oa_pdf/b4/59/jkms-31-1696.PMC5056199.pdf
"The service for customer industry  has accounted for increasingly large proportions of total indus - try across the world; it accounted for 70.2% of world GDP in  2012, 59.3% of GDP in the Republic of Korea, 64% in the East  Asia and Pacific area, 73% in Europe and Central Asia, 43% in  the Middle East and North Africa, and 63% in Latin America  and the Caribbean (The World Bank 2013, data available at  http://data.worldbank.org/indicator/NV .SRV .TETC.ZS).",OADS,/arxiv_data1/oa_pdf/b4/59/jkms-31-1696.PMC5056199.pdf
• Emotional Demand at Workplace and Sleep Disturbance http://jkms.org   1697 http://dx.doi.org/10.3346/jkms.2016.31.11.1696 Insomnia can cause various psychiatric and physical health  problems.,Non-OADS,/arxiv_data1/oa_pdf/b4/59/jkms-31-1696.PMC5056199.pdf
• Emotional Demand at Workplace and Sleep Disturbance 1698  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1696Emotional demand We used two questions to investigate the extent of the emotion - al demands of individuals’ workplace.,Non-OADS,/arxiv_data1/oa_pdf/b4/59/jkms-31-1696.PMC5056199.pdf
"• Emotional Demand at Workplace and Sleep Disturbance http://jkms.org   1699 http://dx.doi.org/10.3346/jkms.2016.31.11.1696OR, 1.45; 95% CI, 0.98-2.04; OR, 1.48; 95% CI 0.98-2.23, respec - tively; Always: OR, 5.46; 95% CI, 3.43-8.68; OR, 5.59; 95% CI, 3.30- 9.46, respectively).",Non-OADS,/arxiv_data1/oa_pdf/b4/59/jkms-31-1696.PMC5056199.pdf
"• Emotional Demand at Workplace and Sleep Disturbance 1700  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1696ing complaining customers and 2) suppressing emotions, and  their effect on sleep disturbance.",Non-OADS,/arxiv_data1/oa_pdf/b4/59/jkms-31-1696.PMC5056199.pdf
"• Emotional Demand at Workplace and Sleep Disturbance http://jkms.org   1701 http://dx.doi.org/10.3346/jkms.2016.31.11.1696and sympathetic nervous system, and thereby causing sleep  disturbances, especially insomnia.",Non-OADS,/arxiv_data1/oa_pdf/b4/59/jkms-31-1696.PMC5056199.pdf
ORCID Sung-Shil Lim http://orcid.org/0000-0001-6733-7933 Wanhyung Lee http://orcid.org/0000-0001-6408-7668 Kwanyoung Hong http://orcid.org/0000-0001-6213-1848 Dayee Jeung http://orcid.org/0000-0003-4730-8814 Sei-Jin Chang http://orcid.org/0000-0001-9347-3592 Jin-Ha Yoon http://orcid.org/0000-0003-4198-2955 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b4/59/jkms-31-1696.PMC5056199.pdf
• Emotional Demand at Workplace and Sleep Disturbance 1702  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.16966.,Non-OADS,/arxiv_data1/oa_pdf/b4/59/jkms-31-1696.PMC5056199.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Public Awareness of Stroke and Its Predicting Factors in Korea: a  National Public Telephone Survey, 2012 and 2014 The aim of this study was to investigate time trends in the public awareness of stroke and  its predicting factors.",Non-OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
"Keywords:  Public; Awareness; Stroke; Warning SignsGyung-Jae Oh,1 Jiyoung Moon,2   Yu-Mi Lee,3 Hyeung-Keun Park,4   Ki Soo Park,5 Yong-Woon Yun,6   Gilwon Kang,7 Byoung-Gwon Kim,8   Jae-Hee Seo,9 Heeyoung Lee,10   Won Kyung Lee,11 Kun Sei Lee,12   Hee-Sook Kim,13 and Young-Hoon Lee1,14 1Jeonbuk Regional Cardiocerebrovascular Center,  Wonkwang University Hospital, Iksan, Korea; 2Gangwon Regional Cardiocerebrovascular Disease  Center, Kangwon National University Hospital,  Chuncheon, Korea; 3Daegu-Gyeongbuk Regional  Cardiocerebrovascular Disease Center, Kyungpook  National University Hospital, Daegu, Korea; 4Jeju Regional Cardiocerebrovascular Disease Center,  Jeju National University Hospital, Jeju, Korea; 5Gyeongnam Regional Cardiocerebrovascular  Disease Center, Gyeongsang National University  Hospital, Jinju, Korea; 6Gwangju-Jeonnam Regional  Cardiocerebrovascular Disease Center, Chonnam  National University Hospital, Gwangju, Korea; 7Chungbuk Regional Cardiocerebrovascular Disease  Center, Chungbuk National University Hospital,  Cheongju, Korea; 8Busan-Ulsan Regional  Cardiocerebrovascular Disease Center, Dong-A  University Hospital, Busan, Korea; 9Daejeon- Chungnam Regional Cardiocerebrovascular Disease  Center, Chungnam National University Hospital,  Daejeon, Korea; 10Gyeonggi Regional  Cardiocerebrovascular Disease Center, Seoul  National University Bundang Hospital, Seongnam,  Korea; 11Incheon Regional Cardiocerebrovascular  Disease Center, Inha University Hospital, Incheon,  Korea; 12Department of Preventive Medicine, School  of Medicine, Konkuk University, Seoul, Korea; 13Division of Chronic Disease Control, Korea Centers  for Disease Control and Prevention, Cheongju,  Korea; 14Department of Preventive Medicine &  Institute of Wonkwang Medical Science, Wonkwang  University School of Medicine, Iksan, Korea Received: 6 May 2016 Accepted: 13 August 2016 Address for Correspondence: Young-Hoon Lee, MD Department of Preventive Medicine & Institute of Wonkwang  Medical Science, Wonkwang University School of Medicine,   460 Iksan-daero, Iksan 54538, Korea E-mail: lyh8275@hanmail.nethttp://dx.doi.org/10.3346/jkms.2016.31.11.1703  • J Korean Med Sci 2016; 31: 1703-1710 INTRODUCTION Stroke is a significant public health issue in Korea; indeed, stroke is the second leading  cause of death after cancer (1).",Non-OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
"• Public Awareness of Stroke in Korea 1704  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1703er, these studies were conducted in limited regions or popula - tions (13-15).",Non-OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
• Public Awareness of Stroke in Korea http://jkms.org   1705 http://dx.doi.org/10.3346/jkms.2016.31.11.1703RESULTS General characteristics of the respondents The respondents’ general characteristics are shown in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
"• Public Awareness of Stroke in Korea 1706  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1703Knowledge of stroke In 2012 and 2014, the proportions of respondents aware of stroke  warning signs were highest for sudden difficulty speaking or  understanding speech (80.9% and 86.4%), followed, in order of  magnitude, by sudden dizziness (70.3% and 75.3%), sudden  numbness or weakness (70.5% and 71.4%), sudden visual im - pairment (56.8% and 62.0%), and sudden severe headache (52.3%  and 57.4%).",Non-OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
• Public Awareness of Stroke in Korea http://jkms.org   1707 http://dx.doi.org/10.3346/jkms.2016.31.11.1703material.,Non-OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
• Public Awareness of Stroke in Korea 1708  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1703Table 4.,Non-OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
• Public Awareness of Stroke in Korea http://jkms.org   1709 http://dx.doi.org/10.3346/jkms.2016.31.11.1703ness of the need for prompt treatment.,Non-OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
ORCID Gyung-Jae Oh http://orcid.org/0000-0001-9869-1564 Jiyoung Moon http://orcid.org/0000-0001-9503-020X Yu-Mi Lee http://orcid.org/0000-0003-3206-7894 Hyeung-Keun Park http://orcid.org/0000-0001-7502-5710 Ki Soo Park http://orcid.org/0000-0001-5571-3639 Yong-Woon Yun http://orcid.org/0000-0001-6715-1768 Gilwon Kang http://orcid.org/0000-0003-0222-1870 Byoung-Gwon Kim http://orcid.org/0000-0002-1762-6320 Jae-Hee Seo http://orcid.org/0000-0002-9166-9986 Heeyoung Lee http://orcid.org/0000-0003-4830-9851,Non-OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
• Public Awareness of Stroke in Korea 1710  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1703Won Kyung Lee http://orcid.org/0000-0002-6014-8854 Kun Sei Lee http://orcid.org/0000-0003-1552-6761 Hee-Sook Kim http://orcid.org/0000-0002-4037-6227 Young-Hoon Lee http://orcid.org/0000-0003-1367-025X   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
Available at  http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=1012  [accessed on 5 August 2015].,OADS,/arxiv_data1/oa_pdf/7f/c0/jkms-31-1703.PMC5056200.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Risk Factors for the Adverse Events after Conversion from Twice- Daily to Once-Daily Tacrolimus in Stable Liver Transplantation  Patients Despite the therapeutic equivalence between twice-daily and once-daily tacrolimus,  patient safety after conversion is still a concern.",Non-OADS,/arxiv_data1/oa_pdf/86/fe/jkms-31-1711.PMC5056201.pdf
"Keywords:  Once-daily Tacrolimus; Twice-daily Tacrolimus; Conversion; Liver  Transplantation; Adverse EventsSuk-Won Suh,1,2 Kwang-Woong Lee,1  Jaehong Jeong,1 Hyeyoung Kim,1   Nam-Joon Yi,1 and Kyung-Suk Suh1 1Department of Surgery, College of Medicine, Seoul  National University, Seoul, Korea; 2Department of  Surgery, College of Medicine, Chung-Ang University,  Seoul, Korea Received: 1 May 2016 Accepted: 19 July 2016 Address for Correspondence: Kwang-Woong Lee, MD Department of Surgery, College of Medicine, Seoul National  University, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: Kwleegs@gmail.comhttp://dx.doi.org/10.3346/jkms.2016.31.11.1711  • J Korean Med Sci 2016; 31: 1711-1716 INTRODUCTION Since effective agents are available for liver transplantation (LT),  medication adherence has become an important factor of suc - cessful treatment outcomes.",Non-OADS,/arxiv_data1/oa_pdf/86/fe/jkms-31-1711.PMC5056201.pdf
"• Adverse Events after Tacrolimus Conversion in Liver Transplants 1712  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1711creatinine level, < 2.0 mg/dL) and liver function (serum aspar - tate aminotransferase and alanine aminotransferase levels were  within normal range).",Non-OADS,/arxiv_data1/oa_pdf/86/fe/jkms-31-1711.PMC5056201.pdf
"• Adverse Events after Tacrolimus Conversion in Liver Transplants http://jkms.org   1713 http://dx.doi.org/10.3346/jkms.2016.31.11.1711dosage ratio, the group that was converted to a < 1 dosage ratio  (11.5%) had a larger proportion of patients with a decreased  (48.0%) tacrolimus serum trough level that consequently re - quired a dose adjustment.",Non-OADS,/arxiv_data1/oa_pdf/86/fe/jkms-31-1711.PMC5056201.pdf
"• Adverse Events after Tacrolimus Conversion in Liver Transplants 1714  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1711tronic monitoring, and the average percentage of missed doses  was increased more in the evening than in the day in the twice- daily group.",Non-OADS,/arxiv_data1/oa_pdf/86/fe/jkms-31-1711.PMC5056201.pdf
• Adverse Events after Tacrolimus Conversion in Liver Transplants http://jkms.org   1715 http://dx.doi.org/10.3346/jkms.2016.31.11.1711single immunosuppressant.,Non-OADS,/arxiv_data1/oa_pdf/86/fe/jkms-31-1711.PMC5056201.pdf
ORCID Suk-Won Suh http://orcid.org/0000-0001-6111-9601 Kwang-Woong Lee http://orcid.org/0000-0001-6412-1926 Jaehong Jeong http://orcid.org/0000-0002-7749-039X Hyeyoung Kim http://orcid.org/0000-0002-3157-8214 Nam-Joon Yi http://orcid.org/0000-0002-5467-425X Kyung-Suk Suh http://orcid.org/0000-0002-9535-7349 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/86/fe/jkms-31-1711.PMC5056201.pdf
• Adverse Events after Tacrolimus Conversion in Liver Transplants 1716  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1711and outcome.,Non-OADS,/arxiv_data1/oa_pdf/86/fe/jkms-31-1711.PMC5056201.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Progression and Cytokine Profiles of Middle East  Respiratory Syndrome Coronavirus Infection Clinical progression over time and cytokine profiles have not been well defined in patients  with Middle East respiratory syndrome coronavirus (MERS-CoV) infection.",Non-OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
"Received: 21 April 2016 Accepted: 12 June 2016 Address for Correspondence: Myoung-don Oh, MD Department of Internal Medicine, Seoul National University  College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080,  Korea E-mail: mdohmd@snu.ac.kr Funding:  This work was supported by a grant from the Korean  Healthcare Technology R &D Project through the Korea Health  Industry Development Institute (KHIDI), funded by the Ministry  of Health and Welfare, Republic of Korea (grant number:  HI15C3227).http://dx.doi.org/10.3346/jkms.2016.31.11.1717  • J Korean Med Sci 2016; 31: 1717-1725 INTRODUCTION Middle East Respiratory Syndrome coronavirus (MERS-CoV)  infection is a highly lethal respiratory disease that has recently  emerged in the Middle East region.",Non-OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
"• Clinical Progressions and Cytokine Profiles in MERS 1718  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1717MATERIALS AND METHODS Patient population During the outbreak of MERS-CoV in Korea, all laboratory-con - firmed cases were admitted to the government-designated hos - pitals regardless of their severity of illness.",Non-OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
"• Clinical Progressions and Cytokine Profiles in MERS http://jkms.org   1719 http://dx.doi.org/10.3346/jkms.2016.31.11.1717analyses were performed with IBM SPSS Statistics software 22.0  (SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
• Clinical Progressions and Cytokine Profiles in MERS 1720  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1717gistration number 1506-093-681).,Non-OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
• Clinical Progressions and Cytokine Profiles in MERS http://jkms.org   1721 http://dx.doi.org/10.3346/jkms.2016.31.11.17171D and 1E).,Non-OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
• Clinical Progressions and Cytokine Profiles in MERS 1722  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1717Fig.,Non-OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
• Clinical Progressions and Cytokine Profiles in MERS http://jkms.org   1723 http://dx.doi.org/10.3346/jkms.2016.31.11.1717gene 1 (RIG-1) and melanoma differentiation-associated pro - tein 5 (MDA-5) in response to MERS-CoV infection (21).,Non-OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
• Clinical Progressions and Cytokine Profiles in MERS 1724  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1717ORCID Eu Suk Kim http://orcid.org/0000-0001-7132-0157 Pyoeng Gyun Choe http://orcid.org/0000-0001-6794-7918 Wan Beom Park http://orcid.org/0000-0003-0022-9625 Hong Sang Oh http://orcid.org/0000-0002-4535-6305 Eun Jung Kim http://orcid.org/0000-0003-3302-7827 Eun Young Nam http://orcid.org/0000-0003-2488-3226 Sun Hee Na http://orcid.org/0000-0002-9605-7807 Moonsuk Kim http://orcid.org/0000-0001-8640-939X Kyoung-Ho Song http://orcid.org/0000-0002-4517-3840 Ji Hwan Bang http://orcid.org/0000-0002-7628-1182 Sang Won Park http://orcid.org/0000-0002-0550-1897 Hong Bin Kim http://orcid.org/0000-0001-6262-372X Nam Joong Kim http://orcid.org/0000-0001-6793-9467 Myoung-don Oh http://orcid.org/0000-0002-2344-7695 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
Available at http://www.who.int/csr/don/14-april-2016-mers- saudi-arabia/en/ [updated on 14 April 2016; accessed on 20 April 2016].,OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
Available at http://who.int/csr/disease/coronavi - rus_infections/risk-assessment-19june2015/en/ [updated on 19 June  2015; accessed on 17 September 2015].,Non-OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
• Clinical Progressions and Cytokine Profiles in MERS http://jkms.org   1725 http://dx.doi.org/10.3346/jkms.2016.31.11.171725.,Non-OADS,/arxiv_data1/oa_pdf/d8/9b/jkms-31-1717.PMC5056202.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Neurocognitive Function and Health-Related Quality of Life in  Pediatric Korean Survivors of Medulloblastoma The neurocognitive function and quality of life of 58 Korean survivors of childhood  medulloblastoma were assessed after surgery, cranial radiation and chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
"0520300).http://dx.doi.org/10.3346/jkms.2016.31.11.1726  • J Korean Med Sci 2016; 31: 1726-1734 INTRODUCTION Half of all pediatric brain tumors are located in the posterior  fossa, and medulloblastomas account for about 50% of posteri - or fossa tumors (1).",Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
• Neuropsychological Outcome of Survivors of Childhood Medulloblastoma http://jkms.org   1727 http://dx.doi.org/10.3346/jkms.2016.31.11.1726 Another limitation of the previous studies is that the health- related quality of life (HRQOL) of the survivors of brain tumors  was assessed with QOL assessment tools that were not specific  to brain tumors.,Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
"• Neuropsychological Outcome of Survivors of Childhood Medulloblastoma 1728  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1726score was determined by the amount of time required to com - plete the task, and higher scores indicated poor performance.",Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
• Neuropsychological Outcome of Survivors of Childhood Medulloblastoma http://jkms.org   1729 http://dx.doi.org/10.3346/jkms.2016.31.11.1726compared with a mean of 10.,Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
• Neuropsychological Outcome of Survivors of Childhood Medulloblastoma 1730  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1726Table 4.,Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
• Neuropsychological Outcome of Survivors of Childhood Medulloblastoma http://jkms.org   1731 http://dx.doi.org/10.3346/jkms.2016.31.11.17260.001).,Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
"• Neuropsychological Outcome of Survivors of Childhood Medulloblastoma 1732  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1726Health related quality of life In the HRQOL assessment, the PedsTotal scores were 100.59 in  the patients diagnosed under the age of 8 and 90.71 in the pa - tients diagnosed over 8 (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
• Neuropsychological Outcome of Survivors of Childhood Medulloblastoma http://jkms.org   1733 http://dx.doi.org/10.3346/jkms.2016.31.11.1726the mean recognition task scores because we did not have a rec - ognition task in the RKMT.,Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
• Neuropsychological Outcome of Survivors of Childhood Medulloblastoma 1734  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1726uscript: Kim H. Approval for the final manuscript: all authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
ORCID Hee Jung Yoo http://orcid.org/0000-0001-8802-0337 Hyery Kim http://orcid.org/0000-0003-2852-6832 Hyeon Jin Park http://orcid.org/0000-0002-9557-3412 Dong-Seok Kim http://orcid.org/0000-0001-8210-170X Young-Shin Ra http://orcid.org/0000-0002-3718-6182 Hee Young Shin http://orcid.org/0000-0003-2091-1947 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/fd/ae/jkms-31-1726.PMC5056203.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Different Effect of VEGF Polymorphisms on the Prognosis of  Non-Small Cell Lung Cancer according to Tumor Histology Vascular endothelial growth factor (VEGF) contributes to tumor angiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/ac/1b/jkms-31-1735.PMC5056204.pdf
"Received: 15 March 2016 Accepted: 23 July 2016 Address for Correspondence: Jae Yong Park, MD Lung Cancer Center, Kyungpook National University Medical  Center, 807 Hoguk-ro, Buk-gu, Daegu 41404, Korea E-mail: jaeyong@knu.ac.kr Funding:  This study was supported by the R&D program of  MKE/KEIT (10040393, Development and commercialization of  molecular diagnostic technologies for lung cancer through  clinical validation).http://dx.doi.org/10.3346/jkms.2016.31.11.1735  • J Korean Med Sci 2016; 31: 1735-1741 INTRODUCTION Lung cancer is the most common cause of cancer-related mortality worldwide (1).",Non-OADS,/arxiv_data1/oa_pdf/ac/1b/jkms-31-1735.PMC5056204.pdf
"• Different Prognostic Effect of  VEGF  Polymorphisms in NSCLC 1736  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1735 Hypoxia is a common feature in most of the solid tumors in - cluding lung cancer, and hypoxic condition is the most impor - tant stimulating factor for the expression of VEGF (17-19).",Non-OADS,/arxiv_data1/oa_pdf/ac/1b/jkms-31-1735.PMC5056204.pdf
"• Different Prognostic Effect of VEGF Polymorphisms in NSCLC http://jkms.org   1737 http://dx.doi.org/10.3346/jkms.2016.31.11.1735DISCUSSION In the present study, we evaluated the association between po - tentially functional VEGF  polymorphisms (rs833061T>C, rs2010  963G>C, and rs3025039C>T) and survival outcomes of NSCLC patients after surgery in a Korean population.",Non-OADS,/arxiv_data1/oa_pdf/ac/1b/jkms-31-1735.PMC5056204.pdf
• Different Prognostic Effect of  VEGF  Polymorphisms in NSCLC 1738  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1735Table 3.,Non-OADS,/arxiv_data1/oa_pdf/ac/1b/jkms-31-1735.PMC5056204.pdf
"• Different Prognostic Effect of VEGF Polymorphisms in NSCLC http://jkms.org   1739 http://dx.doi.org/10.3346/jkms.2016.31.11.1735worse OS and DFS in AC, whereas it was associated with better  OS and DFS in SCC.",Non-OADS,/arxiv_data1/oa_pdf/ac/1b/jkms-31-1735.PMC5056204.pdf
ORCID Soyeon Lee http://orcid.org/0000-0002-1868-7715 Hyo-Gyoung Kang http://orcid.org/0000-0003-0600-227X Jin Eun Choi http://orcid.org/0000-0001-7833-2257 Jang Hyuck Lee http://orcid.org/0000-0001-5537-3013,Non-OADS,/arxiv_data1/oa_pdf/ac/1b/jkms-31-1735.PMC5056204.pdf
• Different Prognostic Effect of  VEGF  Polymorphisms in NSCLC 1740  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1735Hyo Jung Kang http://orcid.org/0000-0002-0011-2542 Sun Ah Baek http://orcid.org/0000-0002-8088-9764 Eungbae Lee http://orcid.org/0000-0002-1727-5380 Yangki Seok http://orcid.org/0000-0001-8212-109X Won Kee Lee http://orcid.org/0000-0003-4217-5792 Shin Yup Lee http://orcid.org/0000-0002-2121-7335 Seung Soo Yoo http://orcid.org/0000-0002-7309-9254 Jaehee Lee http://orcid.org/0000-0001-8111-7320 Seung-Ick Cha http://orcid.org/0000-0002-7246-0909 Chang Ho Kim http://orcid.org/0000-0002-1550-5752 Sukki Cho http://orcid.org/0000-0002-9309-8865 Jae Yong Park http://orcid.org/0000-0001-7993-4495  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ac/1b/jkms-31-1735.PMC5056204.pdf
• Different Prognostic Effect of VEGF Polymorphisms in NSCLC http://jkms.org   1741 http://dx.doi.org/10.3346/jkms.2016.31.11.173528.,Non-OADS,/arxiv_data1/oa_pdf/ac/1b/jkms-31-1735.PMC5056204.pdf
Available at http://www.nccn.org/professionals/physician_gls/ pdf/nscl.pdf [accessed on May 2015].,Non-OADS,/arxiv_data1/oa_pdf/ac/1b/jkms-31-1735.PMC5056204.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparison of Dosimetric Performance among Commercial  Quality Assurance Systems for Verifying Pretreatment Plans of  Stereotactic Body Radiotherapy Using Flattening-Filter-Free  Beams The purpose of this study was to compare the performance of different commercial quality  assurance (QA) systems for the pretreatment verification plan of stereotactic body  radiotherapy (SBRT) with volumetric arc therapy (VMAT) technique using a flattening-filter- free beam.",Non-OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
"Received: 22 March 2016 Accepted: 19 July 2016 Address for Correspondence: Tae Suk Suh, PhD Department of Biomedical Engineering, College of Medicine,   The Catholic University of Korea, 222 Banpo-daero, Seocho-gu,  Seoul 06591, Korea E-mail: suhsanta@catholic.ac.kr Funding:  This research was supported by a grant of the Korea  Health Technology R &D Project through the Korea Health  Industry Development Institute (KHIDI), funded by the Ministry  of Health and Welfare, Republic of Korea (Grant Number:  HI15C0638) and by a grant (2014R1A2A1A10050270) from the  Mid-career Researcher Program through the National Research  Foundation of Korea funded by the Ministry of Science, ICT &  Future Planning.http://dx.doi.org/10.3346/jkms.2016.31.11.1742  • J Korean Med Sci 2016; 31: 1742-1748 INTRODUCTION Intensity-modulated radiation therapy (IMRT) and volumetric- modulated arc therapy (VMAT) treatments utilizing a linear ac - celerator (LINAC) with dynamic multileaf collimators (MLCs)  are extremely complex for both treatment planning and deliv - ery.",Non-OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
• Gamma Index Comparison of Three QA Systems http://jkms.org   1743 http://dx.doi.org/10.3346/jkms.2016.31.11.1742outside the target field (9-12).,OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
"• Gamma Index Comparison of Three QA Systems 1744  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1742I’mRT MatriXX array using MultiCube phantom The ion chamber array (I’mRT MatriXX array; IBA dosimetry,  GmbH, Schwarzenbruck, Germany) system contained 1,024  parallel-plate ion chambers arranged in a 32 × 32 grid with 7.5  mm of separation between the centers of the adjacent cham - bers.",OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
• Gamma Index Comparison of Three QA Systems http://jkms.org   1745 http://dx.doi.org/10.3346/jkms.2016.31.11.1742Fig.,OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
• Gamma Index Comparison of Three QA Systems 1746  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1742Table 4.,Non-OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
"• Gamma Index Comparison of Three QA Systems http://jkms.org   1747 http://dx.doi.org/10.3346/jkms.2016.31.11.1742butions were more sensitive to MLC errors than to collimator,  couch, or gantry errors.",OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
Manuscript approval: all authors.ORCID Jin-Beom Chung http://orcid.org/0000-0003-2668-3906 Sang-Won Kang http://orcid.org/0000-0002-6376-7757 Keun-Yong Eom http://orcid.org/0000-0003-3650-1133 Changhoon Song http://orcid.org/0000-0002-0714-8775 Kyoung-Sik Choi http://orcid.org/0000-0001-6247-4314 Tae Suk Suh http://orcid.org/0000-0002-3057-1627 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
• Gamma Index Comparison of Three QA Systems 1748  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1742Med Phys  2015; 16: 5728.,OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
Available at http://www.iba-dosimetry.com [accessed  on 15 June 2015].,Non-OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
Available at http://www.iba-dosimetry [accessed  on 15 June 2015].,Non-OADS,/arxiv_data1/oa_pdf/a3/c0/jkms-31-1742.PMC5056205.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Natural Course of Adult Ebstein Anomaly When Treated  according to Current Recommendation The objectives of this study were to assess the clinical outcomes of adults with Ebstein  Anomaly (EA) according to their treatment modalities.",Non-OADS,/arxiv_data1/oa_pdf/01/d4/jkms-31-1749.PMC5056206.pdf
"Keywords:  Ebstein Anomaly; Clinical Outcome; Treatment; AdultsHyung Yoon Kim,1,4 Shin Yi Jang,1,4   Ju Ryoung Moon,1,2,4 Eun Kyoung Kim,1,4  Sung-A Chang,1,4 Jinyoung Song,2,4   June Huh,2,4 I-Seok Kang,2,4   Ji-Hyuk Yang,3,4 Tae-Gook Jun,3,4   and Seung Woo Park1,4 1Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul, Korea; 2Department of Pediatrics, Samsung  Medical Center, Sungkyunkwan University School of  Medicine, Seoul, Korea; 3Department of Thoracic  and Cardiovascular Surgery, Samsung Medical  Center, Sungkyunkwan University School of  Medicine, Seoul, Korea; 4Heart Vascular Stroke  Institute, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul, Korea Received: 26 November 2015 Accepted: 16 July 2016 Address for Correspondence: Seung Woo Park, MD Department of Medicine, Heart Vascular Stroke Institute,  Samsung Medical Center, Sungkyunkwan University School of  Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea E-mail: parksmc@gmail.comhttp://dx.doi.org/10.3346/jkms.2016.31.11.1749  • J Korean Med Sci 2016; 31: 1749-1754 INTRODUCTION Ebstein anomaly (EA) is a rare congenital heart malformation  characterized by downward displacement of tricuspid valve  leaflets into the right ventricle.",Non-OADS,/arxiv_data1/oa_pdf/01/d4/jkms-31-1749.PMC5056206.pdf
• Long-term Outcome of Adult EA 1750  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1749arteries were excluded.,Non-OADS,/arxiv_data1/oa_pdf/01/d4/jkms-31-1749.PMC5056206.pdf
"• Long-term Outcome of Adult EA http://jkms.org   1751 http://dx.doi.org/10.3346/jkms.2016.31.11.1749(CI, 0.19-4.57), respectively (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/01/d4/jkms-31-1749.PMC5056206.pdf
• Long-term Outcome of Adult EA 1752  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1749Table 2.,Non-OADS,/arxiv_data1/oa_pdf/01/d4/jkms-31-1749.PMC5056206.pdf
• Long-term Outcome of Adult EA http://jkms.org   1753 http://dx.doi.org/10.3346/jkms.2016.31.11.1749other studies because we included significant arrhythmic events  in MACCE.,Non-OADS,/arxiv_data1/oa_pdf/01/d4/jkms-31-1749.PMC5056206.pdf
ORCID Hyung Yoon Kim http://orcid.org/0000-0002-0692-5640 Shin Yi Jang http://orcid.org/0000-0003-4319-7029 Ju Ryoung Moon http://orcid.org/0000-0002-4285-0295 Eun Kyoung Kim http://orcid.org/0000-0002-7653-3503 Sung-A Chang http://orcid.org/0000-0001-5124-605X Jinyoung Song http://orcid.org/0000-0002-9686-7228,Non-OADS,/arxiv_data1/oa_pdf/01/d4/jkms-31-1749.PMC5056206.pdf
• Long-term Outcome of Adult EA 1754  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1749June Huh http://orcid.org/0000-0003-4523-9632 I-Seok Kang http://orcid.org/0000-0003-4264-0826 Ji-Hyuk Yang http://orcid.org/0000-0002-7349-6778 Tae-Gook Jun http://orcid.org/0000-0002-5161-4665 Seung Woo Park http://orcid.org/0000-0002-2941-515X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/01/d4/jkms-31-1749.PMC5056206.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Characteristics and Treatment Outcomes of Primary  Pulmonary Artery Sarcoma in Korea Pulmonary artery sarcomas (PAS) are rare malignant neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/78/b8/jkms-31-1755.PMC5056207.pdf
"Keywords:  Diagnosis; Pulmonary Artery Sarcoma; Pulmonary Hypertension; Survival;  TreatmentYunkyoung Lee,¹ Hyun Jung Kim,²  Heeyoung Yoon,¹ Chang-Min Choi,¹  Yeon-Mok Oh,¹ Sang-Do Lee,¹   Chae-Man Lim,¹ Woo-Sung Kim,¹  Younsuck Koh,¹ and Jae Seung Lee1 1Division of Pulmonary and Critical Care Medicine,  Department of Internal Medicine, University of  Ulsan College of Medicine, Asan Medical Center,  Seoul, Korea; 2Department of Internal Medicine,  Kyungpook National University Hospital, Kyungpook  National University School of Medicine, Daegu,  Korea Received: 4 March 2016 Accepted: 20 July 2016 Address for Correspondence: Jae Seung Lee, MD Division of Pulmonary and Critical Care Medicine, Department  of Internal Medicine, University of Ulsan College of Medicine,  Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul  05505, Korea E-mail: jsdoc1186@hanmail.nethttp://dx.doi.org/10.3346/jkms.2016.31.11.1755  • J Korean Med Sci 2016; 31: 1755-1760 INTRODUCTION Pulmonary artery sarcoma (PAS) is an extremely rare, malig - nant neoplasm.",Non-OADS,/arxiv_data1/oa_pdf/78/b8/jkms-31-1755.PMC5056207.pdf
"• PAS in Korean Patients 1756  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1755MATERIALS AND METHODS Study patients We retrospectively reviewed the clinical records of all patients  with a pathological diagnosis of PAS at the Asan Medical Center  in Seoul, Korea between January 2000 and December 2014.",Non-OADS,/arxiv_data1/oa_pdf/78/b8/jkms-31-1755.PMC5056207.pdf
"• PAS in Korean Patients http://jkms.org   1757 http://dx.doi.org/10.3346/jkms.2016.31.11.1755Treatment Seventeen patients (85%) underwent surgery, although only  five of these (30%) received complete resections.",Non-OADS,/arxiv_data1/oa_pdf/78/b8/jkms-31-1755.PMC5056207.pdf
"• PAS in Korean Patients 1758  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1755Recurrence Twelve (60%) patients had recurrence or disease progression  (median recurrence-free survival, 15 months; range, 3-45 months).",Non-OADS,/arxiv_data1/oa_pdf/78/b8/jkms-31-1755.PMC5056207.pdf
• PAS in Korean Patients http://jkms.org   1759 http://dx.doi.org/10.3346/jkms.2016.31.11.1755has the greatest correlation with survival (38).,Non-OADS,/arxiv_data1/oa_pdf/78/b8/jkms-31-1755.PMC5056207.pdf
ORCID Yunkyoung Lee http://orcid.org/0000-0001-7364-5609Hyun Jung Kim http://orcid.org/0000-0002-1878-1111 Heeyoung Yoon http://orcid.org/0000-0001-7109-1374 Chang-Min Choi http://orcid.org/0000-0002-2881-4669 Yeon-Mok Oh http://orcid.org/0000-0003-0116-4683 Sang-Do Lee http://orcid.org/0000-0001-8189-4509 Chae-Man Lim http://orcid.org/0000-0001-5400-6588 Woo-Sung Kim http://orcid.org/0000-0002-1254-1264 Younsuck Koh http://orcid.org/0000-0001-5066-2027 Jae Seung Lee http://orcid.org/0000-0003-4130-1486  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/78/b8/jkms-31-1755.PMC5056207.pdf
• PAS in Korean Patients 1760  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.175514.,Non-OADS,/arxiv_data1/oa_pdf/78/b8/jkms-31-1755.PMC5056207.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Risk for Insulin Resistance according to the Degree of Non- Alcoholic Fatty Liver Disease in Korean Men Insulin resistance (IR) plays a significant role in the development and progression of non- alcoholic fatty liver disease (NAFLD).",Non-OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
"Received: 19 May 2016 Accepted: 17 July 2016 Address for Correspondence: Sung Keun Park, MD Total Healthcare Center, Kangbuk Samsung Hospital,  Sungkyunkwan University School of Medicine,   29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea E-mail: kkkmin7@hotmail.comhttp://dx.doi.org/10.3346/jkms.2016.31.11.1761  • J Korean Med Sci 2016; 31: 1761-1767 INTRODUCTION Nonalcoholic fatty liver disease (NAFLD) is getting great con - cern in the clinical field of metabolism as well as hepatology.",Non-OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
"• Clinical Association between NAFLD and Insulin Resistance 1762  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1761Study population A total of 46,693 men who had examined the abdominal ultra - sonography (US) for a medical check-up at Kangbuk Samsung  Total Healthcare Center in 2005 participated in this study.",OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
• Clinical Association between NAFLD and Insulin Resistance http://jkms.org   1763 http://dx.doi.org/10.3346/jkms.2016.31.11.1761eleven radiologists.,Non-OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
• Clinical Association between NAFLD and Insulin Resistance 1764  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.176195% confidence intervals (CI) for incident insulin resistance  comparing the mild and moderate to severe NAFLD categories  vs. the normal group.,Non-OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
• Clinical Association between NAFLD and Insulin Resistance http://jkms.org   1765 http://dx.doi.org/10.3346/jkms.2016.31.11.1761according to the NAFLD categories.,Non-OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
"• Clinical Association between NAFLD and Insulin Resistance 1766  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1761role of HOMA-IR, it is probable that NAFLD affected the devel - opment of IR.",Non-OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
ORCID Jae-Hong Ryoo http://orcid.org/0000-0002-5232-1426 Hyun Pyo Hong http://orcid.org/0000-0003-1451-3141 Sung Keun Park http://orcid.org/0000-0003-4703-9917 Woo Taek Ham http://orcid.org/0000-0003-3212-1627   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
• Clinical Association between NAFLD and Insulin Resistance http://jkms.org   1767 http://dx.doi.org/10.3346/jkms.2016.31.11.1761ol 2003; 38: 153-7.,Non-OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
• Clinical Association between NAFLD and Insulin Resistance http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1761Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
• Clinical Association between NAFLD and Insulin Resistance http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1761Supplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/7c/b1/jkms-31-1761.PMC5056208.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Using Forceps Biopsy after Small Submucosal Dissection in the  Diagnosis of Gastric Subepithelial Tumors The current tissue sampling techniques for subepithelial tumors (SETs) of the  gastrointestinal (GI) tract have limited diagnostic efficacy.",Non-OADS,/arxiv_data1/oa_pdf/5a/44/jkms-31-1768.PMC5056209.pdf
"Keywords:  Subepithelial Tumor; Submucosal Dissection; Forceps BiopsyYoon Suk Jung,1 Hyuk Lee,2   Kyungeun Kim,3 Jin Hee Sohn,3   Hong Joo Kim,1 and Jung Ho Park1 1Division of Gastroenterology, Department of  Internal Medicine, Kangbuk Samsung Hospital,  Sungkyunkwan University School of Medicine,  Seoul, Korea; 2Department of Medicine, Samsung  Medical Center, Sungkyunkwan University School of  Medicine, Seoul, Korea; 3Department of Pathology,  Kangbuk Samsung Hospital, Sungkyunkwan  University School of Medicine, Seoul, Korea Received: 9 June 2016 Accepted: 24 July 2016 Address for Correspondence: Jung Ho Park, MD Division of Gastroenterology, Department of Internal Medicine,  Kangbuk Samsung Hospital, Sungkyunkwan University School  of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea E-mail: pjho3@hotmail.comhttp://dx.doi.org/10.3346/jkms.2016.31.11.1768  • J Korean Med Sci 2016; 31: 1768-1774 INTRODUCTION Subepithelial tumors (SETs) of the gastrointestinal (GI) tract are  sometimes encountered during routine esophagogastroduode - noscopy.",Non-OADS,/arxiv_data1/oa_pdf/5a/44/jkms-31-1768.PMC5056209.pdf
• Forceps Biopsy after Submucosal Dissection in Gastric SETs http://jkms.org   1769 http://dx.doi.org/10.3346/jkms.2016.31.11.1768nancy.,Non-OADS,/arxiv_data1/oa_pdf/5a/44/jkms-31-1768.PMC5056209.pdf
• Forceps Biopsy after Submucosal Dissection in Gastric SETs 1770  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1768adverse events.,Non-OADS,/arxiv_data1/oa_pdf/5a/44/jkms-31-1768.PMC5056209.pdf
• Forceps Biopsy after Submucosal Dissection in Gastric SETs http://jkms.org   1771 http://dx.doi.org/10.3346/jkms.2016.31.11.1768imen also had carcinomatous tissue.,Non-OADS,/arxiv_data1/oa_pdf/5a/44/jkms-31-1768.PMC5056209.pdf
"• Forceps Biopsy after Submucosal Dissection in Gastric SETs 1772  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1768or to that of EUS-FNA (47%-63%) (4,5,23).",Non-OADS,/arxiv_data1/oa_pdf/5a/44/jkms-31-1768.PMC5056209.pdf
• Forceps Biopsy after Submucosal Dissection in Gastric SETs http://jkms.org   1773 http://dx.doi.org/10.3346/jkms.2016.31.11.1768only two endoscopists.,Non-OADS,/arxiv_data1/oa_pdf/5a/44/jkms-31-1768.PMC5056209.pdf
ORCID Yoon Suk Jung http://orcid.org/0000-0002-1963-7170 Hyuk Lee http://orcid.org/0000-0003-4271-7205 Kyungeun Kim http://orcid.org/0000-0001-7938-4673 Jin Hee Sohn http://orcid.org/0000-0002-4735-3853 Hong Joo Kim http://orcid.org/0000-0003-4121-6329 Jung Ho Park http://orcid.org/0000-0002-8367-4371 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/44/jkms-31-1768.PMC5056209.pdf
• Forceps Biopsy after Submucosal Dissection in Gastric SETs 1774  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.176819.,Non-OADS,/arxiv_data1/oa_pdf/5a/44/jkms-31-1768.PMC5056209.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Experience of Human Milk Banking for 8 Years: Korean  Perspective Human milk banks are a solution for mothers who cannot supply their own breast milk to  their sick or hospitalized infants; premature infants, in particular, are unable to receive a  full volume of breast milk for numerous reasons.",Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
"Keywords:  Milk, Human; Milk Banks; Infant, Premature; KoreaHye Lim Jang,1 Jung Yoon Cho,1   Mi-jin Kim,1 Eun Jeong Kim,1   Eun Young Park,2 Sung Ae Park,2   In Young Kim,2 Yong-Sung Choi,1   Chong-Woo Bae,1 and Sung-Hoon Chung1 1Department of Pediatrics, Kyung Hee University  School of Medicine, Seoul, Korea; 2Human Breast  Milk Bank, Mother & Infant Care Center, Kyung Hee  University Hospital at Gangdong, Seoul, Korea Received: 23 March 2016 Accepted: 18 August 2016 Address for Correspondence: Sung-Hoon Chung, MD Department of Pediatrics, Kyung Hee University Hospital at  Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, Korea E-mail: pedc@khnmc.or.krhttp://dx.doi.org/10.3346/jkms.2016.31.11.1775  • J Korean Med Sci 2016; 31: 1775-1783 INTRODUCTION Breast milk has all the nutrients and protective immune com - ponents that infants need for healthy development, and seems  to decrease the risk of allergic and infectious diseases, such as  otitis media, and gastrointestinal tract and respiratory disease  in infancy (1-4).",Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
• Human Milk Banking in Korea 1776  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1775lines of Human Milk Banking Association of North America  (HMBANA).,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
• Human Milk Banking in Korea http://jkms.org   1777 http://dx.doi.org/10.3346/jkms.2016.31.11.1775Ethics statement Data collection was approved by the institutional review board  (IRB) of Kyung Hee University Hospital at Gangdong.,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
• Human Milk Banking in Korea 1778  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1775Table 5.,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
"• Human Milk Banking in Korea http://jkms.org   1779 http://dx.doi.org/10.3346/jkms.2016.31.11.1775Characteristics of recipients A total 36.2% of the recipients resided in Seoul, 45% in the Gye- onggi-Incheon area, and 18.8% in other areas.",Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
• Human Milk Banking in Korea 1780  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1775HMB is essential.,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
"• Human Milk Banking in Korea http://jkms.org   1781 http://dx.doi.org/10.3346/jkms.2016.31.11.1775 During the 8-year period, a total of 861 recipients benefited  from donated human milk, including 836 infants (97.1%) and  25 adults (2.9%).",Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
• Human Milk Banking in Korea 1782  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1775ORCID Hye Lim Jang http://orcid.org/0000-0003-2113-8052 Jung Yoon Cho http://orcid.org/0000-0002-7777-3277 Mi-jin Kim http://orcid.org/0000-0001-9472-3581 Eun Jeong Kim http://orcid.org/0000-0002-2300-2055 Eun Young Park http://orcid.org/0000-0003-2863-8789 Sung Ae Park http://orcid.org/0000-0001-5212-9365 In Young Kim http://orcid.org/0000-0002-5476-7720 Yong-Sung Choi http://orcid.org/0000-0001-9181-7849 Chong-Woo Bae http://orcid.org/0000-0002-0965-5674 Sung-Hoon Chung http://orcid.org/0000-0002-0352-9722  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
Available  at http://www.who.int/nutrition/topics/exclusive_breastfeeding/en [ac - cessed on 10 March 2016].,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
Available at https://www.hmbana.org/locations [accessed on March 2016].,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
Avail - able at http://www.europeanmilkbanking.com/ [accessed on 10 March  2016].,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
Available at http://www.fiocruz.br/redeblh/cgi/cgilua.,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
• Human Milk Banking in Korea http://jkms.org   1783 http://dx.doi.org/10.3346/jkms.2016.31.11.177517: 53-8.,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/jkms-31-1775.PMC5056210.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Distribution of Diseases Causing Liver Function Test Abnormality  in Children and Natural Recovery Time of the Abnormal Liver  Function Although liver function test abnormality is frequently noted in children, there is no report  about the distribution of the etiology and natural recovery time of the abnormal liver  function.",Non-OADS,/arxiv_data1/oa_pdf/79/67/jkms-31-1784.PMC5056211.pdf
"Keywords:  Liver Function Test; Children; RecoveryMirinae Jang, Min Su Oh, Se-Cheol Oh,  and Ki-Soo Kang Department of Pediatrics, Jeju National University  School of Medicine, Jeju, Korea Received: 26 March 2016 Accepted: 24 July 2016 Address for Correspondence: Ki-Soo Kang, MD Department of Pediatrics, Jeju National University School of  Medicine, 15 Aran 13-gil, Jeju 63241, Korea E-mail: kskang@jejunu.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.11.1784  • J Korean Med Sci 2016; 31: 1784-1789 INTRODUCTION In the pediatric ward of our hospital, we often encounter many  children with abnormal liver function test (1).",Non-OADS,/arxiv_data1/oa_pdf/79/67/jkms-31-1784.PMC5056211.pdf
• Liver Function Test Abnormality and Natural Recovery Time http://jkms.org   1785 http://dx.doi.org/10.3346/jkms.2016.31.11.1784into 10 groups.,Non-OADS,/arxiv_data1/oa_pdf/79/67/jkms-31-1784.PMC5056211.pdf
• Liver Function Test Abnormality and Natural Recovery Time 1786  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1784Table 1.,Non-OADS,/arxiv_data1/oa_pdf/79/67/jkms-31-1784.PMC5056211.pdf
• Liver Function Test Abnormality and Natural Recovery Time http://jkms.org   1787 http://dx.doi.org/10.3346/jkms.2016.31.11.1784trophy et cetera.,Non-OADS,/arxiv_data1/oa_pdf/79/67/jkms-31-1784.PMC5056211.pdf
• Liver Function Test Abnormality and Natural Recovery Time 1788  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1784elevation of AST and ALT indicates injury to the hepatocytes (4).,Non-OADS,/arxiv_data1/oa_pdf/79/67/jkms-31-1784.PMC5056211.pdf
ORCID Mirinae Jang http://orcid.org/0000-0002-3466-1435 Min Su Oh http://orcid.org/0000-0001-5327-0934 Se-Cheol Oh http://orcid.org/0000-0003-1415-6543 Ki-Soo Kang http://orcid.org/0000-0001-6374-8356 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/79/67/jkms-31-1784.PMC5056211.pdf
• Liver Function Test Abnormality and Natural Recovery Time http://jkms.org   1789 http://dx.doi.org/10.3346/jkms.2016.31.11.1784er Disease.,Non-OADS,/arxiv_data1/oa_pdf/79/67/jkms-31-1784.PMC5056211.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Prevalence of Low Bone Mineral Density and Associated Risk  Factors in Korean Puerperal Women Although pregnancy is a medical condition that contributes to bone loss, little information  is available regarding bone mineral density (BMD) in puerperal women.",Non-OADS,/arxiv_data1/oa_pdf/dd/41/jkms-31-1790.PMC5056212.pdf
"Received: 24 December 2015 Accepted: 5 August 2016 Address for Correspondence: In Yang Park, MD Department of Obstetrics and Gynecology, The Catholic  University of Korea, Seoul St. Mary’s Hospital, 222 Banpodaero,  Seocho-gu, Seoul 06591, Korea E-mail: ooooobbbbb@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.11.1790  • J Korean Med Sci 2016; 31: 1790-1796 INTRODUCTION Osteoporosis is common health problem in postmenopausal  women that can have serious adverse impacts on life quality (1).",Non-OADS,/arxiv_data1/oa_pdf/dd/41/jkms-31-1790.PMC5056212.pdf
"• Low Bone Mineral Density in Puerperal Women http://jkms.org   1791 http://dx.doi.org/10.3346/jkms.2016.31.11.1790en; 1,672 women consented to and underwent this measure - ment.",Non-OADS,/arxiv_data1/oa_pdf/dd/41/jkms-31-1790.PMC5056212.pdf
• Low Bone Mineral Density in Puerperal Women 1792  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1790Table 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/41/jkms-31-1790.PMC5056212.pdf
• Low Bone Mineral Density in Puerperal Women http://jkms.org   1793 http://dx.doi.org/10.3346/jkms.2016.31.11.1790DISCUSSION This study found that the prevalence of low BMD (i.e.,Non-OADS,/arxiv_data1/oa_pdf/dd/41/jkms-31-1790.PMC5056212.pdf
• Low Bone Mineral Density in Puerperal Women 1794  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1790postmenopausal osteoporosis (2).,Non-OADS,/arxiv_data1/oa_pdf/dd/41/jkms-31-1790.PMC5056212.pdf
"• Low Bone Mineral Density in Puerperal Women http://jkms.org   1795 http://dx.doi.org/10.3346/jkms.2016.31.11.1790manage weight through diet control, even during pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/dd/41/jkms-31-1790.PMC5056212.pdf
ORCID Dong Gyu Jang http://orcid.org/0000-0003-2375-3526 Ji Young Kwon http://orcid.org/0000-0002-7788-7303 Sae Kyung Choi http://orcid.org/0000-0001-6264-4256 Hyun Sun Ko http://orcid.org/0000-0001-6310-6206 Jong Chul Shin http://orcid.org/0000-0002-3059-3842 In Yang Park http://orcid.org/0000-0002-9458-2886REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/41/jkms-31-1790.PMC5056212.pdf
• Low Bone Mineral Density in Puerperal Women 1796  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.179019.,Non-OADS,/arxiv_data1/oa_pdf/dd/41/jkms-31-1790.PMC5056212.pdf
Availabe at http://www.oecd.org/els/health-systems/49712651.,Non-OADS,/arxiv_data1/oa_pdf/dd/41/jkms-31-1790.PMC5056212.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Seasonal Pattern of Preterm Births in Korea for 2000-2012 The aim of this study was to investigate a seasonal pattern of preterm births in Korea.",Non-OADS,/arxiv_data1/oa_pdf/3c/dd/jkms-31-1797.PMC5056213.pdf
"Keywords:  Seasonal Variation; Preterm Birth; Summer; Winter, KoreaYoonmi Woo, Yung-Taek Ouh,   Ki Hoon Ahn, Geum Joon Cho,   Soon Cheol Hong, Min-Jeong Oh,   and Hai-Joong Kim Department of Obstetrics and Gynecology, Korea  University Guro Hospital, Korea University College  of Medicine, Seoul, Korea Received: 19 April 2016 Accepted: 13 August 2016 Address for Correspondence: Geum Joon Cho, MD Department of Obstetrics and Gynecology, Korea University  Guro Hospital, Korea University College of Medicine, 148  Gurodong-ro, Guro-gu, Seoul 08308, Korea E-mail: md_cho@hanmail.net Funding:  This research was supported by a grant from the Korea  Health Technology R &D Project through the Korea Health  Industry Development Institute, funded by the Ministry of  Health and Welfare, Republic of Korea (grant number:  HI15C0810).http://dx.doi.org/10.3346/jkms.2016.31.11.1797  • J Korean Med Sci 2016; 31: 1797-1801 INTRODUCTION Preterm birth is defined as a birth occurring at less than 37 weeks  of completed gestation.",Non-OADS,/arxiv_data1/oa_pdf/3c/dd/jkms-31-1797.PMC5056213.pdf
• Seasonality of Preterm Births 1798  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1797Table 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/dd/jkms-31-1797.PMC5056213.pdf
"• Seasonality of Preterm Births http://jkms.org   1799 http://dx.doi.org/10.3346/jkms.2016.31.11.179795% CI, 1.055-1.100) after adjustment for age, the educational  level of parents, maternal parity, and neonatal gender (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/3c/dd/jkms-31-1797.PMC5056213.pdf
• Seasonality of Preterm Births 1800  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1797oxidative stress with consequent placental inflammation (28).,Non-OADS,/arxiv_data1/oa_pdf/3c/dd/jkms-31-1797.PMC5056213.pdf
ORCID Yung-Taek Ouh http://orcid.org/0000-0001-5887-4497 Geum Joon Cho http://orcid.org/0000-0001-6761-0944REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/dd/jkms-31-1797.PMC5056213.pdf
• Seasonality of Preterm Births http://jkms.org   1801 http://dx.doi.org/10.3346/jkms.2016.31.11.179720.,Non-OADS,/arxiv_data1/oa_pdf/3c/dd/jkms-31-1797.PMC5056213.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cause of Death in Korean Men with Prostate Cancer: an Analysis  of Time Trends in a Nationwide Cohort Despite rapid increase in incidence of prostate cancer (PC) and PC survivors, there are few  studies regarding competing causes of death and time trends in Asian population.",Non-OADS,/arxiv_data1/oa_pdf/01/7a/jkms-31-1802.PMC5056214.pdf
2016026824).http://dx.doi.org/10.3346/jkms.2016.31.11.1802  • J Korean Med Sci 2016; 31: 1802-1807 INTRODUCTION Prostate cancer (PC) is currently the fourth most common male  cancer in Korea (1).,Non-OADS,/arxiv_data1/oa_pdf/01/7a/jkms-31-1802.PMC5056214.pdf
"• Cause of Death in Korean Prostate Cancer Patients http://jkms.org   1803 http://dx.doi.org/10.3346/jkms.2016.31.11.1802population that are randomly selected after stratifying the en - tire population according to socioeconomic parameters (age,  sex, residential area, income, etc.).",Non-OADS,/arxiv_data1/oa_pdf/01/7a/jkms-31-1802.PMC5056214.pdf
"• Cause of Death in Korean Prostate Cancer Patients 1804  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1802going surgery, RT, and ADT constituted 36.9%, 13.2%, and 49.9%,  respectively, of the study population.",OADS,/arxiv_data1/oa_pdf/01/7a/jkms-31-1802.PMC5056214.pdf
"• Cause of Death in Korean Prostate Cancer Patients http://jkms.org   1805 http://dx.doi.org/10.3346/jkms.2016.31.11.1802Overall and PC-specific survival stratified by primary  treatment modalities Five-year overall and PC-specific survival rates were 46.2% and  85.3%, respectively.",OADS,/arxiv_data1/oa_pdf/01/7a/jkms-31-1802.PMC5056214.pdf
"• Cause of Death in Korean Prostate Cancer Patients 1806  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1802ing for 56% and 74.6%, respectively.",OADS,/arxiv_data1/oa_pdf/01/7a/jkms-31-1802.PMC5056214.pdf
ORCID Jinsung Park http://orcid.org/0000-0001-6158-3359 Beomseok Suh http://orcid.org/0000-0003-0644-5855 Dong Wook Shin http://orcid.org/0000-0001-8128-8920 Jun Hyuk Hong http://orcid.org/0000-0003-2705-0481 Hanjong Ahn http://orcid.org/0000-0001-7608-5352 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/01/7a/jkms-31-1802.PMC5056214.pdf
• Cause of Death in Korean Prostate Cancer Patients http://jkms.org   1807 http://dx.doi.org/10.3346/jkms.2016.31.11.180230.,Non-OADS,/arxiv_data1/oa_pdf/01/7a/jkms-31-1802.PMC5056214.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Risk Factor Analysis of Ciprofloxacin-Resistant and Extended  Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial  Prostatitis in Korea The objectives of this study were to investigate risk factors and the incidence of  ciprofloxacin resistance and extended-spectrum beta-lactamases (ESBL) in patients with  acute bacterial prostatitis (ABP).",Non-OADS,/arxiv_data1/oa_pdf/35/cd/jkms-31-1808.PMC5056215.pdf
"Keywords:  Acute Bacterial Prostatitis; Ciprofloxacin; Extended-spectrum Beta-lactamases;  Risk FactorsYoung Lee, Dong-Gi Lee, Sang Hyub Lee,  and Koo Han Yoo Department of Urology, Kyung Hee University  School of Medicine, Seoul, Korea Received: 18 June 2016 Accepted: 17 July 2016 Address for Correspondence: Koo Han Yoo, MD Department of Urology, Kyung Hee University School of  Medicine, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, Korea E-mail: yookoohan@khu.ac.kr Funding:  This research was supported by Basic Science  Research Program through the National Research Foundation of  Korea (NRF) funded by the Ministry of Education (NRF- 2014R1A1A2A16049957).http://dx.doi.org/10.3346/jkms.2016.31.11.1808  • J Korean Med Sci 2016; 31: 1808-1813 INTRODUCTION The prevalence of prostatitis is 8.2% (range 2.2%-9.7%) and the  National Institutes of Health (NIH) classified prostatitis into  four categories: acute bacterial, chronic bacterial, chronic pros - tatitis/chronic pelvic pain syndrome, and asymptomatic (1).",Non-OADS,/arxiv_data1/oa_pdf/35/cd/jkms-31-1808.PMC5056215.pdf
"• Acute Bacterial Prostatitis in Korea http://jkms.org   1809 http://dx.doi.org/10.3346/jkms.2016.31.11.1808and include advanced age, male gender, diabetes mellitus, uri - nary tract abnormalities, recurrent UTIs, previous therapy with  quinolones, urinary catheterization, and presence of compli - cated UTIs (12-15).",Non-OADS,/arxiv_data1/oa_pdf/35/cd/jkms-31-1808.PMC5056215.pdf
"• Acute Bacterial Prostatitis in Korea 1810  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1808transrectal prostate biopsy, 1 had urethral dilation (5.3%), and 1  had a urodynamic study (5.3%).",Non-OADS,/arxiv_data1/oa_pdf/35/cd/jkms-31-1808.PMC5056215.pdf
"• Acute Bacterial Prostatitis in Korea http://jkms.org   1811 http://dx.doi.org/10.3346/jkms.2016.31.11.180897.1% vs. 60.0%; gentamicin 85.7% vs. 70.0%; imipenem, 100%  vs. 100%; and TMP/SMX, 78.6% vs. 50.0%.",Non-OADS,/arxiv_data1/oa_pdf/35/cd/jkms-31-1808.PMC5056215.pdf
"• Acute Bacterial Prostatitis in Korea 1812  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1808study, each group showed different results, and we found that  85.7% of susceptibility was identified in the non-manipulation  group, whereas the manipulation group showed 10.0% suscep - tibility.",OADS,/arxiv_data1/oa_pdf/35/cd/jkms-31-1808.PMC5056215.pdf
ORCID Young Lee http://orcid.org/0000-0003-0737-0293 Dong-Gi Lee http://orcid.org/0000-0001-7369-9252 Sang Hyub Lee http://orcid.org/0000-0002-4509-5846 Koo Han Yoo http://orcid.org/0000-0001-7952-7902 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/35/cd/jkms-31-1808.PMC5056215.pdf
• Acute Bacterial Prostatitis in Korea http://jkms.org   1813 http://dx.doi.org/10.3346/jkms.2016.31.11.180811.,Non-OADS,/arxiv_data1/oa_pdf/35/cd/jkms-31-1808.PMC5056215.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Association of Overweight with the Prevalence of Lifetime  Psychiatric Disorders and Suicidality: General Population-based  Study in Korea Many epidemiological studies suggest that overweight is associated with an elevated risk of  psychiatric disorders and suicidal tendency.",Non-OADS,/arxiv_data1/oa_pdf/32/e8/jkms-31-1814.PMC5056216.pdf
"Keywords:  Overweight; Obesity; Mental Disorders; Suicide; Cross-sectional StudiesByung-Soo Kim,1 Sung Man Chang,1   Su Jeong Seong,2 Jee Eun Park,3   Subin Park,4 Jin Pyo Hong,5   Jae Nam Bae,6 Seong-Jin Cho,7   Bong-Jin Hahm,3,8 Dong-Woo Lee,9   Jong-Ik Park,10 Jun-Young Lee,11   Hong Jin Jeon,5 and Maeng Je Cho3,8 1Department of Psychiatry, Kyungpook National  University School of Medicine, Daegu, Korea; 2Department of Psychiatry, Hallym University  Medical Center, Seoul, Korea; 3Department of  Neuropsychiatry, Seoul National University Hospital,  Seoul, Korea; 4Department of Research Planning,  Mental Health Research Institute, National Center  for Mental Health, Seoul, Korea; 5Department of  Psychiatry, Depression Center, Samsung Medical  Center, Sungkyunkwan University School of  Medicine, Seoul, Korea; 6Department of Psychiatry,  College of Medicine, Inha University, Incheon, Korea; 7Department of Psychiatry, Gachon Medical School,  Gachon University of Medicine and Science,  Incheon, Korea; 8Department of Psychiatry and  Behavioral Science, Seoul National University  College of Medicine, Seoul, Korea; 9Department of  Psychiatry, Sanggye Paik Hospital, College of  Medicine, Inje University, Seoul, Korea; 10Department  of Psychiatry, College of Medicine, Kangwon  National University, Chuncheon, Korea;  11Department of Neuropsychiatry, Seoul  Metropolitan Boramae Medical Center, Seoul, Korea Received: 18 February 2016 Accepted: 19 July 2016 Address for Correspondence: Sung Man Chang, MD Department of Psychiatry, Kyungpook National University  School of Medicine, 130 Dongdeok-ro, Jung-gu,   Daegu 41944, Korea E-mail: psyjang@hanmail.nethttp://dx.doi.org/10.3346/jkms.2016.31.11.1814  • J Korean Med Sci 2016; 31: 1814-1821 INTRODUCTION The worldwide prevalence of obesity is rapidly increasing (1).",Non-OADS,/arxiv_data1/oa_pdf/32/e8/jkms-31-1814.PMC5056216.pdf
"• Overweight and Mental Disorders http://jkms.org   1815 http://dx.doi.org/10.3346/jkms.2016.31.11.1814increasingly exposed to Western culture, wherein slim bodies  are admired and overweight individuals are stigmatized as lazy  or lacking in self-discipline (13,14).",Non-OADS,/arxiv_data1/oa_pdf/32/e8/jkms-31-1814.PMC5056216.pdf
"• Overweight and Mental Disorders 1816  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1814intervals (CIs), using DSM-IV psychiatric disorders and suicid - ality as the main outcome variables and the presence of over - weight as the principal predictor with the normal weight group  treated as the reference group.",Non-OADS,/arxiv_data1/oa_pdf/32/e8/jkms-31-1814.PMC5056216.pdf
• Overweight and Mental Disorders http://jkms.org   1817 http://dx.doi.org/10.3346/jkms.2016.31.11.1814Table 2.,Non-OADS,/arxiv_data1/oa_pdf/32/e8/jkms-31-1814.PMC5056216.pdf
• Overweight and Mental Disorders 1818  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1814existed only in women aged 18-44 years.,Non-OADS,/arxiv_data1/oa_pdf/32/e8/jkms-31-1814.PMC5056216.pdf
"• Overweight and Mental Disorders http://jkms.org   1819 http://dx.doi.org/10.3346/jkms.2016.31.11.1814abolic disorders, so the negative finding in this study may not  be related to low BMI cutoff value.",Non-OADS,/arxiv_data1/oa_pdf/32/e8/jkms-31-1814.PMC5056216.pdf
• Overweight and Mental Disorders 1820  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1814meta-analysis of longitudinal studies confirmed a reciprocal  relationship between obesity and depression (5).,Non-OADS,/arxiv_data1/oa_pdf/32/e8/jkms-31-1814.PMC5056216.pdf
"ORCID Byung-Soo Kim http://orcid.org/0000-0001-6823-4813 Sung Man Chang http://orcid.org/0000-0001-7077-7171 Su Jeong Seong http://orcid.org/0000-0002-6789-8877 Jee Eun Park http://orcid.org/0000-0001-6097-3275 Subin Park http://orcid.org/0000-0002-4623-9899 Jin Pyo Hong http://orcid.org/0000-0001-5384-2605 Jae Nam Bae http://orcid.org/0000-0002-5024-6231 Seong-Jin Cho http://orcid.org/0000-0002-8814-5807 Bong-Jin Hahm http://orcid.org/0000-0002-2366-3275 Dong-Woo Lee http://orcid.org/0000-0002-6383-1974 Jong-Ik Park http://orcid.org/0000-0002-1225-584X Jun-Young Lee http://orcid.org/0000-0002-5893-3124 Hong Jin Jeon http://orcid.org/0000-0002-6126-542X Maeng Je Cho http://orcid.org/0000-0001-8035-2679 REFERENCES 1. von Ruesten A, Steffen A, Floegel A, van der A DL, Masala G, Tjønneland  A, Halkjaer J, Palli D, Wareham NJ, Loos RJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/32/e8/jkms-31-1814.PMC5056216.pdf
• Overweight and Mental Disorders http://jkms.org   1821 http://dx.doi.org/10.3346/jkms.2016.31.11.181412.,Non-OADS,/arxiv_data1/oa_pdf/32/e8/jkms-31-1814.PMC5056216.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Intra-Articular Injections in Patients with Femoroacetabular  Impingement: a Prospective, Randomized, Double-blind,   Cross-over Study We evaluated and compared the effectiveness of intra-articular injection of hip joint using  hyaluronic acid and steroid in patients with femoroacetabular impingement (FAI).",Non-OADS,/arxiv_data1/oa_pdf/78/d5/jkms-31-1822.PMC5056217.pdf
"11-2011-008).http://dx.doi.org/10.3346/jkms.2016.31.11.1822  • J Korean Med Sci 2016; 31: 1822-1827 INTRODUCTION Femoroacetabular impingement (FAI) has been highlighted  because it may cause hip pain, labral injury and early osteoar - thritis in young patients (1-4).",Non-OADS,/arxiv_data1/oa_pdf/78/d5/jkms-31-1822.PMC5056217.pdf
"• Intra-Articular Injections in Patients with FAI http://jkms.org   1823 http://dx.doi.org/10.3346/jkms.2016.31.11.1822ria were as follows: 1) definite radiologic findings of osteoar - thritis in hip joint; 2) hypersensitivity of steroid or contrast; 3)  impossible to intra-articular injection, for example skin lesion  at puncture site; 4) history of intra-articular injection of hip joint;  5) history of previous operation or trauma of hip joint; 6) other  cause of hip pain rather than FAI (rapid destructive hip disease,  avascular necrosis of femoral head, crystalline arthropathy, in - flammatory arthritis, neuropathic arthropathy, etc.",Non-OADS,/arxiv_data1/oa_pdf/78/d5/jkms-31-1822.PMC5056217.pdf
• Intra-Articular Injections in Patients with FAI 1824  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1822Table 1.,Non-OADS,/arxiv_data1/oa_pdf/78/d5/jkms-31-1822.PMC5056217.pdf
• Intra-Articular Injections in Patients with FAI http://jkms.org   1825 http://dx.doi.org/10.3346/jkms.2016.31.11.1822Pain intensity Pain intensity using NRS was listed on Table 1.,Non-OADS,/arxiv_data1/oa_pdf/78/d5/jkms-31-1822.PMC5056217.pdf
• Intra-Articular Injections in Patients with FAI 1826  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.18225).,Non-OADS,/arxiv_data1/oa_pdf/78/d5/jkms-31-1822.PMC5056217.pdf
ORCID Young-Kyun Lee http://orcid.org/0000-0001-6564-4294 Guen Young Lee http://orcid.org/0000-0002-6906-5182 Joon Woo Lee http://orcid.org/0000-0002-7106-5229 Eugene Lee http://orcid.org/0000-0003-4205-2362 Heung Sik Kang http://orcid.org/0000-0002-7024-388X  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/78/d5/jkms-31-1822.PMC5056217.pdf
• Intra-Articular Injections in Patients with FAI http://jkms.org   1827 http://dx.doi.org/10.3346/jkms.2016.31.11.18222013; 95: 82-92.,Non-OADS,/arxiv_data1/oa_pdf/78/d5/jkms-31-1822.PMC5056217.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Pharmacological and Mechanical Thromboprophylaxis in  Critically Ill Patients: a Network Meta-Analysis of 12 Trials Thromboprophylaxis for venous thromboembolism is widely used in critically ill patients.",Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
"Received: 9 March 2016 Accepted: 12 August 2016 Address for Correspondence: Young-Jae Cho, MD Division of Pulmonary and Critical Care Medicine, Department  of Internal Medicine, Seoul National University Bundang  Hospital, 82 Gumi-ro, 173-beon-gil, Bundang-gu,   Seongnam 13620, Korea E-mail: lungdrcho@gmail.com; lungdrcho@snubh.orghttp://dx.doi.org/10.3346/jkms.2016.31.11.1828  • J Korean Med Sci 2016; 31: 1828-1837 INTRODUCTION Venous thromboembolism (VTE), including deep vein throm - bosis (DVT) and pulmonary embolism (PE), is a common pre - ventable complication experienced by critically ill patients hos - pitalized in intensive care units (ICUs).",Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
"• Meta-Analysis for Thromboprophylaxis in Critically Ill Patients http://jkms.org   1829 http://dx.doi.org/10.3346/jkms.2016.31.11.1828laxis is expected to be quite high, despite the lack of evidence  for efficacy and safety in this special population.",Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
• Meta-Analysis for Thromboprophylaxis in Critically Ill Patients 1830  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1828was chosen according to the Brooks-Gelman-Rubin method for  convergence checks (16).,Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
• Meta-Analysis for Thromboprophylaxis in Critically Ill Patients http://jkms.org   1831 http://dx.doi.org/10.3346/jkms.2016.31.11.1828 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
• Meta-Analysis for Thromboprophylaxis in Critically Ill Patients 1832  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1828Trial (Ref)Involved  populationInclusion criteria Exclusion criteriaIntervention   (No.,Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
"• Meta-Analysis for Thromboprophylaxis in Critically Ill Patients http://jkms.org   1833 http://dx.doi.org/10.3346/jkms.2016.31.11.1828RESULTS Search results We identified 254 citations, retrieved 19 studies for detailed eval - uation, and obtained 12 RCTs that met our inclusion criteria  (Fig.",OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
• Meta-Analysis for Thromboprophylaxis in Critically Ill Patients 1834  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1828Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
• Meta-Analysis for Thromboprophylaxis in Critically Ill Patients http://jkms.org   1835 http://dx.doi.org/10.3346/jkms.2016.31.11.1828Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
"• Meta-Analysis for Thromboprophylaxis in Critically Ill Patients 1836  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1828fusion needed, the authors of the trial concluded that the differ - ence in major bleeding risk between UFH and LMWH was not  significant.",Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
ORCID Jonghanne Park http://orcid.org/0000-0002-8860-8445 Joo Myung Lee http://orcid.org/0000-0002-2178-4014 Jeong Seok Lee http://orcid.org/0000-0001-8261-7044 Young-Jae Cho http://orcid.org/0000-0001-6943-4462 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
• Meta-Analysis for Thromboprophylaxis in Critically Ill Patients http://jkms.org   1837 http://dx.doi.org/10.3346/jkms.2016.31.11.18284.,Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
Available at http://handbook.cochrane.,Non-OADS,/arxiv_data1/oa_pdf/37/4c/jkms-31-1828.PMC5056218.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Performance Evaluation of Five Different Disseminated  Intravascular Coagulation (DIC) Diagnostic Criteria for  Predicting Mortality in Patients with Complicated Sepsis Disseminated intravascular coagulation (DIC) is a major complication in sepsis patients.",Non-OADS,/arxiv_data1/oa_pdf/dc/66/jkms-31-1838.PMC5056219.pdf
"Received: 26 April 2016 Accepted: 13 August 2016 Address for Correspondence: Seongsoo Jang, MD Department of Laboratory Medicine, University of Ulsan College  of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 05505, Korea E-mail: ssjang@amc.seoul.kr Funding:  This research was supported by the National Research  Foundation of Korea (NRF) grant funded by the Korean  government (2005-0049489).http://dx.doi.org/10.3346/jkms.2016.31.11.1838  • J Korean Med Sci 2016; 31: 1838-1845 INTRODUCTION Disseminated intravascular coagulation (DIC) is characterised  by thrombotic occlusion and bleeding (1,2).",Non-OADS,/arxiv_data1/oa_pdf/dc/66/jkms-31-1838.PMC5056219.pdf
• Comparison of DIC Criteria for Mortality in Complicated Sepsis Patients http://jkms.org   1839 http://dx.doi.org/10.3346/jkms.2016.31.11.1838MATERIALS AND METHODS Patient selection Patient records and information was anonymized and de-iden - tified prior to analysis.,Non-OADS,/arxiv_data1/oa_pdf/dc/66/jkms-31-1838.PMC5056219.pdf
• Comparison of DIC Criteria for Mortality in Complicated Sepsis Patients 1840  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1838a reduction in systolic blood pressure of > 40 mmHg from base - line (11).,Non-OADS,/arxiv_data1/oa_pdf/dc/66/jkms-31-1838.PMC5056219.pdf
"• Comparison of DIC Criteria for Mortality in Complicated Sepsis Patients http://jkms.org   1841 http://dx.doi.org/10.3346/jkms.2016.31.11.1838nature of this study, informed consent was deemed unneces - sary and was not obtained.",Non-OADS,/arxiv_data1/oa_pdf/dc/66/jkms-31-1838.PMC5056219.pdf
• Comparison of DIC Criteria for Mortality in Complicated Sepsis Patients 1842  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1838Table 5.,Non-OADS,/arxiv_data1/oa_pdf/dc/66/jkms-31-1838.PMC5056219.pdf
"• Comparison of DIC Criteria for Mortality in Complicated Sepsis Patients http://jkms.org   1843 http://dx.doi.org/10.3346/jkms.2016.31.11.1838 Subsequently performed Kaplan-Meier survival curve analy - sis showed that both KSTH and JMHW criteria are statistically  significant in terms of predicting 28-day mortality when applied  at Day 1 and overall period ( P= 0.007 and P= 0.012, respective - ly vs. P= 0.049 and P= 0.014, respectively) (Fig.",OADS,/arxiv_data1/oa_pdf/dc/66/jkms-31-1838.PMC5056219.pdf
• Comparison of DIC Criteria for Mortality in Complicated Sepsis Patients 1844  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1838R-JAAM criteria based on the little effect of fibrinogen level on  the prediction of outcome in the DIC patients.,Non-OADS,/arxiv_data1/oa_pdf/dc/66/jkms-31-1838.PMC5056219.pdf
ORCID Sang Ook Ha http://orcid.org/0000-0002-2651-1023 Sang Hyuk Park http://orcid.org/0000-0001-7284-6273 Sang-Bum Hong http://orcid.org/0000-0003-2737-7695 Seongsoo Jang http://orcid.org/0000-0002-0045-1747   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/66/jkms-31-1838.PMC5056219.pdf
• Comparison of DIC Criteria for Mortality in Complicated Sepsis Patients http://jkms.org   1845 http://dx.doi.org/10.3346/jkms.2016.31.11.1838ill patients: comparing current criteria.,Non-OADS,/arxiv_data1/oa_pdf/dc/66/jkms-31-1838.PMC5056219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Relapsing Polychondritis with Central Nervous System  Involvement: Experience of Three Different Cases in a Single  Center Relapsing polychondritis (RP) is an autoimmune disorder characterized by inflammation in  cartilaginous structures including the ears, noses, peripheral joints, and tracheobronchial  tree.",Non-OADS,/arxiv_data1/oa_pdf/ed/b1/jkms-31-1846.PMC5056220.pdf
"Keywords:  Relapsing Polychondritis; Meningoencephalitis; Limbic Encephalitis; DementiaChan Hong Jeon Division of Rheumatology, Department of Internal  Medicine, Soonchunhyang University Hospital,  Bucheon, Korea Received: 31 July 2015 Accepted: 27 October 2015 Address for Correspondence: Chan Hong Jeon, MD Division of Rheumatology, Department of Internal Medicine,  Soonchunhyang University Hospital, 170 Jomaru-ro, Wonmi-gu,  Bucheon 14584, Korea E-mail: chjeon@gmail.comhttp://dx.doi.org/10.3346/jkms.2016.31.11.1846  • J Korean Med Sci 2016; 31: 1846-1850 INTRODUCTION Relapsing polychondritis (RP) is a rare autoimmune disorder  characterized by inflammation in cartilaginous structures (1).",Non-OADS,/arxiv_data1/oa_pdf/ed/b1/jkms-31-1846.PMC5056220.pdf
Jeon CH • CNS Involvement of Relapsing Polychondritis http://jkms.org   1847 http://dx.doi.org/10.3346/jkms.2016.31.11.1846Fig.,OADS,/arxiv_data1/oa_pdf/ed/b1/jkms-31-1846.PMC5056220.pdf
Jeon CH • CNS Involvement of Relapsing Polychondritis 1848  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1846nant cell on CSF cytology.,OADS,/arxiv_data1/oa_pdf/ed/b1/jkms-31-1846.PMC5056220.pdf
"Jeon CH • CNS Involvement of Relapsing Polychondritis http://jkms.org   1849 http://dx.doi.org/10.3346/jkms.2016.31.11.1846been suggested as the cause of stroke in RP (12,13).",Non-OADS,/arxiv_data1/oa_pdf/ed/b1/jkms-31-1846.PMC5056220.pdf
ORCID Chan Hong Jeon http://orcid.org/0000-0002-2430-7264 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/b1/jkms-31-1846.PMC5056220.pdf
Jeon CH • CNS Involvement of Relapsing Polychondritis 1850  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.184611.,Non-OADS,/arxiv_data1/oa_pdf/ed/b1/jkms-31-1846.PMC5056220.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2016.31.11.1851  • J Korean Med Sci 2016; 31: 1851-1852 Letter to the Editor:  Compression Rate during   Cardiopulmonary Resuscitation Andrew Fu Wah Ho,1 Pin Pin Pek,2 Susan Yap,2   and Marcus Eng Hock Ong2,3 1Singhealth Emergency Medicine Residency, Singapore Health Services, Singapore;  2Department of Emergency Medicine, Singapore General Hospital, Singapore;  3Health Services and Systems Research, Duke-NUS Medical School, Singapore Out-of-hospital cardiac arrest (OHCA) is a global health con - cern, accounting for over 350,000 unexpected deaths in North  America (1).",Non-OADS,/arxiv_data1/oa_pdf/62/99/jkms-31-1851.PMC5056221.pdf
ORCID Andrew Fu Wah Ho http://orcid.org/0000-0003-4338-3876 Pin Pin Pek http://orcid.org/0000-0002-3483-4105 Susan Yap http://orcid.org/0000-0002-7891-1555 Marcus Eng Hock Ong http://orcid.org/0000-0001-7874-7612 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/62/99/jkms-31-1851.PMC5056221.pdf
• Compression Rate 1852  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.11.1851rates during cardiopulmonary resuscitation are suboptimal: a prospec - tive study during in-hospital cardiac arrest.,Non-OADS,/arxiv_data1/oa_pdf/62/99/jkms-31-1851.PMC5056221.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2016.31.11.1853  • J Korean Med Sci 2016; 31: 1853 The Author’s Response: Compression Rate during   Cardiopulmonary Resuscitation Sung Oh Hwang and Kyoung-Chul Cha Department of Emergency Medicine, Yonsei University Wonju College of Medicine,  Wonju, Korea Ho et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/df/jkms-31-1853.PMC5056222.pdf
ORCID Sung Oh Hwang http://orcid.org/0000-0003-4585-3181 Kyoung-Chul Cha http://orcid.org/0000-0003-1818-2466 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/df/jkms-31-1853.PMC5056222.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2016.31.11.1854  • J Korean Med Sci 2016; 31: 1854CORRESPONDENCE Erratum: Correction of Figure Simvastatin Reduces Capsular Fibrosis around Silicone Implants Kyu Jin Chung, Ki Rin Park, Jun Ho Lee, Tae Gon Kim, Yong-Ha Kim J Korean Med Sci.",Non-OADS,/arxiv_data1/oa_pdf/76/7b/jkms-31-1854.PMC5056223.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Nicolas C Buchs, MD, Department  of Colorectal Surgery, Churchill Hospital, Oxford University  Hospitals, Old Road, Oxford OX3 7LE,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/4f/04/WJCO-7-337.PMC5056325.pdf
wjgnet.com/ 2218-4333 /full/v7/i5/337.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/04/WJCO-7-337.PMC5056325.pdf
"On the other hand, the introduction of World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i5.337World J Clin Oncol  2016 October 10; 7(5): 337-339 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/4f/04/WJCO-7-337.PMC5056325.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/4f/04/WJCO-7-337.PMC5056325.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript  source:  Invited  manuscript Correspondence to: Ibrahim Halil Sahin, MD,  Department  of Medicine, Icahn School of Medicine at Mount Sinai St Luke’s  Roosevelt Hospital Center, 1000 10th Avenue, New York, NY  10019, United States.",Non-OADS,/arxiv_data1/oa_pdf/4e/99/WJCO-7-340.PMC5056326.pdf
This review article World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i5.340World J Clin Oncol  2016 October 10; 7(5): 340-351 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/4e/99/WJCO-7-340.PMC5056326.pdf
World J Clin Oncol  2016; 7(5): 340-351   Available from: URL:  http://www.wjgnet.com/ 2218-4333 /full/ v7/i5/340.htm  DOI: http://dx.doi.org/10.5306/wjco.v7.i5.340 INTRODUCTION Colorectal cancer (CRC) with an incidence of 1.2 million  cases per year is now the third most common cancer  in males and second in females[1].,Non-OADS,/arxiv_data1/oa_pdf/4e/99/WJCO-7-340.PMC5056326.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/4e/99/WJCO-7-340.PMC5056326.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Dr. Godefridus J Peters, PhD,  Professor,  Department of Medical Oncology, VU University  Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The  Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/78/05/WJCO-7-352.PMC5056327.pdf
"In model systems inhibition of the Akt  pathway enhanced the cytotoxicity of drugs like taxanes,  antimetabolites, platinum analogs, several targeted drugs World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i5.352World J Clin Oncol  2016 October 10; 7(5): 352-369 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/78/05/WJCO-7-352.PMC5056327.pdf
wjgnet.com/ 2218-4333 /full/v7/i5/352.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/05/WJCO-7-352.PMC5056327.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/78/05/WJCO-7-352.PMC5056327.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Todd A Swanson, MD, PhD, Department  of Radiation Oncology, the University of Texas Medical Branch,  301 University Boulevard, Galveston, TX 77555-0711,  United States.",Non-OADS,/arxiv_data1/oa_pdf/37/5a/WJCO-7-370.PMC5056328.pdf
World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i5.370World J Clin Oncol  2016 October 10; 7(5): 370-379 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/37/5a/WJCO-7-370.PMC5056328.pdf
World J Clin Oncol  2016; 7(5): 370-379  Available from: URL:   http://www.wjgnet.com/ 2218-4333 /full/v7/i5/370.htm  DOI:  http://dx.doi.org/10.5306/wjco.v7.i5.370 INTRODUCTION Breast conservation surgery (BCS) has been offered to  newly diagnosed breast cancer patients as early as the  1950s[1].,Non-OADS,/arxiv_data1/oa_pdf/37/5a/WJCO-7-370.PMC5056328.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/37/5a/WJCO-7-370.PMC5056328.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript  Correspondence to: Shuhei Komatsu, MD, Division of  Digestive Surgery, Department of Surgery, Kyoto Prefectural  University of Medicine, 465 Kawaramachihirokoji, Kamigyo-ku,  Kyoto 602-0855, Japan.",Non-OADS,/arxiv_data1/oa_pdf/71/0d/WJCO-7-380.PMC5056329.pdf
Published by Baishideng Publishing  Group Inc. All rights reserved.World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i5.380World J Clin Oncol  2016 October 10; 7(5): 380-386 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/71/0d/WJCO-7-380.PMC5056329.pdf
World J Clin Oncol  2016; 7(5): 380-386   Available from: URL:  http://www.wjgnet.com/ 2218-4333 /full/ v7/i5/380.htm  DOI: http://dx.doi.org/10.5306/wjco.v7.i5.380 INTRODUCTION  Granulocyte colony-stimulating factor (G-CSF) is a  naturally produced glycoprotein that is synthesized  by stromal cells in bone marrow.,Non-OADS,/arxiv_data1/oa_pdf/71/0d/WJCO-7-380.PMC5056329.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/71/0d/WJCO-7-380.PMC5056329.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Carlos A Castaneda, MD, MSc, Department  of Medical Oncology , Instituto Nacional de Enfermedades  Neoplasicas, Av.",Non-OADS,/arxiv_data1/oa_pdf/b4/b3/WJCO-7-387.PMC5056330.pdf
"carloscastanedaaltamirano@yahoo.com Telephone:  +51-1-2157220 Fax: +51-1-6204991 Received: April 18, 2016 Peer-review started:  April 18, 2016 First decision: June 12, 2016 Revised: August 13, 2016 Accepted:  September 21, 2016 Article in press:  September 23, 2016 Published online:  October 10, 2016 Abstract   AIM To determine influence of neoadjuvant-chemotherapy  (NAC) over tumor-infiltrating-lymphocytes (TIL) in World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i5.387World J Clin Oncol  2016 October 10; 7(5): 387-394 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b4/b3/WJCO-7-387.PMC5056330.pdf
World J Clin Oncol  2016; 7(5): 387-394  Available  from: URL:  http://www.wjgnet.com/ 2218-4333 /full/v7/i5/387.htm   DOI: http://dx.doi.org/10.5306/wjco.v7.i5.387 INTRODUCTION Triple negative breast cancer (TNBC) represents 10%  to 20% of breast cancer (BC) and is a biologically  aggressive tumor with high response to Neoadjuvant  chemotherapy (NAC) but poor outcome[1].,Non-OADS,/arxiv_data1/oa_pdf/b4/b3/WJCO-7-387.PMC5056330.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b4/b3/WJCO-7-387.PMC5056330.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Silvina Richard, PhD,  Instituto Multi - disciplinario de Biología Celular (CIC, UNLP , CONICET), Camino  General Belgrano y 526, La Plata, Buenos Aires B1906APO,  Argentina.",Non-OADS,/arxiv_data1/oa_pdf/ad/f6/WJCO-7-395.PMC5056331.pdf
Deletions in GSTT1  and GSTM1  World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i5.395World J Clin Oncol  2016 October 10; 7(5): 395-405 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/ad/f6/WJCO-7-395.PMC5056331.pdf
"wjgnet.com/ 2218-4333 /full/v7/i5/395.htm  DOI: http://dx.doi.org/10.5306/wjco.v7.i5.395 INTRODUCTION Xenobiotic metabolizing enzymes (XME), coded by a  family of xenobiotic metabolizing genes (XMG), trans­ form endo and exogenous compounds in hydr ophilic  by­products, which are more easily excreted from  the tissues[1].",Non-OADS,/arxiv_data1/oa_pdf/ad/f6/WJCO-7-395.PMC5056331.pdf
"Available from: URL:  https://monographs.iarc.fr/ENG/Classification/Table4.pdf 15 Schnatter AR , Rosamilia K, Wojcik NC.",OADS,/arxiv_data1/oa_pdf/ad/f6/WJCO-7-395.PMC5056331.pdf
"Available from: URL: http://globocan.iarc.fr 17 Ministerio de Salud de la Nación , Secretaría de Políticas Regulación  e Institutos, Dirección de Estadísticas e Información de Salud.",Non-OADS,/arxiv_data1/oa_pdf/ad/f6/WJCO-7-395.PMC5056331.pdf
"Available from: URL: http://dxsp.sergas.es 21 Peakall R , Smouse PE.",Non-OADS,/arxiv_data1/oa_pdf/ad/f6/WJCO-7-395.PMC5056331.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ad/f6/WJCO-7-395.PMC5056331.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Ian K Komenaka, MD, Maricopa Medical  Center, Hogan Building, 2nd Floor, 2601 E Roosevelt Street,  Phoenix, AZ 85008,  United Sta tes.",Non-OADS,/arxiv_data1/oa_pdf/db/57/WJCO-7-406.PMC5056332.pdf
"Sociodemographic information was collected included age,  education, monthly income, race/ethnicity, employment,  insurance status, and primary care provider of the World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i5.406World J Clin Oncol  2016 October 10; 7(5): 406-413 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/db/57/WJCO-7-406.PMC5056332.pdf
World J Clin Oncol  2016; 7(5): 406-413  Available  from: URL:  http://www.wjgnet.com/ 2218-4333 /full/v7/i5/406.,Non-OADS,/arxiv_data1/oa_pdf/db/57/WJCO-7-406.PMC5056332.pdf
htm  DOI: http://dx.doi.org/10.5306/wjco.v7.i5.406 INTRODUCTION Cervical cancer is one of the most preventable and  treatable female cancers.,Non-OADS,/arxiv_data1/oa_pdf/db/57/WJCO-7-406.PMC5056332.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/db/57/WJCO-7-406.PMC5056332.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript  source:  Invited  manuscript Correspondence to: Yoshihiro Matsumoto, Associate  Professor,  Department of Orthopaedic Surgery, Graduate School  of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi- ku, Fukuoka 812-8582, Japan.",Non-OADS,/arxiv_data1/oa_pdf/43/28/WJCO-7-414.PMC5056333.pdf
The authors consider that above mentioned characteristic  findings may facilitate the suspicion of pelvic pathology  and a search for SNDT by MRI or computed tomography  should be considered in patients presenting with sciatica World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i5.414World J Clin Oncol  2016 October 10; 7(5): 414-419 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/43/28/WJCO-7-414.PMC5056333.pdf
World J Clin Oncol  2016; 7(5): 414-419   Available from: URL:  http://www.wjgnet.com/ 2218-4333 /full/v7/ i5/414.htm  DOI: http://dx.doi.org/10.5306/wjco.v7.i5.414 INTRODUCTION Sciatica is a very common disorder .,Non-OADS,/arxiv_data1/oa_pdf/43/28/WJCO-7-414.PMC5056333.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/43/28/WJCO-7-414.PMC5056333.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Peter Paluchowski, MD, Chief, Department of Obstetrics and Gynecology, Regio Klinikum Pinneberg,  Fahltskamp 74, 25421 Pinneberg,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/b1/87/WJCO-7-420.PMC5056334.pdf
"Histological analysis  showed invasive growth besides typical (non-invasive)  papillary carcinoma and was classified as invasive solid  papillary carcinoma; pT3 (10 cm), pN0 (0/15), M0, World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i5.420World J Clin Oncol  2016 October 10; 7(5): 420-424 ISSN 2218-4333 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b1/87/WJCO-7-420.PMC5056334.pdf
wjgnet.com/ 2218-4333 /full/v7/i5/420.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/87/WJCO-7-420.PMC5056334.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b1/87/WJCO-7-420.PMC5056334.pdf
Available from: http://www.censusindia.gov.in/Census_And_You/age_structure_and_marital_status.aspx.,OADS,/arxiv_data1/oa_pdf/96/51/IJO-64-553.PMC5056539.pdf
Available from: http://www.cdc.gov/diabetes/statistics/age/fig2.htm.,Non-OADS,/arxiv_data1/oa_pdf/96/51/IJO-64-553.PMC5056539.pdf
Available from: http://www.nobelprize.org/nobel_prizes/medicine/laureates/2008/press.html.,Non-OADS,/arxiv_data1/oa_pdf/96/51/IJO-64-553.PMC5056539.pdf
An online toric calculator (http://aurolab.com/optical/ loginpage.aspx) was used to determine the axis of placement.,OADS,/arxiv_data1/oa_pdf/71/bd/IJO-64-559.PMC5056541.pdf
Available from: http://www.westbengal.gov.in/BanglarMukh/ Download?FilePath=/alfresco/d/d/workspace/SpacesStore/329b a5f1‑5753‑4c45‑af30‑a191c289fb92/Chap‑p_03_08_15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/83/36/IJO-64-578.PMC5056545.pdf
Available from: http://www.censusindia.gov.in/PopulationFinder/ District_Master.aspx?state_code=19.,OADS,/arxiv_data1/oa_pdf/83/36/IJO-64-578.PMC5056545.pdf
Available from:  http://www.consort‑statement.org/.,Non-OADS,/arxiv_data1/oa_pdf/93/15/IJO-64-614b.PMC5056557.pdf
Available from:  http://www.consort‑statement.org/.,Non-OADS,/arxiv_data1/oa_pdf/1b/d4/IJO-64-615.PMC5056558.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16150 EditorialJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/98/50/jnm-22-543.PMC5056563.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16157 EditorialJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/f8/b4/jnm-22-545.PMC5056564.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16069 ReviewJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/33/af/jnm-22-547.PMC5056565.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16001 ReviewJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/82/5a/jnm-22-558.PMC5056566.pdf
Available from URL: http://www.jupiterpharma.in/ journalpdf/IBS WORLD GASTRO.pdf (accessed 22 Sep 2016) 6.,Non-OADS,/arxiv_data1/oa_pdf/82/5a/jnm-22-558.PMC5056566.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16138 ReviewJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/7e/eb/jnm-22-575.PMC5056567.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16018 ReviewJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/79/de/jnm-22-589.PMC5056568.pdf
Available  from URL: http://handbook.cochrane.org/ (accessed 22 Sep 2016).,OADS,/arxiv_data1/oa_pdf/79/de/jnm-22-589.PMC5056568.pdf
Available from URL: http://www.nccmt.ca/ resources/search/14 (accessed 22 Sep 2016).,OADS,/arxiv_data1/oa_pdf/79/de/jnm-22-589.PMC5056568.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15182 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/6f/f5/jnm-22-606.PMC5056569.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15172 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/b6/7f/jnm-22-613.PMC5056570.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15195 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/cb/92/jnm-22-620.PMC5056571.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16019 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/90/6d/jnm-22-630.PMC5056572.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15135 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/jnm-22-643.PMC5056573.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15203 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/cd/2c/jnm-22-650.PMC5056574.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16035 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/6e/8b/jnm-22-656.PMC5056575.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15160 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/57/fc/jnm-22-661.PMC5056576.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15148 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/12/8a/jnm-22-670.PMC5056577.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15187 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/5a/f9/jnm-22-677.PMC5056578.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 15190 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/32/64/jnm-22-686.PMC5056579.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16007 Original ArticleJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/80/99/jnm-22-694.PMC5056580.pdf
"4   October,  2016pISSN: 2093-0879   eISSN: 2093-0887http://dx.doi.org/10.5056/jnm 16068 Image and LearningJournal of Neurogastroenterology and Motility  ⓒ 2016 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol.",Non-OADS,/arxiv_data1/oa_pdf/fc/53/jnm-22-705.PMC5056581.pdf
"Supplementary Material   Note: T o access the supplementary video mentioned in this  article, visit the online version of Journal of Neurogastroenterology  and Motility  at http://www.jnmjournal.org/, and at http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fc/53/jnm-22-705.PMC5056581.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/83/ircmj-18-08-24836.PMC5056592.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/a4/ircmj-18-08-19650.PMC5056593.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a0/7a/10.1177_2325967116668137.PMC5056595.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/0a/ijp-26-04-6189.PMC5056600.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/94/ircmj-18-08-29382.PMC5056601.pdf
Available from: http://www.who.int/gho / ncd/risk factors/bmi_text/en/.,OADS,/arxiv_data1/oa_pdf/df/94/ircmj-18-08-29382.PMC5056601.pdf
Avail- able from: http://www.who.int/gho/publications/world_health_ statistics/EN_WHS2012_Full.pdf .,Non-OADS,/arxiv_data1/oa_pdf/df/94/ircmj-18-08-29382.PMC5056601.pdf
"4, 506 –518 http://dx.doi.org/10.1080/15384101.2015.1120915",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Phospho-ERK5 TEY (3371,http://www.cellsignal.com/products/primary-antibodies/3371),myc 9B11 (2276, http://www.cellsignal.com/products/primary- antibodies/2276) and phospho-ERK1/2 (9106, http://www.cellsignal.com/products/primary-antibodies/9106) antibodies were from Cell Signaling Technology.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Total ERK5 antibodies were from Santa Cruz (sc1284, Figures 2, 4 and 6 , http://www.scbt.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"com/datasheet-1284-erk-5-c-20-antibody.html) and Cell Sig-naling Technology (3372S, Figure 7 , http://www.cellsignal.com/ products/primary-antibodie s/3372?hit=productId &Ntte D3372S).",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"A total Raf-B antibody (sc-5284, http://www.scbt.com/datasheet-5284-raf-b-f-7-antibody.html) and tubulin (sc-8035, http://www.scbt.com/datasheet-8035- a-tubulin-tu-02-antibody.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"html) were obtained from Santa Cruz and total MEK5 anti- body (AB3184, http://www.merck millipore.com/GB/en/prod uct/Anti-MEK5-Antibody,MM_NF-AB3184) from Chemicon.Total ERK1 antibody was from BD Biosciences (610031,http://www.bdbiosciences.com/d s/pm/tds/610031.pdf).",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Antibodies for actin were from Sigma (A4700, http://www.sigmaaldrich.com/catalog/product/sigma/a4700?lang Denandregion DGB).",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
CellTitre-Glo /C2103D Cell Viability Assay was purchased from Promega (https://www.promega.co.uk/ products/cell-health-and -metabolism/cell-viabi lity-assays/celltiter_ glo-3d-cell-viability-assay/).,Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
Emetine (http://www.sigmaaldrich.com/catalog/product/sigma/e2375?lang Den andregion DGB) and 4HT (http://www.sigmaaldrich.com /catalog/product/sial/t176?lang D en andregion DGB) purchased from Sigma.,Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"HCT116 and HT29 cell spheroids HCT116 and HT29 cells were cultured in round bottom, ultra- low attachment 96-well plate tissue culture plates (http://www.sigmaaldrich.com/catalog /product/sigma/cls4520?lang D enandregion DGB) in 200 ml culture medium (described above) using the method described by Vinci et al.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"The extracts were mixed, for 3 h at 4 /C14C, with a 10 ml bed volume of Protein A –Sepharose (ERK1) (Sigma, http://www.sigmaaldrich.c om/catalog/product/sigma/ p9424?lang=en andregion=GB) or Protein G –Sepharose (ERK5) (GE Healthcare, http: //www.gelifesciences.com/ webapp/wcs/stores/servlet/ ProductDisplay?categoryId D11504 andcatalogId=10101 andprodu ctId=21386 andstoreId=12751 andlangId D¡1) and antibody; 5 ml of rabbit anti-ERK1 anti- body (BD Biosciences, http://www.bdbiosciences.com/eu/applications/research/stem-cell-research/stem-cell-signaling/ human/puri ﬁed-mouse-anti-erk1-mk12/p/610031), or 10 mlo f goat anti-ERK5 antibody (Santa Cruz Biotechnology, http:// www.scbt.com/datasheet-1284-erk-5-c-20-antibody.html).",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Unless otherwise indicated, data are either combined from independent experiments or are from a single experiment on triplicate dishes, representative of at least 2others giving similar results.Luciferase assays HEK293, SW48, CaCo2, HCT116, DLD-1, COLO205 and CO115 cells were transfected using Lipofectamine 2000 (Life Technologies, https://www.lifetechnologies.com/uk/en/home/ brands/product-brand/lipofectamine/lipofectamine-2000.html), according to the manufacturer ’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"HT29 and SNU449 cells were transfected using JetPEI (PolyPlus, http://www.polyplus-transfection.com/2009/08/high-throughput-screening-jetpei/) according to the manufacturer ’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"After a further 16 –18–h cells were harvested and processed for ﬁreﬂy and renilla luciferase activity using the Dual Luciferase Reporter (Promega, http://www.promega.co.uk/products/reporter-assays-and-transfection/reporter-assays/dual_luciferase-reporter-assay-system/) assay according to themanufacturer ’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"(Connections Map in the Data- base of Cell Signaling, as seen 27 February 2014)http://stke.sciencemag.org/cgi/cm/stkecm;CMP_10827.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"(Connections Map in the Database of Cell Signaling, as seen 27 February 2014), http://stke.sciencemag.org/cgi/cm/stkecm;CMP_10958.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"J Biol Chem 1995; 270:12665-9;PMID:7759517; http://dx.doi.org/10.1074/jbc.270.21.12665 [5] Lee JD, Ulevitch RJ, Han J.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Biochem Biophys Res Commun 1995; 213:715- 24; PMID:7646528; http://dx.doi.org/10.1006/bbrc.1995.2189 [6] Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellula r functions.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Growth Factors 2006; 24:21- 44; PMID:16393692; http://dx.doi.org/10.1080/02699050500284218 [7] Roberts PJ, Der CJ.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Oncogene 2007; 26:3291-310; PMID:17496923; http://dx.doi.org/10.1038/sj.onc.1210422 [8] Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O ’Dwyer PJ, Lee RJ, Grippo JF, Nolop K, et al.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"N Engl J Med 2010; 363:809-19; PMID:20818844; http://dx.doi.org/10.1056/ NEJMoa1002011 [9] Gilmartin AG, Bleam MR, Groy A, Moss KG, Minthorn EA, Kul- karni SG, Rominger CM, Erskine S, Fisher KE, Yang J, et al.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Clin Cancer Res 2011; 17:989-1000;PMID:21245089; http://dx.doi.org/10.1158/1078-0432.CCR-10-2200 [10] Davies BR, Logie A, McKay JS, Martin P, Steele S, Jenkins R, Cocker- ill M, Cartlidge S, Smith PD.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Mol Cancer Ther 2007; 6:2209- 19; PMID:17699718; http://dx.doi.org/10.1158/1535-7163.MCT-07-0231 [11] McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Franklin RA, Montalto G, Cervello M, Libra M, Candido S, Malaponte G, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
Oncogene 2013; 32:1207-15; PMID: 22562245; http://dx.doi.org/10.1038/onc.2012.160.,Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
Nature 1998; 395:713-6; PMID:9790194; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
Mol Cell Biol 2002; 22:270-85; PMID:11739740; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"J Biol Chem 1999; 274:31588-92;PMID:10531364; http://dx.doi.org/10.1074/jbc.274.44.31588 [16] Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"J Biol Chem1999; 274:26563-71; PMID:10473620; http://dx.doi.org/10.1074/jbc.274.37.26563 [17] Mody N, Leitch J, Armstrong C, Dixon J, Cohen P. Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"FEBS Lett2001; 502:21-4; PMID:11478941; http://dx.doi.org/10.1016/S0014- 5793(01)02651-5 [18] Squires MS, Nixon PM, Cook SJ.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Biochem J 2002; 366:673-80; PMID: 12069688; http://dx.doi.org/10.1042/bj20020372 [19] Ortiz-Ruiz MJ, Alvarez-Fernandez S, Parrott T, Zaknoen S, Burrows FJ, Ocana A, Pandiella A, Esparis-Ogando A.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
Oncotarget 2014; 5:11308-18; PMID:25350956; http://dx.doi.org/10.18632/oncotarget.,OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"PLoS One 2009; 4:e5565; PMID:19440538; http://dx.doi.org/10.1371/journal.pone.0005565 [21] Mehta PB, Jenkins BL, McCarthy L, Thilak L, Robson CN, Neal DE, Leung HY.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
Oncogene 2003; 22:1381-9; PMID:12618764; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Oncogene 2003; 22:1281-93; PMID:12618753; http://dx.doi.org/10.1038/sj.onc.1206261 [24] Allen LF, Sebolt-Leopold J, Meyer MB.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Semin Oncol2003; 30:105-16; PMID:14613031; http://dx.doi.org/10.1053/j.seminoncol.2003.08.012 [25] Heidorn SJ, Milagre C, Whittaker S, Nourry A, Niculescu-Duvas I, Dhomen N, Hussain J, Reis-Filho JS, Springer CJ, Pritchard C, et al.516 P. A. LOCHHEAD ET AL.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Cell 2010; 140:209-21; PMID:20141835;http://dx.doi.org/10.1016/j.cell.2009.12.040 [26] Gilley R, March HN, Cook SJ.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Cell Sig- nal 2009; 21:969-77; PMID:19249353; http://dx.doi.org/10.1016/j.cellsig.2009.02.006 [27] Carvajal-Vergara X, Tabera S, Montero JC, Esparis-Ogando A, Lopez-Perez R, Mateo G, Gutierrez N, Parmo-Cabanas M, Teixido J,San Miguel JF, et al.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Blood 2005; 105:4492-9; PMID:15692064; http://dx.doi.org/ 10.1182/blood-2004-08-2985 [28] Yang Q, Deng X, Lu B, Cameron M, Fearns C, Patricelli MP, Yates JR, 3rd, Gray NS, Lee JD.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Can- cer Cell 2010; 18:258-67; PMID:20832753; http://dx.doi.org/10.1016/ j.ccr.2010.08.008 [29] Tatake RJ, O ’Neill MM, Kennedy CA, Wayne AL, Jakes S, Wu D, Kugler SZ, Jr., Kashem MA, Kaplita P, Snow RJ.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Biochem Biophys Res Commun 2008; 377:120-5; PMID:18834865; http://dx.doi.org/10.1016/j.bbrc.2008.09.087 [30] Gilley R, Lochhead PA, Balmanno K, Oxley D, Clark J, Cook SJ.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Cell Signal 2012; 24:170-80; PMID:21924351; http://dx.doi.org/10.1016/j.cellsig.2011.08.018 [31] Balmanno K, Chell SD, Gillings AS, Hayat S, Cook SJ.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Int J Cancer 2009; 125:2332-41; PMID:19637312; http://dx.doi.org/10.1002/ijc.24604 [32] Gavine PR, Wang M, Yu D, Hu E, Huang C, Xia J, Su X, Fan J, Zhang T, Ye Q, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
Cell Signal 2012; 24:2187-96; PMID:22800864; http://dx.doi.org/10.1016/j.cellsig.2012.,OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Eur J Med Chem 2013; 70:758- 67; PMID:24239623; http://dx.doi.org/10.1016/j.ejmech.2013.10.052 [38] Deng X, Yang Q, Kwiatkowski N, Sim T, McDermott U, Settleman JE, Lee JD, Gray NS.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"ACS Med Chem Lett 2011; 2:195-200; PMID:21412406;http://dx.doi.org/10.1021/ml100304b [39] Elkins JM, Wang J, Deng X, Pattison MJ, Arthur JS, Erazo T, Gomez N, Lizcano JM, Gray NS, Knapp S. X-ray crystal structure of ERK5(MAPK7) in complex with a speci ﬁc inhibitor.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"J Med Chem 2013; 56:4413-21; PMID:23656407; http://dx.doi.org/10.1021/jm4000837 [40] English JM, Pearson G, Baer R, Cobb MH.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"J Biol Chem 1998; 273:3854-60;PMID:9461566; http://dx.doi.org/10.1074/jbc.273.7.3854 [41] Chiariello M, Marinissen MJ, Gutkind JS.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Mol Cell Biol 2000; 20:1747-58; PMID:10669751; http://dx.doi.org/10.1128/MCB.20.5.1747-1758.2000 [42] Abe J, Takahashi M, Ishida M, Lee JD, Berk BC.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"JCell Sci 2005; 118:1663-71; PMID:15797923; http://dx.doi.org/10.1242/jcs.02308 [44] Schramp M, Ying O, Kim TY, Martin GS.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"J Cell Biol2008; 181:1195-210; PMID:18573916; http://dx.doi.org/10.1083/jcb.200801078 [45] Gangarosa LM, Sizemore N, Graves-Deal R, Oldham SM, Der CJ, Coffey RJ.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Genes Dev 1995; 9:1953-64; PMID:7649477; http://dx.doi.org/10.1101/gad.9.16.1953 [47] Schulze A, Nicke B, Warne PH, Tomlinson S, Downward J.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Mol Biol Cell 2004; 15:3450-63;PMID:15090615; http://dx.doi.org/10.1091/mbc.E03-11-0807 [48] Schulze A, Lehmann K, Jefferies HB, McMahon M, Downward J.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Genes Dev 2001; 15:981-94; PMID:11316792; http://dx.doi.org/ 10.1101/gad.191101 [49] Mulloy R, Salinas S, Philips A, Hipskind RA.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Oncogene 2003; 22:5387-98;PMID:12934098; http://dx.doi.org/10.1038/sj.onc.1206839 [50] Smalley KS, Lioni M, Dalla Palma M, Xiao M, Desai B, Egyhazi S, Hansson J, Wu H, King AJ, Van Belle P, et al.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Mol Cancer Ther 2008; 7:2876-83; PMID: 18790768; http://dx.doi.org/10.1158/1535-7163.MCT-08-0431 [51] Grandis JR, Sok JC.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
Pharmacol Ther 2004; 102:37-46; PMID:15056497; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Leukemia 2012; 26:236-43; PMID:21860433;http://dx.doi.org/10.1038/leu.2011.218 [53] Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, Lomas C, Mendiola M, Hardisson D, Eccles SA.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"BMC Biol2012; 10:29; PMID:22439642; http://dx.doi.org/10.1186/1741-7007- 10-29 [54] Balmanno K, Cook SJ.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Oncogene 1999; 18:3085-97; PMID:10340380; http://dx.doi.org/10.1038/sj.onc.1202647 [55] Garner AP, Weston CR, Todd DE, Balmanno K, Cook SJ.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Oncogene 2002; 21:8089-104; PMID:12444545; http://dx.doi.org/10.1038/sj.onc.1206000 [56] Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cyto- toxicity assay for anticancer-dru g screening.",OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
J Natl Cancer Inst 1990; 82:1107-12; PMID:2359136; http://dx.doi.org/10.1093/jnci/82.13.1107CELL CYCLE 517,Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"Clin Cancer Res 2008; 14:3984- 92; PMID:18559621; http://dx.doi.org/10.1158/1078-0432.CCR-07-5158[58] Roberts OL, Holmes K, Muller J, Cross DA, Cross MJ.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
J Cell Sci2010; 123:3189-200; PMID:20736307; http://dx.doi.org/10.1242/ jcs.072801518 P. A. LOCHHEAD ET AL.,OADS,/arxiv_data1/oa_pdf/00/6b/kccy-15-04-1120915.PMC5056618.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).T rends in Hearing 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/93/e2/10.1177_2331216516669889.PMC5056619.pdf
Retrieved from https://www.g-ba.de/downloads/62-492- 934/HilfsM-RL_2014-07-17.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/e2/10.1177_2331216516669889.PMC5056619.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Trends in Hearing 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ed/84/10.1177_2331216516670279.PMC5056620.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Trends in Hearing 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/fe/f7/10.1177_2331216516667319.PMC5056622.pdf
Keywords p38 MAP kinase; Social interaction; Drugs of abuse; Conditioned place preference; Stress;  Reward This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/2f/emss-65126.PMC5056637.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"3, e1218411 (6 pages)http://dx.doi.org/10.1080/21597081.2016.1218411",Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"Int J Syst Bacteriol 1987; 37:136-43; http://dx.doi.org/10.1099/00207713-37-2-136 [2] Backus EA, Andrews KB, Shugart HJ, Carl Greve L, Laba- vitch JM, Alhaddad H. Salivary enzymes are injected intoxylem by the glassy-winged sharpshooter, a vector of Xylella fastidiosa .",Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"J Insect Physiol 2012; 58:949-59; PMID:22587965; http://dx.doi.org/10.1016/j.jinsphys.2012.04.011 [3] Hopkins DL, Prucell AH.",OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"Plant Disease 2002; 86:1056-66; http://dx.doi.org/10.1094/PDIS.2002.86.10.1056 [4] P /C19erez-Donoso AG, Greve LC, Walton JH, Shackel KA, Labavitch JM.",OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"Plant Physiol 2007; 143:1024-36;http://dx.doi.org/10.1104/pp.106.087023 [5] Redak RA, Purcell AH, Lopes JR, Blua MJ, Mizell RF 3rd.",OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
Annu Rev Entomol 2004; 49:243-70; PMID: 14651464; http://dx.doi.org/10 .1146/annurev.ento.49.061802.,Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
J Econ Entomol 2003; 96:264-71; PMID:14994789; http://dx.doi.org/10.1603/0022-0493-96.2.264BACTERIOPHAGE e1218411-5,Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"Available from: http://winegrapes.tamu.edu/ ﬁles/2015/11/mgt_PD_TX.pdf [10] Lu C, Warchol KM, Callahan RA.",Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"Hilgardia 1949; 19:190-206; http://dx.doi.org/10.3733/hilg.v19n06p190 [13] Redak RA, Prucell AH, Lopes JRS, Blua MJ, Mizell III RF, Andersen PC.",Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"California Agriculture 2014; 68:134-41; http://dx.doi.org/10.3733/ca.v068n04p134[16] Almeida RPP, Prucell AH.",Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"Plant Disease 2003; 87:1255-59; http://dx.doi.org/10.1094/PDIS.2003.87.10.1255 [17] Bextine B, Miller TA.",Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"BioTechniques2005; 38:184-186; PMID:15727122; http://dx.doi.org/ 10.2144/05382BM02 [18] Ahern SJ, Das M, Bhowmick TS, Young R, Gonzalez CF.",OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"J Bacteriol 2014; 196:459-71; PMID:24214944; http://dx.doi.org/10.1128/JB.01080-13 [19] Mizell RF, French WJ.",Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
J Bacteriol 2010; 192:179-90; PMID:19897657; http://dx.doi.org/10.1128/JB.01174-09 [21] Schwartz M. 1975.,Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"J Mol Biol 1975; 99:185-201; PMID:1107562; http://dx.doi.org/10.1016/S0022-2836(75)80167-7 [22] Clokie MR, Milard AD, Letarov AV, Heaphy S. Phages in nature.",OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
Bacteriophage 2011; 1:31-45; PMID:21687533;http://dx.doi.org/10.4161/bact.1.1.14942e1218411-6 T. S. BHOWMICK ET AL.,Non-OADS,/arxiv_data1/oa_pdf/aa/b0/kbac-06-03-1218411.PMC5056766.pdf
"10, 1041 –1050 http://dx.doi.org/10.1080/15476286.2016.1219832",Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Cell 2001; 107:411-4; PMID:11719181; http://dx.doi.org/10.1016/S0092-8674(01)00583-9 2.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Eur J Med Genet 2006; 49:445-50;PMID:16740421; http://dx.doi.org/10.1016/j.ejmg.2006.04.003 3.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Hum Mutat 2008; 29:1037-47; PMID:18454449; http://dx.doi.org/10.1002/humu.20763 4.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Genome Med 2009; 1:13; PMID:19348700; http://dx.doi.org/10.1186/gm13 5.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Clin Pharmacol Ther2007; 81:99-103; PMID:17186006; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Methods Enzymol 2010; 478:437-62; PMID:20816493; http://dx.doi.org/10.1016/S0076-6879 (10)78021-6 7.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
BioDrugs Clin Immunother Biopharm Gene Ther 2016; 30:49-74; PMID: 26886021; http://dx.doi.org/10.1007/s40259-016-0157-6 8.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Eur J Hum Genet 2009; 18:130-2; PMID:19603067; http://dx.doi.org/10.1038/ejhg.2009.122 9.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Pediatr Res 2009; 65:520-3; PMID:19190538; http://dx.doi.org/10.1203/ PDR.0b013e31819d9ebc 10.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Gut 2010;59:496-507; PMID:19951906; http://dx.doi.org/10.1136/gut.2008.169805 11.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
NucleicAcids Res 2011; 39:3350-62; PMID:21149266; http://dx.doi.org/10.1093/nar/gkq1277 12.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
PloS One 2011; 6:e24125;PMID:21909382; http://dx.doi.org/10.1371/journal.pone.0024125 13.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Obesity 2012; 20:1074-81; PMID:21738238; http://dx.doi.org/10.1038/oby.2011.202 14.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
J Inherit Metab Dis 2013; 36:955-9; PMID:23532445; http://dx.doi.org/10.1007/s10545-013-9602-6 15.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
PLoS One 2015; 10:e0135873; PMID:26287674; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
BMC Med 2007; 5:5; PMID:17394637; http://dx.doi.org/10.1186/1741-7015-5-5 17.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Ann Neurol 2010; 67:771-80; PMID:20517938; http://dx.doi.org/ 10.1002/ana.22024 18.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Am J Respir Crit Care Med 2010; 182:1262- 72; PMID:20622033; http://dx.doi.org/10.1164/rccm.201001-0137OC 19.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
PloS One 2013; 8:e81302;PMID:24349052; http://dx.doi.org/10.1371/journal.pone.0081302 20.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Muscle Nerve 2014; 50:477-87; PMID:25042182; http://dx.doi.org/10.1002/ mus.24332 21.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Lancet RespirMed 2014; 2:539-47; PMID:24836205; http://dx.doi.org/10.1016/S2213-2600(14)70100-6 22.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
RNA N Y N 2000; 6:1044-55; PMID:10917599; http://dx.doi.org/10.1017/S1355838200000716 23.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Ann Neurol 2000; 48:164-9; PMID:10939566;http://dx.doi.org/10.1002/1531-8249(200008)48:2%3c164::AID-ANA5 %3e3.0.CO;2-B 24.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
RNA Biol 2015; 12:950-8; PMID:26176195; http://dx.doi.org/10.1080/15476286.2015.1068497 25.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Eur Respir J 2010; 36:1248-58; PMID:20530032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
gov/pmc/articles/PMC4300728/ ; PMID:25610612; http://dx.doi.org/10.1186/s13630-014-0011-8 27.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
J Med Genet 2015; 52:1-9; PMID:25351953; http://dx.doi.org/10.1136/jmedgenet-2014-102755 28.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Paediatric Respiratory Reviews 2016; 18:8-17; [Internet] [cited 2015 Oct 14]; Available from: http://www.sciencedir ect.com/science/article/pii/S1526054215000731 ; PMID:26362507; http://dx.doi.org/10.1016/j.prrv.2015.07.017 29.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Pharmacol Ther 2012; 136:227-66; PMID:22820013; http://dx.doi.org/10.1016/j.pharmthera.2012.07.007 30.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
RNA 1998; 4:479-86; PMID:9630253; http://dx.doi.org/10.1017/S1355838298971576 31.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Ann Neurol 2004; 55:422-6;PMID:14991821; http://dx.doi.org/10.1002/ana.20052 32.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
J Appl Genet 2011; 52:39-51; PMID:21125367; http://dx.doi.org/10.1007/s13353-010-0005-1 34.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
J Microsc 2003; 211:103-11; PMID:12887704; http://dx.doi.org/10.1046/j.1365-2818.2003.01209.x 35.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Exp Lung Res 1987; 13:223-40; PMID:3665853; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Lab Investig JTech Methods Pathol 2002; 82:989-98; PMID:12177237; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Gene Ther 2004; 11:619-27; PMID:14973546; http://dx.doi.org/ 10.1038/sj.gt.3302211RNA BIOLOGY 1049,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
PLoS Genet 2012; 8:e1002608; PMID:22479203; http://dx.doi.org/10.1371/journal.pgen.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Genome Res 2011; 21:2096-113; PMID:21994247; http://dx.doi.org/10.1101/gr.119974.110 42.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Nucleic Acids Res 2014; 42:8928-38; PMID:25013167; http://dx.doi.org/10.1093/nar/gku608 43.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
RNA 2016; 22(3):456-66; [cited 2016 Feb 2]; Available from:http://rnajournal.cshlp.org/content/early/2016/01/11/rna.054452.115 ; PMID:26759455; http://dx.doi.org/10.1261/rna.054452.115 44.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Hum Mol Genet 2001; 10:291-9; PMID:11159948; http://dx.doi.org/10.1093/hmg/10.3.291 45.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Hum Mutat 2012; 33:973-80; PMID:22334403; http://dx.doi.org/10.1002/humu.22047 46.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Bioorg Med Chem 2010; 18:3735-46; PMID:20409719; http://dx.doi.org/10.1016/j.bmc.2010.03.060 4 7 .,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Nature 2007; 447:87-91; PMID:17450125;http://dx.doi.org/; http://dx.doi.org/10.1038/nature05756 48.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
EMBO Mol Med 2012; 4:1186-99; PMID:23027640; http://dx.doi.org/10.1002/emmm.201201438 49.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Hum Mol Genet 2009; 18:3906-13; PMID:19625298; http://dx.doi.org/10.1093/hmg/ddp333 50.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
J Med Chem 2009; 52:2836-45; PMID:19309154; http://dx.doi.org/10.1021/jm801640k 51.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Trends Mol Med 2006; 12:306-16; PMID:16782405; http://dx.doi.org/10.1016/j.molmed.2006.05.005 53.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
J Clin Invest 2007; 117:683-92; PMID:17290305; http://dx.doi.org/10.1172/JCI28523 54.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Kidney Int 1984; 25:643-52; PMID:6482168; http://dx.doi.org/10.1038/ki.1984.69 55.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Toxicol Lett 1990; 51:241-59; discussion 237 9; PMID:2187280; http://dx.doi.org/10.1016/0378-4274(90) 90067-V 56.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Kidney Int 2011; 79:33-45; PMID:20861826; http://dx.doi.org/10.1038/ki.2010.337 57.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Nat Methods 2012; 9:671-5; PMID:22930834; http://dx.doi.org/10.1038/nmeth.2089 58.,OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
Acta Otolaryngol (Stockh) 1995; 115:66-70; PMID:7762388; http://dx.doi.org/10.3109/000164895091333491050 Z. BUKOWY-BIERYLLO ET AL.,Non-OADS,/arxiv_data1/oa_pdf/55/ec/krnb-13-10-1219832.PMC5056772.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"3, e1220349 (17 pages)http://dx.doi.org/10.1080/21597081.2016.1220349",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Genomes were annotated using DNA Master ( coba mide2.bio.pitt.edu ), which includes the gene calling programs Glimmer ( http://ccb.jhu.edu/software/glim mer)39and GeneMark ( exon.gatech.edu ).40We also used GeneMark.hmm ( exon.gatech.edu ).41Details of the annotation procedure are given in26.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"App Microbiol Biotechnol 2010; 87:87-97; PMID:20401479; http://dx.doi.org/10.1007/s00253-010-2573-8 [2] De Graaf DC, Alippi AM, Antunez K, Aronstein KA, Budge G, De Koker D, De Smet L, Dingman DW, EvansJD, Foster LJ, F €unfhaus A, Garcia-Gonzalez E, Gregore A, Human H, Murray KD, Nguyen BK, Poppinga L, Spi-vak M, Engelsdorp D, Wilkins S, and Genersch E. Stan- dard methods for American foulbrood research.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"2012; 52(1):1-26; http://dx.doi.org/10.3896/IBRA.1.52.1.11 [3] Genersch E. American Foulbrood in honeybees and its causative agent, Paenibacillus larvae .",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"J Invertebr Pathol 2009; 103:S10-19; PMID:19909971; http://dx.doi.org/10.1016/j.jip.2009.06.015 [4] Miyagi T, Peng CY, Chuang RY, Mussen EC, Spivak MS, Doi RH.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"J Invertebr Pathol 2000; 75:95-6; PMID:10631065; http://dx.doi.org/10.1006/jipa.1999.4888 [5] Tian B, Fadhil NH, Powell JE, Kwong WK, Moran NA.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"mBio 2012; 3(6):e00377-12; PMID:23111871; http://dx.doi.org/10.1128/mBio.00377-12 [ 6 ] M a t s u z a k iS ,U c h i y a m aJ ,T a k e m u r a - U c h i y a m aI , Daibata M. Perspective: The age of the phage.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Nature2014; 509(7498):S9; PMID:24784429; http://dx.doi.org/10.1038/509S9a [7] Hagens S, Loessner MJ.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Appl Micro-biol Biotechnol 2007; 76(3):513-519; PMID:17554535; http://dx.doi.org/10.1007/s00253-007-1031-8 [8] Loc-Carrillo C, Abedon ST. Pros and cons of phage ther- apy.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Bacteriophage 2011; 1(2):111-4; PMID:22334867;http://dx.doi.org/10.4161/bact.1.2.14590 [9] Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
Fut Microbiol 2013; 8(6):769-783; PMID:23701332; http://dx.doi.org/10.2217/fmb.13.47 [10] Gochnauer TA.,OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
Bee World 1955; 36:101- 3; http://dx.doi.org/10.1080/0005772X.1955.11094880 [11] Gochnauer TA.,Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"J Invertebr Pathol 1970; 15:149-56;PMID:5435792; http://dx.doi.org/10.1016/0022-2011(70)90228-4 [12] Valerianov T, Popova A, Toshkov AS.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"J Apic Res 1982; 21:53-6; http://dx.doi.org/10.1080/00218839.1982.11100516 [14] Benada O, Ludvik J, Drobnikova V. Morphology of a new bacteriophage isolated from Bacillus larvae.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Folia Microbiol1984; 29:520-1; http://dx.doi.org/10.1007/BF02873162 [15] Dingman DW, Bakhiet N, Field CC, Stahly DP.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"J Gen Virol1984; 65:1101-5; PMID:6726188; http://dx.doi.org/10.1099/0022-1317-65-6-1101 [16] Bakhiet N, Stahly DP.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"JInvertebr Pathol 1988; 52:78-83; http://dx.doi.org/10.1016/0022-2011(88)90105-X [17] Campana CF, Bakhiet N, Stahly DP.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"J Invertebr Pathol 1991; 57:141-3; http://dx.doi.org/10.1016/0022-2011(91)90055-U [18] Stahly DP, Alippi AM, Bakhiet N, Campana CF, Novak CC, C o xR .P P L 1 c ,av i r u l e n tm u t a n tb a c t e r i o p h a g eu s e f u lf o ridenti ﬁcation of Paenibacillus larvae subspecies larvae.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Bacte- riophage 2015; 5(4):e1080787; PMID:26904379; http://dx.doi.org/10.1080/21597081.2015.1080787 [20] Yost DG, Tsourkas P, Amy PS.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Bacteriophage 2016; 6(1):e1122698; http://dx.doi.org/10.1080/21597081.2015.1122698 [21] Ghorbani-Nezami S, LeBlanc L, Yost DG, Amy PS.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"J Insect Sci 2015; 15(1):84-9;PMID:26136497; http://dx.doi.org/10.1093/jisesa/iev051 [22] Oliveira A, Leite M, Kluskens LD, Santos SB, Melo LDR, Azeredo J.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"PLoS One 2015; 11(2):e0150157;http://dx.doi.org/10.1371/journal.pone.0150157 [23] Beims H, Wittman J, Bunk B, Sproer C, Rohde C, Gunther G, Rohde M, von der Ohe W, Steinert M. Paeni- bacillus larvae -directed bacteriophage HB10c2 and its application in American Foulbrood-affected honey bee larvae.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Appl Environ Microbiol 2015; 81(16):5411-9; PMID:26048941; http://dx.doi.org/10.1128/AEM.00804-15 [24] Oliveira A, Melo LDR, Kropinski AM, Azeredo J. Com- plete genome sequence of the broad-host-range Paeniba-cillus larvae phage philBB_P123.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Genome Announc2013; 1(5):e00438-13; PMID:24009112; http://dx.doi.org/10.1128/genomeA.00438-13 [25] Carson S, Bruff E, DeFoor W, Dums J, Groth A, Hat ﬁeld T, Iyer A, Joshi K, McAdams S, Miles D, et al.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Genome Announc 2015; 3(3):e00101-15; http://dx.doi.org/10.1128/genomeA.00101-15 [26] Tsourkas P, Yost D, Krohn A, Leblanc L, Zhang A, Stamereilers C, Amy PS.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
Genome Announc 2015; 3(5):e01120-15; PMID:26472825; http://dx.doi.org/10.1128/genomeA.01120-15 [27] White GF.,OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"PLoS One 2012; 7(3):e34052; PMID:22470512;http://dx.doi.org/10.1371/journal.pone.0034052 [30] Walmagh M, Boczkowska B, Grymonprez B, Briers Y, Drulis-Kawa Z, Lavigne R. Characterization of ﬁve novel endolysins from Gram-negative infecting bacteriophages.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Appl Microbiol Biotechnol 2013; 97(10):4369-75;PMID:22832988; http://dx.doi.org/10.1007/s00253-012-4294-7 [31] Cotter PD, Ross RP, Hill C. Bacteriocins - a viable alter- native to antibiotics?",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Nat Rev Microbiol 2013 Feb; 11(2):95-105; PMID:23268227; http://dx.doi.org/10.1038/nrmicro2937 [32] Aunpad R, Panbangred W. Evidence for two putative holin-like peptides encoding genes of Bacillus pumilusstrain WAPB4.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Curr Microbiol 2012; 64(4):343-8;PMID:22231453; http://dx.doi.org/10.1007/s00284-011-0074-3 [33] Anthony T, Chellappa GS, Rajesh T, Gunasekaran P. Functional analysis of a putative holin-like peptide-cod-ing gene in the genome of Bacillus licheniformis AnBa9.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Arch Microbiol 2010; 192(1):51-6; PMID:19967339; http://dx.doi.org/10.1007/s00203-009-0530-7 [34] Hatfull GF, Jacobs-Sera D, Lawrence JG, Pope WH, Russell DA, Ko CC, Weber RJ, Patel MC, Germane KL, Edgar RH,et al.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"J Mol Biol 2010; 397:119-43; PMID:20064525; http://dx.doi.org/10.1016/j.jmb.2010.01.011 [35] Pope WH, Bowman CA, Russell DA, Jacobs-Sera D, Asai DJ, Cresawn SG, Jacobs WR, Hendrix RW, Lawrence JG,Hatfull GF.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
Elife 2015; 4:e06416; PMID:25919952;http://dx.doi.org/10.7554/eLife.06416 [36] Casjens Sr.,Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
Curr Opin Microbiol 2005; 8:451-8; PMID:16019256; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Bioinformatics 2012; 28(12):1647-9; PMID:22543367; http://dx.doi.org/10.1093/bioinformatics/ bts199 [39] Delcher AL, Harmon D, Kasif S, White O, Salzberg S. Improved microbial gene identi ﬁcation with GLIMMER.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Nucl Acids Res 1999; 27(23):4636-41; PMID:10556321;http://dx.doi.org/10.1093/nar/27.23.4636 [40] Besemer J, Borodovsky M. GeneMark: Web software for gene ﬁnding in prokaryotes eukaryotes, and viruses.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Nucl Acids Res 2005; 33(suppl 2):W451-4; http://dx.doi.org/ 10.1093/nar/gki487 [41] Lukashin AV, Borodovsky M. GeneMark.hmm: New solu- tions for gene ﬁnding.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Nucl Acids Res 1998; 26(4):1107-15; PMID:9461475; http://dx.doi.org/10.1093/nar/26.4.1107 [42] Krumsiek J, Arnold R, Rattei R. Gepard: a rapid and sen- sitive tool for creating dotplots on genome scale.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Nucl Acids Res 1994; 22(22):4673-80; PMID:7984417;http://dx.doi.org/10.1093/nar/22.22.4673 [44] Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, S €oding J, et al.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"Mol Syst Biol 2011; 7(1):1-6; PMID:21988835; http://dx.doi.org/10.1038/msb.2011.75 [45] Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JF, Geer LY, Geer RC,Gonzales NR, Gwadz M, et al.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"NuclAcids Res 2009; 37(suppl 1):D205-10; PMID:18984618; http://dx.doi.org/10.1093/nar/gkn845 [46] Cresawn SG, Bogel M, Day N, Jacobs-Sera D, Hendrix RW, Hatfull GR.",OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"BMC Bioinformat-ics 2011; 12:395-409; PMID:21219653; http://dx.doi.org/10.1186/1471-2105-12-395 [47] Merrill BD, Grose JH, Breakwell DP, Burnett SH.",Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
BMC Genomics 2014; 15:745; PMID:25174730; http://dx.doi.org/10.1186/1471-2164-15-745BACTERIOPHAGE e1220349-17,Non-OADS,/arxiv_data1/oa_pdf/e4/6f/kbac-06-03-1220349.PMC5056774.pdf
"10, 946 –954 http://dx.doi.org/10.1080/15476286.2016.1216304",Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Cell 2013; 152:17-24; PMID:23332744; http://dx.doi.org/10.1016/j.cell.2012.12.024 2.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Trends Genet 2015; 31:150-56; PMID:25708284; http://dx.doi.org/ 10.1016/j.tig.2015.01.005 3.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Annu Rev Microbiol 2005; 59:487-517; PMID:16153177;http://dx.doi.org/10.1146/annurev.micro.59.030804.121336 4.,Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Mol Cell 2011; 43:867-79; PMID:21925376; http://dx.doi.org/10.1016/j.molcel.2011.08.024 5.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Int J Med Microbiol 2014; 304:79-92; PMID:24140145; http://dx.doi.org/10.1016/j.ijmm.2013.09.002 6.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Proc Natl Acad Sci USA 2002; 99:15908-13; PMID:12456892; http://dx.doi.org/10.1073/ pnas.212628899 7.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Cell 2002; 111:747-56;PMID:12464185; http://dx.doi.org/10.1016/S0092-8674(02)01134-0 8.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Nature 2002; 419:952-56; PMID:12410317; http://dx.doi.org/10.1038/nature01145 9.,Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Nat Struct Mol Biol 2004; 11:29-35; PMID:14718920; http://dx.doi.org/10.1038/nsmb710 10.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Science 2004; 306:275-79; PMID:15472076; http://dx.doi.org/10.1126/science.1100829 11.,Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Proc Natl Acad Sci USA 2003; 100:12057-62; PMID:14523230; http://dx.doi.org/ 10.1073/pnas.2133705100 12.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
RNA Biol 2011; 8:82-9; PMID:21282981; http://dx.doi.org/ 10.4161/rna.8.1.1386413.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Structure and mechanism of a metal-sensing regulatory RNA.Cell 2007; 130:878-92; PMID:17803910; http://dx.doi.org/10.1016/j.cell.2007.06.051 14.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Science 2012; 335:233-35; PMID:22194412; http://dx.doi.org/ 10.1126/science.1215063 15.,Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Nucleic Acids Res 2002; 30:3141-51; PMID:12136096; http://dx.doi.org/10.1093/nar/gkf433 17.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Bio- chem Soc Trans 2000; 28:283-96; PMID:10961912; http://dx.doi.org/10.1042/bst0280283 18.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Nat Biotech 2006; 24:1558-64; PMID:17160062; http://dx.doi.org/10.1038/nbt1268 19.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Chem Biol 2005; 12:1325-35;PMID:16356850; http://dx.doi.org/10.1016/j.chembiol.2005.10.007 20.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
RNA Biol 2009; 6:187-94; PMID:19246992; http://dx.doi.org/10.4161/rna.6.2.7727 21.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
PLoS Pathog 2010; 6(4):e1000865; PMID:20421948; http://dx.doi.org/10.1371/ journal.ppat.1000865 22.,Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
J Med Chem 2015; 58:3275-86; PMID:25603286; http://dx.doi.org/10.1021/jm500868e 23.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
(Tokyo) 1974; 27:86-87; PMID:4843053; http://dx.doi.org/10.7164/antibiotics.27.88 24.,Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Nature 2009; 458:233- 237; PMID:19169240; http://dx.doi.org/10.1038/nature07642 26.,Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Curr Pharm Des 2013; 19:2552-2560;PMID:23116394; http://dx.doi.org/10.2174/1381612811319140006 27.,Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
"Langer, S, Hashimoto, M, Hobl, B, Mathes, T, Mack, M. Flavoproteins are potential targets for the antibiotic roseo ﬂavin in Escherichia coli .J Bacteriol 2013; 195:4037-45; PMID:23836860; http://dx.doi.org/10.1128/JB.00646-13 2 8 .",Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Nature 2015; 526:672-7; PMID:26416753; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Antimicrob Agents Chemother 2015; 59:5736-46; PMID:26169403; http://dx.doi.org/10.1128/AAC.01282-15 30.,Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Nuc Acids Res 2011; 39:8586-98; PMID:21745821; http://dx.doi.org/10.1093/nar/gkr565 33.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
ACS Chem Biol 2012; 7:73-86; PMID:22185671;http://dx.doi.org/10.1021/cb200447r 34.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Science 2005; 309:1559-63; PMID:16141072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Nature 2012; 489:101-8; PMID:22955620; http://dx.doi.org/10.1038/nature11233 38.,Non-OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
Nat Rev Genet 2014; 15:423-37; PMID:24776770; http://dx.doi.org/10.1038/nrg3722954 J.,OADS,/arxiv_data1/oa_pdf/31/03/krnb-13-10-1216304.PMC5056776.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"3, e1219440 (13 pages)http://dx.doi.org/10.1080/21597081.2016.1219440",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"[4] Antimicrobial resistance: global report on surveillance World Health Organization, April 2014:1-257; http://www.who.int/drugresistance/d ocuments/surve illancereport/ en/.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"J Clin Microbiol 2010; 48:609-11; PMID:20007392; http://dx.doi.org/10.1128/JCM.02297-09 [6] Chhibber S, Kaur T, Sandeep K. Co-therapy using lytic bacteriophage and linezolid: effective treatment in elimi-nating methicillin resistant Staphylococcus aureus(MRSA) from diabetic foot infections.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Plos One 2013; 8:e56022; PMID:23418497; http://dx.doi.org/10.1371/ journal.pone.0056022[7] Cadena J, Richardson AM, Frei CR.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"J Athletic Training 2015; 50:432-7; PMID:25710853; http://dx.doi.org/10.4085/1062-6050-49.3.96 [10] Montazeri EA, Khosravi AD, Jolodar A, Ghaderpanah M, Azarpira S. Identi ﬁcation of methicillin-resistant Staphylo- coccus aureus (MRSA) strains isolated from burn patients bymultiplex PCR.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Burns 2015; 41:590-4; PMID:25441547;http://dx.doi.org/10.1016/j.burns.2014.08.018 [11] Khokhlova OE, Hung WC, Wan TW, Iwao Y, Takano T, Higuchi W, Yachenko SV, Teplyakova OV, Kamshilova VV, Kotlovsky YV, et al.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"PloSOne 2015; 10:e0128017; PMID:26047024; http://dx.doi.org/10.1371/journal.pone.0128017 [12] Zapun A, Contreras-Martel C, Vernet T. Penicillin-bind- ing proteins and b-lactam resistance.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"FEMS Microbiol Rev 2008; 32:361-85; PMID:18248419; http://dx.doi.org/10.1111/j.1574-6976.2007.00095.x [13] Ballhausen B, Kriegeskorte A, Schleimer N, Peters G, Becker K. The mecA homolog mecC confers resistanceagainst b-lactams in Staphylococcus aureus irrespective of the genetic strain background.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
CurrOpin Pharmacol 2005; 5:479-89; PMID:16095969; http://dx.doi.org/10.1016/j.coph.2005.06.002 [15] Center for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"JClin Microbiol 2003; 41:5113-20; PMID:14605147; http://dx.doi.org/10.1128/JCM.41.11.5113-5120.2003 [17] McDougal LK, Fosheim GE, Nicholson A, Bulens SN, Limbago BM, Shearer JE, Summers AO, Patel JB.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Antimicrobial Agents Chemotherapy2010; 54:3804-11; PMID:20585117; http://dx.doi.org/10.1128/AAC.00351-10 [18] Hershey AD, Chase M. Genetic recombination and hetero- zygosis in bacteriophage.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"PloS One 2015; 10:e0131714; PMID:26131892; http://dx.doi.org/10.1371/journal.pone.0131714 [20] Kutateladze M, Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.Trends Biotechnol 2010; 28:591-5; PMID:20810181;http://dx.doi.org/10.1016/j.tibtech.2010.08.001 [21] Adhya S, Merril CR, Biswas B.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Cold Spring Harb Perspect Med 2014; 4:a012518; PMID:24384811; http://dx.doi.org/10.1101/ cshperspect.a012518 [22] O ’Flaherty S, Ross RP, Meaney W, Fitzgerald GF, Elbreki MF, Coffey A.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Applied EnvironmentalMicrobiol 2005; 71:1836-42; PMID:15812009; http://dx.doi.org/10.1128/AEM.71.4.1836-1842.2005 [23] Synnott AJ, Kuang Y, Kurimoto M, Yamamichi K, Iwano H, Tanji Y.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Isolation from sewage in ﬂuent and character- ization of novel Staphylococcus aureus bacteriophageswith wide host ranges and potent lytic capabilities.Applied Environmental Microbiol 2009; 75:4483-90;http://dx.doi.org/10.1128/AEM.02641-08 [24] Becker SC, Foster-Frey J, Donovan DM.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"FEMS Microbiol Letters 2008; 287:185- 91; PMID:18721148; http://dx.doi.org/10.1111/j.1574- 6968.2008.01308.x [25] O ’Flaherty S, Coffey A, Edwards R, Meaney W, Fitzgerald GF, Ross RP.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
J Bacteriol 2004; 186:2862-71; PMID:15090528; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"J Bacteriol 2011;193:4006-9; PMID:21642458; http://dx.doi.org/10.1128/JB.01412-10 [27] Brown S, Santa Maria JP, Jr, Walker S. Wall teichoic acids of gram-positive bacteria.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Annu Rev Microbiol 2013;67:313-36; PMID:24024634; http://dx.doi.org/10.1146/ annurev-micro-092412-155620[28] Peschel A, Vuong C, Otto M, Gotz F. The D-alanine resi- dues of Staphylococcus aureus teichoic acids alter thesusceptibility to vancomycin and the activity of autolyticenzymes.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Antimicrobial Agents Chemotherapy 2000;44:2845-7; PMID:10991869; http://dx.doi.org/10.1128/AAC.44.10.2845-2847.2000 [29] Brown S, Xia G, Luhachack LG, Campbell J, Meredith TC, Chen C, Winstel V, Gekeler C, Irazoqui JE, Peschel A, et al.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Nat Med 2004; 10:243-5; PMID:14758355; http://dx.doi.org/10.1038/nm991 [31] Weidenmaier C, Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology andhost interactions.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Nat Rev Microbiol 2008; 6:276-87;PMID:18327271; http://dx.doi.org/10.1038/nrmicro1861 [32] Xia G, Kohler T, Peschel A.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Int J Med Microbiol 2010; 300:148-54; PMID:19896895; http://dx.doi.org/10.1016/j.ijmm.2009.10.001 [33] Jenni R, Berger-Bachi B. Teichoic acid content in differ- ent lineages of Staphylococcus aureus NCTC8325.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"ArchMicrobiol 1998; 170:171-8; PMID:9683656; http://dx.doi.org/10.1007/s002030050630 [34] Winstel V, Sanchez-Carballo P, Holst O, Xia G, Peschel A. Biosynthesis of the unique wall teichoic acid of Staph- ylococcus aureus lineage ST395.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Mbio 2014; 5:e00869; PMID:24713320; http://dx.doi.org/10.1128/mBio.00869-14 [35] Xia G, Maier L, Sanchez-Carballo P, Li M, Otto M, Holst O, Peschel A. Glycosylation of wall teichoic acid inStaphylococcus aureus by TarM.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"J Biol Chem 2010;285:13405-15; PMID:20185825; http://dx.doi.org/10.1074/jbc.M109.096172 [36] Hershey AD, Dixon J, Chase M. Nucleic acid economy in bacteria infected with bacteriophage T2.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
J General Physiol 1953; 36:777-89;PMID:13069681; http://dx.doi.org/10.1085/jgp.36.6.777 [37] Kutter E. Phage host range and ef ﬁciency of plating.,Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Methods Mol Biol 2009; 501:141-9; PMID:19066818;http://dx.doi.org/10.1007/978-1-60327-164-6_14 [38] Deghorain M, Van Melderen L. The Staphylococci phages family: an overview.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Viruses 2012; 4:3316-35; PMID:23342361; http://dx.doi.org/10.3390/v4123316 [39] Rosato RR, Cameron JA.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"2:159-67; PMID:23275867; http://dx.doi.org/10.4161/ bact.21440 [41] Pasquina LW, Santa Maria JP, Walker S. Teichoic acid bio- synthesis as an antibiotic target.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Curr Opin Microbiol 2013;16:531-7; PMID:23916223; http://dx.doi.org/10.1016/j.mib.2013.06.014 [42] Kamal F, Dennis JJ.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Applied Environmental Microbiol 2015; 81:1132-8;PMID:25452284; http://dx.doi.org/10.1128/AEM.02850-14[43] Comeau AM, Tetart F, Trojet SN, Prere MF, Krisch HM.",OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"Med Sci (Paris) 2008; 24:449-51; PMID:18466714; http://dx.doi.org/10.1051/medsci/2008245449 [44] Comeau AM, Tetart F, Trojet SN, Prere MF, Krisch HM.",Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
PloS One 2007; 2:e799; PMID:17726529; http://dx.doi.org/10.1371/journal.pone.0000799BACTERIOPHAGE e1219440-13,Non-OADS,/arxiv_data1/oa_pdf/75/5e/kbac-06-03-1219440.PMC5056778.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"3, e1220348 (6 pages)http://dx.doi.org/10.1080/21597081.2016.1220348",Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"J Virol 2002; 76:5557-64; PMID:11991984;http://dx.doi.org/10.1128/JVI.76.11.5557-5564.2002 [ 2 ] S u t h e r l a n dI W ,H u g h e sK A ,S k i l l m a nL C ,T a i tK .T h ei n t e r - action of phage and bio ﬁlms.",OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
FEMS Microbiol Lett 2004; 232:1-6; PMID:15061140; http://dx.doi.org/10.1016/S0378-1097(04)00041-2 [3] Abedon ST. Bacteriophage exploitation of bacterial bioﬁlms: phage preference for less mature targets?,Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"FEMS Microbiol Lett 2016; 363:fnv246; PMID:26738755; http://dx.doi.org/10.1093/femsle/fnv246 [4] Payne RJH, Jansen VAA.",OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
J TheorBiol 2001; 208:37-48; PMID:11162051; http://dx.doi.org/10.1006/jtbi.2000.2198 [5] Harper DR.,Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"Foodborne Pathog Dis 2009; 6:807-15; PMID:19459758;http://dx.doi.org/10.1089/fpd.2008.0242 [7] Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM.",Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
Bacteriophage 2011; 1:66-85; PMID:22334863; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"Biotechnol J 2016; 11:1-6; http://dx.doi.org/10.1002/biot.201670002 [10] Abedon ST. Phage population growth: constraints, games, adaptation.",Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"Meth Mol Biol 2009; 501:175-202; PMID:19066822; http://dx.doi.org/10.1007/978-1- 60327-164-6_18 [12] Abedon ST, Thomas-Abedon C. Phage therapy pharmacol- ogy.",Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
Curr Pharm Biotechnol 2010; 11:28-47; PMID:20214606;http://dx.doi.org/10.2174/138920110790725410 [13] Abedon S. Phage therapy pharmacology: calculating phage dosing.,Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"Adv Appl Microbiol 2011; 77:1-40;PMID:22050820; http://dx.doi.org/10.1016/B978-0-12-387044-5.00001-7 [14] Abedon ST. Bacteriophages and Bio ﬁlms: Ecology, Phage Therapy, Plaques.",OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
J Gen Physiol 1939; 22:365-84; PMID:19873108; http://dx.doi.org/10.1085/jgp.22.3.365 [17] Delbr €uck M. The growth of bacteriophage and lysis of the host.,Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"J Gen Physiol 1940; 23:643-60; PMID:19873180;http://dx.doi.org/10.1085/jgp.23.5.643 [18] Benzer S, Hudson W, Weidel W, Delbr €uck M, Stent GS, Weigle JJ, et al.",OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
Adv Appl Microbiol 2010; 70:217-48;PMID:20359459; http://dx.doi.org/10.1016/S0065-2164 (10)70007-1 [20] Stent GS.,OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"J Theor Biol 1990; 146:501-11; PMID:2273898;http://dx.doi.org/10.1016/S0022-5193(05)80375-3 [25] Stopar D, Abedon ST.",Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"Genet Res 1999; 74:1-11; PMID:10505404;http://dx.doi.org/10.1017/S0016672399003833 [28] Abedon ST. Spatial vulnerability: bacterial arrangements, microcolonies, and bio ﬁlms as responses to low rather than high phage densities.",OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
Viruses 2012; 4:663-87; PMID:22754643; http://dx.doi.org/10.3390/v4050663 [29] Abedon ST. Bacteriophages as drugs: the pharmacology of phage therapy.,Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations.Curr Pharm Biotechnol 2010; 11:58-68; PMID:20214608; http://dx.doi.org/10.2174/138920110790725429e1220348-6 S. T. ABEDON,Non-OADS,/arxiv_data1/oa_pdf/9e/ae/kbac-06-03-1220348.PMC5056779.pdf
"Published with license by Taylor & Francis Group, LLC © Janis Kruse, Doreen Meier, Fides Zenk, Maren Rehders, Wolfgang Nellen, and Christian Hammann This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
"10, 1000 –1010 http://dx.doi.org/10.1080/15476286.2016.1212153",Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Cell 2004; 116:281-97; PMID:14744438; http://dx.doi.org/ 10.1016/S0092-8674(04)00045-5 2.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nature 2003; 425:415-9; PMID:14508493; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Science 2001; 293:834-8;PMID:11452083; http://dx.doi.org/10.1126/science.1062961 4.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
EMBO J 2002; 21:4663- 70; PMID:12198168; http://dx.doi.org/10.1093/emboj/cdf476 5.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nature 2001; 409:363-6; PMID:11201747; http://dx.doi.org/10.1038/35053110 6.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Cell 2004; 117:69-81; PMID:15066283; http://dx.doi.org/10.1016/S0092-8674(04)00261-2 7.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nature 2000; 404:293-6; PMID:10749213; http://dx.doi.org/ 10.1038/350051071008 J. KRUSE ET AL.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
PLoS Biol 2004; 2:E104; PMID:15024409; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Science 2004; 303:95-8; PMID:14631048; http://dx.doi.org/10.1126/science.1090599 10.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Genes Dev 2003;17:3011-6; PMID:14681208; http://dx.doi.org/10.1101/gad.1158803 11.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Wiley Interdiscip Rev RNA 2014; 5:31-48; PMID:24124076; http://dx.doi.org/10.1002/wrna.1195 13.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Cell 2004; 118:57-68; PMID:15242644; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nature 2003; 426:468- 74; PMID:14615802; http://dx.doi.org/10.1038/nature02129 15.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nat Struct Mol Biol 2011; 18:1153-8; PMID:21926993; http://dx.doi.org/10.1038/nsmb.2125 16.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nucleic Acids Res 2008; 36:6511-22; PMID:18927112; http://dx.doi.org/10.1093/nar/gkn687 18.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nature 2004;429:318-22; PMID:15152257; http://dx.doi.org/10.1038/nature02519 19.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nature 2003; 426:465-9; PMID:14615801; http://dx.doi.org/10.1038/nature02123 20.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Cell 2013; 152:844-58; PMID:23415231; http://dx.doi.org/10.1016/j.cell.2013.01.031 22.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
J Biol Chem 2005; 280:27595-603; PMID:15932881; http://dx.doi.org/10.1074/jbc.M504714200 23.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nature 2004; 432:231-5; PMID:15531879; http://dx.doi.org/10.1038/nature03049 24.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nature 2004; 432:235-40; PMID:15531877;http://dx.doi.org/10.1038/nature03120 25.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Curr Biol 2007; 17:818-23; PMID:17442570; http://dx.doi.org/10.1016/j.cub.2007.04.005 26.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
PLoS One 2013; 8:e65652; PMID:23776518; http://dx.doi.org/10.1371/journal.pone.006565227.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
J Eukaryot Microbiol 2012; 59:429-93; PMID:23020233;http://dx.doi.org/10.1111/j.1550-7408.2012.00644.x 29.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
"Meier D, Kruse J, Buttlar J, Friedrich M, Zenk F, Boesler B, F€orstner K. Hammann C, Nellen W. Analysis of the microproces- sor in Dictyostelium: the role of RbdB, a dsRNA binding protein.PLoS Genet 2016; 12:e1006057; PMID:27272207; http://dx.doi.org/ 10.1371/journal.pgen.1006057 30.",OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nature 2005; 435:43- 57; PMID:15875012; http://dx.doi.org/10.1038/nature03481 31.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nucleic Acids Res 2007; 35:6714-26; PMID:17916577; http://dx.doi.org/10.1093/nar/gkm707 32.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Gene 2010; 465:1-8; PMID:20600701; http://dx.doi.org/10.1016/j.gene.2010.06.010 33.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Plasmid 2009; 61:110-8; PMID:19063918; http://dx.doi.org/ 10.1016/j.plasmid.2008.11.003 34.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nucleic Acids Res 1994; 22:5099-111; PMID:7800506; http://dx.doi.org/10.1093/nar/22.23.5099 35.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Mol Cell 2010; 38:323-32; PMID:20471939; http://dx.doi.org/10.1016/j.molcel.2010.03.013 37.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
His- tochem Cell Biol 2011; 135:239-49; PMID:21327858; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Mol Biol Cell 2005; 16:2395-413; PMID:15758027; http://dx.doi.org/10.1091/mbc.E04-11-0992 39.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Cold Spring Harb Perspect Biol 2011; 3; PMID:21106648; http://dx.doi.org/cshperspect.a000638 40.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
NucleicAcids Res 2007; 35:W585-7; PMID:17517783; http://dx.doi.org/ 10.1093/nar/gkm259 42.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Cell 2006; 125:887-901; PMID:16751099; http://dx.doi.org/10.1016/j.cell.2006.03.043 43.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Cell 2009; 136:75-84; PMID:19135890; http://dx.doi.org/10.1016/j.cell.2008.10.053 44.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nucleic Acids Res 2014; 42:D222-30; PMID:24288371; http://dx.doi.org/10.1093/nar/gkt1223 45.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Eur J Cell Biol 2008; 87:57-68; PMID:18054409; http://dx.doi.org/10.1016/j.ejcb.2007.10.003 48.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Science 2006; 311:195-8; PMID:16410517; http://dx.doi.org/ 10.1126/science.1121638 49.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
J Mol Biol 2006; 358:430-42; PMID:16516925; http://dx.doi.org/10.1016/j.jmb.2006.01.099 51.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Genes Dev 2004; 18:3016-27; PMID:15574589; http://dx.doi.org/10.1101/gad.1262504 52.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Proc Natl Acad Sci U S A 2012; 109:523-8; PMID:22173636; http://dx.doi.org/10.1073/ pnas.1118859109 53.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Cell 2014; 159:1153-67; PMID:25416952; http://dx.doi.org/10.1016/j.cell.2014.10.040 54.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
"Vazquez F, Gasciolli V, Crete P, Vaucheret H. The nuclear dsRNA binding protein HYL1 is required for microRNA accumulation andplant development, but not posttranscriptional transgene silencing.Curr Biol 2004; 14:346-51; PMID:14972688; http://dx.doi.org/ 10.1016/j.cub.2004.01.035 56.",OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Curr Genet 2006; 50:81-99;PMID:16691418; http://dx.doi.org/10.1007/s00294-006-0078-x 59.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Nucleic Acids Res 1988; 16:2613-23;PMID:3362676; http://dx.doi.org/10.1093/nar/16.6.2613 60.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Methods Mol Biol 2013; 983:283-94; PMID:23494313; http://dx.doi.org/10.1007/978-1-62703-302-2_15 61.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Cell1985; 43:633-41; PMID:4075402; http://dx.doi.org/10.1016/0092-8674(85)90235-1 62.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
NucleicAcids Res 2007; 35:e60; PMID:17405769; http://dx.doi.org/10.1093/ nar/gkm112 63.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Mol Biol Cell 2010; 21:4212-26; PMID:20926688; http://dx.doi.org/10.1091/mbc.E10-04-0287 64.,Non-OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
Plos One 2013; 8:e64804; PMID:23724097; http://dx.doi.org/10.1371/journal.pone.00648041010 J. KRUSE ET AL.,OADS,/arxiv_data1/oa_pdf/57/99/krnb-13-10-1212153.PMC5056781.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(3):104-111 http://dx.doi.org/10.5808/GI.2016.14.3.104 ORIGINAL ARTICLE Received May 23, 2016; Revised June 16, 2016; Accepted June 29, 2016 *Corresponding author:  Tel: +91-7152-284679, Fax: +91-7152-284038, E-mail: satishangral@gmail.com Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Virtual Screening for Potential Inhibitors of NS3  Protein of Zika Virus Maheswata Sahoo1, Lingaraja Jena1, Sangeeta Daf2, Satish Kumar1* 1Bioinformatics Centre & Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442-102, India, 2Obstetrics & Gynaecology, Datta Meghe Institute of Medical Sciences (Deemed University), Nagpur 440-022, India Zika virus (ZIKV) is a mosquito borne pathogen, belongs to Fl aviviridae family having a positive-sense single-stranded RNA  genome, currently known for causing large epidemics in Brazil.",Non-OADS,/arxiv_data1/oa_pdf/c4/1d/gni-14-104.PMC5056895.pdf
"Bioinformatics software, such  as PyRx 0.8 [24], Phyre2 [25], AutoDock Vina [26] and o n l i n e  r e s o u r c e s  l i k e  N C B I  [ 2 7 ] ,  P r o C h e c k  a t  R C S B   validation server [28], ProSA-web [29], ZINC database  (https://zinc.docking.org), ProQ [30], ERRAT server [31], etc.",OADS,/arxiv_data1/oa_pdf/c4/1d/gni-14-104.PMC5056895.pdf
Available from: http://www.paho.org/  hq/index.php?option=com_docman&task=doc_view&Itemid =270&gid=30075=en.,OADS,/arxiv_data1/oa_pdf/c4/1d/gni-14-104.PMC5056895.pdf
Available from: http://www.ncbi.nlm.nih.gov.,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/gni-14-104.PMC5056895.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(3):112-124 http://dx.doi.org/10.5808/GI.2016.14.3.112 ORIGINAL ARTICLE Received June 13, 2016; Revised August 2, 2016; Accepted August 9, 2016 *Corresponding author:  Tel: +91-06742-565760, Fax: +91-06742-565760, E-mail: snrbioinfo@gmail.com Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).In Silico  Study of miRNA Based Gene Regulation,  Involved in Solid Cancer, by the Assistance of  Argonaute Protein Surya Narayan Rath1*, Debasrita Das1, V Badireenath Konkimalla2, Sukanta Kumar Pradhan1 1BIF Centre, Department of Bioinformatics, Orissa University of Agriculture & T echnology, Bhubaneswar 751003, India, 2School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar 751005, India Solid tumor is generally observed in tissues  of epithelial or endothelial cells of lung, breast, prostate, pancreases, colorect al,  stomach, and bladder, where several genes transcription is regulated by the microRNAs (miRNAs).",Non-OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
Methods Screening of miRNAs and genes  Extensive literature search and exploration of online  databases were conducted to understand miRNAs mediated  regulation of solid cancer associated target genes using miRCancer (http://mircancer.ecu.edu/) and miRDisease  (http://mir2disease.org).,OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
"The 23 target genes and their involvement in different biological functions like angiogenesis, apoptosis, cell cycle, cell proliferation, and others are plotted using Venn diagram (http://bioinformatics.psb.ugent.be/webtools/Venn/).",OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
"Further, minimum free energy (MFE) score based binding affinity between miRNAs and their target genes were  explored and inspected using miRTarbase web server  (http://mirtarbase.mbc.nctu.edu.tw/).",OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
"Furthermore, the involvement of target genes in different biological function  was inspected using UniProt (http://www.uniprot.org/)  web server and plotted using Venn (http://bioinformatics.",OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
"Prediction of structural model of miRNA-mRNA  complexes To verify the folding affinity between selected miRNAs  and their target genes, secondary structures were predicted using RNAfold web server (http://rna.tbi.univie.ac.at/cgi-bin/  RNAfold.cgi).",OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
The resulted dot bracketed structures of duplex  were used for prediction of their tertiary structure using RNA COMPOSER (http://rnacomposer.cs.put poznan.pl/).,OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
"Docking were performed between AGO protein and miRNA-mRNA duplexes (miR-106 and PTEN ;  miR-21 and TGFBR2 ; and miR-29b-2 and VEGFA ) using  PatchDock web server (http://bioinfo3d.cs.tau.ac.il/PatchDock /),algorithm ranked the docked complexes on the basis of hi- ghest geometrical shape complementary scores.",OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
The involvement of these 23 genes in different  biological functions are explored and inspected from  UniProt web server (http://www.uniprot.org/).,OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
"Further, the conservation in binding pattern among selected  miRNAs and mRNAs (Table 3) were studied through sequence similarity algorithm using Clustal Omega (http://www.ebi.",OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
"Further, different biological  activities of selected genes were studied using UniProt  database (http://www.uniprot.org/) to screen out important genes and their contribution towards seven types of solid  tumors.",OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
Supplementary materials Supplementary data including two tables can be found  with this article online at http://www.genominfo.org/src/sm/  gni-14-112-s001.pdf Acknowledgments  Authors are thankful to Department of Biotechnology;  Govetment of India for providing BIF Centre facility to carry  out the current research work.,Non-OADS,/arxiv_data1/oa_pdf/bc/be/gni-14-112.PMC5056896.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(3):125-135 http://dx.doi.org/10.5808/GI.2016.14.3.125 ORIGINAL ARTICLE Received July 20, 2016; Revised August 5, 2016; Accepted August 29, 2016 *Corresponding author:  Tel: +91-11-2698-3409, Fax: +91-11-2698-3409, E-mail: mihassan@jmi.ac.in §These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/45/e6/gni-14-125.PMC5056897.pdf
"Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Sequence Analysis of Hypothetical Proteins  from Helicobacter pylori 26695 to Identify  Potential Virulence Factors Ahmad Abu Turab Naqvi1§, Farah Anjum2§, Faez Iqbal Khan3,  Asimul Islam1, Faizan Ahmad1, Md.",Non-OADS,/arxiv_data1/oa_pdf/45/e6/gni-14-125.PMC5056897.pdf
Supplementary materials Supplementary data including five tables can be found  with this article online at http://www.genominfo.org/src/  sm/gni-14-125-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/45/e6/gni-14-125.PMC5056897.pdf
http://dx.doi.org/10.1007/s12539-  015-0134-7.,Non-OADS,/arxiv_data1/oa_pdf/45/e6/gni-14-125.PMC5056897.pdf
"3, 2016G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(3):69 http://dx.doi.org/10.5808/GI.2016.14.3.69 EDITORIAL *Corresponding author:  Tel: +82-2-2258-7343, Fax: +82-2-537-0572, E-mail: yejun@catholic.ac.kr Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Editor’s Introduction to This Issue Yeun-Jun Chung*  IRCGP , College of Medicine, The Catholic University of Korea, Seoul 06591, Korea This is a special issue, consisting of three selected  dissertations that were awarded the KOGO Young Scientist  Best Paper Award, hosted by KOGO (Korea Genome Organization) in 2016.",Non-OADS,/arxiv_data1/oa_pdf/21/56/gni-14-69.PMC5056898.pdf
"For further details, please visit the G&I homepage  (http://www.genominfo.org/).",Non-OADS,/arxiv_data1/oa_pdf/21/56/gni-14-69.PMC5056898.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(3):70-77 http://dx.doi.org/10.5808/GI.2016.14.3.70 REVIEW ARTICLE Received June 9, 2016; Revised August 9, 2016; Accepted August 10, 2016 *Corresponding author:  Tel: +1-352-294-5200, Fax: +1-352-273-6059, E-mail: Jungnam.lee@medicine.ufl.edu Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Structural Variation of Alu Element and  Human Disease Songmi Kim1,2, Chun-Sung Cho3, Kyudong Han1,2, Jungnam Lee4* 1Department of Nanobiomedical Science, Dankook University, Cheonan 31116, Korea, 2BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31116, Korea, 3Department of Neurosurgery, Dankook University College of Medicine, Cheonan 31116, Korea, 4Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL 32610, USA Transposable elements are one of major sources to cause genomic instability through various mechanisms including de novo   insertion, insertion-mediated genomic deletion, and rec ombination-associated genomic deletion.",Non-OADS,/arxiv_data1/oa_pdf/34/07/gni-14-70.PMC5056899.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(3):78-84 http://dx.doi.org/10.5808/GI.2016.14.3.78 ORIGINAL ARTICLE Received August 1, 2016; Revised August 10, 2016; Accepted August 11, 2016 *Corresponding author:  Tel: +82-41-550-3567, Fax: +82-41-550-3450, E-mail: kyudong.han@gmail.com Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Mutational Analysis of Extranodal NK/T-Cell  Lymphoma Using Targeted Sequencing  with a Comprehensive Cancer Panel Seungkyu Choi1, Jai Hyang Go1, Eun Kyung Kim2, Hojung Lee2, Won Mi Lee2,  Chun-Sung Cho3, Kyudong Han4* 1Department of Pathology, Dankook University College of Medicine, Cheonan 31116, Korea, 2Department of Pathology, Eulji  Medical Center, Eulji University School of Medicine, Seoul 01830, Korea, 3Department of Neurosurgery, Dankook University  College of Medicine, Cheonan 31116, Korea, 4Department of Nanobiomedical Science, BK21 PLUS NBM Global Research Center  for Regenerative Medicine, Dankook University, Cheonan 31116, Korea Extranodal natural killer (NK)/T-cell lymphoma,  nasal type (NKTCL), is a malignant diso rder of cytotoxic lymphocytes of NK or  T cells.",Non-OADS,/arxiv_data1/oa_pdf/ca/90/gni-14-78.PMC5056900.pdf
"To minimize false positives, variants were filtered with a normal population variant database, The  Korean Personal Genome Project (http://opengenome.net/)  [12].",Non-OADS,/arxiv_data1/oa_pdf/ca/90/gni-14-78.PMC5056900.pdf
A primer pair for the PCR am-plification was designed in the flanking region of each target  locus using OligoCalc (http://www.basic.northwestern.edu/  biotools/oligocalc.html) and Oligo Analysis T ools (http:// www.operon.com/tools/oligo-analysis-tool.aspx).,Non-OADS,/arxiv_data1/oa_pdf/ca/90/gni-14-78.PMC5056900.pdf
Supplementary materials Supplementary data including five tables and six figures  can be found with this article online at http://www.genominfo.,OADS,/arxiv_data1/oa_pdf/ca/90/gni-14-78.PMC5056900.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(3):85-89 http://dx.doi.org/10.5808/GI.2016.14.3.85 ORIGINAL ARTICLE Received July 30, 2016; Revised August 26, 2016; Accepted August 28, 2016 *Corresponding author:  Tel: +82-2-2258-7343, Fax: +82-2-537-0572, E-mail: yejun@catholic.ac.kr Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Recapitulation of Candidate Systemic Lupus  Erythematosus-Associated Variants in Koreans Ki-Sung Kwon1,2, Hye-Young Cho1,2, Yeun-Jun Chung1,2* 1Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea, 2Integrated Research  Center for Genome Polymorphism, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple organ systems.",Non-OADS,/arxiv_data1/oa_pdf/e2/e1/gni-14-85.PMC5056901.pdf
Supplementary materials Supplementary data including one table can be found with  this article online at http://www.genominfo.org/src/sm/gni-  14-85-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e2/e1/gni-14-85.PMC5056901.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(3):90-95 http://dx.doi.org/10.5808/GI.2016.14.3.90 ORIGINAL ARTICLE Received August 2, 2016; Revised August 16, 2016; Accepted August 29, 2016 *Corresponding author:  Tel: +82-2-820-0457, Fax: +82-2-820-0816, E-mail: sskimb@ssu.ac.kr Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Analysis of Nuclear Mitochondrial DNA Segments  of Nine Plant Species: Size, Distribution,  and Insertion Loci Young-Joon Ko, Sangsoo Kim* Department of Bioinformatics and Life Science, Soongsil University, Seoul 06978, Korea Nuclear mitochondrial DNA segment (Num t) insertion describes a well-known ph enomenon of mitochondrial DNA transfer  into a eukaryotic nuclear genome.",OADS,/arxiv_data1/oa_pdf/1d/9d/gni-14-90.PMC5056902.pdf
"of  mitochondrial DNA Chlamydomonas reinhardtii http://genome.jgi.doe.gov/ Chlamydomonas_reinhardtii.v3.1.31.dna.genome.fa NC_001638 Coccomyxa subellipsoidea http://genome.jgi.doe.gov/ CsubellipsoideaC_169_227_v2.0.softmasked.fa NC_015316 Oryza sativa Ensemblgenomes.org Oryza_sativa.IRGSP-1.0.31.dna.genome.fa DQ_167400 Sorghum bicolor plantgdb.org SBgenome DQ_984518 Zea mays Ensemblegenomes.org Zea_mays.AGPv3.31.dna.genome.fa NC_007982 Vitis vinifera Ensemblegenomes.org Vitis_vinifera.IGGP_12x.31.dna.genome.fa NC_012119 Glycine max Plantgdb.org Gmax_109.fa NC_020455 Brassica rapa Brassicadb.org Brapa_sequence_v1.5.fa NC_016125 Arabidopsis thaliana Ensemblegenomes.org Arabidopsis_thaliana.TAIR10.31.dna.genome.fa Y08501Methods Data sources We downloaded all of the genomic data and gene  annotation data (gff3) of two green algae genomes ( C. rein- hardtii  and C. subellipsoidea ) from the Joint Genome Institute,  four plant genomes ( O. sativa, Z. mays, V .",OADS,/arxiv_data1/oa_pdf/1d/9d/gni-14-90.PMC5056902.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(3):96-103 http://dx.doi.org/10.5808/GI.2016.14.3.96 ORIGINAL ARTICLE Received December 30, 2015; Revised May 28, 2016; Accepted June 1, 2016 *Corresponding author:  Tel: +91-7152-284038, Fax: +91-7152-284038, E-mail: satishangral@gmail.com Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Identification of Suitable Natural Inhibitor against  Influenza A (H1N1) Neuraminidase Protein by  Molecular Docking Maheswata Sahoo1, Lingaraja Jena1, Surya Narayan Rath2, Satish Kumar1* 1Bioinformatics Centre & Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102, India 2Department of Bioinformatics, Orissa University of Agriculture & T echnology, Bhubaneswar 751003, India The influenza A (H1N1) virus, also known as swine flu is a lead ing cause of morbidity and mortality since 2009.",Non-OADS,/arxiv_data1/oa_pdf/57/d2/gni-14-96.PMC5056903.pdf
The  protein sequence of H1N1 NA (ID: ADJ40637.1) was retrieved from NCBI (http://www.ncbi.nlm.nih.gov/).,OADS,/arxiv_data1/oa_pdf/57/d2/gni-14-96.PMC5056903.pdf
Available from: http://www.cfsph.iastate.edu/  Factsheets/pdfs/influenza.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/d2/gni-14-96.PMC5056903.pdf
Chapter 22 Physical Activity and Fitness 2010.Available at http://hp2010.nhlbihin.net/2010Objs/22Physical.html#_Toc471793- 048.h (accessed on 28 August 2012).,Non-OADS,/arxiv_data1/oa_pdf/bc/8e/ijo2016107a.PMC5056957.pdf
Available at http://www.who.int/ growthref/en/ (accessed on 10 December 2015).,OADS,/arxiv_data1/oa_pdf/bc/8e/ijo2016107a.PMC5056957.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Effects of a school physical activity intervention JL Hollis et al 1493 International Journal of Obesity (2016) 1486 –1493",Non-OADS,/arxiv_data1/oa_pdf/bc/8e/ijo2016107a.PMC5056957.pdf
"Data pre-processing and compound identi ﬁcation GC –MS analysis .D a t a were pre-processed as previously reported.16In brief, Automated Mass Spectrometry Deconvolution and Identi ﬁcation System (AMDIS version 2.71, http://chemdata.nist.gov/mass-spc/ amdis/downloads/) were employed to deconvolute and to simultaneously identify the eluted compounds.",OADS,/arxiv_data1/oa_pdf/56/63/ijo201692a.PMC5056960.pdf
"To putatively identify only the statistically signi ﬁcant compounds, their accurate mass was searched against public databases, that is, METLIN (http://metlin.scripps.",OADS,/arxiv_data1/oa_pdf/56/63/ijo201692a.PMC5056960.pdf
"edu), KEGG (http://genome.jp/kegg), LIPIDMAPS (http://lipidmaps.org) and HMDB (http://hmdb.ca).",OADS,/arxiv_data1/oa_pdf/56/63/ijo201692a.PMC5056960.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Insulin resistance in prepubertal obese children A Mastrangelo et al 1502 International Journal of Obesity (2016) 1494 –1502 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/56/63/ijo201692a.PMC5056960.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Letters to the Editor 2093 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/ef/df/leu2016127a.PMC5056961.pdf
Further details can be obtainedfrom the website of PROFAMILIA-ENSIN (http://www.icbf.gov.co/portal/ page/portal/PortalICBF/Bienestar/ENSIN1).,Non-OADS,/arxiv_data1/oa_pdf/d2/1e/ejcn201646a.PMC5056989.pdf
"Available at http://www.icbf.gov.co/portal/page/portal/porta licbf/normatividadc/ensin1/ensin2010/libroensin2010.pdf.Obesity among Colombian adults R Ramírez-Vélez et al 1195 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/d2/1e/ejcn201646a.PMC5056989.pdf
The analysis was per-formed in the R statistical environment (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/9e/30/mtna201666a.PMC5056990.pdf
"Cell line names were collected from ATCC (http://www.atcc.org), COSMIC (http://cancer.sanger.",Non-OADS,/arxiv_data1/oa_pdf/9e/30/mtna201666a.PMC5056990.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/9e/30/mtna201666a.PMC5056990.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/97/bb/mtna201667a.PMC5056991.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/b5/15/mtna201668a.PMC5056992.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/05/b9/mtna201669a.PMC5056993.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/f4/ea/mtna201671a.PMC5056994.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/fe/b4/mtna201673a.PMC5056995.pdf
"135 Lab Anim Res 2016: 32(3), 135-143 http://dx.doi.org/10.5625/lar.2016.32.3.135ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Assessment of collagen antibody-ind uced arthritis in BALB/c mice  using bioimaging analysis and histopathological examination Joo Hye Sim1, Won Kil Lee1, Yun Seok Lee2, Jin Seok Kang1,* 1Department of Biomedical Laboratory Science, Namseoul University, Cheonan, Korea 2Department of Health Administration, Namseoul University, Cheonan, Korea The aim of this study was to examine the therapeutic potential of sulfasalazine and prednisolone in a mouse collagen antibody-induced arthritis (CAIA) model.",OADS,/arxiv_data1/oa_pdf/3e/ea/lar-32-135.PMC5057001.pdf
"144 Lab Anim Res 2016: 32(3), 144-150 http://dx.doi.org/10.5625/lar.2016.32.3.144ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Acute toxicity and cytotoxicity evaluation of Dendrobium  moniliforme  aqueous extract in vivo  and in vitro Mu-Jin Lee1,2, Ho-Kyung Jung1,2, Min-Suk Kim1, Ji-Hun Jang1, Mi-Ok Sim1, Tea-Mook Kim1, Ho Park1, Byung-Kwan Ahn1, Hyun-Woo Cho1, Jung-Hee Cho1, Won-Seok Jung1,*, Jong-Choon Kim2,* 1Division of Tradition Korean Medicine Research, National Development Institute of Korean Medicine, Jangheung, Korea 2College of Veterinary Medicine, Chonnam National University, Gwangju, Korea Dendrobium moniliforme  (L.) Sw., an herb of the Orchidaceae  family, has long been used in traditional medicine to strengthen bones, nourish the stomach, and promote the production of bodily fluid.",Non-OADS,/arxiv_data1/oa_pdf/d3/d1/lar-32-144.PMC5057002.pdf
"151 Lab Anim Res 2016: 32(3), 151-159 http://dx.doi.org/10.5625/lar.2016.32.3.151ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Fermented Pueraria Lobata  extract ameliorates dextran sulfate  sodium-induced colitis by reducing pro-inflammatory cytokines and recovering intestinal barrier function Seungho Choi1, Jong-Kyu Woo1, Yeong-Su Jang2, Ju-Hee Kang2,3, Jung-Eun Jang2, Tae-Hoo Yi4,5, Sang-Yong Park4, Sun-Yeou Kim2, Yeo-Sung Yoon1, Seung Hyun Oh2,* 1Department of Anatomy and Cell Biology, College of Veterinary Medicine, Seoul National University, Seoul, Korea 2Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, Korea  3Research Institute, National Cancer Center, Gyeonggi-do, Korea 4Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Gyeonggi-do, Korea 5Department of Oriental Medicine Biotechnology, College of Life Science, Kyung Hee University Global Campus, Gyeonggi-do, Korea Inflammatory bowel disease is a chronic inflammatory disorder occurring in the gastrointestinal track.",Non-OADS,/arxiv_data1/oa_pdf/1e/05/lar-32-151.PMC5057003.pdf
"160 Lab Anim Res 2016: 32(3), 160-165 http://dx.doi.org/10.5625/lar.2016.32.3.160ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) The effects of dosage and the routes of administrations of  streptozotocin and alloxan on induction rate of type1 diabetes mellitus and mortality rate in rats Ataroalsadat Mostafavinia1, Abdodlah Amini2, Seyed Kamran Ghorishi3, Ramin Pouriran4, Mohammad Bayat5,* 1Department of Biology and Anatomical sciences, School of medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2Department of Biology and Anatomical sciences , School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Ira n 3Department of Statistics, Qom University, Qom, Iran 4School of medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 5Department of Biology and Anatomical sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran The approach and novelty of this scientific work was to formulate the appropriate Streptozotocin (STZ) and Alloxan dosage in different routes of administration to imply minimum mortality rate and highincidence of diabetes mellitus (DM) in the rat experiment model.",Non-OADS,/arxiv_data1/oa_pdf/e3/71/lar-32-160.PMC5057004.pdf
"166 Lab Anim Res 2016: 32(3), 166-170 http://dx.doi.org/10.5625/lar.2016.32.3.166ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Prevalence of Salmonella spp.",Non-OADS,/arxiv_data1/oa_pdf/0d/ae/lar-32-166.PMC5057005.pdf
"Lastly, hospitals and health care providers must educatepatients about the risks of pet turtles and emphasize the importance of hand-washing (http://www.cdc.gov/salmonella/small-turtles-03-12).",Non-OADS,/arxiv_data1/oa_pdf/0d/ae/lar-32-166.PMC5057005.pdf
The samples were cultured according to the International Standard method (http://www.iso.org/iso/catalogue_detail.,Non-OADS,/arxiv_data1/oa_pdf/0d/ae/lar-32-166.PMC5057005.pdf
"171 Lab Anim Res 2016: 32(3), 171-179 http://dx.doi.org/10.5625/lar.2016.32.3.171ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Anti-atherosclerotic effect s of perilla oil in rabbits fed a high-cholesterol diet Yeseul Cha1,#, Ja Young Jang1,#, Young-Hwan Ban1, Haiyu Guo1, Kyungha Shin1, Tae-Su Kim2, Sung-Pyo Lee2,  Jieun Choi1, Eun-Suk An1, Da-Woom Seo1, Jung-Min Yon1, Ehn-Kyoung Choi1,*, Yun-Bae Kim1,* 1College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea 2Anydoctor Healthcare Co., Ltd., Cheonan, Korea Anti-atherosclerosis effects of perilla oil were investigated, in comparison with lovastatin, in rabbits fed a high-cholesterol diet (HCD).",Non-OADS,/arxiv_data1/oa_pdf/4e/df/lar-32-171.PMC5057006.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(5):319-325 http://dx.doi.org/10.3341/kjo.2016.30.5.319 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.319 Original ArticleThe Change of Lacrimal Gland Volume in Korean Patients with  Thyroid-associated Ophthalmopathy Hyoun-Do Huh1, Ji-Hye Kim1, Seong-Jae Kim1,2, Ji-Myong Yoo1,2, Seong-Wook Seo1,2 1Department of Ophthalmology, Gyeongsang National University College of Medicine, Jinju, Korea 2Gyeongsang Institute of Health Science, Gyeongsang National University, Jinju, Korea Purpose:  To describe the change of lacrimal gland volumes in Korean patients with thyroid-associated ophthal - mopathy (TAO) via computed tomography (CT).",Non-OADS,/arxiv_data1/oa_pdf/46/6a/kjo-30-319.PMC5057007.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(5):326-334 http://dx.doi.org/10.3341/kjo.2016.30.5.326 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.326 Original ArticleKeratoconus is a non-inflammatory disease with pro - gressive corneal ectasia.",Non-OADS,/arxiv_data1/oa_pdf/8e/06/kjo-30-326.PMC5057008.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(5):335-343 http://dx.doi.org/10.3341/kjo.2016.30.5.335 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.335 Original ArticleMorphologic evaluation of the optic nerve head (ONH)  is an essential step in the proper diagnosis of optic nerve  diseases, including glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/62/eb/kjo-30-335.PMC5057009.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(5):344-351 http://dx.doi.org/10.3341/kjo.2016.30.5.344 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.344 Original ArticleAnterior Diabetic Retinopathy Studied by Ultra-widefield  Angiography Kunho Bae1, Ju Yeon Lee1, Tae Hyup Kim1, Ga Eun Cho1, Jeeyun Ahn2, Sang Jin Kim1, Jae Hyun Kim3, Se Woong Kang1 1Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 2Department of Ophthalmology, SMG-SNU Boramae Medical Center, Seoul, Korea 3Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of  Medicine, Seoul, Korea Purpose:  To evaluate the prevalence of anterior type diabetic retinopathy (DR) using ultra-widefield fluorescein  angiography and to identify the factors associated with anterior type DR incidence.",Non-OADS,/arxiv_data1/oa_pdf/de/17/kjo-30-344.PMC5057010.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(5):352-359 http://dx.doi.org/10.3341/kjo.2016.30.5.352 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.352 Original ArticleIncidence and Clinical Features of Neovascularization of the Iris  following Acute Central Retinal Artery Occlusion Young Ho Jung1,2, Seong Joon Ahn3, Jeong-Ho Hong4, Kyu Hyung Park1, Moon-Ku Han5, Cheolkyu Jung6, Se Joon Woo1 1Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea 2Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 3Department of Ophthalmology, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Korea 4Department of Neurology, Keimyung University Dongsan Medical Center, Daegu, Korea 5Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea 6Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Purpose:  To investigate the incidence of neovascularization of the iris (NVI) and clinical features of patients with  NVI following acute central retinal artery occlusion (CRAO).",Non-OADS,/arxiv_data1/oa_pdf/ed/bb/kjo-30-352.PMC5057011.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(5):360-368 http://dx.doi.org/10.3341/kjo.2016.30.5.360 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.360 Original ArticleSyphilis is a sexually-transmitted disease that can result  in multiple organ involvement and demonstrates various  disease progressions [1,2].",Non-OADS,/arxiv_data1/oa_pdf/99/40/kjo-30-360.PMC5057012.pdf
Available from: http://is.cdc.go.kr/dstat/jsp/stat/stat0001.,OADS,/arxiv_data1/oa_pdf/99/40/kjo-30-360.PMC5057012.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(5):369-376 http://dx.doi.org/10.3341/kjo.2016.30.5.369 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.369 Original ArticleThe wet age-related macular degeneration (AMD) that is  accompanied by submacular hemorrhage (SMH) may  cause sudden visual loss.",Non-OADS,/arxiv_data1/oa_pdf/4d/f4/kjo-30-369.PMC5057013.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(5):377-381 http://dx.doi.org/10.3341/kjo.2016.30.5.377 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.377 Original ArticleAge-related macular degeneration (ARMD) is a one of  the leading causes of blindness worldwide.",Non-OADS,/arxiv_data1/oa_pdf/00/3c/kjo-30-377.PMC5057014.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(5):382-389 http://dx.doi.org/10.3341/kjo.2016.30.5.382 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.382 Original ArticleClinical Evaluation of Functional Vision of +1.5 Diopters near  Addition, Aspheric, Rotational Asymmetric Multifocal Intraocular  Lens Florian Tobias Alwin Kretz1,2,3, Rahmin Khoramnia1, Mary Safwat Attia1, Michael Janusz Koss1,2, Katharina Linz1, Gerd Uwe Auffarth1,2 1International Vision Correction and Research Centre & David J Apple International Laboratory on Ocular Pathology,  Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany 2International Vision Correction Research Centre Network, Heidelberg, Germany 3Eye-Clinic Ahaus-Raesfeld-Rheine, Gerl Group, Ahaus, Germany Purpose:  To evaluate postoperative outcomes and visual performance in intermediate distance after  implantation of a +1.5 diopters (D) addition, aspheric, rotational asymmetric multifocal intraocular  lens (MIOL).",Non-OADS,/arxiv_data1/oa_pdf/45/3d/kjo-30-382.PMC5057015.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.390Central Retinal Artery Occlusion  Masquerading as Branch Retinal  Artery Occlusion Dear Editor,  Retinal artery occlusion (RAO) is characterized by at - tenuated arterioles and ischemic retinal opacity, which  suggest retinal infarction.",Non-OADS,/arxiv_data1/oa_pdf/31/b3/kjo-30-390.PMC5057016.pdf
Korean J Ophthalmol 2016;30(5):390-391 http://dx.doi.org/10.3341/kjo.2016.30.5.390Correspondence  Fig.,Non-OADS,/arxiv_data1/oa_pdf/31/b3/kjo-30-390.PMC5057016.pdf
"On this initial examination, twin 1 exhibited left exotropia Korean J Ophthalmol 2016;30(5):392-393 http://dx.doi.org/10.3341/kjo.2016.30.5.392 Fig.",Non-OADS,/arxiv_data1/oa_pdf/86/f9/kjo-30-392.PMC5057017.pdf
The culture Korean J Ophthalmol 2016;30(5):394-395 http://dx.doi.org/10.3341/kjo.2016.30.5.394 Fig.,Non-OADS,/arxiv_data1/oa_pdf/52/15/kjo-30-394.PMC5057018.pdf
A CB DKorean J Ophthalmol 2016;30(5):396-397 http://dx.doi.org/10.3341/kjo.2016.30.5.396,Non-OADS,/arxiv_data1/oa_pdf/55/88/kjo-30-396.PMC5057019.pdf
"Selection of co-expressed genes Whole-genome gene expression data for ESCs and Fibroblast cells were obtained from two meta-sets: GeneChip Human Genome U133 Plus 2.0 Array (408 samples) and Illumina (San Diego, CA, USA) Sentrix HumanRef-8Expression BeadChip (245 samples) available in the ESTOOLs database(http://estools.cs.tut.",OADS,/arxiv_data1/oa_pdf/77/58/onc201659a.PMC5057041.pdf
"Identi ﬁcation of cancer cell lines with K-ras-nanoclustering signature Gene expression data for cancer cell lines was extracted from the Cancer Cell Line Encyclopedia (CCLE) resource (http://www.broadinstitute.org/ ccle/home).41On the basis of gene expression data of the 13 genes representing the K-ras-nanoclustering signature, Spearman correlationcoefﬁcients were calculated between the cancer cell lines and the ESCs and ﬁbroblasts.",OADS,/arxiv_data1/oa_pdf/77/58/onc201659a.PMC5057041.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Cancer stem cell drugs target K-ras signaling AK Najumudeen et al 5262 Oncogene (2016) 5248 –5262 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/77/58/onc201659a.PMC5057041.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)CD146 is a therapeutic target in malignant rhabdoid tumor S Nodomi et al 5327 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/20/90/onc201672a.PMC5057042.pdf
"Enrichment analyses of gene ontology categories, which include diseasemarkers, as well as biological process and pathway analyses, were performedusing MetaCore web-access software (http://www.genego.com).",OADS,/arxiv_data1/oa_pdf/46/0a/onc201658a.PMC5057043.pdf
The GEO database is available at http://www.ncbi.nlm.nih.gov/ geo/info/linking.html.,OADS,/arxiv_data1/oa_pdf/46/0a/onc201658a.PMC5057043.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Olfm4 is a regulator of colon carcinogenesis W Liu et al 5247 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/46/0a/onc201658a.PMC5057043.pdf
"The metallic device  and metallic wire were removed intact through the V I D E O A B S T R A C T VIDEOSURGERY Transvesical laparoendoscopic single-site surgery (T-LESS)  to remove an unusual foreign body from the bladder Maciej Przudzik, Michał Borowik, Roman Łesiów, Zbigniew Purpurowicz, Marek Roslan Department of Urology, Uniwersity of Warmia and Mazury, Olsztyn, Poland Key Words:  urinary bladder ‹› foreign bodies ‹› transvesical LESSVideo can be found at: http://ceju.online/journal/video.php?inp=783 Cent European J Urol.",Non-OADS,/arxiv_data1/oa_pdf/af/26/CEJU-69-00790.PMC5057045.pdf
2016; 69: 313.Video can be found at: http://ceju.online/journal/video.php?inp=798  Cent European J Urol.,Non-OADS,/arxiv_data1/oa_pdf/da/32/CEJU-69-00805.PMC5057047.pdf
Available  at: http://uroweb.org/ wp-content/ uploads/1607-Prostate-Cancer_LRV3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/ce/CEJU-69-00832.PMC5057051.pdf
Available at website:  http://www.kpcb.com/internet-trends 3.,Non-OADS,/arxiv_data1/oa_pdf/87/9a/CEJU-69-00848.PMC5057055.pdf
Available at Slideshare Web site:  http://es.slideshare.net/NoirPiggott/a- brief-history-of-social-media-by-c-piggott- 2012?related=2 8.,Non-OADS,/arxiv_data1/oa_pdf/87/9a/CEJU-69-00848.PMC5057055.pdf
2016; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/9a/CEJU-69-00848.PMC5057055.pdf
"Leading social networks worldwide   as of April 2016, ranked by number  of active users Statista; 2016 Available  from: http://www.statista.com/ statistics/272014/global-social-networks- ranked-by-number-of-users/  Corresponding author  Roman Sosnowski, FEBU, M.D., Ph.D.   roman.sosnowski@gmail.com",OADS,/arxiv_data1/oa_pdf/1a/b7/CEJU-69-00894.PMC5057059.pdf
"   Case Rep Oncol 2016;9:351 –357  DOI: 10.1159/000447351   Published online: June 27, 2016  © 2016 The Author(s)   Published by S. Kar ger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c5/3b/cro-0009-0351.PMC5057066.pdf
"To view a copy  of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/c4/9c/aps201631a.PMC5057231.pdf
"1  15–25 https://doi.org/10.1083/jcb.201603076Introduction Life evolved with daily predictable changes in light, tempera - ture, and food availability.",Non-OADS,/arxiv_data1/oa_pdf/7d/4d/JCB_201603076.PMC5057284.pdf
"Available at: http://www.iso.org (last accessed July 31th, 2015).",Non-OADS,/arxiv_data1/oa_pdf/2c/32/JEMT-78-1082.PMC5057294.pdf
URL http://liforma.tumblr.com (last accessed: 7 October2014).,Non-OADS,/arxiv_data1/oa_pdf/01/7a/JDV-30-211.PMC5057295.pdf
URL http://www.bio-oilprofes-sional.co.uk/clinical-research/ (last accessed: 7 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/01/7a/JDV-30-211.PMC5057295.pdf
URL http://www.bio-oilprofes-sional.co.uk/clinical-research/ (last accessed: 7 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/01/7a/JDV-30-211.PMC5057295.pdf
URL https://www.sin- clairisonline.com/ProductRange.aspx?id=26 (last accessed: 7 October2014).,Non-OADS,/arxiv_data1/oa_pdf/01/7a/JDV-30-211.PMC5057295.pdf
"DNA Samples With the aim to cover the global variation of the mtDNA phy- logeny [van Oven and Kayser 2009], 20 DNA samples known to belong to widely divergent haplogroups were selected from four different sources: the Centre d’Etude du Polymorphisme Humain (CEPH, Paris, France) Human Genome Diversity Project (HGDP) panel (http://www.ceph.fr/HGDP-CEPH-Panel), individuals from across The Netherlands [Lao et al., 2013], the commercially avail- able Ethnic Diversity DNA panel (EDP-1) manufactured by the European Collection of Cell Cultures (ECACC) (http://www.phe- culturecollections.org.uk/products/dna/ethnicdna.jsp), and dis- tributed by Sigma, and volunteers recruited at the Erasmus MC with informed consent.",Non-OADS,/arxiv_data1/oa_pdf/7d/98/HUMU-36-1236.PMC5057296.pdf
"With the mtDNA sequence variants detected, the haplogroups were inferred using the Web-based bioinformatics tool, MitoT ool [Fan and Y ao, 2011], which uses the most recent version of PhyloTree (http://www.phylotree.org; Build 16) [van Oven and Kayser, 2009].",OADS,/arxiv_data1/oa_pdf/7d/98/HUMU-36-1236.PMC5057296.pdf
Available from:http://www.ema.europa.eu/docs/en_GB/doc- ument_library/Scientiﬁc_guideline/2009/09/ WC500003605.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/64/ALL-71-99.PMC5057302.pdf
Available at: https://online.epocrates.com/u/10b2236/oxytocin/Black+Box+ Warnings.,Non-OADS,/arxiv_data1/oa_pdf/37/a1/BIRT-42-319.PMC5057303.pdf
"XML on-line corrected version: http://goldbook.iupac.org (2006-) created by Nic M, Jirat J,Kosata B; updates compiled by Jenkins A. ISBN 0-9678550-9-8.",OADS,/arxiv_data1/oa_pdf/2e/6e/WCMS-5-440.PMC5057308.pdf
"Annotated in-frame and frameshift variants were downloaded from the Exome Variant Server using (ESP6500SI- V2-SSA137) [Fu et al., 2013] and from the 1000 Genomes Project Phase 3 (ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/) [Clarkeet al., 2012].",OADS,/arxiv_data1/oa_pdf/49/3e/HUMU-37-28.PMC5057310.pdf
"Table S1), using PARF software (http://code.google.com/p/parf), with 100 trees and default parameters.",OADS,/arxiv_data1/oa_pdf/49/3e/HUMU-37-28.PMC5057310.pdf
The VEST-indel independent test set is included in Additional File 1 (http://karchinlab.org/vest_indel_additional_ﬁles/Additional_File_ 1.xlsx).,OADS,/arxiv_data1/oa_pdf/49/3e/HUMU-37-28.PMC5057310.pdf
"All provide an easy-to-use Web interface that can handle batch submissions: PROVEAN URL is http://provean.jcvi.org/genome_submit_2.php?species =human, SIFT-indel URL is http://sift.bii.a-star.edu.sg/www/SIFT_indels2.",OADS,/arxiv_data1/oa_pdf/49/3e/HUMU-37-28.PMC5057310.pdf
"html, DDig-In URL is http://sparks-lab.org/ddig/, and CADD URL is http://cadd.gs.washington.edu/.",OADS,/arxiv_data1/oa_pdf/49/3e/HUMU-37-28.PMC5057310.pdf
"The ﬁnal multi-method benchmark set comprised 59 benign frameshift insertion/deletion and 163 benign in-frame insertion/deletion variants (MAF /22650.1 from 1000G AFR super- population), as well as 474 pathogenic frameshift and 53 pathogenic in-frame variants from HGMD v.2014.4 (Additional File 2http://karchinlab.org/vest_indel_additional_ﬁles/Additional_File_ 2.xlsx).",OADS,/arxiv_data1/oa_pdf/49/3e/HUMU-37-28.PMC5057310.pdf
Availability VEST-indel is freely available for non-commercial use via a batch Web service at http://cravat.us.,OADS,/arxiv_data1/oa_pdf/49/3e/HUMU-37-28.PMC5057310.pdf
An example for such a SfM stimulus can be found at: http://www.michaelbach.de/ot/col_equilu/.,Non-OADS,/arxiv_data1/oa_pdf/58/aa/HBM-37-94.PMC5057312.pdf
"BrainVoyager QX Software version 2.8 (Brain Innovation, Maastricht, The Netherlands), andthe Neuroelf 0.9c toolbox for Matlab (retrieved from http://neuroelf.net/) were used for the preprocessing and analysisof the functional data.",OADS,/arxiv_data1/oa_pdf/58/aa/HBM-37-94.PMC5057312.pdf
"For labeling the signiﬁcant regions, the peak activationvoxel from each cluster was entered into the Talairach cli-ent tool (http://www.talairach.org/client.html), a 5-mmrange cube was deﬁned around the peak voxel and thecluster was labeled according to the region to which mostof the deﬁned voxels belong.",OADS,/arxiv_data1/oa_pdf/58/aa/HBM-37-94.PMC5057312.pdf
WES data were generated with various enrichment kits and sequencing was performed on the IlluminaR/circlecopyrtNextSeq (http://www.illumina.com) or on the Applied Biosystems SOLiD 5500 (http://www.solid.appliedbiosystems.com) systems.,OADS,/arxiv_data1/oa_pdf/9f/cd/HUMU-36-1226.PMC5057316.pdf
"Sequencing data obtained from the SOLiD 5500 sys- tem where analyzed using LifeScopeTMGenomic Analysis Soft- ware (http://www.lifetechnologies.com/lifescope), annotated and analyzed using the GenomeComb package [Reumers et al., 2012].",OADS,/arxiv_data1/oa_pdf/9f/cd/HUMU-36-1226.PMC5057316.pdf
"Coding and splice variants with a coverage /226520×and a minor allele frequency (MAF) lower than 1% in the Exome Variant Server (EVS; http://evs.gs.washington.edu/EVS/) were selected.PLD3 Sequencing in EOAD Patient/Control Cohorts In the Belgian cohort, the CDS of PLD3 (RefSeq NM 001031696.3) was analyzed by Sanger sequencing (BigDye T er- minator Cycle Sequencing kit v3.1 on the ABI 3730 DNA Ana- lyzer (both Applied BiosystemsR/circlecopyrt, Waltham, Massachusetts, USA).",OADS,/arxiv_data1/oa_pdf/9f/cd/HUMU-36-1226.PMC5057316.pdf
variants identiﬁed in this study have been submitted to the Leiden Open Variation Database (LOVD) Locus Speciﬁc Database (LSDB) (http://databases.lovd.nl/shared/genes/PLD3).,OADS,/arxiv_data1/oa_pdf/9f/cd/HUMU-36-1226.PMC5057316.pdf
"Characterization of PLD3 Splicing Variants Bioinformatic prediction analysis of splicing variants was performed using both FSPLICE 1.0 (http://www.softberry.com/; Softberry, Inc., Mount Kisco, NY, USA) and NNSPLICE 0.9 (http:// www.fruitﬂy.org/seq_tools/splice.html) [Reese et al., 1997].",OADS,/arxiv_data1/oa_pdf/9f/cd/HUMU-36-1226.PMC5057316.pdf
PCR prod- uct agarose gel band extraction was performed using QIAquick Gel Extraction Kit (http://www.qiagen.com) following the manu- facturer guidelines.,Non-OADS,/arxiv_data1/oa_pdf/9f/cd/HUMU-36-1226.PMC5057316.pdf
"14Samples with risk scores 1% or greater were classi ﬁed as high risk, and those with risk scores below 1% were classi ﬁed as low risk.7,14 Nonpolymorphic DANSR assays on chromosomes 13, 18, and21 were used to assess relative chromosome representation, while 576 single-nucleotide polymorphic (SNP) DANSR assays were used to estimate fetal fraction.7,14Fetal fraction calculation was described previously.7Brieﬂy, SNPs were optimized for minor allele frequency in the MapMap-3 dataset (http://hapmap.ncbi.",OADS,/arxiv_data1/oa_pdf/53/d2/PD-35-1243.PMC5057317.pdf
Expressed sequence tag proﬁles data source Expressed sequence tag (EST) pro ﬁles of cervix tissues were down- loaded from the UniGene database (http://www.ncbi.nlm.nih.gov/ unigene/).,OADS,/arxiv_data1/oa_pdf/59/d9/IJC-138-1163.PMC5057319.pdf
"Gene functional annotation analysis DAVID (http://david.abcc.ncifcrf.gov/) was used to performthe gene functional annotation analysis, and the categories ofgene ontology (GO) and KEGG Pathways were chosen asbackground databases.",OADS,/arxiv_data1/oa_pdf/59/d9/IJC-138-1163.PMC5057319.pdf
All genes of Homo sapiens obtained from the UCSC database (http://genome.ucsc.edu/) were usedas the background gene list.What’s new?,Non-OADS,/arxiv_data1/oa_pdf/59/d9/IJC-138-1163.PMC5057319.pdf
HeLa and SiHa cell lines usedin this study were tested in the last 2 months by short tan- dem repeats (STR) matching analysis of their STR proﬁle using the online STR analysis tools provided by the DSMZdatabase (http://www.dsmz.de) for human cell lines.,OADS,/arxiv_data1/oa_pdf/59/d9/IJC-138-1163.PMC5057319.pdf
Two spe-ciﬁc sgRNA targeted to the HPV genome was designed using the optimized CRISPR design software (http://crispr.mit.edu/).,OADS,/arxiv_data1/oa_pdf/59/d9/IJC-138-1163.PMC5057319.pdf
Available at http://www.unicef.org/infobycountry/ malaysia_statistics.html.,Non-OADS,/arxiv_data1/oa_pdf/ae/7e/DME-33-674.PMC5057321.pdf
Analyses of Exome Sequencing Data and Filtering of Variants Quality assessment of the sequence reads was performed by generating QC statistics with FastQC (http://www.bioinformatic s.bbsrc.ac.uk/projects/ fastqc).,OADS,/arxiv_data1/oa_pdf/3a/6b/GCC-55-95.PMC5057327.pdf
"After removal of PCR duplicates (Picard tools, http://picard.sour- ceforge.net) and ﬁle conversion (Samtools (Liet al., 2009)) quality score recalibration, indelrealignment, and variant calling were performed with the Genome Analysis Tool Kit (GATK) package (McKenna et al., 2010).",OADS,/arxiv_data1/oa_pdf/3a/6b/GCC-55-95.PMC5057327.pdf
"Variants wereannotated with Annovar (Wang et al., 2010) using a wide range of databases such as dbSNP build 135 (Sherry et al., 2001), dbNSFP (Liu et al.,2011), KEGG (Kanehisa et al., 2012), the GeneOntology project (Ashburner et al., 2000), MITO- MAP (Ruiz-Pesini et al., 2007) and tracks from the UCSC (Fujita et al., 2010), and also the NationalHeart, Lung and Blood Institute (NHLBI) ExomeSequencing Project (ESP6500) (http://evs.gs.wash- ington.edu/EVS/).",OADS,/arxiv_data1/oa_pdf/3a/6b/GCC-55-95.PMC5057327.pdf
"Variants werethen compared with the following public data-bases; the Single Nucleotide Polymorphism data- base (dbSNP) together with 1000 Genomes (Abecasis et al., 2012), the National Heart, Lungand Blood Institute (NHLBI) Exome SequencingProject (ESP6500) (http://evs.gs.washington.edu/EVS/), and the Exome Aggregation Consortium(ExAC), Cambridge, MA (URL:http://exac.broad-institute.org).",OADS,/arxiv_data1/oa_pdf/3a/6b/GCC-55-95.PMC5057327.pdf
"Sequence reads were aligned back tothe reference genome using Bismark (http://www.bioinformatics.babraham.ac.uk/projects/bismark/),GREM1 AND POLE IN CRC SYNDROMES 99 Genes, Chromosomes & Cancer DOI 10.1002/gcc",OADS,/arxiv_data1/oa_pdf/3a/6b/GCC-55-95.PMC5057327.pdf
http://www.who.int/ inﬂuenza/human_animal_interface/EN_ GIP_20150501CumulativeNumberH5N1-cases.pdf?ua=1 [3 June 2015].,OADS,/arxiv_data1/oa_pdf/ad/0b/RMV-25-406.PMC5057330.pdf
In ﬂuenza at the human-animal interface: summary and assessment as of 2 October 2014. http://www.who.int/in ﬂuenza/ human_animal_interface/In ﬂuenza_ Summary_IRA_HA_interface_October14.pdf?ua=1 [7 November 2014].,OADS,/arxiv_data1/oa_pdf/ad/0b/RMV-25-406.PMC5057330.pdf
http://www.who.int/in ﬂuenza/ resources/documents/h5n1_assessing_pandemic_threat/en/index.html [27 January2012].,Non-OADS,/arxiv_data1/oa_pdf/ad/0b/RMV-25-406.PMC5057330.pdf
"To assay functional annotation, weused the list of relevant genes in the DAVID online database ( http://david.abcc.ncifcrf.gov /), Medline ( http:// www.ncbi.nlm.nih.gov /) and the KEGG database ( http:// www.genome.jp/kegg/ ).Antibacterial effects of MSCs via beta defensin-2 433 © 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 424 –436",OADS,/arxiv_data1/oa_pdf/f2/43/CMI-18-424.PMC5057339.pdf
Available at: http://www.webcitation.org/6YhjFWVGF .,Non-OADS,/arxiv_data1/oa_pdf/d7/b0/ADD-111-1521.PMC5057341.pdf
Availableat: http://www.webcitation.org/6beErfCKl (accessed on 18 September 2015) 43.,Non-OADS,/arxiv_data1/oa_pdf/d7/b0/ADD-111-1521.PMC5057341.pdf
Available at: http://www.access data.fda.gov/drugsatfda_docs/label/20 11/011287s023lbl.pdf (2 1June 20 15).,Non-OADS,/arxiv_data1/oa_pdf/06/06/EJHF-17-1057.PMC5057342.pdf
Available at: http://products.sanofi.ca/en/resonium-calcium.pdf (2 1June 20 15).,Non-OADS,/arxiv_data1/oa_pdf/06/06/EJHF-17-1057.PMC5057342.pdf
Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm 186845.htm ( 17 June 20 15).,Non-OADS,/arxiv_data1/oa_pdf/06/06/EJHF-17-1057.PMC5057342.pdf
http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2009-0156-0006 (accessed 19 June 2015).,OADS,/arxiv_data1/oa_pdf/bf/43/JAT-36-1025.PMC5057344.pdf
http://ntp.niehs.nih.gov/iccvam/docs/ocutox_docs/invitro-2010/appj-analysis.pdf(accessed 19 June 2015).,OADS,/arxiv_data1/oa_pdf/bf/43/JAT-36-1025.PMC5057344.pdf
http://ntp.niehs.nih.gov/iccvam/docs/ocutox_docs/STE-SRD-NICEATM-508.pdf (accessed 19 June 2015).,OADS,/arxiv_data1/oa_pdf/bf/43/JAT-36-1025.PMC5057344.pdf
"Bioinformatics Analysis To better appreciate the data set generated, the list of signiﬁcantly altered proteins was uploaded intoIngenuity Pathway Analysis (IPA) software server(http://www.ingenuity.com) and analyzed using theCore Analysis module to rank the proteins into topbiological functions including disease and disordersas well as molecular and cellular functions.",OADS,/arxiv_data1/oa_pdf/7c/0f/MC-55-1688.PMC5057350.pdf
Available from: http://www.scotland.gov.uk/Topics/Statistics/SIMD [Accessed 07/03/2015].,Non-OADS,/arxiv_data1/oa_pdf/39/d1/PON-25-760.PMC5057352.pdf
Available from: http://www.educationscotland.gov.uk/thecurriculum/howisthecurriculumorganised/ curriculumareas/index.asp [Accessed 07/03/ 2015].771 School-based psycho-educational intervention to raise cancer awareness © 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/d1/PON-25-760.PMC5057352.pdf
CMT is geneticallyheterogeneous (The Mutation Database of Inherited Peripheral Neuropathies (IPNMDB) (http://www.molgen.ua.ac.be/cmtmutations/) and Neuromuscular Disease Center (http://neuromus cular.wustl.edu/)).,Non-OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
"Sequence analysis Bioinformatic analysis consisted of a standardprotocol including image analysis and base callingby Illumina RTA 1.12.4.2, demultiplexing byCASAVA 1.8 (Illumina Inc, San Diego, CA,USA), and alignment of sequence reads to the ref-erence genome GRCh37/hg19 by BWA (13).Picard was used for removing PCR duplicates(http://picard.sourceforge.net/).",OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
The variants identiﬁed in this family have been submitted to the ClinVar database (http://www.ncbi.nlm.nih.gov/clinvar/).,OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
visualized using Alamut to see conservation across several species (http://www.interactive-biosoftware.com/).,Non-OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
"The variant was conﬁrmed bySanger sequencing in all ﬁve affected members,while three unaffected members did not have it.The variant was neither seen in the 180 neuro-logically assessed in-house Norwegian controlsnor in the Single Nucleotide Polymorphism Database (dbSNP) 135 (http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
"gov/snp/), Exome Aggregation Consortium(ExAC) (http://exac.broadinstitute.org), GEnomesTable 2 Neurophysiology in affected members carrying the DCTN2 variant.",OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
"Management Application (GEM.app) (https://ge- nomics.med.miami.edu/gem-app/), and 1000genomes (http://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/).",OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
"The DNAH10 gene is the force-generating protein of respiratory cilia and is a paralog toDYNC1H1 , another CMT gene (ExAC and GeneCards (http://www.genecards.org/) data-bases).",Non-OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
"In addi- tion, DNAH10 might be expressed in peripheral nerves (http://www.proteinatlas.org/ENSG00000197653-DNAH10/tissue/soft+tissue).Table 3 In silico tests of our variant and dynamitin mutants used in targeted mutagenesis to evaluate how dynamitin ’s different structural domains contribute to its ability to self-associate, interact with dynactin, and assemble into a complex with its close binding partner, p24 Motif Side chain alterationPhylop scoreGrantham distance Align GVGD (Class)Mutation Taster PolyPhen (score) SIFT (score) SNAP Our variant His113Tyr Coiled-coil (Cc1) Polar ?hydrophobic 2.95 83 C0 (GV:160.13 –GD:0.00) Disease causing Possibly damaging (0.802) Tolerated (1.00) Neutral Dynamitin mutants Leu11 8Pro (C1) Coiled-coil (Cc1) Hydrophobic ?hydrophobic 4.08 98 C65 (GV: 0.00 –GD: 97.78) Disease causing Probably damaging (0.999) Deleterious (0.00) Non-neutral Val122Pro (C1) Coiled-coil (Cc1) Hydrophobic ?hydrophobic 2.55 68 C25 (GV: 28.68- GD: 68.57) Disease causing* Probably damaging (0.999) Deleterio us (0.00) Neutral Pro140Ala Helix-turn-helix Hydrophobic ?hydrophobic 3.84 27 C0 (GV: 173.88 –GD: 13.77) Disease causing Possibly damaging (0.802) Tolerated(0.45) Neutral Leu236Pro (C2) Coiled-coil (Cc2) Hydrophobic ?hydrophobic 4.40 98 C65 (GV: 4.86 –GD: 95.38) Disease causing Probably damaging (0.994) Deleterious (0.00) Non-neutral Val295Pro (C3) Coiled-coil (Cc3) Hydrophobic ?hydrophobic 4.48 68 C0 (GV: 235.27 –GD: 33.99) Disease causing* Possibly damaging(0.574) Deleterious (0.02) Non-neutral Side chain charges carried at physiological pH 7.4.",Non-OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
The LRIG3 gene may play a role in craniofa- cial and inner ear morphogenesis during embry-onic development (ExAC and GeneCards (http://www.genecards.org/) databases).,Non-OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
The MYO1A gene is associated with non-syn- dromic hearing loss and deafness (ExAC andGeneCards (http://www.genecards.org/) data-bases).,Non-OADS,/arxiv_data1/oa_pdf/bd/36/ANE-134-67.PMC5057358.pdf
Available at https://www.diabetes.org.uk/About_ us/News_Landing_Page/Number-of-people-diagnosed-with-diabetes- reaches-three-million/ Last accessed 23 May 2015.,Non-OADS,/arxiv_data1/oa_pdf/0a/7f/DME-33-904.PMC5057362.pdf
Available at http://www.nice.org.uk/guidance/cg87/chapter/1-rec-ommendations#/eye-damage Last accessed 23 May 2015.,Non-OADS,/arxiv_data1/oa_pdf/0a/7f/DME-33-904.PMC5057362.pdf
"In 1993, the number of cataractextractions was 247 300 in France, while it rose to 667 365 in 2010 (Atih, http://www.atih.sante.fr/statistiques-utilisation-des-codes-diagnostics-principa ux-ou-actes-classants-dans-les-bases: ac- cessed on May 20, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/f3/b8/AOS-94-e90.PMC5057364.pdf
"3, e1204848 (8 pages)http://dx.doi.org/10.1080/21592799.2016.1204848",Non-OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
The Z-stacks were average projected using ImageJ (https://imagej.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Cell 2013; 152:1134-45; PMID:23452858; http://dx.doi.org/10.1016/j.cell.2013.02.003 [2] Bevis BJ, Hammond AT, Reinke CA, Glick BS.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Nat Cell Biol 2002; 4:750-6; PMID:12360285; http://dx.doi.org/10.1038/ncb852 [3] Boncompain G, Divoux S, Gareil N, de Forges H, Lescure A, Latreche L, Mercanti V, Jollivet F, Raposo G, Perez F. Synchronization ofsecretory protein traf ﬁc in populations of cells.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Nat Methods 2012; 9:493-8; PMID:22406856; http://dx.doi.org/10.1038/nmeth.1928 [4] Charvin G, Oikonomou C, Cross F. Long-term imaging in micro ﬂui- dic devices.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Methods Mol Biol 2010; 591:229-42; PMID:19957134;http://dx.doi.org/10.1007/978-1-60761-404-3_14 [5] Chen D, Gibson ES, Kennedy MJ.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"J Cell Biol 2013; 201:631-40; PMID:23671313; http://dx.doi.org/10.1083/jcb.201210119 [6] Coorey NVC, Matthews JH, Bellows DS, Atkinson PH.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Mol Biosyst 2015; 11:3129-36; PMID:26381459;http://dx.doi.org/10.1039/C5MB00406C [7] Day KJ, Papanikou E, Glick BS.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Protein Eng 1996; 9:173-80; PMID:9005438;http://dx.doi.org/10.1093/protein/9.2.173 [9] Fegan A, White B, Carlson JC, Wagner CR.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Chem Rev 2010; 110:3315-36; PMID:20353181; http://dx.doi.org/10.1021/cr8002888 [10] Fitzgerald I, Glick BS.",Non-OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
Microb Cell Fact 2014; 13:125; PMID:25164324; http://dx.doi.org/10.1186/s12934-014-0125-0 [11] Galat A. Functional drift of sequence attributes in the FK506-binding proteins (FKBPs).,OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
J Chem Inf Model 2008; 48:1118-30; PMID:18412331; http://dx.doi.org/10.1021/ci700429n [12] Galat A. Functional diversity and pharmacological pro ﬁles of the FKBPs and their complexes with small natural ligands.,OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Cell Mol Life Sci 2013; 70:3243-75; PMID:23224428; http://dx.doi.org/10.1007/ s00018-012-1206-z [13] Gietz RD, Sugino A.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
Gene 1988; 74:527-34; PMID:3073106; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Methods Enzymol 2002; 350:87-96; PMID:12073338; http://dx.doi.org/ 10.1016/S0076-6879(02)50957-5 [15] Glick BS, Luini A.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Yeast 1999; 15:1541-53; PMID:10514571; http://dx.doi.org/10.1002/(SICI)1097-0061(199910)15:14%3c1541::AID-YEA476%3e3.0.CO;2-K [17] Holt DA, Luengo JI, Yamashita DS, Oh HJ, Konialian AL, Yen HK, Rozamus LW, Brandt M, Bossard MJ, Levy MA, et al.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"J Am Chem Soc 1993; 115:9925-38; http://dx.doi.org/10.1021/ja00075a008 [18] Kaiser CA, Gimeno RE, Shaywitz DA.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Cell 1993; 73:585-96;PMID:8387896; http://dx.doi.org/10.1016/0092-8674(93)90144-F [20] Lavieu G, Zheng H, Rothman JE.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"eLife 2013; 2:e00558; PMID:23755362; http://dx.doi.org/10.7554/eLife.00558 [21] Lee PJ, Helman NC, Lim WA, Hung PJ.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"BioTechniques 2008; 44:91-5; PMID:18254385; http://dx.doi.org/10.2144/000112673 [22] Lisenbee CS, Karnik SK, Trelease RN.",Non-OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Traf ﬁc 2003; 4:491-501; PMID:12795694; http://dx.doi.org/ 10.1034/j.1600-0854.2003.00107.x [23] Longtine MS, McKenzie A, 3rd, Demarini DJ, Shah NG, Wach A, Brachat A, Philippsen P, Pringle JR. Additional modules for versatile and economical PCR-based gene deletion and modi ﬁcation in Sac- charomyces cerevisiae .",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Nature 2006; 22:1002-6;PMID:16699524; http://dx.doi.org/10.1038/nature04717 [25] Moscovici M, Chien WY, Abdelgawad M, Sun Y.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Biomicro ﬂuidics 2010; 4:46501; PMID:21057609; http://dx.doi.org/10.1063/1.3499939 [26] Ng DT, Brown JD, Walter P. Signal sequences specify the targeting route to the endoplasmic reticulum membrane.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"J Cell Biol 1996;134:269-78; PMID:8707814; http://dx.doi.org/10.1083/jcb.134.2.269 [27] Otte S, Barlowe C. Sorting signals can direct receptor-mediated export of soluble proteins into COPII vesicles.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Nat Cell Biol 2004;6:1189-94; PMID:15516922; http://dx.doi.org/10.1038/ncb1195 [28] Papanikou E, Glick BS.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
FEBS Lett 2009; 583:3746-51; PMID:19879270; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Nat Struct Mol Biol 2014; 21:1100-05; PMID:25420103; http://dx.doi.org/10.1038/nsmb.2919 [30] Rivera VM, Wang X, Wardwell S, Courage NL, Volchuk A, Keenan T, Holt DA, Gilman M, Orci L, Cerasoli FJ, et al.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Science 2000; 287:826-30; PMID:10657290; http://dx.doi.org/10.1126/science.287.5454.826 [31] Rizzo R, Parashuraman S, Mirabelli P, Puri C, Lucocq J, Luini A.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"J Cell Biol 2013; 201:1027-36;PMID:23775191; http://dx.doi.org/10.1083/jcb.201211147 [32] Rogers B, Decottignies A, Kolaczkowski M, Carvajal E, Balzi E, Goffeau A.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
Mol Biol Cell 2007; 18:4932- 44; PMID:17881724; http://dx.doi.org/10.1091/mbc.E07-06-0610 [35] Sherman F. Getting started with yeast.,Non-OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Methods Enzymol 1991; 194:3-21; PMID:2005794; http://dx.doi.org/10.1016/0076-6879(91) 94004-V [36] Snapp EL, Hegde RS, Francolini M, Lombardo F, Colombo S, Pedrazzini E, Borgese N, Lippincott-Schwartz J.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"J Cell Biol 2003; 163:257-69; PMID:14581454; http://dx.doi.org/10.1083/ jcb.200306020 [37] Strack RL, Hein B, Bhattacharyya D, Hell SW, Keenan RJ, Glick BS.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Nature 2008; 452:604-9; PMID:18385733; http://dx.doi.org/10.1038/nature06836 [39] Thor F, Gautschi M, Geiger R, Helenius A.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"Traf ﬁc 2009; 10:1819-30; PMID:19843282; http://dx.doi.org/10.1111/j.1600-0854.2009.00989.x [40] Volchuk A, Amherdt M, Ravazzola M, Brugger B, Rivera VM, Clack- son T, Perrelet A, S €ollner TH, Rothman JE, Orci L. Megavesicles implicated in the rapid transport of intracisternal aggregates acrossthe Golgi stack.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"J Biol Chem 2008; 283:33883- 8; PMID:18819915; http://dx.doi.org/10.1074/jbc.M803054200 [42] Zacharias DA, Violin JD, Newton AC, Tsien RY.",OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
Science 2002; 296:913-6; PMID:11988576; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
Electrophoresis 2012; 33:89- 104; PMID:22128067; http://dx.doi.org/10.1002/elps.201100482e1204848-8 J. J. BARRERO ET AL.,OADS,/arxiv_data1/oa_pdf/a9/be/kcll-06-03-1204848.PMC5058350.pdf
"3, e1228791 (13 pages)http://dx.doi.org/10.1080/21592799.2016.1228791",Non-OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Biochim Biophys Acta 1991; 1071 (3):313-29; PMID:1958692; http://dx.doi.org/10.1016/0304-4157(91) 90019-S [4] Coleman JA, Kwok MC, Molday RS.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"J Biol Chem 2009; 284(47):32670-9; PMID:19778899; http://dx.doi.org/10.1074/jbc.M109.047415 [5] Zhou X, Graham TR.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Biochim Biophys Acta 2015; 1850(3):461-75; PMID:24746984; http://dx.doi.org/10.1016/j.bbagen.2014.04.008 [7] Coleman JA, Quazi F, Molday RS.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
BiochimBiophys Acta 2013; 1831(3):555-74; PMID:23103747; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"PhysiolRev 2016; 96(2):605-45; PMID:26936867; http://dx.doi.org/10.1152/ physrev.00020.2015 [9] Suzuki J, Denning DP, Imanishi E, Horvitz HR, Nagata S. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apo- ptotic cells.",Non-OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Nature 2010; 468(7325):834-8; PMID:21107324; http://dx.doi.org/10.1038/nature09583 [11] Hua Z, Fatheddin P, Graham TR.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Mol Biol Cell 2002; 13(9):3162-77; PMID:12221123; http://dx.doi.org/10.1091/mbc.E02-03-0172 [12] Hua Z, Graham TR.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Mol Biol Cell 2003; 14(12):4971-83; PMID:12960419; http://dx.doi.org/10.1091/mbc.E03-07-0463 [13] Huh WK, Falvo JV, Gerke LC, Carroll AS, Howson RW, Weissman JS, O ’Shea EK.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Nature 2003; 425(6959):686-91; PMID:14562095; http://dx.doi.org/10.1038/nature02026 [14] Wicky S, Schwarz H, Singer-Kruger B. Molecular interactions of yeast Neo1p, an essential member of the Drs2 family of aminophospholipidtranslocases, and its role in membrane traf ﬁcking within the endo- membrane system.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Mol Cell Biol 2004; 24(17):7402-18; PMID:15314152; http://dx.doi.org/10.1128/MCB.24.17.7402-7418.2004 [15] Takatsu H, Baba K, Shima T, Umino H, Kato U, Umeda M, Nakayama K, Shin HW.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"J Biol Chem 2011; 286 (44):38159-67; PMID:21914794; http://dx.doi.org/10.1074/jbc.M111.281006 [16] Wehman AM, Poggioli C, Schweinsberg P, Grant BD, Nance J.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"PloS one 2011; 6(3):e17619;PMID:21423800; http://dx.doi.org/10.1371/journal.pone.0017619 [19] Wickner W. Membrane fusion: ﬁve lipids, four SNAREs, three chap- erones, two nucleotides, and a Rab, all dancing in a ring on yeastvacuoles.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Ann Rev Cell Dev Biol 2010; 26:115-36; PMID:20521906;http://dx.doi.org/10.1146/annurev-cellbio-100109-104131 [20] Hickey CM, Stroupe C, Wickner W. The major role of the Rab Ypt7p in vacuole fusion is supporting HOPS membrane association.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"J BiolChem 2009; 284(24):16118-25; PMID:19386605; http://dx.doi.org/10.1074/jbc.M109.000737 [21] Wang L, Seeley ES, Wickner W, Merz AJ.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Vacuole fusion at a ring of vertex docking sites leaves membrane fragments within the organelle.Cell 2002; 108(3):357-69; PMID:11853670; http://dx.doi.org/10.1016/S0092-8674(02)00632-3 [22] Mima J, Hickey CM, Xu H, Jun Y, Wickner W. Reconstituted mem- brane fusion requires regulatory lipids, SNAREs and synergisticSNARE chaperones.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"EMBO J 2008; 27(15):2031-42; PMID:18650938; http://dx.doi.org/10.1038/emboj.2008.139 [23] Stroupe C, Collins KM, Fratti RA, Wickner W. Puri ﬁcation of active HOPS complex reveals its af ﬁnities for phosphoinositides and the SNARE Vam7p.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"EMBO J 2006; 25(8):1579-89; PMID:16601699; http://dx.doi.org/10.1038/sj.emboj.7601051 [24] Mima J, Wickner W. Complex lipid requirements for SNARE- and SNARE chaperone-dependent membrane fusion.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
J Biol Chem 2009;284(40):27114-22; PMID:19654322; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Mol Biol Cell 2002; 13(3):782-94; PMID:11907261; http://dx.doi.org/10.1091/mbc.01-10-0512 [28] Fratti RA, Jun Y, Merz AJ, Margolis N, Wickner W. Interdepen- dent assembly of speci ﬁc regulatory lipids and membrane fusion proteins into the vertex ring domain of docked vacuoles.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"J Cell Biol 2004; 167(6):1087-98; PMID:15611334; http://dx.doi.org/10.1083/jcb.200409068 [29] Keenan Curtis K, Kane PM.",Non-OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"J Biol Chem 2002; 277(4):2716-24; PMID:11717306; http://dx.doi.org/10.1074/jbc.M107777200 [30] Haas A, Scheglmann D, Lazar T, Gallwitz D, Wickner W. The GTPase Ypt7p of Saccharomyces cerevisiae is required on both part- ner vacuoles for the homotypic fusion step of vacuole inheritance.EMBO J 1995; 14(21):5258-70; PMID:7489715 [31] Mumberg D, Muller R, Funk M. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds.Gene 1995; 156(1):119-22; PMID:7737504; http://dx.doi.org/10.1016/0378-1119(95)00037-7 [32] Wood CS, Hung CS, Huoh YS, Mousley CJ, Stefan CJ, Bankaitis V, Ferguson KM, Burd CG.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Mol Biol Cell 2012; 23(13):2527-36; PMID:22553352; http://dx.doi.org/10.1091/mbc.E12-01-0077 [33] Katzmann DJ, Stefan CJ, Babst M, Emr SD.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"J Cell Biol 2003; 162 (3):413-23; PMID:12900393; http://dx.doi.org/10.1083/jcb.200302136 [34] Baldridge RD, Graham TR.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"J Cell Biol 2001; 152(5):935-44; PMID:11238450; http://dx.doi.org/10.1083/jcb.152.5.935 [36] Birner R, Burgermeister M, Schneiter R, Daum G. Roles of phospha- tidylethanolamine and of its several biosynthetic pathways in Saccha- romyces cerevisiae.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Mol Biol Cell 2001; 12(4):997-1007; PMID:11294902; http://dx.doi.org/10.1091/mbc.12.4.997 [37] Gulshan K, Shahi P, Moye-Rowley WS.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Mol Biol Cell 2010; 21(3):443-55; PMID:20016005; http://dx.doi.org/10.1091/mbc.E09-06-0519 [38] Alder-Baerens N, Lisman Q, Luong L, Pomorski T, Holthuis JC.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Mol Biol Cell 2006; 17(4):1632-42; PMID:16452632; http://dx.doi.org/10.1091/mbc.E05-10-0912[39] Natarajan P, Wang J, Hua Z, Graham TR.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Proc Natl Acad Sci U S A 2004; 101(29):10614-9; PMID:15249668; http://dx.doi.org/10.1073/ pnas.0404146101 [40] Liu K, Hua Z, Nepute JA, Graham TR.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
Mol Biol Cell 2007; 18(2):487-500; PMID:17122361; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Mol Biol Cell 2008; 19 (8):3526-35; PMID:18508916; http://dx.doi.org/10.1091/mbc.E08-01-0025 [42] Mima J, Wickner W. Phosphoinositides and SNARE chaperones synergistically assemble and remodel SNARE complexes for mem- brane fusion.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Mol Biol Cell 2003; 14(12):4971-83; PMID:12960419; http://dx.doi.org/10.1091/mbc.E03-07-0463 [44] Janke C, Magiera MM, Rathfelder N, Taxis C, Reber S, Maekawa H, Moreno-Borchart A, Doenges G, Schwob E, Schiebel E, et al.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Yeast 2004; 21(11):947-62; PMID:15334558; http://dx.doi.org/10.1002/ yea.1142 [45] Jones GM, Stalker J, Humphray S, West A, Cox T, Rogers J, Dunham I, Prelich G. A systematic library for comprehensive overexpression screens in Saccharomyces cerevisiae.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Nat Methods 2008; 5(3):239-41; PMID:18246075; http://dx.doi.org/10.1038/nmeth.1181 [46] Vida TA, Emr SD.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"J Cell Biol 1995; 128(5):779-92; PMID:7533169; http://dx.doi.org/10.1083/jcb.128.5.779 [47] Katzmann DJ, Stefan CJ, Babst M, Emr SD.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"J Cell Biol 2003; 162(3):413-23; PMID:12900393; http://dx.doi.org/10.1083/jcb.200302136 [48] Sato K, Sato M, Nakano A. Rer1p, a retrieval receptor for endoplas- mic reticulum membrane proteins, is dynamically localized to the Golgi apparatus by coatomer.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"J Cell Biol 2001; 152(5):935-44;PMID:11238450; http://dx.doi.org/10.1083/jcb.152.5.935 [49] Wood CS, Hung CS, Huoh YS, Mousley CJ, Stefan CJ, Bankai- tis V, Ferguson KM, Burd CG.",OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
Mol Biol Cell 2012; 23 (13):2527-36; PMID:22553352; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
Mol Cell Biol 2008; 28(19):5851-64; PMID:18644857; http://dx.doi.org/10.1128/MCB.00405-08CELLULAR LOGISTICS e1228791-13,Non-OADS,/arxiv_data1/oa_pdf/48/93/kcll-06-03-1228791.PMC5058351.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6e/57/tom215.PMC5058361.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2016.00253 TOMOGRAPHY.ORG | VOLUME 2 NUMBER 3 |SEPTEMBER 2016 215,Non-OADS,/arxiv_data1/oa_pdf/6e/57/tom215.PMC5058361.pdf
"IRDye800CW (LI-COR Biosciences) with ﬂuorescence emission centered around 800 nm is a commercially availableNIR dye with functional groups for conjugation, and it has passedanimal toxicity studies using a protocol reviewed by the FDA in2007 (https://www.licor.com/clinical_translation/index.html).",Non-OADS,/arxiv_data1/oa_pdf/6e/57/tom215.PMC5058361.pdf
"In addi-tion, data from LI-COR Biosciences (http://biosupport.licor.com/docs/IntegrinSpecNIRImagingv2_AACR09_JK.pdf) also supporta 22-hour waiting period before imaging, as the best SNR with areasonably good background clearance was obtained at 22hours post injection of RGD-IRDye800CW.",OADS,/arxiv_data1/oa_pdf/6e/57/tom215.PMC5058361.pdf
Supplemental Materials Supplemental Figures 1-3: http://dx.doi.org/10.18383/j.,Non-OADS,/arxiv_data1/oa_pdf/6e/57/tom215.PMC5058361.pdf
"9, e1221558 (5 pages)http://dx.doi.org/10.1080/15592324.2016.1221558",Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Nat Rev Mol Cell Biol 2011; 12:48-59; PMID:21139638; http://dx.doi.org/10.1038/nrm3027 2.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Plant Cell 2009; 21:2844-58;PMID:19767453; http://dx.doi.org/10.1105/tpc.109.068288 3.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Nat Cell Biol 2005; 7:1224-31; PMID:16284624; http://dx.doi.org/10.1038/ncb1330 4.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Plant Cell Physiol 2016; 57(8):1610-28; PMID:27335351; http://dx.doi.org/10.1093/pcp/pcw089 5.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Mol Cell 2012; 46:542-8; PMID:22633491; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Plant Cell 2006; 18:2582-92; PMID:17028208;http://dx.doi.org/10.1105/tpc.105.039891 7.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
PLoS One 2011; 6:e21021; PMID:21695217; http://dx.doi.org/10.1371/journal.pone.0021021 8.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
PLoS One 2008; 3(4):e1994;PMID:18431481; http://dx.doi.org/10.1371/journal.pone.0001994 9.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Plant Cell Physiol 2005; 46:858-69; PMID:15821023; http://dx.doi.org/10.1093/pcp/pci091 10.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Plant Biotechnol J 2015; 13:1251-63; PMID:25586098; http://dx.doi.org/10.1111/pbi.12314 11.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Trends Bio- chem Sci 2006; 31:156-63; PMID:16473013; http://dx.doi.org/10.1016/ j.tibs.2006.01.003 12.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Biochem J2000; 348:1-13; PMID:10794707; http://dx.doi.org/10.1042/bj348000113.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Plant Physiol 2015; 168:768- 75; http://dx.doi.org/10.1104/pp.15.00117 14.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Plant Cell Rep 2011; 31:453-60; PMID:21960098; http://dx.doi.org/ 10.1007/s00299-011-1152-5 15.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Front Plant Sci 2014; 5:359; PMID:25183966; http://dx.doi.org/10.3389/fpls.2014.00359 16.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Mol Cell Proteomics 2014; 13:566-79; PMID:24198434; http://dx.doi.org/ 10.1074/mcp.M113.028969 17.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Plant Mol Biol 1998; 38:31-48; PMID:9738959; http://dx.doi.org/10.1023/A:1006012005654 18.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Cell 2010; 141:897-907; PMID:20510933; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Mol Cell Prote-omics 2013; 12:3160-83; PMID:23912651; http://dx.doi.org/10.1074/mcp.M113.028191 20.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Biol Direct 2013; 8:18; PMID:23845039; http://dx.doi.org/10.1186/1745-6150-8-18 21.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
J Proteomics 2011;74:1256-65; PMID:21440687; http://dx.doi.org/10.1016/j.jprot.2011.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Plant Cell Physiol2011; 52:96-111; PMID:21098556; http://dx.doi.org/10.1093/pcp/pcq177 24.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Biochim Biophys Acta 2005; 1744:93-107; PMID:15922463; http://dx.doi.org/10.1016/j.bbamcr.2005.03.009 25.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
FEBS Lett 2009; 583:3752-7; PMID:19800330; http://dx.doi.org/10.1016/j.febslet.2009.09.046 26.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Nat Rev Mol Cell Biol 2013; 14:382-92; PMID:23698585; http://dx.doi.org/10.1038/nrm3588 27.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Biochim Biophys Acta 2013; 1833:332-40; PMID: 22521451; http://dx.doi.org/10.1016/j.bbamcr.2012.03.019 28.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Trends Cell Biol 2006; 16:385-7;PMID:16815014; http://dx.doi.org/10.1016/j.tcb.2006.06.003 29.,OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
Plant Mol Biol 2016; 91:81-95; PMID:26879413; http://dx.doi.org/10.1007/ s11103-016-0444-0PLANT SIGNALING & BEHAVIOR e1221558-5,Non-OADS,/arxiv_data1/oa_pdf/aa/69/kpsb-11-09-1221558.PMC5058459.pdf
"70, 67663 Kaiserslautern, Germany Published with license by Taylor & Francis Group, LLC © Jasmine Theis and Michael Schroda This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), , which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
"9, e1218587 (8 pages)http://dx.doi.org/10.1080/15592324.2016.1218587",Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochem J 2005; 388:159-68; PMID: 15638811; http://dx.doi.org/10.1042/BJ20042098 2.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Annu Rev Plant Biol 2013; 64:609-35; PMID:23451783; http://dx.doi.org/10.1146/annurev-arplant-050312-120124 4.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
AnnBot 2010; 106:1-16; PMID:20338950; http://dx.doi.org/10.1093/aob/ mcq059 5.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
CurrOpin Plant Biol 2012; 15:245-51; PMID:22386092; http://dx.doi.org/ 10.1016/j.pbi.2012.01.017 6.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
FEBS Lett 2013; 587:3372-81; PMID:24056074; http://dx.doi.org/10.1016/j.febslet.2013.09.015 7.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochim Biophys Acta 2012; 1817:247-57;PMID:21565160; http://dx.doi.org/10.1016/j.bbabio.2011.04.011 9.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Biol Chem 2006; 281:14241- 9; PMID:16537530; http://dx.doi.org/10.1074/jbc.M600634200 11.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochim BiophysActa 2005; 1706:12-39; PMID:15620363; http://dx.doi.org/ 10.1016/j.bbabio.2004.09.009 12.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochim Biophys Acta 2012; 1817:2-12; PMID:21723248; http://dx.doi.org/10.1016/j.bbabio.2011.05.024 13.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2010; 22:1299-312; PMID:20388855; http://dx.doi.org/10.1105/tpc.109.071431 14.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochim Biophys Acta 2008; 1777:1432-7; PMID:18774768; http://dx.doi.org/10.1016/j.bbabio.2008.08.004 16.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2009; 21:3950-64; PMID:20028840; http://dx.doi.org/10.1105/tpc.109.069435 17.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Front Plant Sci 2013; 4:417; PMID:24151498; http://dx.doi.org/10.3389/fpls.2013.00417 18.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Nature 2005;437:1179-82; PMID:16237446; http://dx.doi.org/10.1038/nature04016 21.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Mol Plant 2013; 6:1673-91; PMID:23671330; http://dx.doi.org/10.1093/ mp/sst069 23.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Physiol 2004; 136:3594-604;PMID:15516501; http://dx.doi.org/10.1104/pp.104.049841PLANT SIGNALING & BEHAVIOR e1218587-5,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant J 2013; 74:652-62; PMID:23432654; http://dx.doi.org/10.1111/tpj.12154 25.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2005; 17:2768-81; PMID:16155179; http://dx.doi.org/10.1105/tpc.105.035048 26.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochemistry 1995; 34:16022-9; PMID: 8519758; http://dx.doi.org/10.1021/bi00049a016 27.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant J 2014; 79:312-21; PMID:24862025; http://dx.doi.org/10.1111/tpj.12562 28.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Biol Chem 1996; 271:14870-5; PMID:8663006; http://dx.doi.org/10.1074/jbc.271.25.14870 29.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
"Puthiyaveetil S, Woodiwiss T, Knoerdel R, Zia A, Wood M, Hoehner R, Kirchhoff H. Signi ﬁcance of the photosystem II core phosphatase PBCP for plant viability and protein repair in thylakoid membranes.Plant Cell Physiol 2014; 55:1245-54; PMID:24793754; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2012; 24:2596-609; PMID:22706287; http://dx.doi.org/ 10.1105/tpc.112.095703 31.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochemistry 1999; 38:14955-65;PMID:10555977; http://dx.doi.org/10.1021/bi990971v 32.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Physiol 2000; 123:1525-36;PMID:10938368; http://dx.doi.org/10.1104/pp.123.4.1525 33.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant J 2008; 55:639-51; PMID:18445132; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Exp Bot 2005; 56:347-56; PMID:15569703; http://dx.doi.org/10.1093/jxb/eri041 35.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
PlantCell 2014; 26:1213-29; PMID:24632535; http://dx.doi.org/10.1105/ tpc.113.122424 36.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2011; 23:1861-75; PMID:21586683; http://dx.doi.org/10.1105/ tpc.111.085456 37.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Physiol 2009; 149:1076-86; PMID:19036835; http://dx.doi.org/10.1104/pp.108.130039 38.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochim Biophys Acta 2013; 1827:50-9;PMID:23084968; http://dx.doi.org/10.1016/j.bbabio.2012.10.00439.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2003; 15:2843-55; PMID:14630971; http://dx.doi.org/10.1105/ tpc.017319 40.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant J 2004; 37:864-76; PMID:14996218; http://dx.doi.org/10.1111/j.1365-313X.2003.02014.x 41.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2014; 26:373-90; PMID:24449688; http://dx.doi.org/10.1105/tpc.113.120113 42.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Biochem 2009; 146:463-9; PMID:19451147; http://dx.doi.org/10.1093/jb/mvp073 43.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2007; 19:1039-47; PMID:17351117; http://dx.doi.org/10.1105/tpc.106.046573 45.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2007; 19:1347-61; PMID:17449806; http://dx.doi.org/10.1105/tpc.106.049510 46.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Physiol 2010; 152:1263-73;PMID:20089771; http://dx.doi.org/10.1104/pp.109.150722 47.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochem J 2007; 406:415-25;PMID:17576201; http://dx.doi.org/10.1042/BJ20070460 48.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Planta 2012; 235:279-88; PMID:21877139; http://dx.doi.org/ 10.1007/s00425-011-1505-x 50.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochem J 2015; 468:315-24; PMID:25803492; http://dx.doi.org/10.1042/BJ20141425 51.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Biol Chem 1999; 274:16062-7; PMID:10347157; http://dx.doi.org/10.1074/jbc.274.23.16062 52.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
EMBO J 1999; 18:733-42; PMID:9927433; http://dx.doi.org/10.1093/emboj/18.3.733 54.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
FEBS Lett 2002; 524:127-33; PMID:12135754; http://dx.doi.org/10.1016/S0014-5793(02)03016-8e1218587-6 J. THEIS AND M. SCHRODA,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Appl Microbiol Biotechnol 2005; 69:440-7; PMID:15988575; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochem J 2002; 368:777-81; PMID:12217076; http://dx.doi.org/10.1042/bj20021291 58.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant J 2014; 78:1003-13;PMID:24684167; http://dx.doi.org/10.1111/tpj.12525 59.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2006; 18:955-69;PMID:16531500; http://dx.doi.org/10.1105/tpc.105.037689 60.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Physiol 2009; 151:88-99;PMID:19574473; http://dx.doi.org/10.1104/pp.109.140798 61.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Phys- iol 2007; 143:1547-60; PMID:17416639; http://dx.doi.org/ 10.1104/pp.107.096396 62.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2010; 22:3439-60;PMID:20923938; http://dx.doi.org/10.1105/tpc.110.077453 63.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant J 2008; 55:428-42;PMID:18429937; http://dx.doi.org/10.1111/j.1365-313X.2008.03523.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant J 2014;78:344-56; PMID:24612058; http://dx.doi.org/10.1111/tpj.12474 65.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2014; 26:1183-99; PMID:24619613;http://dx.doi.org/10.1105/tpc.113.120444 66.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
EMBO J1998; 17:1577-87; PMID:9501079; http://dx.doi.org/10.1093/emboj/ 17.6.1577 67.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Physiol 2011; 157:608-19; PMID:21862668; http://dx.doi.org/10.1104/pp.111.183301 69.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant CellPhysiol 2001; 42:1389-97; PMID:11773532; http://dx.doi.org/ 10.1093/pcp/pce179 70.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Biochem Soc Trans 2001; 29:413-8; PMID:11497999; http://dx.doi.org/10.1042/bst0290413 71.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
PlantCell 1999; 11:1165-78; PMID:10368186; http://dx.doi.org/10.1105/tpc.11.6.1165 72.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant J 2007; 50:265-77; PMID:17355436; http://dx.doi.org/ 10.1111/j.1365-313X.2007.03047.x 74.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2012; 24:637-59; PMID:22307852; http://dx.doi.org/10.1105/tpc.111.092692 75.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plantsignaling & behavior 2013; 8:e27037; PMID:24300099; http://dx.doi.org/10.4161/psb.27037 76.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Cell Sci 2009; 122:2887-94; PMID:19638406; http://dx.doi.org/ 10.1242/jcs.051227 77.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Cell Biol 2011; 195:889-902; PMID:22123866; http://dx.doi.org/10.1083/jcb.201104040 78.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Annu Rev Plant Biol 2013; 64:501-29; PMID:23638827; http://dx.doi.org/10.1146/annurev-arplant-050312-120103 79.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
ApplMicrobiol Biotechnol 2007; 73:1150-7; PMID:17106680; http://dx.doi.org/10.1007/s00253-006-0571-7 80.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
"J Bacteriol 2004; 186:366-73; PMID:14702305; http://dx.doi.org/10.1128/JB.186.2.366-373.2004 81. van der Does C, Swaving J, van Klompenburg W, Driessen AJ.",Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Biol Chem 2000; 275:2472-8; PMID:10644701;http://dx.doi.org/10.1074/jbc.275.4.2472 82.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant J 2012; 71:656-68;PMID:22487220; http://dx.doi.org/10.1111/j.1365-313X.2012.05020.x 83.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2006; 18:1454-66; PMID:16679460; http://dx.doi.org/10.1105/tpc.105.038695 84.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Physiol 2010; 154:109-20; PMID:20605914; http://dx.doi.org/10.1104/pp.110.159558 85.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2015; 27:262-85; PMID:25587003; http://dx.doi.org/10.1105/tpc.114.132787 86.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Physiol 2016; 170:821-40; PMID:26644506; http://dx.doi.org/10.1104/pp.15.01458 87.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Proc Natl Acad Sci US A 1994; 91:8082-6; PMID:8058761; http://dx.doi.org/10.1073/ pnas.91.17.8082 89.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Cell 2006; 18:3121-31; PMID:17114356; http://dx.doi.org/10.1105/tpc.106.042671 90.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Front Plant Sci 2016; 7:157; PMID:26925076; http://dx.doi.org/10.3389/fpls.2016.00157 91.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Biol Chem 2008; 283:4044-50; PMID:18089572; http://dx.doi.org/10.1074/jbc.M708960200 92.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Mol Biol 2006; 61:567-75; PMID:16897475; http://dx.doi.org/10.1007/s11103-006-0031-x 93.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Biol Chem 2010; 285:21391-8; PMID:20444695; http://dx.doi.org/10.1074/jbc.M110.105064 94.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Physiol 2015; 167:481-92; PMID:25511433; http://dx.doi.org/10.1104/pp.114.25333696.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Photosynth Res 2013; 116:167-88;PMID:23417641; http://dx.doi.org/10.1007/s11120-013-9803-8 97.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
PhotochemPhotobiol 2008; 84:1343-8; PMID:19067955; http://dx.doi.org/10.1111/j.1751-1097.2008.00448.x 99.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant Physiol 2007; 145:668-79; PMID:17827269; http://dx.doi.org/10.1104/pp.107.105866 100.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plantsignaling & behavior 2015; 10:e1076602; PMID:26337456; http://dx.doi.org/10.1080/15592324.2015.1076602 101.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
Plant J2015; 82:731-43; PMID:25846821; http://dx.doi.org/10.1111/tpj.12845 102.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
EMBO J 1998; 17:5286-97;PMID:9736608; http://dx.doi.org/10.1093/emboj/17.18.5286 103.,Non-OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
FEBS Lett 2002;532:85-90; PMID:12459468; http://dx.doi.org/10.1016/S0014-5793 (02)03634-7 104.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Biol Chem 2008; 283:22390-9; PMID:18550538;http://dx.doi.org/10.1074/jbc.M801917200 105.,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
J Integr Plant Biol 2014; 56:1136-50; PMID:25146729; http://dx.doi.org/10.1111/jipb.12275e1218587-8 J. THEIS AND M. SCHRODA,OADS,/arxiv_data1/oa_pdf/c1/25/kpsb-11-09-1218587.PMC5058467.pdf
"7, 1361 –1370 http://dx.doi.org/10.1080/19420862.2016.1204503",Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Breast Dis 2000; 11:91-102; PMID:15687595; http://dx.doi.org/10.3233/BD-1999-11108 2.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Clinical Breast Cancer 2004; 5:63-9; PMID:15140287; http://dx.doi.org/10.3816/ CBC.2004.n.0111368 G. T/C19OTH ET AL.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Ann Oncol 2005; 16:273-8; PMID:15668283; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Immunol Lett 2008; 116:126-40; PMID:18201769; http://dx.doi.org/10.1016/j.imlet.2007.12.001 5.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
J Clin Oncol 2002; 20:1800-8; PMID:11919237; http://dx.doi.org/10.1200/JCO.2002.07.058 7.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
N Engl J Med 2001; 344:783-92;PMID:11248153; http://dx.doi.org/10.1056/NEJM200103153441101 8.,OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Cancer Cell 2004; 6:117-27; PMID:15324695;http://dx.doi.org/10.1016/j.ccr.2004.06.022 10.,OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Nature 2002; 416:279-80; PMID:11907566; http://dx.doi.org/10.1038/416279b 11.,OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Nat Med 2000; 6:443-6; PMID:10742152; http://dx.doi.org/10.1038/74704 12.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Mol Cancer Ther 2007; 6:2065-72; PMID:17620435; http://dx.doi.org/10.1158/1535-7163.MCT-06-0766 13.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
JNatl Cancer Inst 2001; 93:1852-7; PMID:11752009; http://dx.doi.org/ 10.1093/jnci/93.24.1852 15.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Oncoimmunology 2012; 1:810-21; PMID:23162748; http://dx.doi.org/10.4161/onci.20447 18.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Cancer Lett2008; 263:231-42; PMID:18276068; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Cancer Lett 2008; 260:198-208; PMID:18096313; http://dx.doi.org/10.1016/j.canlet.2007.10.043 20.,OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Cancer Cell 2004; 5:317-28; PMID:15093539;http://dx.doi.org/10.1016/S1535-6108(04)00083-2 21.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Proc NatlAcad Sci U S Am 2009; 106:3294-9; PMID:19218427; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Can- cer Cell 2005; 7:287-8; PMID:15837615; http://dx.doi.org/10.1016/j.ccr.2005.04.004 24.,OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Clin Cancer Res 2014; 20:5359-64; PMID:25204553; http://dx.doi.org/10.1158/1078-0432.CCR-14-1268 26.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Oncologist 2014; 19:766-73; PMID:24928613; http://dx.doi.org/10.1634/theoncologist.2013-0348 27.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
N Engl J Med 2015; 372:724-34; PMID:25693012; http://dx.doi.org/ 10.1056/NEJMoa1413513 28.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
BMC Med 2014; 12:132; PMID:25285786; http://dx.doi.org/10.1186/s12916-014-0132-3 29.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Methods Mol Biol 2013; 986:165-78; PMID:23436412;http://dx.doi.org/10.1007/978-1-62703-311-4_11 30.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
AAPS J 2010; 12:33-43; PMID:19924542; http://dx.doi.org/10.1208/s12248-009-9157-5 31.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
AAPS J 2012; 14:612-8; PMID:22648903; http://dx.doi.org/10.1208/s12248-012-9374-1 3 2 .,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
J Clin Oncol 2014; 32:3753-61; PMID:25332247; http://dx.doi.org/10.1200/JCO.2013.54.5384 33.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
The oncologist 2008; 13:1114-9; PMID:18849320; http://dx.doi.org/10.1634/theoncologist.2008-0816MABS 1369,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Breast Cancer 2012; 6:191-207; PMID:23226023; http://dx.doi.org/10.4137/ BCBCR.S930137.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
Eur J Immunol 2014; 44:2331-9; PMID:24810893; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
J Immunol 2008; 180:6392-401; PMID:18424763; http://dx.doi.org/ 10.4049/jimmunol.180.9.63921370 G. T/C19OTH ET AL.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/kmab-08-07-1204503.PMC5058622.pdf
"7, 1347 –1360 http://dx.doi.org/10.1080/19420862.2016.1215791",Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Semin Immunopathol 2012; 34:237- 59; PMID:22080185; http://dx.doi.org/10.1007/s00281-011-0295-3 2.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Annu Rev Micro- biol 2013; 67:629-50; PMID:23834243; http://dx.doi.org/10.1146/ annurev-micro-092412-155746 3.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Front Cell Infect Microbiol 2012; 2:12; PMID:22919604; http://dx.doi.org/10.3389/fcimb.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Microbiol Mol Biol Rev MMBR 2014; 78:199- 230; PMID:24847020; http://dx.doi.org/10.1128/MMBR.00055-13 5.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Lancet 1932; 219:506-8; http://dx.doi.org/10.1016/S0140-6736(01)24468-7 6.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Protein Sci Publ Protein Soc 2005; 14:2550-61;PMID:16195546; http://dx.doi.org/10.1110/ps.051648505 7.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Protein Sci Publ Protein Soc 2002; 11:894-902; PMID:11910032; http://dx.doi.org/10.1110/ps.4360102 8.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
PloS One 2010; 5:e11634; PMID:20661294; http://dx.doi.org/10.1371/ journal.pone.0011634 11.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Mol Microbiol 2011; 79:814-25; PMID:21255120; http://dx.doi.org/10.1111/j.1365-2958.2010.07490.x 12.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
J Biol Chem 2015; 290:142-56; PMID:25371205; http://dx.doi.org/10.1074/jbc.M114.598110 13.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Infect Immun 2014; 82:1268-76; PMID:24379286; http://dx.doi.org/10.1128/IAI.01444-13 14.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Nat Commun 2014; 5:5438; PMID:25384670; http://dx.doi.org/10.1038/ncomms6438 15.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Cell Host Microbe 2013; 13:584-94; PMID:23684309;http://dx.doi.org/10.1016/j.chom.2013.04.006 16.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Infect Immun 2013; 81:1830-41;PMID:23509138; http://dx.doi.org/10.1128/IAI.00095-13 19.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
J Infect Dis 2012; 206:1185-93; PMID:22872735; http://dx.doi.org/10.1093/infdis/jis495 20.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Nat Biotechnol 1997; 15:553-7;PMID:9181578; http://dx.doi.org/10.1038/nbt0697-553 21.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Gene 2004; 342:211-8; PMID:15527980; http://dx.doi.org/10.1016/j.gene.2004.08.014 22.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Protein Eng Des Sel PEDS 2011; 24:525-30; PMID:21402751; http://dx.doi.org/10.1093/protein/gzr008 23.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Protein Eng Des Sel PEDS 2013; 26:663-70; PMID:24046438; http://dx.doi.org/10.1093/ protein/gzt047 25.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Mabs 2013; 5:270-8; PMID:23575269; http://dx.doi.org/10.4161/mabs.23049 26.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
J Biol Chem 2004; 279:41028-37; PMID:15262988; http://dx.doi.org/10.1074/jbc.M406904200 28.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Infect Immun 2014; 82:1234-42; PMID:24379282; http://dx.doi.org/10.1128/IAI.01558-13 29.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Clin Infect Dis Off Publ Infect Dis Soc Am 2013; 56:1554-61; PMID:23446627; http://dx.doi.org/10.1093/cid/cit123 3 0 .,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
J Infect Dis 2012; 206:915- 23; PMID:22807524; http://dx.doi.org/10.1093/infdis/jis462 31.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Arch Biochem Biophys 2012; 526:124-31; PMID:22705202; http://dx.doi.org/10.1016/j.abb.2012.06.001 32.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Expert Opin Ther Targets 2012; 16:601-12; PMID:22530584; http://dx.doi.org/10.1517/14728222.2012.682573 3 3 .,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
J Biol Chem 2014; 289:29874- 80; PMID:25210036; http://dx.doi.org/10.1074/jbc.M114.601328 3 4 .,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Antimicrob Agents Chemother 2015; 59:4526-32; PMID:25987629; http://dx.doi.org/10.1128/AAC.00510-15 35.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Mabs 2015; 7:243-54; PMID:25523282; http://dx.doi.org/10.4161/19420862.2014.985132 36.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
J Microbiol Methods 2011; 87:76-81; PMID:21801759; http://dx.doi.org/10.1016/j.mimet.2011.07.010 37.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Methods Mol Biol Clifton NJ 2014; 1131:151-81; PMID:24515465; http://dx.doi.org/10.1007/978-1-62703-992-5_10 39.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
J SynchrotronRadiat 2013; 20:648-53; PMID:23765310; http://dx.doi.org/10.1107/S0909049513011734 40.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Acta Crystallogr D Biol Crystallogr 2010; 66:125-32; PMID:20124692; http://dx.doi.org/10.1107/S0907444909047337 41.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Acta Crystallogr D Biol Crystallogr 2013; 69:1204-14; PMID:23793146; http://dx.doi.org/10.1107/S0907444913000061 42.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Acta Crystallogr D Biol Crys- tallogr 2011; 67:235-42; PMID:21460441; http://dx.doi.org/10.1107/ S0907444910045749 43.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
J Appl Crystallogr 2007; 40:658-74; PMID:19461840; http://dx.doi.org/10.1107/S0021889807021206 44.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Acta Crystallogr D Biol Crystal-logr 2011; 67:355-67; PMID:21460454; http://dx.doi.org/10.1107/S0907444911001314 45.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Acta Crystallogr D Biol Crystallogr 2010; 66:486-501;PMID:20383002; http://dx.doi.org/10.1107/S0907444910007493 46.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
Methods Enzymol 2003;374:300-21; PMID:14696379; http://dx.doi.org/10.1016/S0076-6879(03)74014-2 47.,OADS,/arxiv_data1/oa_pdf/df/d3/kmab-08-07-1215791.PMC5058624.pdf
"7, 1319 –1335 http://dx.doi.org/10.1080/19420862.2016.1210747",Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
"Amino acids Theoretical mass1Expected mass [M]2Observed mass [M] Light chain 341 36300.2 36294.1 Heavy chain 357 37335.8 37329.7Intact Fab-dsFv 698 73636.0 73619.8 73616.0 1The theoretical mass of light and heavy chains, and the resulting mass of the intact molecule as calculated from the amino acid sequence of Fab-dsFv usi ng the ExPASy Compute pI/Mw tool http://web.expasy.org/compute_pi/.",OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Mol CancerTher 2012; 11:582-593; PMID:22248472; http://dx.doi.org/10.1158/1535-7163.MCT-11-0820 3.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
MAbs 2012; 4:182-197; PMID:22453100; http://dx.doi.org/10.4161/mabs.4.2.19000 4.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Thrombosis2014; 2014:714218; PMID:25610642; http://dx.doi.org/10.1155/2014/714218 5.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Clin Ophthalmol 2015; 9:533-542; PMID:25848203; http://dx.doi.org/10.2147/OPTH.S80049 6.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Br J Pharmacol 2009; 157:220-33; PMID:19459844; http://dx.doi.org/10.1111/j.1476-5381.2009.00190.x 8.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
MAbs 2010; 2(1):77- 83; PMID:20093855; http://dx.doi.org/10.4161/mabs.2.1.10786 1 0 .,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Nat Med 2000; 6(2):114; PMID:10655072; http://dx.doi.org/10.1038/72162 11.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Thromb Haemost 2005; 93(6):1137-46; PMID:15968400; http://dx.doi.org/ 10.1160/TH04-12-0774 12.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Immunol 2010; 185(3):1577-83;PMID:20585032; http://dx.doi.org/10.4049/jimmunol.0903888 13.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Arthritis Rheum 2010; 62:1243; http://dx.doi.org/10.1002/art.29009 14.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Arthritis ResTher 2015; 17:234; PMID:26335795; http://dx.doi.org/10.1186/s13075-015-0757-4 16.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Biodrugs 2009; 23:93-109; PMID:19489651; http://dx.doi.org/10.2165/00063030-200923020-00003 17.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Curr Opin Biotechnol 2011; 22:868-876; PMID:21862310; http://dx.doi.org/10.1016/j.copbio.2011.06.012 18.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
PEGylated antibodies and antibody fragments for improved therapy: a review.Adv Drug Deliv Rev 2002; 54:531-545; PMID:12052713; http://dx.doi.org/10.1016/S0169-409X(02)00026-1 19.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
28:15-23; PMID:24687235; http://dx.doi.org/10.1007/s40259-013- 0064-z 20.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Biotechnol J 2010; 5:113-128; PMID:20069580; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Protein Eng Des Sel 2013; 26:489-501; PMID:23754528; http://dx.doi.org/10.1093/protein/gzt023 22.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Methods Enzymol 2012;502:215-237; PMID:22208987; http://dx.doi.org/10.1016/B978-0-12- 416039-2.00024-0 25.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Biopolymers 2010; 94:60-77;PMID:20091871; http://dx.doi.org/10.1002/bip.21327 26.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
EMBO Mol Med 2012; 4:1015-1028; PMID:22837174; http://dx.doi.org/10.1002/emmm.201201379 27.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Protein Expr Purif 2010; 73:113-124; PMID:20546898; http://dx.doi.org/10.1016/j.pep.2010.05.009 28.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Biol Chem 2011; 287:4462-4469; PMID:22147690; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Biocon- jug Chem 2009; 20: 2286-2292; PMID:19916518; http://dx.doi.org/ 10.1021/bc9002772 30.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
"Expert Opin, Pharmacother 2006; 7:325-43; PMID: 16448327; http://dx.doi.org/10.1517/14656566.7.3.325 31.",Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Biol Chem 2002; 277:35035-35043; PMID:12119302; http://dx.doi.org/10.1074/jbc.M205854200 32.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Protein Eng Des Sel 2006; 9:291-297; PMID:16621915; http://dx.doi.org/10.1093/protein/gzl011 33.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Biol Chem 2011; 286:5234-5241; PMID:21138843; http://dx.doi.org/ 10.1074/jbc.M110.164848 34.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Biol Chem2013; 288:24277-24285; PMID:23818524; http://dx.doi.org/10.1074/jbc.M113.463000 35.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Protein Eng Des Sel 2010; 23:827-834; PMID:20817756; http://dx.doi.org/10.1093/protein/gzq058 36.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Protein Eng Des Sel 2008; 21:283-288; PMID:18387938; http://dx.doi.org/10.1093/protein/gzm067 37.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Improved tumor target- ing of anti-epidermal growth factor receptor Nanobodies throughalbumin binding: taking advantage of modular Nanobody technology.Mol Cancer Ther 2008; 8:2288-2297; PMID: 18723476; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Int J Biol Macromol 1997; 20:63-73; PMID:Can ’t; http://dx.doi.org/10.1016/S0141-8130(96)01153-1 40.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
"San Diego CA: Academic Press, 1996; http://dx.doi.org/ 10.1002/food.19970410631 41.",Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Drug Metab Rev 1976; 5(1):43-140; PMID:829788; http://dx.doi.org/10.3109/03602537608995839 42.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Biol Chem 2007;282:12650-12660; PMID:17347147; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Bioconjug Chem 2001; 12: 750-756; PMID:11562193; http://dx.doi.org/10.1021/bc010003g 45.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Protein Eng Des Sel 2010; 23:789-798;PMID:20802234; http://dx.doi.org/10.1093/protein/gzq054 46.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Biochim Biophys Acta 2013; 1830:5526-5534; PMID:23639804; http://dx.doi.org/10.1016/j.bbagen.2013.04.023 47.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Biomed Res Int 2013; 2013:107238; PMID:24151579;http://dx.doi.org/10.1155/2013/107238 48.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Control Release 2012; 157:4-28; PMID:21959118; http://dx.doi.org/10.1016/j.jconrel.2011.09.069 49.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Biol Chem 2014; 289: 13492-13502; PMID:24652290;http://dx.doi.org/10.1074/jbc.M114.549832 50.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
"Cambridge University Press, 1995; http://dx.doi.org/10.1385/1-59259-076-4:267 51.",Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Protein Eng 1993; 6: 989-95 ; PMID:8309948;http://dx.doi.org/10.1093/protein/6.8.989 52.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J M icrobiol Biotechnol 2007; 17:1670-1674; PMID:18156783; http://dx.doi.org/10.1016/j.pnsc.2008.12.007 55.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Proc Nat Acad Sci 1993; 90:7538-7542; PMID:8356052; http://dx.doi.org/ 10.1073/pnas.90.16.7538 57.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
PLoS One 2012; 7:e30083; PMID:22272277; http://dx.doi.org/10.1371/ journal.pone.0030083 58.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Biochem J 1968; 109:825-30; PMID:4177067; http://dx.doi.org/10.1042/bj1090825 59.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Biochem J 1976; 153(2):191-7; PMID:1275884; http://dx.doi.org/10.1042/bj1530191 60.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Nat Struct Biol 2001; 8(7):597-601;PMID:11427889; http://dx.doi.org/10.1038/89631 61.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
2010 Apr;23(4):221-8; PMID:17321501;http://dx.doi.org/10.1093/protein/gzp077 62.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Biochem Biophys Res Commun 2007; 355(3):751-7; PMID:17321501; http://dx.doi.org/10.1016/j.bbrc.2007.02.042 63.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Eur J PharmBiopharm 2010; 74(2): 139-47; PMID:19922795; http://dx.doi.org/10.1016/j.ejpb.2009.11.005 64.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Biochem Pharmacol 2006;72(1):1-10; PMID:16469301; http://dx.doi.org/10.1016/j.bcp.2005.12.041 6 5 .,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Pharmacokinet Pharmacodyn 2014; 41(4):375-87; PMID:25077917; http://dx.doi.org/10.1007/s10928-014- 9372-2 66.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Toxicol Appl Pharmacol 2014: 279(2):230-9; PMID:24937321; http://dx.doi.org/10.1016/j.taap.2014.06.002 67.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Regul To xicol Pharmacol 2009; 54(2):164-82; PMID:19345250; http://dx.doi.org/10.1016/j.yrtph.2009.03.012 68.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Regul Tox-icol Pharmacol 2011; 59(2):334-42; PMID:21130822; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
MAbs 2011; 3(1):61-6; PMID: 20962582; http://dx.doi.org/10.4161/mabs.3.1.13799 70.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Exp Biol 2005; 208(Pt 9):1575-92; PMID:15855389; http://dx.doi.org/10.1242/jeb.01589 71.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
2007; 67(1):254-61; PMID:17210705; http://dx.doi.org/10.1158/0008-5472.CAN-06-2531 72.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
1975; 11:824-832; PMID:1207674; http://dx.doi.org/10.1371/journal.pcbi.1000231 73.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
2002; 25(6):695-704; PMID:12081132; http://dx.doi.org/10.1248/bpb.25.695 75.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
1999; 274(41):29303-10; PMID:10506189;http://dx.doi.org/10.1074/jbc.274.41.29303 76.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
2013; 1830(12):5444-55; PMID:23811338; http://dx.doi.org/10.1016/j.bbagen.2013.06.018 77.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Albumin binding to FcRn: distinct from the FcRn-IgG interaction.Biochemistry 2006; 45:4983-4990; PMID:16605266; http://dx.doi.org/10.1021/bi052628y 78.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
2014; 289(50):34583-94; PMID:25344603; http://dx.doi.org/10.1074/jbc.M114.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
PLoS Comput Biol 2008; 4(11):e1000231; PMID:19023401; http://dx.doi.org/10.1371/journal.pcbi.1000231 80.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
"Wyeth-Ayerst, Gemtuzumab ozogamicin summary for presentation to the FDA ’s Oncologic Division Advisory Committee, 2000; PMID:10429243; http://dx.doi.org/10.1038/11717 81.",Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Bioanalysis 2013; 5(9):1007-23; PMID:23641693; http://dx.doi.org/10.4155/bio.13.64 82.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Expert Opin Drug Deliv 2015; 12(5):793-812; PMID:25518870; http://dx.doi.org/ 10.1517/17425247.2015.993313 85.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Mol Biol 1999; 290:535-46; PMID: 10390351; http://dx.doi.org/10.1006/jmbi.1999.2854 86.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
1999; 17:780-783; http://dx.doi.org/10.1038/11717 88.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
Clin Pharmacol Ther 2014; 96:704-712; PMID:25238251; http://dx.doi.org/10.1038/clpt.2014.1871334 E. DAV /C19EE TA L .,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J Immunol Methods 2006; 316:133-143; PMID:17027850; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
MAbs 2014; 6:143-159; PMID:24423622; http://dx.doi.org/10.4161/mabs.27044 92.,OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
J BiomolScreen 2015; 20(4):492-497; PMID:25548140; http://dx.doi.org/ 10.1177/1087057114564760 93.,Non-OADS,/arxiv_data1/oa_pdf/b7/40/kmab-08-07-1210747.PMC5058625.pdf
"7, 1336 –1346 http://dx.doi.org/10.1080/19420862.2016.1185581",Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Curr Opin Biotechnol 2011; 22:868-76; PMID:21862310; http://dx.doi.org/10.1016/j.copbio.2011.06.012 2.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Biochim Biophys Acta 2013; 1830:5526-34;PMID:23639804; http://dx.doi.org/10.1016/j.bbagen.2013.04.023 3.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Exp Med 2003; 197:315-22; PMID:12566415; http://dx.doi.org/ 10.1084/jem.20021829 5.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Biol Chem2007; 282:12650-60; PMID:17347147; http://dx.doi.org/10.1074/jbc.M700820200 7.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Control Release 2012; 157:4-28;PMID:21959118; http://dx.doi.org/10.1016/j.jconrel.2011.09.069 8.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Diabetes Obes Metab 2010; 12:655-73; PMID:20590743; http://dx.doi.org/10.1111/j.1463- 1326.2010.01206.x 9.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Biocon-jug Chem 2009; 20:2286-92; PMID:19916518; http://dx.doi.org/ 10.1021/bc9002772 10.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Biol Chem 2002; 277:35035-43; PMID:12119302; http://dx.doi.org/10.1074/jbc.M205854200 11.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Pro- tein Eng Des Sel 2006; 9:291-7; PMID:16621915; http://dx.doi.org/10.1093/protein/gzl01112.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Protein Eng Des Sel 2010; 23:827-34; PMID:20817756; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Biol Chem 2011; 286:5234-41; PMID:21138843; http://dx.doi.org/10.1074/jbc.M110.164848 14.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Improved tumor target- ing of anti-epidermal growth factor receptor Nanobodies throughalbumin binding: taking advantage of modular Nanobody technology.Mol Cancer Ther 2008; 8:2288-97; PMID:18723476; http://dx.doi.org/ 10.1158/1535-7163.MCT-07-2384 15.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Arthritis Res Ther 2015; 17:135; PMID:25994180; http://dx.doi.org/10.1186/s13075-015-0651-0 16.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Protein Eng Des Sel 2008; 21:283-8;PMID:18387938; http://dx.doi.org/10.1093/protein/gzm067 17.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Clin Pharmacol Ther 2014; 96:704-12; PMID:25238251; http://dx.doi.org/10.1038/ clpt.2014.187 18.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Drug Safety 2004; 27:1115-33; PMID:15554746; http://dx.doi.org/10.2165/00002018- 200427140-00004 19.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Bioconjug Chem 2001; 12:750-6; PMID:11562193; http://dx.doi.org/10.1021/bc010003g 20.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Immunol Methods 2006; 316:133-43; PMID:17027850; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Lab Auto 2009; 14(5):303-07; http://dx.doi.org/10.1016/j.jala.2009.05.004 22.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
MAbs 2014; 6:143- 59; PMID:24423622; http://dx.doi.org/10.4161/mabs.27044 23.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Drug Metab Pharmacokinet 2009; 24 (4):342-57; PMID:19745561; http://dx.doi.org/10.2133/dmpk.24.342 25.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Biol Chem 2014; 289:7812-24; PMID:24469444; http://dx.doi.org/10.1074/jbc.M113.537563 26.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Biophys Chem 2010; 148:16-22; PMID:20346571; http://dx.doi.org/10.1016/j.bpc.2010.03.001 27.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Biochim Et Biophys Act 2013; 1830(12):5444-45; http://dx.doi.org/10.1016/j.bbagen.2013.06.018MABS 1345,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Mol Biol 2005; 353:38-52; PMID:16169013; http://dx.doi.org/10.1016/j.jmb.2005.07.075 29.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Nat Struct Biol 1998; 5:827-35; PMID:9731778; http://dx.doi.org/10.1038/1869 30.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Mol Immunol 2012; 52:174- 82; PMID:22677715; http://dx.do i.org/10.1016/j.molimm.2012.05.011 31.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Biol Chem 2014; 289:34583-94; PMID:25344603; http://dx.doi.org/10.1074/jbc.M114.587675 32.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Biotechnol Prog 2013; 29:697-706; PMID:23335490; http://dx.doi.org/10.1002/btpr.1693 35.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Acta Crysta 2006; D62:48-57; PMID:16369093; http://dx.doi.org/10.1107/ S0907444905039107 36.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Acta Cryst 2006; D62:72-82; PMID: 16369096; http://dx.doi.org/10.1107/S0907444905036693 38.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
J Appl Cryst 2007; 40:658-74; PMID:19461840; http://dx.doi.org/10.1107/S0021889807021206 39.,Non-OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Acta Cryst 2010; D66:125-32; PMID: 20124692; http://dx.doi.org/10.1107/S0907444909047337 40.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
High-resolution Crystal Structural Variance Analy- sis between Recombinant and Wild-type Human Serum Albumin.http://dx.doi.org/10.2210/pdb4g03/pdb 41.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Acta Crystallogr D Biol Crystal-logr 1998; 54(Pt 5):905-21; PMID:9757107; http://dx.doi.org/ 10.1107/S0907444998003254 42.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Nat Protoc 2007; 2:2728-33; PMID:18007608; http://dx.doi.org/10.1038/ nprot.2007.406 43.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Acta Crystallogr D Biol Crystallogr 2004; D60:2126-32;PMID:15572765; http://dx.doi.org/10.1107/S0907444904019158 44.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
MolProbity:all-atom structure validation for macromolecular crystallography;Acta Crystallogr D Biol Crystallogr 2010; D66: 12-21; PMID: 20057044; http://dx.doi.org/10.1107/S0907444909042073 45.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
Chem 2008; 80:4200-7; PMID:18465883; http://dx.doi.org/ 10.1021/AC800205S1346 R. ADAMS ET AL.,OADS,/arxiv_data1/oa_pdf/88/0d/kmab-08-07-1185581.PMC5058626.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
"7, 1417 –1424 http://dx.doi.org/10.1080/19420862.2016.1207031",Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
J Clin Immunol 2007; 27:1-18; PMID:17216565; http://dx.doi.org/10.1007/s10875-006-9060-0 2.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Neurothera- peutics 2013; 10:55-67; PMID:23055048; http://dx.doi.org/10.1007/ s13311-012-0147-4 3.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
N Engl J Med 1998; 338:161-65; PMID:9428817; http://dx.doi.org/10.1056/NEJM199801153380304 4.,OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Lancet 2013; 381:2167-75; PMID:23562009; http://dx.doi.org/10.1016/S0140-6736 (12)62190-4 5.,OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
N Engl J Med 2015; 373:1418-28; PMID:26444729; http://dx.doi.org/10.1056/NEJMoa1501481 6.,OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Expert Rev Clin Pharma- col 2014; 7:9-19; PMID:24308792; http://dx.doi.org/10.1586/17512433.2014.865516 7 .,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
J Immunol 2002; 169:2736-46;PMID:12193748; http://dx.do i.org/10.4049/jimmunol.169.5.2736 8.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Blood 2007; 109:5399-406; PMID:17344465;http://dx.doi.org/10.1182/blood-2006-12-062943 10.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Sci Transl Med 2012; 4:1-8; PMID: 22855463; http://dx.doi.or g/10.1126/scitranslmed.3004140 11.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Nat Med 2011; 17:604-09; PMID:21532597; http://dx.doi.org/10.1038/nm.2365 12.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Anti-CD20monoclonal antibody with enhanced af ﬁnity for CD16 activates NK cells at lower concentrations and more effectively than rituximab.Blood 2006; 108:2648-54; PMID:16825493; http://dx.doi.org/10.1182/blood-2006-04-020057 14.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Arch Biochem Biophys 2012; 526:159-66; PMID:22465822; http://dx.doi.org/10.1016/j.abb.2012.03.021 16.,OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
2014Oct;111(10):1907-19; PMID:24975601; http://dx.dpoi.org/10.1002/ bit.25318.,OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
ClinPharmacokinet 2014; 53:863-4; PMID:25212704; http://dx.doi.org/ 10.1007/s40262-014-0186-6 18.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Glycobiology 2011; 21:949-59; PMID:21421994; http://dx.doi.org/10.1093/glycob/cwr027 19.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Glycobiology 2007; 17:104-18; PMID: 17012310; http://dx.doi.org/10.1093/glycob/cwl057 20.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Clin Pharmacokinet 2014; 53:907-18; PMID:25212703; http://dx.doi.org/10.1007/s40262-014-0159-9 21.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Nat Rev Neurol 2013; 9:394-404; PMID:23732529; http://dx.doi.org/10.1038/nrneurol.2013.95 22.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
J Immunol 2015; 194:84-92; PMID:25416807; http://dx.doi.org/10.4049/jimmunol.1402140 23.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Nat Immunol 2005; 6:1142-51; PMID:16227984; http://dx.doi.org/10.1038/ni1263 24.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
Annu Rev Immunol 2012; 30:531-64; PMID:22224781; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
J Exp Med 2013; 210:2707-20; PMID:24249704; http://dx.doi.org/10.1084/jem.20122759 27.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
J Neurol 2014; 261:316-23; PMID:24375015; http://dx.doi.org/10.1007/s00415-013-7196-4 28.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/kmab-08-07-1207031.PMC5058627.pdf
"7, 1286 –1301 http://dx.doi.org/10.1080/19420862.2016.1216742",Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Mol Immunol 2015; 67:28-45; PMID:25911943; http://dx.doi.org/10.1016/j.molimm.2015.04.002 2.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Nat Rev Cancer 2012; 12:278-87; PMID:22437872; http://dx.doi.org/10.1038/ nrc3236 3.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
J Clin Oncol 2015; 33:1974-82; PMID:25605845; http://dx.doi.org/10.1200/JCO.2014.59.4358 4.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Nature 2014; 515:568-71; PMID:25428505; http://dx.doi.org/10.1038/nature13954 5.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.Cancer Cell 2015; 28:500-14; PMID:26461094; http://dx.doi.org/10.1016/j.ccell.2015.09.003 6.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Blood Cancer J 2015; 5:e316; PMID:26024286; http://dx.doi.org/10.1038/bcj.2015.39MABS 1299,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Nat Rev Immunol 2010;10:345-52; PMID:20414207; http://dx.doi.org/10.1038/nri2747 8.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
mAbs 2016; in press; PMID:27416017; http://dx.doi.org/10.1080/19420862.2016.1212149 9.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Trends Bio- technol 2010; 28:355-62; PMID:20447706; http://dx.doi.org/10.1016/j.tibtech.2010.03.007 10.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Nat Biotechnol 2005; 23:1126-36; PMID:16151406; http://dx.doi.org/10.1038/nbt1142 11.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Methods Mol Biol 2002; 178:1-37; PMID:11968478;http://dx.doi.org/10.1385/1-59259-240-6:001 13.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Eur J Biochem 1999; 260:774-84; PMID:10103007; http://dx.doi.org/10.1046/j.1432-1327.1999.00214.x 14.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Cancer Res 2004; 64:704-10;PMID:14744788; http://dx.doi.org/10.1158/0008-5472.CAN-03-2732 15.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
J Immunol Methods 2008; 330:109- 19; PMID:18096183; http://dx.doi.org/10.1016/j.jim.2007.11.008 16.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Br J Cancer 2000; 83:252-60; PMID:10901379; http://dx.doi.org/10.1054/bjoc.2000.1226 18.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Guided selection of a pan carcinoma speci ﬁc antibody reveals similar binding characteristics yet structural diver- gence between the original murine antibody and its human equivalent.J Mol Biol 2000; 296:833-49; PMID:10677285; http://dx.doi.org/10.1006/jmbi.2000.3512 19.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Biochem Biophys Res Commun 2011; 408:692-6; PMID:21539817; http://dx.doi.org/10.1016/j.bbrc.2011.04.090 20.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
J Mol Biol 2008; 379:261-72; PMID:18455737; http://dx.doi.org/10.1016/j.jmb.2008.03.072 21.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Mol Cell Proteomics 2014; 13:653-65; PMID:24361863; http://dx.doi.org/10.1074/mcp.O112.025486 23.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
PLoS ONE 2013; 8:e75126; PMID:24086454; http://dx.doi.org/10.1371/journal.pone.0075126 24.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
J Bacteriol 2009; 191:5169-79; PMID:Can ’t; http://dx.doi.org/10.1128/JB.00458-09 25.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Struc- ture 2012; 20:1233-43; PMID:22658748; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Annu Rev Biochem 2013; 82:775-97; PMID:23495938; http://dx.doi.org/ 10.1146/annurev-biochem-063011-092449 27.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
"Nanomedicine (Lon-don, England) 2015; 10:161-74; PMID:25597775; http://dx.doi.org/ 10.2217/nnm.14.178 28.",OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Theranostics 2014; 4:386-98; PMID:24578722; http://dx.doi.org/10.7150/thno.8006 29.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Cancer Treat Rev 2009; 35:354-63; PMID:19269105; http://dx.doi.org/10.1016/j.ctrv.2009.02.001 31.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Expert Opin Biol Ther 2006; 6:605-17; PMID:16706607; http://dx.doi.org/10.1517/14712598.6.6.605 33.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
J Clin Oncol 2005; 23:2445- 59; PMID:15753456; http://dx.doi.org/10.1200/JCO.2005.11.890 34.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Nat Rev Mol Cell Biol 2001; 2:127-37; PMID:11252954; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Cell 2013; 152:557-69; PMID:23374350; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Mol Syst Biol 2007; 3:144; PMID:18004277; http://dx.doi.org/10.1038/ msb4100188 37.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
EMBO J 2000; 19:3159-67; PMID:10880430; http://dx.doi.org/ 10.1093/emboj/19.13.3159 38.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Cancer Immunol Immunother 2007; 56:303-17;PMID:16738850; http://dx.doi.org/10.1007/s00262-006-0180-4 39.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Proc Natl AcadSci U S A 1989; 86:925-9; PMID:2915986; http://dx.doi.org/10.1073/ pnas.86.3.925 40.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Structure 2013; 21:1214-24; PMID:23791944; http://dx.doi.org/10.1016/j.str.2013.05.008 41.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Cell 1987; 51:199-209; PMID:3499230;http://dx.doi.org/10.1016/0092-8674(87)90147-4 42.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Cell 2013; 152:543-56; PMID:23374349; http://dx.doi.org/10.1016/j.cell.2012.12.032 43.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
"The Intimin peri-plasmic domain mediates dimerisation and binding to peptidoglycan.Mol Microbiol 2015; 95:80-100; PMID:25353290; http://dx.doi.org/ 10.1111/mmi.12840 44. Pepper LR, Cho YK, Boder ET, Shusta EV.",OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
J Immunol Methods 2004; 284:119-32; PMID:14736422; http://dx.doi.org/10.1016/j.jim.2003.11.001 46.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Nat Biotechnol2001; 19:75-8; PMID:11135557; http://dx.doi.org/10.1038/83567 47.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
J Bacteriol 2005; 187:4531-41;PMID:15968064; http://dx.doi.org/10.1128/JB.187.13.4531-4541.2005 48.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
AntimicrobAgents Chemother 2001; 45:2807-12; PMID:11557473; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Nucleic Acids Res 1991; 19:4133-7; PMID:1908075; http://dx.doi.org/ 10.1093/nar/19.15.4133 50.,Non-OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
J Cell Biol 1992; 117:203-12; PMID:1556153; http://dx.doi.org/10.1083/ jcb.117.1.203 52.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
J Mol Biol 2002; 320:1-10; PMID:12079330; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
Methods Enzymol 2000; 323:325-40; PMID:10944758; http://dx.doi.org/10.1016/S0076- 6879(00)23372-7MABS 1301,OADS,/arxiv_data1/oa_pdf/ab/2f/kmab-08-07-1216742.PMC5058628.pdf
"7, 1195 –1209 http://dx.doi.org/10.1080/19420862.2016.1212147",Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Nat Rev Cancer 2012; 12:278-87; PMID:22437872; http://dx.doi.org/10.1038/nrc3236 2.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Expert Rev Mol Med 2006; 8:1-21; PMID:16984691; http://dx.doi.org/ 10.1017/S146239940600010X 4 .,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Nat Rev Cancer 2009; 9:463-75; PMID:19536107; http://dx.doi.org/10.1038/nrc2656 5.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Nat Rev Cancer 2012; 12:553-63; PMID:22785351;http://dx.doi.org/10.1038/nrc3309 6.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Science (80- ) 2002; 297:1330-3;PMID:12154198; http://dx.doi.org/10.1126/science.1074611 7.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cell 2002; 110:775-87; PMID:12297050; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Mol Cell 2003; 11:507-17; PMID:12620237; http://dx.doi.org/10.1016/S1097-2765(03)00047-9 9.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Mol Cell Biol 1996; 16:5276-87; PMID:8816440; http://dx.do i.org/10.1128/MCB.16.10.5276 12.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
EMBO J 1997; 16:1647-55; PMID:9130710; http://dx.doi.org/10.1093/emboj/16.7.1647 14.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Proceeding Natl Acad Sci United States Am1999; 96:4995-5000; PMID:10220407; http://dx.doi.org/10.1073/ pnas.96.9.4995 15.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Mol Cell 2003;11:495-505; PMID:12620236; http://dx.doi.org/10.1016/S1097-2765(03)00048-0 16.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Biochem J 1997; 322 (Pt 3:757-63; PMID:9148746; http://dx.doi.org/10.1042/bj3220757 18.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Proceeding Natl Acad Sci United States Am 2010; 107:7692-7; PMID:20351256; http://dx.doi.org/ 10.1073/pnas.1002753107 19.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
FEBS Lett 2004; 569:332-6; PMID:15225657; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Clin Cancer Res 2014; 20:4436-41;PMID:24879797; http://dx.doi.org/10.1158/1078-0432.CCR-14-0012 22.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Semin Cell Dev Biol 2010; 21:944-50;PMID:20816829; http://dx.doi.org/10.1016/j.semcdb.2010.08.007 23.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Pharmaco- therapy 2008; 28:31S-41S; PMID:18980550; http://dx.doi.org/10.1592/phco.28.11-supp.31S 24.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer Cell 2011; 20:423-5; PMID:22014569; http://dx.doi.org/10.1016/j.ccr.2011.10.006 2 5 .,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
J Mammary Gland Biol Neoplasia 2008; 13:259-68; PMID:18454307; http://dx.doi.org/10.1007/s10911-008-9079-3 26.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Proceeding Natl Acad Sci United States Am 1989; 86:9193-7; PMID: 2687875; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Br J Cancer 1996; 74:229-33;PMID:8688326; http://dx.doi.org/10.1038/bjc.1996.342 29.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Eur J Cancer1997; 33:1846-50; PMID:9470844; http://dx.doi.org/10.1016/S0959-8049(97)00244-X 30.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Clin Mol Pathol 1996; 49:M199-202;PMID:16696074; http://dx.doi.org/10.1136/mp.49.4.M199 31.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Proceeding Natl Acad Sci United States Am 1991; 88:7792-6; PMID: 1715580; http://dx.doi.org/10.1073/ pnas.88.17.7792 33.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Clin Cancer Res 2008; 14:5188-97; PMID:18698037; http://dx.doi.org/10.1158/1078-0432.CCR-08-0186 34.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Br J Urol 1997; 79:212-6; PMID:9052472;http://dx.doi.org/10.1046/j.1464-410X.1997.30412.x 35.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
"Bi /C18eche I, Onody P, Tozlu S, Driouch K, Vidaud M, Lidereau R. Prog- nostic value of ERBB family mRNA expression in breast carcinomas.Int J Cancer 2003; 106:758-65; PMID:12866037; http://dx.doi.org/10.1002/ijc.11273 36.",OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
J Clin Oncol 2006; 24:4317-23; PMID:16896008; http://dx.doi.org/10.1200/JCO.2005.04.8397 37.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Clin Cancer Res 2012; 18:956-68; PMID:22142822; http://dx.doi.org/10.1158/1078-0432.CCR-11-1186 38.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Mol Cell Biol 1994; 14:3550-8; PMID:7515147; http://dx.doi.org/10.1128/MCB.14.6.3550 39.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Mol Cell Biol 1994; 14:492- 500; PMID:8264617; http://dx.doi.org/10.1128/MCB.14.1.492 41.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Br J Cancer 1998; 78:1385-90;PMID:9823984; http://dx.doi.org/10.1038/bjc.1998.689 43.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
2008; 68:5878-87; PMID:18632642; http://dx.doi.org/10.1158/0008- 5472.CAN-08-0380 44.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Clin Cancer Res 2004;10:6779-88; PMID:15501954; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Int J Cancer 2006; 118:284-9; PMID:16049961; http://dx.doi.org/10.1002/ijc.21358 46.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Sci Signal 2009; 2:ra31; PMID:19567914; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Int J Cancer 2006; 119:2986-7; PMID:16998794; http://dx.doi.org/10.1002/ijc.22257 49.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Nature 2007; 445:437-41; PMID:17206155; http://dx.doi.org/10.1038/nature05474 50.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer Cell 2011; 19:58-71;PMID:21215704; http://dx.doi.org/10.1016/j.ccr.2010.10.031 51.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
PLoS Biol 2010; 8:e1000563; PMID:21203579; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer Cell 2013; 23:603-17; PMID:23680147; http://dx.doi.org/10.1016/j.ccr.2013.04.012 53.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer Cell 2010; 17:298-310; PMID:20227043; http://dx.doi.org/10.1016/j.ccr.2009.12.047 55.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer Cell 2009; 15:429-40; PMID:19411071; http://dx.doi.org/10.1016/ j.ccr.2009.03.020 56.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Clin Cancer Res 2007; 13:4909-19; PMID:17699871; http://dx.doi.org/10.1158/1078-0432.CCR-07-0701 58.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Activa- tion of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab .S c iT r a n s lM e d2 0 1 1 ;3 : 9 9 r a 8 6 ; PMID:21900593; http://dx.doi.org/10.1126/scitranslmed.3002442 59.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Mol Oncol 2012; 6:516-29; PMID:22841590; http://dx.doi.org/10.1016/j.molonc.2012.07.001 60.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Oncogene 2010; 29:4225-36;PMID:20498641; http://dx.doi.org/10.1038/onc.2010.180 61.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Int J Cancer 2007; 120:1874-82;PMID:17266042; http://dx.doi.org/10.1002/ijc.22423 62.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Clin Cancer Res 2009;15:5445-56; PMID:19706799; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Immunol Endocr MetabAgents Med Chem 2011; 11:131-49; PMID:21603064; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Clin Cancer Res 2013; 19:3078-87; PMID:23591447; http://dx.doi.org/10.1158/1078- 0432.CCR-12-3051 67.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
2010; Available from: http://cancerres.aacrjournals.org/cgi/content/ meeting_abstract/70/8_MeetingAbstracts/LB-306 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
CancerRes 2010; 70:2485-94; PMID:20215504; http://dx.doi.org/10.1158/ 0008-5472.CAN-09-3145 71.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
[cited 2016 Apr 7]; Available from: http://investors.merrimack.com/release detail.cfm?releaseid D809634 73.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer Res 2013; 73:6024-35; PMID:23928993;http://dx.doi.org/10.1158/0008-5472.CAN-13-1198 75.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
CancerRes 2013; 73:5183-94; PMID:23780344; http://dx.doi.org/10.1158/ 0008-5472.CAN-13-0099 76.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Clin Cancer Res 2016; 22(4):877-85; PMID:26463709; http://dx.doi.org/ 10.1158/1078-0432.ccr-15-1683 78.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Eur J Cancer 2012; 48:126; http://dx.doi.org/10.1016/S0959-8049(12)72212-8 79.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Mol Cancer Ther 2016; 1535 –7163.MCT –15–0555 15 (2):689-701; http://dx.doi.org/10.1158/1535-7163.mct-15-0555 81.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer Cell 2004; 6:117-27;PMID:15324695; http://dx.doi.org/10.1016/j.ccr.2004.06.022 82.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
J Cell Physiol 2012; 227:3381-8; PMID:22213458; http://dx.doi.org/10.1002/jcp.24037 83.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Oncotarget 2012; 3:744-58; PMID:22889873; http://dx.doi.org/ 10.18632/oncotarget.550 84.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cell Cycle 2012;11:1455-67; PMID:22421160; http://dx.doi.org/10.4161/cc.19861 85.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Oncogene 2012; 31:1275-86; PMID:21822299; http://dx.doi.org/10.1038/onc.2011.322 86.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Transl Oncol 2013; 6:676-84; PMID:24466370; http://dx.doi.org/10.1593/tlo.13475 87.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Neoplasia 2013; 15:335-47; PMID:23479511; http://dx.doi.org/10.1593/neo.121960 88.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Mol Cancer Ther 2012; 11:1411-20; PMID:22553357; http://dx.doi.org/10.1158/ 1535-7163.MCT-12-0068 89.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
MAbs 8:197-204; PMID:26651519; http://dx.doi.org/10.1080/19420862.2015.1125583 90.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
243-272; http://dx.doi.org/10.1017/CBO9780511596773.021 91.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
89-116; http://dx.doi.org/ 10.1007/978-1-4020-8696-0_6 92.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer 2007; 109:170-9; PMID:17154393; http://dx.doi.org/10.1002/cncr.22402 93.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
1-26; http://dx.doi.org/10.1007/978-1-61779-921-1_1 94.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Nat Rev Immunol 2010; 10:345-52; PMID:20414207; http://dx.doi.org/10.1038/nri2747 95.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
MAbs 2010; 2:77- 83; PMID:20093855; http://dx.doi.org/10.4161/mabs.2.1.10786 96.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Nat Biotechnol 2005; 23:1126-36; PMID:16151406; http://dx.doi.org/10.1038/nbt1142 97.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
[cited 2016 May 9]; Available from: http://tabs.craic.com/antibodies/1680 98.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Annu Rev Biochem 2013; 82:775-97; PMID:23495938; http://dx.doi.org/10.1146/annurev-biochem-063011-092449 99.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Nature 1985; 314:628-31; PMID:2859527;http://dx.doi.org/10.1038/314628a0 100.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Clin Cancer Res 2015; 21:4035-9;PMID:26374073; http://dx.doi.or g/10.1158/1078-0432.CCR-15-0612 102.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Nat Rev Drug Discov 2011; 10:798-800; PMID:22037028; http://dx.doi.org/10.1038/nrd3581 103.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
MAbs 2012; 4:182-97; PMID:22453100; http://dx.doi.org/10.4161/ mabs.4.2.19000 104.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
J Clin Oncol 2006; 24:823-34; PMID:16380412; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
MAbs 2012; 4:653-63; PMID:22925968;http://dx.doi.org/10.4161/mabs.21379 106.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Protein Eng Des Sel 1996; 9:617-21; PMID:8844834; http://dx.doi.org/10.1093/protein/9.7.617 107.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Biotechnol Appl Biochem 2009; 54:121-31; PMID:19492986; http://dx.doi.org/10.1042/BA20090096 110.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
J Mol Biol 2009; 393:598-607; PMID:19683003;http://dx.doi.org/10.1016/j.jmb.2009.08.014 111.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
J Biol Chem 2011; 286:41273-85; PMID:21979953; http://dx.doi.org/10.1074/jbc.M111.293266 112.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Structure 2013; 21:1979-91; PMID:24095059; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
MAbs 2011; 3:38-48;PMID:21099371; http://dx.doi.org/10.4161/mabs.3.1.14168 114.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
PLoS One 2013; 8:e61432; PMID:23630589; http://dx.doi.org/ 10.1371/journal.pone.0061432 115.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer Cell 2011; 20:472-86; PMID:22014573; http://dx.doi.org/10.1016/j.ccr.2011.09.003 116.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer Res 2013; 73:824-33; PMID:23172311; http://dx.doi.org/10.1158/0008-5472.CAN-12-1611117.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Mol Cancer Ther 2012; 11:582-93; PMID:22248472; http://dx.doi.org/10.1158/ 1535-7163.MCT-11-0820 118.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Mol Cancer Ther2014; 13:410-25; PMID:24282274; http://dx.doi.org/10.1158/1535- 7163.MCT-13-0255 119.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Br J Cancer 2008; 99:1415-25; PMID:18841159; http://dx.doi.org/10.1038/sj.bjc.6604700 120.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
[cited 2016 Apr 12]; Available from: http://www.proteinat las.org/ENSG00000065361-ERBB3/tissue 121.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
MAbs 5:237-54; PMID:23392215; http://dx.doi.org/10.4161/mabs.23363 126.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
MAbs 2014; 6:340-53;PMID:24492289; http://dx.doi.org/10.4161/mabs.27658 127.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Int J Cancer 2015;137:267-77; PMID:25471734; http://dx.doi.org/10.1002/ijc.29378 128.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
PLoS One 2015; 10:e0124135;PMID:25997020; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Cancer Res 2015; 75:159-70; PMID:25371409; http://dx.doi.org/10.1158/0008-5472.CAN-14-1670 130.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Science 2009; 323:1610-4; PMID:19299620; http://dx.doi.org/ 10.1126/science.1165480 131.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Curr Opin Biotechnol 2011; 22:843-8; PMID:21726995; http://dx.doi.org/10.1016/j.copbio.2011.06.002 132.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Trends Biotechnol 2012; 30:575-82; PMID:22944617; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
BioDrugs 2015; 29:215-39; PMID:26177629; http://dx.doi.org/10.1007/s40259-015-0133-6 135.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
"Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA; 2012. page 269- 83; http://dx.doi.org/10.1002/9783527644827.ch14 136.",Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Protein Eng Des Sel 2011; 24:385-96; PMID:21177282; http://dx.doi.org/10.1093/ protein/gzq118 138.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
PLoS One 2012; 7:e40023; PMID:22768204; http://dx.doi.org/ 10.1371/journal.pone.0040023 139.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
PLoS One 2013; 8:e62791; PMID:23675426; http://dx.doi.org/10.1371/journal.pone.0062791 140.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Eur J Nucl Med Mol Imaging 2014;41(7):1450-9; PMID:24622956; http://dx.doi.org/10.1007/s00259- 014-2733-7 141.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Oncol Rep 2015;34:1042-8; PMID:26059265; http://dx.doi.org/10.3892/or.2015.4046 142.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Sci Rep 2015; 5:15226; PMID:26477646;http://dx.doi.org/10.1038/srep15226 143.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
MAbs 2013; 5:208-18; PMID:23575268; http://dx.doi.org/ 10.4161/mabs.23043 144.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
Biotechnol J 2014; 9:1215-22; PMID:24678002; http://dx.doi.org/10.1002/biot.201400009 145.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
J Nucl Med 2012; 53:1943-50; PMID:23096164; http://dx.doi.org/ 10.2967/jnumed.112.106906 146.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
[cited 2016 Apr 12]; Available from: https://clinicaltrials.gov/ct2/show/ NCT02345174?term Derbb3&rank D3 147.,OADS,/arxiv_data1/oa_pdf/b4/b0/kmab-08-07-1212147.PMC5058629.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
"7, 1210 –1223 http://dx.doi.org/10.1080/19420862.2016.1204502",Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Nat Rev Cancer 2007; 7 (9):701 –706; PMID:17721434; http://dx.doi.org/10.1038/nrc2209 2.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Curr Opin Pharmacol 2005; 5(5):543 –549; PMID:16087399; http://dx.doi.org/10.1016/j.coph.2005.04.017 3 .,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Cancer Research 2008; 68 (22):9280 –9290; PMID:19010901; http://dx.doi.org/10.1158/0008- 5472.CAN-08-1776 4.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Blood 2003; 102(4):1458 – 1465; PMID:12714494; http://dx.doi.org/10.1182/blood-2003-01-0039 5.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
mAbs 2014; 6(1):15 –17; PMID:24423577; http://dx.doi.org/10.4161/ mabs.27436 7.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Bioconjugate Chemistry 2014; 25(7):1223 –1232; PMID:24873191; http://dx.doi.org/10.1021/bc5000109 8.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Protein Sci 2005; 14(9):2436 –2446; PMID:16081651; http://dx.doi.org/10.1110/ ps.051478705 9.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
mAbs2011; 3(2):161 –172; PMID:21441786; http://dx.doi.org/10.4161/ mabs.3.2.14960 10.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
J Mass Spectrom 2015; 50(2):285 –297; PMID:25800010; http://dx.doi.org/ 10.1002/jms.3554 11.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Expert Rev Proteomics 2016; 13(2):157 –183; PMID:26653789; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Mass Spectrom Rev 2016; PMID:27097288; http://dx.doi.org/10.1002/mas.21500 13.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Drug Discov Today 2016; 21(5):850 –5; PMID:27080148; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Analytical Chem 2012; 84(17):7479 –7486; PMID:22913809; http://dx.doi.org/10.1021/ac301568f 1 5 .,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
MAbs 2015; 7(6):1036 –1044; PMID:26305867; http://dx.doi.org/10.1080/19420862.2015.1083665 16.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Mol Pharm 2015; 12(6):1738 – 1744; PMID:25635630; http://dx.doi.org/10.1021/mp500753617.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Protein Sci 2015; 24(8):1210 –1223; PMID:25694334; http://dx.doi.org/10.1002/pro.2666 18.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
J Am Soc Mass Spectrom 2015; 26(10):1791 –4; PMID:26122520; http://dx.doi.org/10.1007/s13361-015-1203-1 19.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
MAbs 2015; 8(2):306 –17; PMID:26651262; http://dx.doi.org/10.1080/ 19420862.2015.1116659 21.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
mAbs 2014; 6(5):1163 –1177; PMID:25517302; http://dx.doi.org/ 10.4161/mabs.32221 22.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Chem Biol 2013; 20(2):161 –167; PMID:23438745; http://dx.doi.org/10.1016/j.chembiol.2013.01.010 23.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Bioconjug Chem 2010; 21(9):1588 –1595; PMID:20698491; http://dx.doi.org/10.1021/bc900434c 24.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Rapid Commu- nications in Mass Spectrometry 2005; 19(13):1806 –1814; PMID:15945030; http://dx.doi.org/10.1002/rcm.1987 26.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
J Pharm Biomed Anal 2016; 120:322 –332; PMID:26771131; http://dx.doi.org/ 10.1016/j.jpba.2015.12.026 27.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
MAbs 2010; 2(4):379 –394; PMID:20458189; http://dx.doi.org/10.4161/mabs.11986 28.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
J Med Chem 2010; 53(2):586 –594; PMID:19958000; http://dx.doi.org/10.1021/jm900899g 29.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Clin Cancer Res 2004; 10(20):7063 –7070; PMID:15501986; http://dx.doi.org/10.1158/1078-0432.CCR-04-0789 32.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Bioconjug Chem 2013; 24(6):1008 –1016; PMID:23777335; http://dx.doi.org/10.1021/bc4000564 33.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Analytical Chem 2009; 81(20):8354 – 8364; PMID:19764700; http://dx.doi.org/10.1021/ac901193n 34.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
MAbs 2014; 6(2):327 –339; PMID:24441081; http://dx.doi.org/10.4161/mabs.27876 36.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
J Pharm Bioallied Sci 2011; 3(1):39 –59; PMID:21430954; http://dx.doi.org/10.4103/0975-7406.7646337.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Pharm Sci Technolo Today 1999; 2(8):311 –320; PMID:10441275; http://dx.doi.org/10.1016/S1461-5347 (99)00181-9 38.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Proteins 2007; 66(4):954 –962; PMID:17154421; http://dx.doi.org/10.1002/prot.21243 39.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
Pharm Res 1997; 14(5):591 –595; PMID:9165528; http://dx.doi.org/10.1023/A:1012144810067 40.,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
ImmunolLett 2006; 106(2):144 –153; PMID:16831470; http://dx.doi.org/ 10.1016/j.imlet.2006.05.011 41.,OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
AAPS J 2014; 16 (5):994 –1008; PMID:24917179; http://dx.doi.org/10.1208/s12248- 014-9618-3MABS 1223,Non-OADS,/arxiv_data1/oa_pdf/a8/f3/kmab-08-07-1204502.PMC5058630.pdf
"7, 1276 –1285 http://dx.doi.org/10.1080/19420862.2016.1214785",Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
mAbs 2015; 7:9-14; PMID:25529996; http://dx.doi.org/ 10.4161/19420862.2015.989042 2.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Biochim Biophys Acta 2014; 1844:2024-31; PMID:24931831; http://dx.doi.org/10.1016/j.bbapap.2014.06.004 4.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Biophys J 2000;78:394-404; PMID:10620303; http://dx.doi.org/10.1016/S0006-3495(00)76602-1 5.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Biochem Biophys Res Commun2007; 355:751-7; PMID:17321501; http://dx.doi.org/10.1016/j.bbrc.2007.02.042 6.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
J Pharm Sci 2007; 96:532-46; PMID:17083094; http://dx.doi.org/10.1002/jps.20753 7.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
JMol Biol 2005; 347:773-89; PMID:15769469; http://dx.doi.org/ 10.1016/j.jmb.2005.01.053 9.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Biochemistry 1989; 28:8588-96; PMID:2690944; http://dx.doi.org/ 10.1021/bi00447a048 10.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Protein Eng Des Sel 2006; 19:325-36; http://dx.doi.org/10.1093/protein/gzl016 11.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
mAbs 2009; 1:128-41; PMID:20061822; http://dx.doi.org/10.4161/mabs.1.2.7631 12.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Dev Comp Immunol 1990; 14:1-8; PMID:2338149; http://dx.doi.org/ 10.1016/0145-305X(90)90002-V 14.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Cancer Cell 2004; 5:317-28; PMID:15093539; http://dx.doi.org/10.1016/S1535-6108(04)00083-2 15.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Science 2011; 334:1097-103; PMID:21998254; http://dx.doi.org/10.1126/science.121325616.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
J Virol 2012; 86:10857-61; PMID:22837204; http://dx.doi.org/ 10.1128/JVI.01414-12 17.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
mAbs 2015; 7:364-76; PMID:25611120; http://dx.doi.org/10.1080/19420862.2015.1007826 18.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Mol Cell 2009;34:569-79; PMID:19524537; http://dx.doi.org/10.1016/j.molcel.2009.04.028 20.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Trends Biotechnol 2003; 21:484-90; PMID:14573361; http://dx.doi.org/10.1016/j.tibtech.2003.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
J Immunol 2011; 187:2453- 63; http://dx.doi.org/10.4049/jimmunol.1101268 22.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
J Exp Med 2005; 201:1243-55; PMID:15837811; http://dx.doi.org/10.1084/ jem.20042323 23.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Biopolymers 1991; 31:119-28; PMID:2025683; http://dx.doi.org/10.1002/bip.360310111 24.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
J Biol Chem 2004; 279:14338-46; PMID: 14722079; http://dx.doi.org/10.1074/jbc.M314011200 26.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Cell Death Differ 2012; 19:1187-95; PMID:22261618; http://dx.doi.org/10.1038/cdd.2011.208 27.,Non-OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Acta Crys- tallogr D Biol Crystallogr 2014; 70:708-19; http://dx.doi.org/10.1107/ S1399004713032446 28.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Nat Biotechnol 2014; 32:191-8; PMID:24463572; http://dx.doi.org/10.1038/nbt.2797 29.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Protein Eng Des Sel 2010; 23:549-57; http://dx.doi.org/ 10.1093/protein/gzq028 30.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
Protein Sci 1995; 4:2138-48; PMID:8535251; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/91/kmab-08-07-1214785.PMC5058631.pdf
